Terminology

CodeSystem:ACMECholCodesBlood

This is an example code system that includes all the ACME codes for serum/plasma cholesterol from v2.36.
CodeDisplayDefinition
chol-mmolSChol (mmol/L)Serum Cholesterol, in mmol/L
chol-massSChol (mg/L)Serum Cholesterol, in mg/L
cholSCholSerum Cholesterol

CodeSystem:NHIN PurposeOfUse

This value set is suitable for use with the provenance resource. It is derived from, but not compatible with, the HL7 v3 Purpose of use Code system.
CodeDisplayDefinition
TREATMENTTreatmentTreatment
PAYMENTPaymentPayment
OPERATIONSOperationsHealthcare Operations
SYSADMINSysadminSystem Administration
FRAUDFraudFraud detection
PSYCHOTHERAPYPsychotherapyUse or disclosure of Psychotherapy Notes
TRAININGTrainingUse or disclosure by the covered entity for its own training programs
LEGALLegalUse or disclosure by the covered entity to defend itself in a legal action
MARKETINGMarketingMarketing
DIRECTORYDirectoryUse and disclosure for facility directories
FAMILYFamilyDisclose to a family member, other relative, or a close personal friend of the individual
PRESENTPresentUses and disclosures with the individual present.
EMERGENCYEmergencyPermission cannot practicably be provided because of the individual's incapacity or an emergency.
DISASTERDisasterUse and disclosures for disaster relief purposes.
PUBLICHEALTHPublic HealthUses and disclosures for public health activities.
ABUSEAbuseDisclosures about victims of abuse, neglect or domestic violence.
OVERSIGHTOversightUses and disclosures for health oversight activities.
JUDICIALJudicialDisclosures for judicial and administrative proceedings.
LAWLaw EnforcementDisclosures for law enforcement purposes.
DECEASEDDeceasedUses and disclosures about decedents.
DONATIONDonationUses and disclosures for cadaveric organ, eye or tissue donation purposes
RESEARCHResearchUses and disclosures for research purposes.
THREATThreatUses and disclosures to avert a serious threat to health or safety.
GOVERNMENTGovernmentUses and disclosures for specialized government functions.
WORKERSCOMPWorker's CompDisclosures for workers' compensation.
COVERAGECoverageDisclosures for insurance or disability coverage determination
REQUESTRequestRequest of the Individual

CodeSystem:CholCodeLegacyStatus

undefined
CodeDisplayDefinition
chol-mmolundefinedundefined
chol-massundefinedundefined
cholundefinedundefined

CodeSystem:PayeeResourceType

The type of payee Resource.
CodeDisplayDefinition
organizationOrganizationOrganization resource.
patientPatientPatient resource.
practitionerPractitionerPractitioner resource.
relatedpersonRelatedPersonRelatedPerson resource.

CodeSystem:CoverageSelfPayCodes

This value set includes Coverage SelfPay codes.
CodeDisplayDefinition
payPayAn individual or organization is paying directly for goods and services.

CodeSystem:MatchGrade

A Master Patient Index (MPI) assessment of whether a candidate patient record is a match or not.
CodeDisplayDefinition
certainCertain MatchThis record meets the matching criteria to be automatically considered as a full match.
probableProbable MatchThis record is a close match, but not a certain match. Additional review (e.g. by a human) may be required before using this as a match.
possiblePossible MatchThis record may be a matching one. Additional review (e.g. by a human) SHOULD be performed before using this as a match.
certainly-notCertainly Not a MatchThis record is known not to be a match. Note that usually non-matching records are not returned, but in some cases records previously or likely considered as a match may specifically be negated by the matching engine.

CodeSystem:FinancialTaskCodes

This value set includes Financial Task codes.
CodeDisplayDefinition
cancelCancelCancel or reverse a resource, such as a claim or preauthorization, which is in-process or complete.
pollPollRetrieve selected or all queued resources or messages.
releaseReleaseRelease any reserved funds or material obligations associated with a resource. For example, any unused but reserved funds or treatment allowance associated with a preauthorization once treatment is complete.
reprocessReprocessIndication that the processing of a resource, such as a claim, for some or all of the required work is now being requested.
statusStatus checkCheck on the processing status of a resource such as the adjudication of a claim.

CodeSystem:QuestionnaireItemOperator

The criteria by which a question is enabled.
CodeDisplayDefinition
existsExistsTrue if whether an answer exists is equal to the enableWhen answer (which must be a boolean).
=EqualsTrue if whether at least one answer has a value that is equal to the enableWhen answer.
!=Not EqualsTrue if whether at least no answer has a value that is equal to the enableWhen answer.
>Greater ThanTrue if whether at least no answer has a value that is greater than the enableWhen answer.
<Less ThanTrue if whether at least no answer has a value that is less than the enableWhen answer.
>=Greater or EqualsTrue if whether at least no answer has a value that is greater or equal to the enableWhen answer.
<=Less or EqualsTrue if whether at least no answer has a value that is less or equal to the enableWhen answer.

CodeSystem:AlternativeCodeKind

Indicates the type of use for which the code is defined.
CodeDisplayDefinition
alternateAlternate CodeThe code is an alternative code that can be used in any of the circumstances that the primary code can be used.
deprecatedDeprecatedThe code should no longer be used, but was used in the past.
case-insensitiveCase InsensitiveThe code is an alternative to be used when a case insensitive code is required (when the primary codes are case sensitive).
case-sensitiveCase SensitiveThe code is an alternative to be used when a case sensitive code is required (when the primary codes are case insensitive).
expressionExpressionThe code is an alternative for the primary code that is built using the expression grammar defined by the code system.

CodeSystem:AllergyIntoleranceCertainty

Statement about the degree of clinical certainty that a specific substance was the cause of the manifestation in a reaction event.
CodeDisplayDefinition
unlikelyUnlikelyThere is a low level of clinical certainty that the reaction was caused by the identified substance.
likelyLikelyThere is a high level of clinical certainty that the reaction was caused by the identified substance.
confirmedConfirmedThere is a very high level of clinical certainty that the reaction was due to the identified substance, which may include clinical evidence by testing or rechallenge.
unknownUnknownThe clinical certainty that the reaction was caused by the identified substance is unknown. It is an explicit assertion that certainty is not known.

CodeSystem:ReferenceVersionRules

Whether a reference needs to be version specific or version independent, or whether either can be used.
CodeDisplayDefinition
eitherEither Specific or independentThe reference may be either version independent or version specific.
independentVersion independentThe reference must be version independent.
specificVersion SpecificThe reference must be version specific.

CodeSystem:StructureMapContextType

How to interpret the context.
CodeDisplayDefinition
typeTypeThe context specifies a type.
variableVariableThe context specifies a variable.

CodeSystem:ConceptSubsumptionOutcome

The subsumption relationship between code/Coding "A" and code/Coding "B". There are 4 possible codes to be returned: equivalent, subsumes, subsumed-by, and not-subsumed. If the server is unable to determine the relationship between the codes/Codings, then it returns an error (i.e. an OperationOutcome).
CodeDisplayDefinition
equivalentEquivalentThe two concepts are equivalent (have the same properties).
subsumesSubsumesCoding/code "A" subsumes Coding/code "B" (e.g. B has all the properties A has, and some of it's own).
subsumed-bySubsumed-ByCoding/code "A" is subsumed by Coding/code "B" (e.g. A has all the properties B has, and some of it's own).
not-subsumedNot-SubsumedCoding/code "A" and Coding/code "B" are disjoint (e.g. each has propeties that the other doesn't have).

CodeSystem:ClaimPayeeResourceType

The type of Claim payee Resource.
CodeDisplayDefinition
organizationOrganizationOrganization resource.
patientPatientPatient resource.
practitionerPractitionerPractitioner resource.
relatedpersonRelatedPersonRelatedPerson resource.

CodeSystem:HumanNameAssemblyOrder

A code that represents the preferred display order of the components of a human name.
CodeDisplayDefinition
NL1Own Nameundefined
NL2Partner Nameundefined
NL3Partner Name followed by Maiden Nameundefined
NL4Own Name followed by Partner Nameundefined

CodeSystem:TransactionMode

A code that indicates how transactions are supported.
CodeDisplayDefinition
not-supportedNoneNeither batch or transaction is supported.
batchBatches supportedBatches are supported.
transactionTransactions SupportedTransactions are supported.
bothBatches & TransactionsBoth batches and transactions are supported.

CodeSystem:InterventionCodes

This value set includes sample Intervention codes.
CodeDisplayDefinition
unknownUnknownUnknown
otherOtherOther

CodeSystem:StandardsStatus

HL7 Ballot/Standards status of artifact.
CodeDisplayDefinition
draftDraftThis portion of the specification is not considered to be complete enough or sufficiently reviewed to be safe for implementation. It may have known issues or still be in the "in development" stage. It is included in the publication as a place-holder, to solicit feedback from the implementation community and/or to give implementers some insight as to functionality likely to be included in future versions of the specification. Content at this level should only be implemented by the brave or desperate and is very much "use at your own risk". The content that is Draft that will usually be elevated to Trial Use once review and correction is complete after it has been subjected to ballot.
normativeNormativeThis content has been subject to review and production implementation in a wide variety of environments. The content is considered to be stable and has been 'locked', subjecting it to FHIR Inter-version Compatibility Rules. While changes are possible, they are expected to be infrequent and are tightly constrained. Compatibility Rules.
trial-useTrial-UseThis content has been well reviewed and is considered by the authors to be ready for use in production systems. It has been subjected to ballot and approved as an official standard. However, it has not yet seen widespread use in production across the full spectrum of environments it is intended to be used in. In some cases, there may be documented known issues that require implementation experience to determine appropriate resolutions for. Future versions of FHIR may make significant changes to Trial Use content that are not compatible with previously published content.
informativeInformativeThis portion of the specification is provided for implementer assistance, and does not make rules that implementers are required to follow. Typical examples of this content in the FHIR specification are tables of contents, registries, examples, and implementer advice.
deprecatedDeprecatedThis portion of the specification is provided for implementer assistance, and does not make rules that implementers are required to follow. Typical examples of this content in the FHIR specification are tables of contents, registries, examples, and implementer advice.
externalExternalThis is content that is managed outside the FHIR Specification, but included for implementer convenience.

CodeSystem:RestfulCapabilityMode

The mode of a RESTful capability statement.
CodeDisplayDefinition
clientClientThe application acts as a client for this resource.
serverServerThe application acts as a server for this resource.

CodeSystem:OralProsthoMaterialTypeCodes

This value set includes sample Oral Prosthodontic Material type codes.
CodeDisplayDefinition
1Fixed BridgeFixed Bridge
2Maryland BridgeMaryland Bridge
3Denture AcrylicDenture Acrylic
4Denture Chrome CobaltDenture Chrome Cobalt

CodeSystem:GraphCompartmentUse

Defines how a compartment rule is used.
CodeDisplayDefinition
conditionConditionThis compartment rule is a condition for whether the rule applies.
requirementRequirementThis compartment rule is enforced on any relationships that meet the conditions.

CodeSystem:DeviceDefinitionParameterGroup

Codes identifying groupings of parameters; e.g. Cardiovascular.
CodeDisplayDefinition
haemodynamicHaemodynamic Parameter GroupHaemodynamic Parameter Group - MDC_PGRP_HEMO.
ecgECG Parameter GroupECG Parameter Group - MDC_PGRP_ECG.
respiratoryRespiratory Parameter GroupRespiratory Parameter Group - MDC_PGRP_RESP.
ventilationVentilation Parameter GroupVentilation Parameter Group - MDC_PGRP_VENT.
neurologicalNeurological Parameter GroupNeurological Parameter Group - MDC_PGRP_NEURO.
drug-deliveryDrug Delivery Parameter GroupDrug Delivery Parameter Group - MDC_PGRP_DRUG.
fluid-chemistryFluid Chemistry Parameter GroupFluid Chemistry Parameter Group - MDC_PGRP_FLUID.
blood-chemistryBlood Chemistry Parameter GroupBlood Chemistry Parameter Group - MDC_PGRP_BLOOD_CHEM.
miscellaneousMiscellaneous Parameter GroupMiscellaneous Parameter Group - MDC_PGRP_MISC.

CodeSystem:CopyNumberEvent

Copy Number Event.
CodeDisplayDefinition
ampamplificationamplification.
deldeletiondeletion.
lofloss of functionloss of function.

CodeSystem:OperationOutcomeCodes

Operation Outcome codes used by FHIR test servers (see Implementation file translations.xml)
CodeDisplayDefinition
DELETE_MULTIPLE_MATCHESError: Multiple matches exist for the conditional deleteundefined
MSG_AUTH_REQUIREDYou must authenticate before you can use this serviceundefined
MSG_BAD_FORMATBad Syntax: "%s" must be a %s'undefined
MSG_BAD_SYNTAXBad Syntax in %sundefined
MSG_CANT_PARSE_CONTENTUnable to parse feed (entry content type = "%s")undefined
MSG_CANT_PARSE_ROOTUnable to parse feed (root element name = "%s")undefined
MSG_CREATEDNew resource createdundefined
MSG_DATE_FORMATThe Date value %s is not in the correct format (Xml Date Format required)undefined
MSG_DELETEDThis resource has been deletedundefined
MSG_DELETED_DONEResource deletedundefined
MSG_DELETED_IDThe resource "%s" has been deletedundefined
MSG_DUPLICATE_IDDuplicate Id %s for resource type %sundefined
MSG_ERROR_PARSINGError parsing resource Xml (%s)undefined
MSG_ID_INVALIDId "%s" has an invalid character "%s"undefined
MSG_ID_TOO_LONGId "%s" too long (length limit 36)undefined
MSG_INVALID_IDId not acceptedundefined
MSG_JSON_OBJECTJson Source for a resource should start with an objectundefined
MSG_LOCAL_FAILUnable to resolve local reference to resource %sundefined
MSG_NO_EXISTResource Id "%s" does not existundefined
MSG_NO_MATCHNo Resource found matching the query "%s"undefined
MSG_NO_MODULENo module could be found to handle the request "%s"undefined
MSG_NO_SUMMARYNo Summary for this resourceundefined
MSG_OP_NOT_ALLOWEDOperation %s not allowed for resource %s (due to local configuration)undefined
MSG_PARAM_CHAINEDUnknown chained parameter name "%s"undefined
MSG_PARAM_INVALIDParameter "%s" content is invalidundefined
MSG_PARAM_MODIFIER_INVALIDParameter "%s" modifier is invalidundefined
MSG_PARAM_NO_REPEATParameter "%s" is not allowed to repeatundefined
MSG_PARAM_UNKNOWNParameter "%s" not understoodundefined
MSG_RESOURCE_EXAMPLE_PROTECTEDResources with identity "example" cannot be deleted (for testing/training purposes)undefined
MSG_RESOURCE_ID_FAILunable to allocate resource idundefined
MSG_RESOURCE_ID_MISMATCHResource Id Mismatchundefined
MSG_RESOURCE_ID_MISSINGResource Id Missingundefined
MSG_RESOURCE_NOT_ALLOWEDNot allowed to submit a resource for this operationundefined
MSG_RESOURCE_REQUIREDA resource is requiredundefined
MSG_RESOURCE_TYPE_MISMATCHResource Type Mismatchundefined
MSG_SORT_UNKNOWNUnknown sort parameter name "%s"undefined
MSG_TRANSACTION_DUPLICATE_IDDuplicate Identifier in transaction: %sundefined
MSG_TRANSACTION_MISSING_IDMissing Identifier in transaction - an entry.id must be providedundefined
MSG_UNHANDLED_NODE_TYPEUnhandled xml node type "%s"undefined
MSG_UNKNOWN_CONTENTUnknown Content (%s) at %sundefined
MSG_UNKNOWN_OPERATIONunknown FHIR http operationundefined
MSG_UNKNOWN_TYPEResource Type "%s" not recognisedundefined
MSG_UPDATEDexisting resource updatedundefined
MSG_VERSION_AWAREVersion aware updates are required for this resourceundefined
MSG_VERSION_AWARE_CONFLICTUpdate Conflict (server current version = "%s", client version referenced = "%s")undefined
MSG_VERSION_AWARE_URLVersion specific URL not recognisedundefined
MSG_WRONG_NSThis does not appear to be a FHIR element or resource (wrong namespace "%s")undefined
SEARCH_MULTIPLEError: Multiple matches exist for %s search parameters "%s"undefined
SEARCH_NONEError: no processable search found for %s search parameters "%s"undefined
UPDATE_MULTIPLE_MATCHESError: Multiple matches exist for the conditional updateundefined

CodeSystem:TestScriptProfileOriginType

This value set defines a set of codes that are used to indicate the profile type of a test system when acting as the origin within a TestScript.
CodeDisplayDefinition
FHIR-ClientFHIR ClientGeneral FHIR client used to initiate operations against a FHIR server.
FHIR-SDC-FormFillerFHIR SDC FormFillerA FHIR client acting as a Structured Data Capture Form Filler.

CodeSystem:SubscriptionTag

Tags to put on a resource after subscriptions have been sent.
CodeDisplayDefinition
queuedQueuedThe message has been queued for processing on a destination systems.
deliveredDeliveredThe message has been delivered to its intended recipient.

CodeSystem:QuestionnaireItemUsageMode

Identifies the modes of usage of a questionnaire that should enable a particular questionnaire item.
CodeDisplayDefinition
capture-displayCapture & DisplayRender the item regardless of usage mode.
captureCapture OnlyRender the item only when capturing data.
displayDisplay OnlyRender the item only when displaying a completed form.
display-non-emptyDisplay when AnsweredRender the item only when displaying a completed form and the item has been answered (or has child items that have been answered).
capture-display-non-emptyCapture or, if answered, DisplayRender the item when capturing data or when displaying a completed form and the item has been answered (or has child items that have been answered).

CodeSystem:TestReportStatus

The current status of the test report.
CodeDisplayDefinition
completedCompletedAll test operations have completed.
in-progressIn ProgressA test operations is currently executing.
waitingWaitingA test operation is waiting for an external client request.
stoppedStoppedThe test script execution was manually stopped.
entered-in-errorEntered In ErrorThis test report was entered or created in error.

CodeSystem:ResourceVersionPolicy

How the system supports versioning for a resource.
CodeDisplayDefinition
no-versionNo VersionId SupportVersionId meta-property is not supported (server) or used (client).
versionedVersionedVersionId meta-property is supported (server) or used (client).
versioned-updateVersionId tracked fullyVersionId must be correct for updates (server) or will be specified (If-match header) for updates (client).

CodeSystem:GenderStatus

This example value set defines a set of codes that can be used to indicate the current state of the animal's reproductive organs.
CodeDisplayDefinition
neuteredNeuteredThe animal has been sterilized, castrated or otherwise made infertile.
intactIntactThe animal's reproductive organs are intact.
unknownUnknownUnable to determine whether the animal has been neutered.

CodeSystem:ExampleServiceModifierCodes

This value set includes sample Service Modifier codes which may support differential payment.
CodeDisplayDefinition
srSide of the RoadServices provided on the side of the road or such other non-conventional setting.
ahAfter hoursServices provided outside or normal business hours.

CodeSystem:ConditionState

Enumeration indicating whether the condition is currently active, inactive, or has been resolved.
CodeDisplayDefinition
activeActiveThe condition is active.
inactiveInactiveThe condition is inactive, but not resolved.
resolvedResolvedThe condition is resolved.

CodeSystem:CommonTags

Common Tag Codes defined by FHIR project
CodeDisplayDefinition
actionableActionableThis request is intended to be acted upon, not merely stored

CodeSystem:MaxOccurs

Flags an element as having unlimited repetitions.
CodeDisplayDefinition
*RepeatingElement can repeat an unlimited number of times.

CodeSystem:SPDXLicense

The license that applies to an Implementation Guide (using an SPDX license Identifiers, or 'not-open-source'). The binding is required but new SPDX license Identifiers are allowed to be used (https://spdx.org/licenses/).
CodeDisplayDefinition
not-open-sourceNot open sourceNot an open source license.
0BSDBSD Zero Clause LicenseBSD Zero Clause License.
AALAttribution Assurance LicenseAttribution Assurance License.
AbstylesAbstyles LicenseAbstyles License.
Adobe-2006Adobe Systems Incorporated Source Code License AgreementAdobe Systems Incorporated Source Code License Agreement.
Adobe-GlyphAdobe Glyph List LicenseAdobe Glyph List License.
ADSLAmazon Digital Services LicenseAmazon Digital Services License.
AFL-1.1Academic Free License v1.1Academic Free License v1.1.
AFL-1.2Academic Free License v1.2Academic Free License v1.2.
AFL-2.0Academic Free License v2.0Academic Free License v2.0.
AFL-2.1Academic Free License v2.1Academic Free License v2.1.
AFL-3.0Academic Free License v3.0Academic Free License v3.0.
AfmparseAfmparse LicenseAfmparse License.
AGPL-1.0-onlyAffero General Public License v1.0 onlyAffero General Public License v1.0 only.
AGPL-1.0-or-laterAffero General Public License v1.0 or laterAffero General Public License v1.0 or later.
AGPL-3.0-onlyGNU Affero General Public License v3.0 onlyGNU Affero General Public License v3.0 only.
AGPL-3.0-or-laterGNU Affero General Public License v3.0 or laterGNU Affero General Public License v3.0 or later.
AladdinAladdin Free Public LicenseAladdin Free Public License.
AMDPLPAAMD's plpa_map.c LicenseAMD's plpa_map.c License.
AMLApple MIT LicenseApple MIT License.
AMPASAcademy of Motion Picture Arts and Sciences BSDAcademy of Motion Picture Arts and Sciences BSD.
ANTLR-PDANTLR Software Rights NoticeANTLR Software Rights Notice.
Apache-1.0Apache License 1.0Apache License 1.0.
Apache-1.1Apache License 1.1Apache License 1.1.
Apache-2.0Apache License 2.0Apache License 2.0.
APAFMLAdobe Postscript AFM LicenseAdobe Postscript AFM License.
APL-1.0Adaptive Public License 1.0Adaptive Public License 1.0.
APSL-1.0Apple Public Source License 1.0Apple Public Source License 1.0.
APSL-1.1Apple Public Source License 1.1Apple Public Source License 1.1.
APSL-1.2Apple Public Source License 1.2Apple Public Source License 1.2.
APSL-2.0Apple Public Source License 2.0Apple Public Source License 2.0.
Artistic-1.0-cl8Artistic License 1.0 w/clause 8Artistic License 1.0 w/clause 8.
Artistic-1.0-PerlArtistic License 1.0 (Perl)Artistic License 1.0 (Perl).
Artistic-1.0Artistic License 1.0Artistic License 1.0.
Artistic-2.0Artistic License 2.0Artistic License 2.0.
BahyphBahyph LicenseBahyph License.
BarrBarr LicenseBarr License.
BeerwareBeerware LicenseBeerware License.
BitTorrent-1.0BitTorrent Open Source License v1.0BitTorrent Open Source License v1.0.
BitTorrent-1.1BitTorrent Open Source License v1.1BitTorrent Open Source License v1.1.
BorceuxBorceux licenseBorceux license.
BSD-1-ClauseBSD 1-Clause LicenseBSD 1-Clause License.
BSD-2-Clause-FreeBSDBSD 2-Clause FreeBSD LicenseBSD 2-Clause FreeBSD License.
BSD-2-Clause-NetBSDBSD 2-Clause NetBSD LicenseBSD 2-Clause NetBSD License.
BSD-2-Clause-PatentBSD-2-Clause Plus Patent LicenseBSD-2-Clause Plus Patent License.
BSD-2-ClauseBSD 2-Clause "Simplified" LicenseBSD 2-Clause "Simplified" License.
BSD-3-Clause-AttributionBSD with attributionBSD with attribution.
BSD-3-Clause-ClearBSD 3-Clause Clear LicenseBSD 3-Clause Clear License.
BSD-3-Clause-LBNLLawrence Berkeley National Labs BSD variant licenseLawrence Berkeley National Labs BSD variant license.
BSD-3-Clause-No-Nuclear-License-2014BSD 3-Clause No Nuclear License 2014BSD 3-Clause No Nuclear License 2014.
BSD-3-Clause-No-Nuclear-LicenseBSD 3-Clause No Nuclear LicenseBSD 3-Clause No Nuclear License.
BSD-3-Clause-No-Nuclear-WarrantyBSD 3-Clause No Nuclear WarrantyBSD 3-Clause No Nuclear Warranty.
BSD-3-ClauseBSD 3-Clause "New" or "Revised" LicenseBSD 3-Clause "New" or "Revised" License.
BSD-4-Clause-UCBSD-4-Clause (University of California-Specific)BSD-4-Clause (University of California-Specific).
BSD-4-ClauseBSD 4-Clause "Original" or "Old" LicenseBSD 4-Clause "Original" or "Old" License.
BSD-ProtectionBSD Protection LicenseBSD Protection License.
BSD-Source-CodeBSD Source Code AttributionBSD Source Code Attribution.
BSL-1.0Boost Software License 1.0Boost Software License 1.0.
bzip2-1.0.5bzip2 and libbzip2 License v1.0.5bzip2 and libbzip2 License v1.0.5.
bzip2-1.0.6bzip2 and libbzip2 License v1.0.6bzip2 and libbzip2 License v1.0.6.
CalderaCaldera LicenseCaldera License.
CATOSL-1.1Computer Associates Trusted Open Source License 1.1Computer Associates Trusted Open Source License 1.1.
CC-BY-1.0Creative Commons Attribution 1.0 GenericCreative Commons Attribution 1.0 Generic.
CC-BY-2.0Creative Commons Attribution 2.0 GenericCreative Commons Attribution 2.0 Generic.
CC-BY-2.5Creative Commons Attribution 2.5 GenericCreative Commons Attribution 2.5 Generic.
CC-BY-3.0Creative Commons Attribution 3.0 UnportedCreative Commons Attribution 3.0 Unported.
CC-BY-4.0Creative Commons Attribution 4.0 InternationalCreative Commons Attribution 4.0 International.
CC-BY-NC-1.0Creative Commons Attribution Non Commercial 1.0 GenericCreative Commons Attribution Non Commercial 1.0 Generic.
CC-BY-NC-2.0Creative Commons Attribution Non Commercial 2.0 GenericCreative Commons Attribution Non Commercial 2.0 Generic.
CC-BY-NC-2.5Creative Commons Attribution Non Commercial 2.5 GenericCreative Commons Attribution Non Commercial 2.5 Generic.
CC-BY-NC-3.0Creative Commons Attribution Non Commercial 3.0 UnportedCreative Commons Attribution Non Commercial 3.0 Unported.
CC-BY-NC-4.0Creative Commons Attribution Non Commercial 4.0 InternationalCreative Commons Attribution Non Commercial 4.0 International.
CC-BY-NC-ND-1.0Creative Commons Attribution Non Commercial No Derivatives 1.0 GenericCreative Commons Attribution Non Commercial No Derivatives 1.0 Generic.
CC-BY-NC-ND-2.0Creative Commons Attribution Non Commercial No Derivatives 2.0 GenericCreative Commons Attribution Non Commercial No Derivatives 2.0 Generic.
CC-BY-NC-ND-2.5Creative Commons Attribution Non Commercial No Derivatives 2.5 GenericCreative Commons Attribution Non Commercial No Derivatives 2.5 Generic.
CC-BY-NC-ND-3.0Creative Commons Attribution Non Commercial No Derivatives 3.0 UnportedCreative Commons Attribution Non Commercial No Derivatives 3.0 Unported.
CC-BY-NC-ND-4.0Creative Commons Attribution Non Commercial No Derivatives 4.0 InternationalCreative Commons Attribution Non Commercial No Derivatives 4.0 International.
CC-BY-NC-SA-1.0Creative Commons Attribution Non Commercial Share Alike 1.0 GenericCreative Commons Attribution Non Commercial Share Alike 1.0 Generic.
CC-BY-NC-SA-2.0Creative Commons Attribution Non Commercial Share Alike 2.0 GenericCreative Commons Attribution Non Commercial Share Alike 2.0 Generic.
CC-BY-NC-SA-2.5Creative Commons Attribution Non Commercial Share Alike 2.5 GenericCreative Commons Attribution Non Commercial Share Alike 2.5 Generic.
CC-BY-NC-SA-3.0Creative Commons Attribution Non Commercial Share Alike 3.0 UnportedCreative Commons Attribution Non Commercial Share Alike 3.0 Unported.
CC-BY-NC-SA-4.0Creative Commons Attribution Non Commercial Share Alike 4.0 InternationalCreative Commons Attribution Non Commercial Share Alike 4.0 International.
CC-BY-ND-1.0Creative Commons Attribution No Derivatives 1.0 GenericCreative Commons Attribution No Derivatives 1.0 Generic.
CC-BY-ND-2.0Creative Commons Attribution No Derivatives 2.0 GenericCreative Commons Attribution No Derivatives 2.0 Generic.
CC-BY-ND-2.5Creative Commons Attribution No Derivatives 2.5 GenericCreative Commons Attribution No Derivatives 2.5 Generic.
CC-BY-ND-3.0Creative Commons Attribution No Derivatives 3.0 UnportedCreative Commons Attribution No Derivatives 3.0 Unported.
CC-BY-ND-4.0Creative Commons Attribution No Derivatives 4.0 InternationalCreative Commons Attribution No Derivatives 4.0 International.
CC-BY-SA-1.0Creative Commons Attribution Share Alike 1.0 GenericCreative Commons Attribution Share Alike 1.0 Generic.
CC-BY-SA-2.0Creative Commons Attribution Share Alike 2.0 GenericCreative Commons Attribution Share Alike 2.0 Generic.
CC-BY-SA-2.5Creative Commons Attribution Share Alike 2.5 GenericCreative Commons Attribution Share Alike 2.5 Generic.
CC-BY-SA-3.0Creative Commons Attribution Share Alike 3.0 UnportedCreative Commons Attribution Share Alike 3.0 Unported.
CC-BY-SA-4.0Creative Commons Attribution Share Alike 4.0 InternationalCreative Commons Attribution Share Alike 4.0 International.
CC0-1.0Creative Commons Zero v1.0 UniversalCreative Commons Zero v1.0 Universal.
CDDL-1.0Common Development and Distribution License 1.0Common Development and Distribution License 1.0.
CDDL-1.1Common Development and Distribution License 1.1Common Development and Distribution License 1.1.
CDLA-Permissive-1.0Community Data License Agreement Permissive 1.0Community Data License Agreement Permissive 1.0.
CDLA-Sharing-1.0Community Data License Agreement Sharing 1.0Community Data License Agreement Sharing 1.0.
CECILL-1.0CeCILL Free Software License Agreement v1.0CeCILL Free Software License Agreement v1.0.
CECILL-1.1CeCILL Free Software License Agreement v1.1CeCILL Free Software License Agreement v1.1.
CECILL-2.0CeCILL Free Software License Agreement v2.0CeCILL Free Software License Agreement v2.0.
CECILL-2.1CeCILL Free Software License Agreement v2.1CeCILL Free Software License Agreement v2.1.
CECILL-BCeCILL-B Free Software License AgreementCeCILL-B Free Software License Agreement.
CECILL-CCeCILL-C Free Software License AgreementCeCILL-C Free Software License Agreement.
ClArtisticClarified Artistic LicenseClarified Artistic License.
CNRI-JythonCNRI Jython LicenseCNRI Jython License.
CNRI-Python-GPL-CompatibleCNRI Python Open Source GPL Compatible License AgreementCNRI Python Open Source GPL Compatible License Agreement.
CNRI-PythonCNRI Python LicenseCNRI Python License.
Condor-1.1Condor Public License v1.1Condor Public License v1.1.
CPAL-1.0Common Public Attribution License 1.0Common Public Attribution License 1.0.
CPL-1.0Common Public License 1.0Common Public License 1.0.
CPOL-1.02Code Project Open License 1.02Code Project Open License 1.02.
CrosswordCrossword LicenseCrossword License.
CrystalStackerCrystalStacker LicenseCrystalStacker License.
CUA-OPL-1.0CUA Office Public License v1.0CUA Office Public License v1.0.
CubeCube LicenseCube License.
curlcurl Licensecurl License.
D-FSL-1.0Deutsche Freie Software LizenzDeutsche Freie Software Lizenz.
diffmarkdiffmark licensediffmark license.
DOCDOC LicenseDOC License.
DotseqnDotseqn LicenseDotseqn License.
DSDPDSDP LicenseDSDP License.
dvipdfmdvipdfm Licensedvipdfm License.
ECL-1.0Educational Community License v1.0Educational Community License v1.0.
ECL-2.0Educational Community License v2.0Educational Community License v2.0.
EFL-1.0Eiffel Forum License v1.0Eiffel Forum License v1.0.
EFL-2.0Eiffel Forum License v2.0Eiffel Forum License v2.0.
eGenixeGenix.com Public License 1.1.0eGenix.com Public License 1.1.0.
EntessaEntessa Public License v1.0Entessa Public License v1.0.
EPL-1.0Eclipse Public License 1.0Eclipse Public License 1.0.
EPL-2.0Eclipse Public License 2.0Eclipse Public License 2.0.
ErlPL-1.1Erlang Public License v1.1Erlang Public License v1.1.
EUDatagridEU DataGrid Software LicenseEU DataGrid Software License.
EUPL-1.0European Union Public License 1.0European Union Public License 1.0.
EUPL-1.1European Union Public License 1.1European Union Public License 1.1.
EUPL-1.2European Union Public License 1.2European Union Public License 1.2.
EurosymEurosym LicenseEurosym License.
FairFair LicenseFair License.
Frameworx-1.0Frameworx Open License 1.0Frameworx Open License 1.0.
FreeImageFreeImage Public License v1.0FreeImage Public License v1.0.
FSFAPFSF All Permissive LicenseFSF All Permissive License.
FSFULFSF Unlimited LicenseFSF Unlimited License.
FSFULLRFSF Unlimited License (with License Retention)FSF Unlimited License (with License Retention).
FTLFreetype Project LicenseFreetype Project License.
GFDL-1.1-onlyGNU Free Documentation License v1.1 onlyGNU Free Documentation License v1.1 only.
GFDL-1.1-or-laterGNU Free Documentation License v1.1 or laterGNU Free Documentation License v1.1 or later.
GFDL-1.2-onlyGNU Free Documentation License v1.2 onlyGNU Free Documentation License v1.2 only.
GFDL-1.2-or-laterGNU Free Documentation License v1.2 or laterGNU Free Documentation License v1.2 or later.
GFDL-1.3-onlyGNU Free Documentation License v1.3 onlyGNU Free Documentation License v1.3 only.
GFDL-1.3-or-laterGNU Free Documentation License v1.3 or laterGNU Free Documentation License v1.3 or later.
GiftwareGiftware LicenseGiftware License.
GL2PSGL2PS LicenseGL2PS License.
Glide3dfx Glide License3dfx Glide License.
GlulxeGlulxe LicenseGlulxe License.
gnuplotgnuplot Licensegnuplot License.
GPL-1.0-onlyGNU General Public License v1.0 onlyGNU General Public License v1.0 only.
GPL-1.0-or-laterGNU General Public License v1.0 or laterGNU General Public License v1.0 or later.
GPL-2.0-onlyGNU General Public License v2.0 onlyGNU General Public License v2.0 only.
GPL-2.0-or-laterGNU General Public License v2.0 or laterGNU General Public License v2.0 or later.
GPL-3.0-onlyGNU General Public License v3.0 onlyGNU General Public License v3.0 only.
GPL-3.0-or-laterGNU General Public License v3.0 or laterGNU General Public License v3.0 or later.
gSOAP-1.3bgSOAP Public License v1.3bgSOAP Public License v1.3b.
HaskellReportHaskell Language Report LicenseHaskell Language Report License.
HPNDHistorical Permission Notice and DisclaimerHistorical Permission Notice and Disclaimer.
IBM-pibsIBM PowerPC Initialization and Boot SoftwareIBM PowerPC Initialization and Boot Software.
ICUICU LicenseICU License.
IJGIndependent JPEG Group LicenseIndependent JPEG Group License.
ImageMagickImageMagick LicenseImageMagick License.
iMatixiMatix Standard Function Library AgreementiMatix Standard Function Library Agreement.
Imlib2Imlib2 LicenseImlib2 License.
Info-ZIPInfo-ZIP LicenseInfo-ZIP License.
Intel-ACPIIntel ACPI Software License AgreementIntel ACPI Software License Agreement.
IntelIntel Open Source LicenseIntel Open Source License.
Interbase-1.0Interbase Public License v1.0Interbase Public License v1.0.
IPAIPA Font LicenseIPA Font License.
IPL-1.0IBM Public License v1.0IBM Public License v1.0.
ISCISC LicenseISC License.
JasPer-2.0JasPer LicenseJasPer License.
JSONJSON LicenseJSON License.
LAL-1.2Licence Art Libre 1.2Licence Art Libre 1.2.
LAL-1.3Licence Art Libre 1.3Licence Art Libre 1.3.
Latex2eLatex2e LicenseLatex2e License.
LeptonicaLeptonica LicenseLeptonica License.
LGPL-2.0-onlyGNU Library General Public License v2 onlyGNU Library General Public License v2 only.
LGPL-2.0-or-laterGNU Library General Public License v2 or laterGNU Library General Public License v2 or later.
LGPL-2.1-onlyGNU Lesser General Public License v2.1 onlyGNU Lesser General Public License v2.1 only.
LGPL-2.1-or-laterGNU Lesser General Public License v2.1 or laterGNU Lesser General Public License v2.1 or later.
LGPL-3.0-onlyGNU Lesser General Public License v3.0 onlyGNU Lesser General Public License v3.0 only.
LGPL-3.0-or-laterGNU Lesser General Public License v3.0 or laterGNU Lesser General Public License v3.0 or later.
LGPLLRLesser General Public License For Linguistic ResourcesLesser General Public License For Linguistic Resources.
Libpnglibpng Licenselibpng License.
libtifflibtiff Licenselibtiff License.
LiLiQ-P-1.1Licence Libre du Québec – Permissive version 1.1Licence Libre du Québec – Permissive version 1.1.
LiLiQ-R-1.1Licence Libre du Québec – Réciprocité version 1.1Licence Libre du Québec – Réciprocité version 1.1.
LiLiQ-Rplus-1.1Licence Libre du Québec – Réciprocité forte version 1.1Licence Libre du Québec – Réciprocité forte version 1.1.
Linux-OpenIBLinux Kernel Variant of OpenIB.org licenseLinux Kernel Variant of OpenIB.org license.
LPL-1.0Lucent Public License Version 1.0Lucent Public License Version 1.0.
LPL-1.02Lucent Public License v1.02Lucent Public License v1.02.
LPPL-1.0LaTeX Project Public License v1.0LaTeX Project Public License v1.0.
LPPL-1.1LaTeX Project Public License v1.1LaTeX Project Public License v1.1.
LPPL-1.2LaTeX Project Public License v1.2LaTeX Project Public License v1.2.
LPPL-1.3aLaTeX Project Public License v1.3aLaTeX Project Public License v1.3a.
LPPL-1.3cLaTeX Project Public License v1.3cLaTeX Project Public License v1.3c.
MakeIndexMakeIndex LicenseMakeIndex License.
MirOSMirOS LicenseMirOS License.
MIT-0MIT No AttributionMIT No Attribution.
MIT-advertisingEnlightenment License (e16)Enlightenment License (e16).
MIT-CMUCMU LicenseCMU License.
MIT-ennaenna Licenseenna License.
MIT-fehfeh Licensefeh License.
MITMIT LicenseMIT License.
MITNFAMIT +no-false-attribs licenseMIT +no-false-attribs license.
MotosotoMotosoto LicenseMotosoto License.
mpich2mpich2 Licensempich2 License.
MPL-1.0Mozilla Public License 1.0Mozilla Public License 1.0.
MPL-1.1Mozilla Public License 1.1Mozilla Public License 1.1.
MPL-2.0-no-copyleft-exceptionMozilla Public License 2.0 (no copyleft exception)Mozilla Public License 2.0 (no copyleft exception).
MPL-2.0Mozilla Public License 2.0Mozilla Public License 2.0.
MS-PLMicrosoft Public LicenseMicrosoft Public License.
MS-RLMicrosoft Reciprocal LicenseMicrosoft Reciprocal License.
MTLLMatrix Template Library LicenseMatrix Template Library License.
MulticsMultics LicenseMultics License.
MupMup LicenseMup License.
NASA-1.3NASA Open Source Agreement 1.3NASA Open Source Agreement 1.3.
NaumenNaumen Public LicenseNaumen Public License.
NBPL-1.0Net Boolean Public License v1Net Boolean Public License v1.
NCSAUniversity of Illinois/NCSA Open Source LicenseUniversity of Illinois/NCSA Open Source License.
Net-SNMPNet-SNMP LicenseNet-SNMP License.
NetCDFNetCDF licenseNetCDF license.
NewsletrNewsletr LicenseNewsletr License.
NGPLNethack General Public LicenseNethack General Public License.
NLOD-1.0Norwegian Licence for Open Government DataNorwegian Licence for Open Government Data.
NLPLNo Limit Public LicenseNo Limit Public License.
NokiaNokia Open Source LicenseNokia Open Source License.
NOSLNetizen Open Source LicenseNetizen Open Source License.
NowebNoweb LicenseNoweb License.
NPL-1.0Netscape Public License v1.0Netscape Public License v1.0.
NPL-1.1Netscape Public License v1.1Netscape Public License v1.1.
NPOSL-3.0Non-Profit Open Software License 3.0Non-Profit Open Software License 3.0.
NRLNRL LicenseNRL License.
NTPNTP LicenseNTP License.
OCCT-PLOpen CASCADE Technology Public LicenseOpen CASCADE Technology Public License.
OCLC-2.0OCLC Research Public License 2.0OCLC Research Public License 2.0.
ODbL-1.0ODC Open Database License v1.0ODC Open Database License v1.0.
OFL-1.0SIL Open Font License 1.0SIL Open Font License 1.0.
OFL-1.1SIL Open Font License 1.1SIL Open Font License 1.1.
OGTSLOpen Group Test Suite LicenseOpen Group Test Suite License.
OLDAP-1.1Open LDAP Public License v1.1Open LDAP Public License v1.1.
OLDAP-1.2Open LDAP Public License v1.2Open LDAP Public License v1.2.
OLDAP-1.3Open LDAP Public License v1.3Open LDAP Public License v1.3.
OLDAP-1.4Open LDAP Public License v1.4Open LDAP Public License v1.4.
OLDAP-2.0.1Open LDAP Public License v2.0.1Open LDAP Public License v2.0.1.
OLDAP-2.0Open LDAP Public License v2.0 (or possibly 2.0A and 2.0B)Open LDAP Public License v2.0 (or possibly 2.0A and 2.0B).
OLDAP-2.1Open LDAP Public License v2.1Open LDAP Public License v2.1.
OLDAP-2.2.1Open LDAP Public License v2.2.1Open LDAP Public License v2.2.1.
OLDAP-2.2.2Open LDAP Public License 2.2.2Open LDAP Public License 2.2.2.
OLDAP-2.2Open LDAP Public License v2.2Open LDAP Public License v2.2.
OLDAP-2.3Open LDAP Public License v2.3Open LDAP Public License v2.3.
OLDAP-2.4Open LDAP Public License v2.4Open LDAP Public License v2.4.
OLDAP-2.5Open LDAP Public License v2.5Open LDAP Public License v2.5.
OLDAP-2.6Open LDAP Public License v2.6Open LDAP Public License v2.6.
OLDAP-2.7Open LDAP Public License v2.7Open LDAP Public License v2.7.
OLDAP-2.8Open LDAP Public License v2.8Open LDAP Public License v2.8.
OMLOpen Market LicenseOpen Market License.
OpenSSLOpenSSL LicenseOpenSSL License.
OPL-1.0Open Public License v1.0Open Public License v1.0.
OSET-PL-2.1OSET Public License version 2.1OSET Public License version 2.1.
OSL-1.0Open Software License 1.0Open Software License 1.0.
OSL-1.1Open Software License 1.1Open Software License 1.1.
OSL-2.0Open Software License 2.0Open Software License 2.0.
OSL-2.1Open Software License 2.1Open Software License 2.1.
OSL-3.0Open Software License 3.0Open Software License 3.0.
PDDL-1.0ODC Public Domain Dedication & License 1.0ODC Public Domain Dedication & License 1.0.
PHP-3.0PHP License v3.0PHP License v3.0.
PHP-3.01PHP License v3.01PHP License v3.01.
PlexusPlexus Classworlds LicensePlexus Classworlds License.
PostgreSQLPostgreSQL LicensePostgreSQL License.
psfragpsfrag Licensepsfrag License.
psutilspsutils Licensepsutils License.
Python-2.0Python License 2.0Python License 2.0.
QhullQhull LicenseQhull License.
QPL-1.0Q Public License 1.0Q Public License 1.0.
RdiscRdisc LicenseRdisc License.
RHeCos-1.1Red Hat eCos Public License v1.1Red Hat eCos Public License v1.1.
RPL-1.1Reciprocal Public License 1.1Reciprocal Public License 1.1.
RPL-1.5Reciprocal Public License 1.5Reciprocal Public License 1.5.
RPSL-1.0RealNetworks Public Source License v1.0RealNetworks Public Source License v1.0.
RSA-MDRSA Message-Digest LicenseRSA Message-Digest License.
RSCPLRicoh Source Code Public LicenseRicoh Source Code Public License.
RubyRuby LicenseRuby License.
SAX-PDSax Public Domain NoticeSax Public Domain Notice.
SaxpathSaxpath LicenseSaxpath License.
SCEASCEA Shared Source LicenseSCEA Shared Source License.
SendmailSendmail LicenseSendmail License.
SGI-B-1.0SGI Free Software License B v1.0SGI Free Software License B v1.0.
SGI-B-1.1SGI Free Software License B v1.1SGI Free Software License B v1.1.
SGI-B-2.0SGI Free Software License B v2.0SGI Free Software License B v2.0.
SimPL-2.0Simple Public License 2.0Simple Public License 2.0.
SISSL-1.2Sun Industry Standards Source License v1.2Sun Industry Standards Source License v1.2.
SISSLSun Industry Standards Source License v1.1Sun Industry Standards Source License v1.1.
SleepycatSleepycat LicenseSleepycat License.
SMLNJStandard ML of New Jersey LicenseStandard ML of New Jersey License.
SMPPLSecure Messaging Protocol Public LicenseSecure Messaging Protocol Public License.
SNIASNIA Public License 1.1SNIA Public License 1.1.
Spencer-86Spencer License 86Spencer License 86.
Spencer-94Spencer License 94Spencer License 94.
Spencer-99Spencer License 99Spencer License 99.
SPL-1.0Sun Public License v1.0Sun Public License v1.0.
SugarCRM-1.1.3SugarCRM Public License v1.1.3SugarCRM Public License v1.1.3.
SWLScheme Widget Library (SWL) Software License AgreementScheme Widget Library (SWL) Software License Agreement.
TCLTCL/TK LicenseTCL/TK License.
TCP-wrappersTCP Wrappers LicenseTCP Wrappers License.
TMateTMate Open Source LicenseTMate Open Source License.
TORQUE-1.1TORQUE v2.5+ Software License v1.1TORQUE v2.5+ Software License v1.1.
TOSLTrusster Open Source LicenseTrusster Open Source License.
Unicode-DFS-2015Unicode License Agreement - Data Files and Software (2015)Unicode License Agreement - Data Files and Software (2015).
Unicode-DFS-2016Unicode License Agreement - Data Files and Software (2016)Unicode License Agreement - Data Files and Software (2016).
Unicode-TOUUnicode Terms of UseUnicode Terms of Use.
UnlicenseThe UnlicenseThe Unlicense.
UPL-1.0Universal Permissive License v1.0Universal Permissive License v1.0.
VimVim LicenseVim License.
VOSTROMVOSTROM Public License for Open SourceVOSTROM Public License for Open Source.
VSL-1.0Vovida Software License v1.0Vovida Software License v1.0.
W3C-19980720W3C Software Notice and License (1998-07-20)W3C Software Notice and License (1998-07-20).
W3C-20150513W3C Software Notice and Document License (2015-05-13)W3C Software Notice and Document License (2015-05-13).
W3CW3C Software Notice and License (2002-12-31)W3C Software Notice and License (2002-12-31).
Watcom-1.0Sybase Open Watcom Public License 1.0Sybase Open Watcom Public License 1.0.
WsuipaWsuipa LicenseWsuipa License.
WTFPLDo What The F*ck You Want To Public LicenseDo What The F*ck You Want To Public License.
X11X11 LicenseX11 License.
XeroxXerox LicenseXerox License.
XFree86-1.1XFree86 License 1.1XFree86 License 1.1.
xinetdxinetd Licensexinetd License.
XnetX.Net LicenseX.Net License.
xppXPP LicenseXPP License.
XSkatXSkat LicenseXSkat License.
YPL-1.0Yahoo! Public License v1.0Yahoo! Public License v1.0.
YPL-1.1Yahoo! Public License v1.1Yahoo! Public License v1.1.
ZedZed LicenseZed License.
Zend-2.0Zend License v2.0Zend License v2.0.
Zimbra-1.3Zimbra Public License v1.3Zimbra Public License v1.3.
Zimbra-1.4Zimbra Public License v1.4Zimbra Public License v1.4.
zlib-acknowledgementzlib/libpng License with Acknowledgementzlib/libpng License with Acknowledgement.
Zlibzlib Licensezlib License.
ZPL-1.1Zope Public License 1.1Zope Public License 1.1.
ZPL-2.0Zope Public License 2.0Zope Public License 2.0.
ZPL-2.1Zope Public License 2.1Zope Public License 2.1.

CodeSystem:AssertionDirectionType

The type of direction to use for assertion.
CodeDisplayDefinition
responseresponseThe assertion is evaluated on the response. This is the default value.
requestrequestThe assertion is evaluated on the request.

CodeSystem:ResourceValidationMode

Codes indicating the type of validation to perform.
CodeDisplayDefinition
createValidate for CreateThe server checks the content, and then checks that the content would be acceptable as a create (e.g. that the content would not violate any uniqueness constraints).
updateValidate for UpdateThe server checks the content, and then checks that it would accept it as an update against the nominated specific resource (e.g. that there are no changes to immutable fields the server does not allow to change and checking version integrity if appropriate).
deleteValidate for DeleteThe server ignores the content and checks that the nominated resource is allowed to be deleted (e.g. checking referential integrity rules).
profileValidate Against a ProfileThe server checks an existing resource (must be nominated by id, not provided as a parameter) as valid against the nominated profile.

CodeSystem:ExtraActivityType

This value set includes coded concepts not well covered in any of the included valuesets.
CodeDisplayDefinition
aggregateaggregateActivity resulting in a structured collection of preexisting content that does not necessarily result in an integral object with semantic context making it more than the sum of component parts, from which components could be disaggregated without loss of semantic context, e.g., the assembly of multiple stand-alone documents.
composecomposeActivity resulting in the structured compilation of new and preexisting content for the purposes of forming an integral object with semantic context making it more than the sum of component parts, which would be lost if decomposed. For example, the composition of a document that includes in whole or part other documents along with new content that result in a new document that has unique semantic meaning.
labellabelThe means used to associate a set of security attributes with a specific information object as part of the data structure for that object. [ISO-10181-3 Access Control]

CodeSystem:StructureMapTargetListMode

If field is a list, how to manage the production.
CodeDisplayDefinition
firstFirstwhen the target list is being assembled, the items for this rule go first. If more than one rule defines a first item (for a given instance of mapping) then this is an error.
shareSharethe target instance is shared with the target instances generated by another rule (up to the first common n items, then create new ones).
lastLastwhen the target list is being assembled, the items for this rule go last. If more than one rule defines a last item (for a given instance of mapping) then this is an error.
collateCollatere-use the first item in the list, and keep adding content to it.

CodeSystem:QuestionnaireTextCategories

Codes defining the purpose of a Questionnaire item of type 'text'.
CodeDisplayDefinition
instructionsInstructionsThe text provides guidance on how to populate or use a portion of the questionnaire (or the questionnaire as a whole).
securitySecurityThe text provides guidance on how the information should be or will be handled from a security/confidentiality/access control perspective when completed
helpHelpThe text provides additional guidance on populating the containing item. Help text isn't necessarily expected to be rendered as part of the form, but may instead be made available through fly-over, pop-up button, link to a "help" page, etc.

CodeSystem:GoalStatusReason

Example codes indicating the reason for a current status. Note that these are in no way complete and might not even be appropriate for some uses.
CodeDisplayDefinition
surgerySurgeryGoal suspended or ended because of a surgical procedure.
life-eventLife EventGoal suspended or ended because of a significant life event (marital change, bereavement, etc.).
replacedReplacedGoal has been superseded by a new goal.
patient-requestPatient RequestPatient wishes the goal to be set aside, at least temporarily.
temp-not-attainableGoal Not Attainable TemporarilyGoal cannot be reached temporarily.
permanent-not-attainableGoal Not Attainable PermanentlyGoal cannot be reached permanently.
financial-barrierFinancial ReasonGoal cannot be reached due to financial barrier or reason.
lack-of-transportationLack Of TransportationGoal cannot be reached due to a lack of transportation.
lack-of-social-supportLack Of Social SupportGoal cannot be reached due to a lack of social support.

CodeSystem:SpecialValues

A set of generally useful codes defined so they can be included in value sets.
CodeDisplayDefinition
truetrueBoolean true.
falsefalseBoolean false.
traceTrace Amount DetectedThe content is greater than zero, but too small to be quantified.
sufficientSufficient QuantityThe specific quantity is not known, but is known to be non-zero and is not specified because it makes up the bulk of the material.
withdrawnValue WithdrawnThe value is no longer available.
nil-knownNil KnownThe are no known applicable values in this context.

CodeSystem:OperationParameterUse

Whether an operation parameter is an input or an output parameter.
CodeDisplayDefinition
inInThis is an input parameter.
outOutThis is an output parameter.

CodeSystem:SearchEntryMode

Why an entry is in the result set - whether it's included as a match or because of an _include requirement, or to convey information or warning information about the search process.
CodeDisplayDefinition
matchMatchThis resource matched the search specification.
includeIncludeThis resource is returned because it is referred to from another resource in the search set.
outcomeOutcomeAn OperationOutcome that provides additional information about the processing of a search.

CodeSystem:TestScriptProfileDestinationType

This value set defines a set of codes that are used to indicate the profile type of a test system when acting as the destination within a TestScript.
CodeDisplayDefinition
FHIR-ServerFHIR ServerGeneral FHIR server used to respond to operations sent from a FHIR client.
FHIR-SDC-FormManagerFHIR SDC FormManagerA FHIR server acting as a Structured Data Capture Form Manager.
FHIR-SDC-FormProcessorFHIR SDC FormProcessorA FHIR server acting as a Structured Data Capture Form Processor.
FHIR-SDC-FormReceiverFHIR SDC FormReceiverA FHIR server acting as a Structured Data Capture Form Receiver.

CodeSystem:BindingStrength

Indication of the degree of conformance expectations associated with a binding.
CodeDisplayDefinition
requiredRequiredTo be conformant, the concept in this element SHALL be from the specified value set.
extensibleExtensibleTo be conformant, the concept in this element SHALL be from the specified value set if any of the codes within the value set can apply to the concept being communicated. If the value set does not cover the concept (based on human review), alternate codings (or, data type allowing, text) may be included instead.
preferredPreferredInstances are encouraged to draw from the specified codes for interoperability purposes but are not required to do so to be considered conformant.
exampleExampleInstances are not expected or even encouraged to draw from the specified value set. The value set merely provides examples of the types of concepts intended to be included.

CodeSystem:PropertyRepresentation

How a property is represented when serialized.
CodeDisplayDefinition
xmlAttrXML AttributeIn XML, this property is represented as an attribute not an element.
xmlTextXML TextThis element is represented using the XML text attribute (primitives only).
typeAttrType AttributeThe type of this element is indicated using xsi:type.
cdaTextCDA Text FormatUse CDA narrative instead of XHTML.
xhtmlXHTMLThe property is represented using XHTML.

CodeSystem:NamingSystemIdentifierType

Identifies the style of unique identifier used to identify a namespace.
CodeDisplayDefinition
oidOIDAn ISO object identifier; e.g. 1.2.3.4.5.
uuidUUIDA universally unique identifier of the form a5afddf4-e880-459b-876e-e4591b0acc11.
uriURIA uniform resource identifier (ideally a URL - uniform resource locator); e.g. http://unitsofmeasure.org.
otherOtherSome other type of unique identifier; e.g. HL7-assigned reserved string such as LN for LOINC.

CodeSystem:PerformerRoleCodes

This value set includes sample Performer Role codes.
CodeDisplayDefinition
consenterConsenterAn entity or an entity's delegatee who is the grantee in an agreement such as a consent for services, advanced directive, or a privacy consent directive in accordance with jurisdictional, organizational, or patient policy.
granteeGranteeAn entity which accepts certain rights or authority from a grantor.
grantorGrantorAn entity which agrees to confer certain rights or authority to a grantee.
delegateeDelegateeA party to whom some right or authority is granted by a delegator.
delegatorDelegatorA party that grants all or some portion its right or authority to another party.

CodeSystem:RequestPriority

Identifies the level of importance to be assigned to actioning the request.
CodeDisplayDefinition
routineRoutineThe request has normal priority.
urgentUrgentThe request should be actioned promptly - higher priority than routine.
asapASAPThe request should be actioned as soon as possible - higher priority than urgent.
statSTATThe request should be actioned immediately - highest possible priority. E.g. an emergency.

CodeSystem:TemplateStatusCodeLifeCycle

Life cycle of the Status Code of a Template Design (Version)
CodeDisplayDefinition
draftDraftDesign is under development (nascent).
pendingUnder pre-publication reviewDesign is completed and is being reviewed.
activeactiveDesign has been deemed fit for the intended purpose and is published by the governance group.
reviewIn ReviewDesign is active, but is under review. The review may result in a change to the design. The change may necessitate a new version to be created. This in turn may result in the prior version of the template to be retired. Alternatively, the review may result in a change to the design that does not require a new version to be created, or it may result in no change to the design at all.
cancelledCancelledA drafted design is determined to be erroneous or not fit for intended purpose and is discontinued before ever being published in an active state.
rejectedRejectedA previously drafted design is determined to be erroneous or not fit for intended purpose and is discontinued before ever being published for consideration in a pending state.
retiredretiredA previously active design is discontinued from use. It should no longer be used for future designs, but for historical purposes may be used to process data previously recorded using this design. A newer design may or may not exist. The design is published in the retired state.
terminatedTerminatedA design is determined to be erroneous or not fit for the intended purpose and should no longer be used, even for historical purposes. No new designs can be developed for this template. The associated template no longer needs to be published, but if published, is shown in the terminated state.

CodeSystem:AnimalSpecies

This example value set defines a set of codes that can be used to indicate species of animal patients.
CodeDisplayDefinition
canislfDogCanis lupus familiaris
ovisaSheepOvis aries
serinuscdDomestic CanarySerinus canaria domestica

CodeSystem:StructureDefinitionKind

Defines the type of structure that a definition is describing.
CodeDisplayDefinition
primitive-typePrimitive Data TypeA primitive type that has a value and an extension. These can be used throughout complex datatype, Resource and extension definitions. Only the base specification can define primitive types.
complex-typeComplex Data TypeA complex structure that defines a set of data elements that is suitable for use in 'resources'. The base specification defines a number of complex types, and other specifications can define additional types. These structures do not have a maintained identity.
resourceResourceA 'resource' - a directed acyclic graph of elements that aggregrates other types into an identifiable entity. The base FHIR resources are defined by the FHIR specification itself but other 'resources' can be defined in additional specifications (though these will not be recognised as 'resources' by the FHIR specification (i.e. they do not get end-points etc, or act as the targets of references in FHIR defined resources - though other specificatiosn can treat them this way).
logicalLogicalA pattern or a template that is not intended to be a real resource or complex type.

CodeSystem:SubscriptionStatus

The status of a subscription.
CodeDisplayDefinition
requestedRequestedThe client has requested the subscription, and the server has not yet set it up.
activeActiveThe subscription is active.
errorErrorThe server has an error executing the notification.
offOffToo many errors have occurred or the subscription has expired.

CodeSystem:AdditionalMaterialCodes

This value set includes sample additional material type codes.
CodeDisplayDefinition
xrayXRayXRay
imageImageImage
emailEmailEmail
modelModelModel
documentDocumentDocument
otherOtherOther

CodeSystem:UsageContextType

A code that specifies a type of context being specified by a usage context.
CodeDisplayDefinition
genderGenderThe gender of the patient. For this context type, appropriate values can be found in the http://hl7.org/fhir/ValueSet/administrative-gender value set.
ageAge RangeThe age of the patient. For this context type, the value could be a range that specifies the applicable ages or a code from an appropriate value set such as the MeSH value set http://terminology.hl7.org/ValueSet/v3-AgeGroupObservationValue.
focusClinical FocusThe clinical concept(s) addressed by the artifact. For example, disease, diagnostic test interpretation, medication ordering as in http://hl7.org/fhir/ValueSet/condition-code.
userUser TypeThe clinical specialty of the context in which the patient is being treated - For example, PCP, Patient, Cardiologist, Behavioral Professional, Oral Health Professional, Prescriber, etc... taken from a specialty value set such as the NUCC Health Care provider taxonomy value set http://hl7.org/fhir/ValueSet/provider-taxonomy.
workflowWorkflow SettingThe settings in which the artifact is intended for use. For example, admission, pre-op, etc. For example, the ActEncounterCode value set http://terminology.hl7.org/ValueSet/v3-ActEncounterCode.
taskWorkflow TaskThe context for the clinical task(s) represented by this artifact. For example, this could be any task context represented by the HL7 ActTaskCode value set http://terminology.hl7.org/ValueSet/v3-ActTaskCode. General categories include: order entry, patient documentation and patient information review.
venueClinical VenueThe venue in which an artifact could be used. For example, Outpatient, Inpatient, Home, Nursing home. The code value may originate from the HL7 ServiceDeliveryLocationRoleType value set (http://terminology.hl7.org/ValueSet/v3-ServiceDeliveryLocationRoleType).
speciesSpeciesThe species to which an artifact applies. For example, SNOMED - 387961004 | Kingdom Animalia (organism).
programProgramA program/project of work for which this artifact is applicable.

CodeSystem:ContractDataMeaning

How a resource reference is interpreted when evaluating contract offers.
CodeDisplayDefinition
instanceInstanceThe consent applies directly to the instance of the resource.
relatedRelatedThe consent applies directly to the instance of the resource and instances it refers to.
dependentsDependentsThe consent applies directly to the instance of the resource and instances that refer to it.
authoredbyAuthoredByThe consent applies to instances of resources that are authored by.

CodeSystem:PatientMedicineChangeTypes

Example Item Flags for the List Resource. In this case, these are the kind of flags that would be used on a medication list at the end of a consultation.
CodeDisplayDefinition
01UnchangedNo change has been made to the status of this medicine item.
02ChangedThe medicine item has changed. The change may be described in an extension (not defined yet)
03CancelledThe prescription for this medicine item was cancelled by an authorized health care provider. The patient may be advised to complete the course of the prescribed medicine. This advice is a clinical decision made based on assessment of the patient's clinical condition.
04PrescribedA new medicine item has been prescribed
05CeasedAdministration of this medication item that the patient is currently taking is stopped or recommended to be stopped (i.e. instructed to be ceased by a health care provider). This cessation is anticipated to be permanent. The Change Description should describe the reason for cessation. Example uses: the medication in question is considered ineffective or has caused serious adverse effects. This value applies both to the cessation of a medication that is prescribed by another healthcare provider or patient self-administration of OTC medicines.
06SuspendedAdministration of this medication item that the patient is currently taking is on hold, or instructed or recommended by a health care provider to be temporarily stopped, or subject to clinical review (i.e. the stop may be temporary or permanent depending on the outcome of clinical review), or temporarily suspended as a pre-requisite to certain surgical or diagnostic procedures.

CodeSystem:UnknownContentCode

A code that indicates whether an application accepts unknown elements or extensions when reading resources.
CodeDisplayDefinition
noNeither Elements or ExtensionsThe application does not accept either unknown elements or extensions.
extensionsUnknown ExtensionsThe application accepts unknown extensions, but not unknown elements.
elementsUnknown ElementsThe application accepts unknown elements, but not unknown extensions.
bothUnknown Elements and ExtensionsThe application accepts unknown elements and extensions.

CodeSystem:sequenceStatus

Codes providing the status of the variant test result.
CodeDisplayDefinition
positivepositivethe variant is detected.
negativenegativeno variant is detected.
absentabsentresult of the variant is missing.

CodeSystem:ConditionalReadStatus

A code that indicates how the server supports conditional read.
CodeDisplayDefinition
not-supportedNot SupportedNo support for conditional reads.
modified-sinceIf-Modified-SinceConditional reads are supported, but only with the If-Modified-Since HTTP Header.
not-matchIf-None-MatchConditional reads are supported, but only with the If-None-Match HTTP Header.
full-supportFull SupportConditional reads are supported, with both If-Modified-Since and If-None-Match HTTP Headers.

CodeSystem:DefinitionUseCodes

Structure Definition Use Codes / Keywords
CodeDisplayDefinition
fhir-structureFHIR StructureThis structure is defined as part of the base FHIR Specification
custom-resourceCustom ResourceThis structure is intended to be treated like a FHIR resource (e.g. on the FHIR API)
damDomain Analysis ModelThis structure captures an analysis of a domain
wire-formatWire FormatThis structure represents and existing structure (e.g. CDA, HL7 v2)
archetypeDomain Analysis ModelThis structure captures an analysis of a domain
templateTemplateThis structure is a template (n.b: 'template' has many meanings)

CodeSystem:UDICodes

This value set includes sample UDI codes.
CodeDisplayDefinition
gudidGUDID (FDA)GUDID (FDA) US Repository

CodeSystem:DataType

A version specific list of the data types defined by the FHIR specification for use as an element type (any of the FHIR defined data types).
CodeDisplayDefinition
AddressAddressAn address expressed using postal conventions (as opposed to GPS or other location definition formats). This data type may be used to convey addresses for use in delivering mail as well as for visiting locations which might not be valid for mail delivery. There are a variety of postal address formats defined around the world.
AgeAgeA duration of time during which an organism (or a process) has existed.
AnnotationAnnotationA text note which also contains information about who made the statement and when.
AttachmentAttachmentFor referring to data content defined in other formats.
BackboneElementBackboneElementBase definition for all elements that are defined inside a resource - but not those in a data type.
CodeableConceptCodeableConceptA concept that may be defined by a formal reference to a terminology or ontology or may be provided by text.
CodingCodingA reference to a code defined by a terminology system.
ContactDetailContactDetailSpecifies contact information for a person or organization.
ContactPointContactPointDetails for all kinds of technology mediated contact points for a person or organization, including telephone, email, etc.
ContributorContributorA contributor to the content of a knowledge asset, including authors, editors, reviewers, and endorsers.
CountCountA measured amount (or an amount that can potentially be measured). Note that measured amounts include amounts that are not precisely quantified, including amounts involving arbitrary units and floating currencies.
DataRequirementDataRequirementDescribes a required data item for evaluation in terms of the type of data, and optional code or date-based filters of the data.
DistanceDistanceA length - a value with a unit that is a physical distance.
DosageDosageIndicates how the medication is/was taken or should be taken by the patient.
DurationDurationA length of time.
ElementElementBase definition for all elements in a resource.
ElementDefinitionElementDefinitionCaptures constraints on each element within the resource, profile, or extension.
ExpressionExpressionA expression that is evaluated in a specified context and returns a value. The context of use of the expression must specify the context in which the expression is evaluated, and how the result of the expression is used.
ExtensionExtensionOptional Extension Element - found in all resources.
HumanNameHumanNameA human's name with the ability to identify parts and usage.
IdentifierIdentifierAn identifier - identifies some entity uniquely and unambiguously. Typically this is used for business identifiers.
MarketingStatusMarketingStatusThe marketing status describes the date when a medicinal product is actually put on the market or the date as of which it is no longer available.
MetaMetaThe metadata about a resource. This is content in the resource that is maintained by the infrastructure. Changes to the content might not always be associated with version changes to the resource.
MoneyMoneyAn amount of economic utility in some recognized currency.
MoneyQuantityMoneyQuantityundefined
NarrativeNarrativeA human-readable summary of the resource conveying the essential clinical and business information for the resource.
ParameterDefinitionParameterDefinitionThe parameters to the module. This collection specifies both the input and output parameters. Input parameters are provided by the caller as part of the $evaluate operation. Output parameters are included in the GuidanceResponse.
PeriodPeriodA time period defined by a start and end date and optionally time.
PopulationPopulationA populatioof people with some set of grouping criteria.
ProdCharacteristicProdCharacteristicThe marketing status describes the date when a medicinal product is actually put on the market or the date as of which it is no longer available.
ProductShelfLifeProductShelfLifeThe shelf-life and storage information for a medicinal product item or container can be described using this class.
QuantityQuantityA measured amount (or an amount that can potentially be measured). Note that measured amounts include amounts that are not precisely quantified, including amounts involving arbitrary units and floating currencies.
RangeRangeA set of ordered Quantities defined by a low and high limit.
RatioRatioA relationship of two Quantity values - expressed as a numerator and a denominator.
ReferenceReferenceA reference from one resource to another.
RelatedArtifactRelatedArtifactRelated artifacts such as additional documentation, justification, or bibliographic references.
SampledDataSampledDataA series of measurements taken by a device, with upper and lower limits. There may be more than one dimension in the data.
SignatureSignatureA signature along with supporting context. The signature may be a digital signature that is cryptographic in nature, or some other signature acceptable to the domain. This other signature may be as simple as a graphical image representing a hand-written signature, or a signature ceremony Different signature approaches have different utilities.
SimpleQuantitySimpleQuantityundefined
SubstanceAmountSubstanceAmountChemical substances are a single substance type whose primary defining element is the molecular structure. Chemical substances shall be defined on the basis of their complete covalent molecular structure; the presence of a salt (counter-ion) and/or solvates (water, alcohols) is also captured. Purity, grade, physical form or particle size are not taken into account in the definition of a chemical substance or in the assignment of a Substance ID.
TimingTimingSpecifies an event that may occur multiple times. Timing schedules are used to record when things are planned, expected or requested to occur. The most common usage is in dosage instructions for medications. They are also used when planning care of various kinds, and may be used for reporting the schedule to which past regular activities were carried out.
TriggerDefinitionTriggerDefinitionA description of a triggering event. Triggering events can be named events, data events, or periodic, as determined by the type element.
UsageContextUsageContextSpecifies clinical/business/etc. metadata that can be used to retrieve, index and/or categorize an artifact. This metadata can either be specific to the applicable population (e.g., age category, DRG) or the specific context of care (e.g., venue, care setting, provider of care).
base64Binarybase64BinaryA stream of bytes
booleanbooleanValue of "true" or "false"
canonicalcanonicalA URI that is a reference to a canonical URL on a FHIR resource
codecodeA string which has at least one character and no leading or trailing whitespace and where there is no whitespace other than single spaces in the contents
datedateA date or partial date (e.g. just year or year + month). There is no time zone. The format is a union of the schema types gYear, gYearMonth and date. Dates SHALL be valid dates.
dateTimedateTimeA date, date-time or partial date (e.g. just year or year + month). If hours and minutes are specified, a time zone SHALL be populated. The format is a union of the schema types gYear, gYearMonth, date and dateTime. Seconds must be provided due to schema type constraints but may be zero-filled and may be ignored. Dates SHALL be valid dates.
decimaldecimalA rational number with implicit precision
ididAny combination of letters, numerals, "-" and ".", with a length limit of 64 characters. (This might be an integer, an unprefixed OID, UUID or any other identifier pattern that meets these constraints.) Ids are case-insensitive.
instantinstantAn instant in time - known at least to the second
integerintegerA whole number
markdownmarkdownA string that may contain Github Flavored Markdown syntax for optional processing by a mark down presentation engine
oidoidAn OID represented as a URI
positiveIntpositiveIntAn integer with a value that is positive (e.g. >0)
stringstringA sequence of Unicode characters
timetimeA time during the day, with no date specified
unsignedIntunsignedIntAn integer with a value that is not negative (e.g. >= 0)
uriuriString of characters used to identify a name or a resource
urlurlA URI that is a literal reference
uuiduuidA UUID, represented as a URI
xhtmlXHTMLXHTML format, as defined by W3C, but restricted usage (mainly, no active content)

CodeSystem:QuestionnaireResponseStatus

Lifecycle status of the questionnaire response.
CodeDisplayDefinition
in-progressIn ProgressThis QuestionnaireResponse has been partially filled out with answers but changes or additions are still expected to be made to it.
completedCompletedThis QuestionnaireResponse has been filled out with answers and the current content is regarded as definitive.
amendedAmendedThis QuestionnaireResponse has been filled out with answers, then marked as complete, yet changes or additions have been made to it afterwards.
entered-in-errorEntered in ErrorThis QuestionnaireResponse was entered in error and voided.
stoppedStoppedThis QuestionnaireResponse has been partially filled out with answers but has been abandoned. It is unknown whether changes or additions are expected to be made to it.

CodeSystem:AddressUse

The use of an address.
CodeDisplayDefinition
homeHomeA communication address at a home.
workWorkAn office address. First choice for business related contacts during business hours.
tempTemporaryA temporary address. The period can provide more detailed information.
oldOld / IncorrectThis address is no longer in use (or was never correct but retained for records).
billingBillingAn address to be used to send bills, invoices, receipts etc.

CodeSystem:TriggerType

The type of trigger.
CodeDisplayDefinition
named-eventNamed EventThe trigger occurs in response to a specific named event, and no other information about the trigger is specified. Named events are completely pre-coordinated, and the formal semantics of the trigger are not provided.
periodicPeriodicThe trigger occurs at a specific time or periodically as described by a timing or schedule. A periodic event cannot have any data elements, but may have a name assigned as a shorthand for the event.
data-changedData ChangedThe trigger occurs whenever data of a particular type is changed in any way, either added, modified, or removed.
data-accessedData AccessedThe trigger occurs whenever data of a particular type is accessed.
data-access-endedData Access EndedThe trigger occurs whenever access to data of a particular type is completed.

CodeSystem:ExpressionLanguage

The media type of the expression language.
CodeDisplayDefinition
text/cqlCQLClinical Quality Language.
text/fhirpathFHIRPathFHIRPath.
application/x-fhir-queryFHIR QueryFHIR's RESTful query syntax - typically independent of base URL.

CodeSystem:TeethCodes

This value set includes the FDI Teeth codes.
CodeDisplayDefinition
1111Upper Right Tooth 1 from the central axis, permanent dentition.
1212Upper Right Tooth 2 from the central axis, permanent dentition.
1313Upper Right Tooth 3 from the central axis, permanent dentition.
1414Upper Right Tooth 4 from the central axis, permanent dentition.
1515Upper Right Tooth 5 from the central axis, permanent dentition.
1616Upper Right Tooth 6 from the central axis, permanent dentition.
1717Upper Right Tooth 7 from the central axis, permanent dentition.
1818Upper Right Tooth 8 from the central axis, permanent dentition.
2121Upper Left Tooth 1 from the central axis, permanent dentition.
2222Upper Left Tooth 2 from the central axis, permanent dentition.
2323Upper Left Tooth 3 from the central axis, permanent dentition.
2424Upper Left Tooth 4 from the central axis, permanent dentition.
2525Upper Left Tooth 5 from the central axis, permanent dentition.
2626Upper Left Tooth 6 from the central axis, permanent dentition.
2727Upper Left Tooth 7 from the central axis, permanent dentition.
2828Upper Left Tooth 8 from the central axis, permanent dentition.
3131Lower Left Tooth 1 from the central axis, permanent dentition.
3232Lower Left Tooth 2 from the central axis, permanent dentition.
3333Lower Left Tooth 3 from the central axis, permanent dentition.
3434Lower Left Tooth 4 from the central axis, permanent dentition.
3535Lower Left Tooth 5 from the central axis, permanent dentition.
3636Lower Left Tooth 6 from the central axis, permanent dentition.
3737Lower Left Tooth 7 from the central axis, permanent dentition.
3838Lower Left Tooth 8 from the central axis, permanent dentition.
4141Lower Right Tooth 1 from the central axis, permanent dentition.
4242Lower Right Tooth 2 from the central axis, permanent dentition.
4343Lower Right Tooth 3 from the central axis, permanent dentition.
4444Lower Right Tooth 4 from the central axis, permanent dentition.
4545Lower Right Tooth 5 from the central axis, permanent dentition.
4646Lower Right Tooth 6 from the central axis, permanent dentition.
4747Lower Right Tooth 7 from the central axis, permanent dentition.
4848Lower Right Tooth 8 from the central axis, permanent dentition.

CodeSystem:FHIR Restful Interactions

The set of interactions defined by the RESTful part of the FHIR specification.
CodeDisplayDefinition
readreadRead the current state of the resource.
vreadvreadRead the state of a specific version of the resource.
updateupdateUpdate an existing resource by its id (or create it if it is new).
patchpatchUpdate an existing resource by posting a set of changes to it.
deletedeleteDelete a resource.
historyhistoryRetrieve the change history for a particular resource, type of resource, or the entire system.
createcreateCreate a new resource with a server assigned id.
searchsearchSearch a resource type or all resources based on some filter criteria.
capabilitiescapabilitiesGet a Capability Statement for the system.
transactiontransactionUpdate, create or delete a set of resources as a single transaction.
batchbatchperform a set of a separate interactions in a single http operation
operationoperationPerform an operation as defined by an OperationDefinition.

CodeSystem:EventTiming

Real world event relating to the schedule.
CodeDisplayDefinition
MORNMorningEvent occurs during the morning. The exact time is unspecified and established by institution convention or patient interpretation.
MORN.earlyEarly MorningEvent occurs during the early morning. The exact time is unspecified and established by institution convention or patient interpretation.
MORN.lateLate MorningEvent occurs during the late morning. The exact time is unspecified and established by institution convention or patient interpretation.
NOONNoonEvent occurs around 12:00pm. The exact time is unspecified and established by institution convention or patient interpretation.
AFTAfternoonEvent occurs during the afternoon. The exact time is unspecified and established by institution convention or patient interpretation.
AFT.earlyEarly AfternoonEvent occurs during the early afternoon. The exact time is unspecified and established by institution convention or patient interpretation.
AFT.lateLate AfternoonEvent occurs during the late afternoon. The exact time is unspecified and established by institution convention or patient interpretation.
EVEEveningEvent occurs during the evening. The exact time is unspecified and established by institution convention or patient interpretation.
EVE.earlyEarly EveningEvent occurs during the early evening. The exact time is unspecified and established by institution convention or patient interpretation.
EVE.lateLate EveningEvent occurs during the late evening. The exact time is unspecified and established by institution convention or patient interpretation.
NIGHTNightEvent occurs during the night. The exact time is unspecified and established by institution convention or patient interpretation.
PHSAfter SleepEvent occurs [offset] after subject goes to sleep. The exact time is unspecified and established by institution convention or patient interpretation.

CodeSystem:TestScriptOperationCode

This value set defines a set of codes that are used to indicate the supported operations of a testing engine or tool.
CodeDisplayDefinition
readReadRead the current state of the resource.
vreadVersion ReadRead the state of a specific version of the resource.
updateUpdateUpdate an existing resource by its id.
updateCreateCreate using UpdateUpdate an existing resource by its id (or create it if it is new).
patchPatchPatch an existing resource by its id.
deleteDeleteDelete a resource.
deleteCondSingleConditional Delete SingleConditionally delete a single resource based on search parameters.
deleteCondMultipleConditional Delete MultipleConditionally delete one or more resources based on search parameters.
historyHistoryRetrieve the change history for a particular resource or resource type.
createCreateCreate a new resource with a server assigned id.
searchSearchSearch based on some filter criteria.
batchBatchUpdate, create or delete a set of resources as independent actions.
transactionTransactionUpdate, create or delete a set of resources as a single transaction.
capabilitiesCapabilitiesGet a capability statement for the system.
apply$applyRealizes an ActivityDefinition in a specific context
closure$closureClosure Table Maintenance
find-matches$find-matchesFinding Codes based on supplied properties
conforms$conformsCompare two systems CapabilityStatements
data-requirements$data-requirementsAggregates and returns the parameters and data requirements for a resource and all its dependencies as a single module definition
document$documentGenerate a Document
evaluate$evaluateRequest clinical decision support guidance based on a specific decision support module
evaluate-measure$evaluate-measureInvoke an eMeasure and obtain the results
everything$everythingReturn all the related information as described in the Encounter or Patient
expand$expandValue Set Expansion
find$findFind a functional list
graphql$graphqlInvoke a GraphQL query
implements$implementsTest if a server implements a client's required operations
lastn$lastnLast N Observations Query
lookup$lookupConcept Look Up and Decomposition
match$matchFind patient matches using MPI based logic
meta$metaAccess a list of profiles, tags, and security labels
meta-add$meta-addAdd profiles, tags, and security labels to a resource
meta-delete$meta-deleteDelete profiles, tags, and security labels for a resource
populate$populatePopulate Questionnaire
populatehtml$populatehtmlGenerate HTML for Questionnaire
populatelink$populatelinkGenerate a link to a Questionnaire completion webpage
process-message$process-messageProcess a message according to the defined event
questionnaire$questionnaireBuild Questionnaire
stats$statsObservation Statistics
subset$subsetFetch a subset of the CapabilityStatement resource
subsumes$subsumesCodeSystem Subsumption Testing
transform$transformModel Instance Transformation
translate$translateConcept Translation
validate$validateValidate a resource
validate-code$validate-codeValueSet based Validation

CodeSystem:NamingSystemType

Identifies the purpose of the naming system.
CodeDisplayDefinition
codesystemCode SystemThe naming system is used to define concepts and symbols to represent those concepts; e.g. UCUM, LOINC, NDC code, local lab codes, etc.
identifierIdentifierThe naming system is used to manage identifiers (e.g. license numbers, order numbers, etc.).
rootRootThe naming system is used as the root for other identifiers and naming systems.

CodeSystem:FHIRDeviceStatus

Codes representing the current status of the device - on, off, suspended, etc.
CodeDisplayDefinition
activeActiveThe device is available for use. Note: For *implanted devices* this means that the device is implanted in the patient.
inactiveInactiveThe device is no longer available for use (e.g. lost, expired, damaged). Note: For *implanted devices* this means that the device has been removed from the patient.
entered-in-errorEntered in ErrorThe device was entered in error and voided.
unknownUnknownThe status of the device has not been determined.

CodeSystem:GoalAcceptanceStatus

Codes indicating whether the goal has been accepted by a stakeholder.
CodeDisplayDefinition
agreeAgreeStakeholder supports pursuit of the goal.
disagreeDisagreeStakeholder is not in support of the pursuit of the goal.
pendingPendingStakeholder has not yet made a decision on whether they support the goal.

CodeSystem:ConstraintSeverity

SHALL applications comply with this constraint?
CodeDisplayDefinition
errorErrorIf the constraint is violated, the resource is not conformant.
warningWarningIf the constraint is violated, the resource is conformant, but it is not necessarily following best practice.

CodeSystem:BasicResourceTypes

This value set defines codes for resources not yet supported by (or which will never be supported by) FHIR. Many of the codes listed here will eventually be turned into official resources. However, there is no guarantee that any particular resource will be created nor that the scope will be exactly as defined by the codes presented here. Codes in this set will be deprecated if/when formal resources are defined that encompass these concepts.
CodeDisplayDefinition
consentConsentAn assertion of permission for an activity or set of activities to occur, possibly subject to particular limitations; e.g. surgical consent, information disclosure consent, etc.
referralReferralA request that care of a particular type be provided to a patient. Could involve the transfer of care, a consult, etc.
adveventAdverse EventAn undesired reaction caused by exposure to some agent (e.g. a medication, immunization, food, or environmental agent).
aptmtreqAppointment RequestA request that a time be scheduled for a type of service for a specified patient, potentially subject to other constraints
transferTransferThe transition of a patient or set of material from one location to another
dietDietThe specification of a set of food and/or other nutritional material to be delivered to a patient.
adminactAdministrative ActivityAn occurrence of a non-care-related event in the healthcare domain, such as approvals, reviews, etc.
exposureExposureRecord of a situation where a subject was exposed to a substance. Usually of interest to public health.
investigationInvestigationA formalized inquiry into the circumstances surrounding a particular unplanned event or potential event for the purposes of identifying possible causes and contributing factors for the event
accountAccountA financial instrument used to track costs, charges or other amounts.
invoiceInvoiceA request for payment for goods and/or services. Includes the idea of a healthcare insurance claim.
adjudicatInvoice AdjudicationThe determination of what will be paid against a particular invoice based on coverage, plan rules, etc.
predetreqPre-determination RequestA request for a pre-determination of the cost that would be paid under an insurance plan for a hypothetical claim for goods or services
predeterminePredeterminationAn adjudication of what would be paid under an insurance plan for a hypothetical claim for goods or services
studyStudyAn investigation to determine information about a particular therapy or product
protocolProtocolA set of (possibly conditional) steps to be taken to achieve some aim. Includes study protocols, treatment protocols, emergency protocols, etc.

CodeSystem:CapabilityStatementKind

How a capability statement is intended to be used.
CodeDisplayDefinition
instanceInstanceThe CapabilityStatement instance represents the present capabilities of a specific system instance. This is the kind returned by /metadata for a FHIR server end-point.
capabilityCapabilityThe CapabilityStatement instance represents the capabilities of a system or piece of software, independent of a particular installation.
requirementsRequirementsThe CapabilityStatement instance represents a set of requirements for other systems to meet; e.g. as part of an implementation guide or 'request for proposal'.

CodeSystem:TestReportActionResult

The results of executing an action.
CodeDisplayDefinition
passPassThe action was successful.
skipSkipThe action was skipped.
failFailThe action failed.
warningWarningThe action passed but with warnings.
errorErrorThe action encountered a fatal error and the engine was unable to process.

CodeSystem:EnableWhenBehavior

Controls how multiple enableWhen values are interpreted - whether all or any must be true.
CodeDisplayDefinition
allAllEnable the question when all the enableWhen criteria are satisfied.
anyAnyEnable the question when any of the enableWhen criteria are satisfied.

CodeSystem:CompartmentType

Which type a compartment definition describes.
CodeDisplayDefinition
PatientPatientThe compartment definition is for the patient compartment.
EncounterEncounterThe compartment definition is for the encounter compartment.
RelatedPersonRelatedPersonThe compartment definition is for the related-person compartment.
PractitionerPractitionerThe compartment definition is for the practitioner compartment.
DeviceDeviceThe compartment definition is for the device compartment.

CodeSystem:QuestionnaireItemType

Distinguishes groups from questions and display text and indicates data type for questions.
CodeDisplayDefinition
groupGroupAn item with no direct answer but should have at least one child item.
displayDisplayText for display that will not capture an answer or have child items.
questionQuestionAn item that defines a specific answer to be captured, and which may have child items. (the answer provided in the QuestionnaireResponse should be of the defined datatype).

CodeSystem:StructureMapTransform

How data is copied/created.
CodeDisplayDefinition
createcreatecreate(type : string) - type is passed through to the application on the standard API, and must be known by it.
copycopycopy(source).
truncatetruncatetruncate(source, length) - source must be stringy type.
escapeescapeescape(source, fmt1, fmt2) - change source from one kind of escaping to another (plain, java, xml, json). note that this is for when the string itself is escaped.
castcastcast(source, type?) - case source from one type to another. target type can be left as implicit if there is one and only one target type known.
appendappendappend(source...) - source is element or string.
translatetranslatetranslate(source, uri_of_map) - use the translate operation.
referencereferencereference(source : object) - return a string that references the provided tree properly.
dateOpdateOpPerform a date operation. *Parameters to be documented*.
uuiduuidGenerate a random UUID (in lowercase). No Parameters.
pointerpointerReturn the appropriate string to put in a reference that refers to the resource provided as a parameter.
evaluateevaluateExecute the supplied FHIRPath expression and use the value returned by that.
ccccCreate a CodeableConcept. Parameters = (text) or (system. Code[, display]).
ccCreate a Coding. Parameters = (system. Code[, display]).
qtyqtyCreate a quantity. Parameters = (text) or (value, unit, [system, code]) where text is the natural representation e.g. [comparator]value[space]unit.
ididCreate an identifier. Parameters = (system, value[, type]) where type is a code from the identifier type value set.
cpcpCreate a contact details. Parameters = (value) or (system, value). If no system is provided, the system should be inferred from the content of the value.

CodeSystem:ListStatus

The current state of the list.
CodeDisplayDefinition
currentCurrentThe list is considered to be an active part of the patient's record.
retiredRetiredThe list is "old" and should no longer be considered accurate or relevant.
entered-in-errorEntered In ErrorThe list was never accurate. It is retained for medico-legal purposes only.

CodeSystem:ContactPointSystem

Telecommunications form for contact point.
CodeDisplayDefinition
phonePhoneThe value is a telephone number used for voice calls. Use of full international numbers starting with + is recommended to enable automatic dialing support but not required.
faxFaxThe value is a fax machine. Use of full international numbers starting with + is recommended to enable automatic dialing support but not required.
emailEmailThe value is an email address.
pagerPagerThe value is a pager number. These may be local pager numbers that are only usable on a particular pager system.
urlURLA contact that is not a phone, fax, pager or email address and is expressed as a URL. This is intended for various institutional or personal contacts including web sites, blogs, Skype, Twitter, Facebook, etc. Do not use for email addresses.
smsSMSA contact that can be used for sending an sms message (e.g. mobile phones, some landlines).
otherOtherA contact that is not a phone, fax, page or email address and is not expressible as a URL. E.g. Internal mail address. This SHOULD NOT be used for contacts that are expressible as a URL (e.g. Skype, Twitter, Facebook, etc.) Extensions may be used to distinguish "other" contact types.

CodeSystem:StructureMapInputMode

Mode for this instance of data.
CodeDisplayDefinition
sourceSource InstanceNames an input instance used a source for mapping.
targetTarget InstanceNames an instance that is being populated.

CodeSystem:CatalogType

The type of catalog.
CodeDisplayDefinition
medicationMedication CatalogMedication Catalog.
deviceDevice CatalogDevice Catalog.
protocolProtocol ListProtocol List.

CodeSystem:RelatedArtifactType

The type of relationship to the related artifact.
CodeDisplayDefinition
documentationDocumentationAdditional documentation for the knowledge resource. This would include additional instructions on usage as well as additional information on clinical context or appropriateness.
justificationJustificationA summary of the justification for the knowledge resource including supporting evidence, relevant guidelines, or other clinically important information. This information is intended to provide a way to make the justification for the knowledge resource available to the consumer of interventions or results produced by the knowledge resource.
citationCitationBibliographic citation for papers, references, or other relevant material for the knowledge resource. This is intended to allow for citation of related material, but that was not necessarily specifically prepared in connection with this knowledge resource.
predecessorPredecessorThe previous version of the knowledge resource.
successorSuccessorThe next version of the knowledge resource.
derived-fromDerived FromThe knowledge resource is derived from the related artifact. This is intended to capture the relationship in which a particular knowledge resource is based on the content of another artifact, but is modified to capture either a different set of overall requirements, or a more specific set of requirements such as those involved in a particular institution or clinical setting.
depends-onDepends OnThe knowledge resource depends on the given related artifact.
composed-ofComposed OfThe knowledge resource is composed of the given related artifact.

CodeSystem:GenderIdentity

This example value set defines a set of codes that can be used to indicate a patient's gender identity.
CodeDisplayDefinition
transgender-femaletransgender femalethe patient identifies as transgender male-to-female
transgender-maletransgender malethe patient identifies as transgender female-to-male
non-binarynon-binarythe patient identifies with neither/both female and male
malemalethe patient identifies as male
femalefemalethe patient identifies as female
otherotherother gender identity
non-disclosedoes not wish to disclosethe patient does not wish to disclose his gender identity

CodeSystem:StrengthOfRecommendationRating

A rating system that describes the strength of the recommendation, such as the GRADE, DynaMed, or HGPS systems.
CodeDisplayDefinition
strongStrongStrong recommendation.
weakWeakWeak recommendation.

CodeSystem:GraphCompartmentRule

How a compartment must be linked.
CodeDisplayDefinition
identicalIdenticalThe compartment must be identical (the same literal reference).
matchingMatchingThe compartment must be the same - the record must be about the same patient, but the reference may be different.
differentDifferentThe compartment must be different.
customCustomThe compartment rule is defined in the accompanying FHIRPath expression.

CodeSystem:ActivityDefinitionCategory

High-level categorization of the type of activity.
CodeDisplayDefinition
treatmentTreatmentThe activity is intended to provide or is related to treatment of the patient.
educationEducationThe activity is intended to provide or is related to education of the patient.
assessmentAssessmentThe activity is intended to perform or is related to assessment of the patient.

CodeSystem:IssueSeverity

How the issue affects the success of the action.
CodeDisplayDefinition
fatalFatalThe issue caused the action to fail and no further checking could be performed.
errorErrorThe issue is sufficiently important to cause the action to fail.
warningWarningThe issue is not important enough to cause the action to fail but may cause it to be performed suboptimally or in a way that is not as desired.
informationInformationThe issue has no relation to the degree of success of the action.

CodeSystem:StructureMapSourceListMode

If field is a list, how to manage the source.
CodeDisplayDefinition
firstFirstOnly process this rule for the first in the list.
not_firstAll but the firstProcess this rule for all but the first.
lastLastOnly process this rule for the last in the list.
not_lastAll but the lastProcess this rule for all but the last.
only_oneEnforce only oneOnly process this rule is there is only item.

CodeSystem:GoalRelationshipType

Types of relationships between two goals.
CodeDisplayDefinition
predecessorPredecessorIndicates that the target goal is one which must be met before striving for the current goal.
successorSuccessorIndicates that the target goal is a desired objective once the current goal is met.
replacementReplacementIndicates that this goal has been replaced by the target goal.
milestoneMilestoneIndicates that the target goal is considered to be a "piece" of attaining this goal.
otherOtherIndicates that the relationship is not covered by one of the pre-defined codes. (An extension may convey more information about the meaning of the relationship.).

CodeSystem:ClaimItemTypeCodes

This value set includes sample Item Type codes.
CodeDisplayDefinition
groupGroupA group of products and/or Services, amount ar the summary or detail level products and services.
productProductA billed product line item.
serviceServiceA billed service line item.

CodeSystem:AddressType

The type of an address (physical / postal).
CodeDisplayDefinition
postalPostalMailing addresses - PO Boxes and care-of addresses.
physicalPhysicalA physical address that can be visited.
bothPostal & PhysicalAn address that is both physical and postal.

CodeSystem:TypeDerivationRule

How a type relates to its baseDefinition.
CodeDisplayDefinition
specializationSpecializationThis definition defines a new type that adds additional elements to the base type.
constraintConstraintThis definition adds additional rules to an existing concrete type.

CodeSystem:AssertionResponseTypes

The type of response code to use for assertion.
CodeDisplayDefinition
okayokayResponse code is 200.
createdcreatedResponse code is 201.
noContentnoContentResponse code is 204.
notModifiednotModifiedResponse code is 304.
badbadResponse code is 400.
forbiddenforbiddenResponse code is 403.
notFoundnotFoundResponse code is 404.
methodNotAllowedmethodNotAllowedResponse code is 405.
conflictconflictResponse code is 409.
gonegoneResponse code is 410.
preconditionFailedpreconditionFailedResponse code is 412.
unprocessableunprocessableResponse code is 422.

CodeSystem:AllergyIntoleranceSubstanceExposureRisk

The risk of an adverse reaction (allergy or intolerance) for this patient upon exposure to the substance (including pharmaceutical products).
CodeDisplayDefinition
known-reaction-riskKnown Reaction RiskKnown risk of allergy or intolerance reaction upon exposure to the specified substance.
no-known-reaction-riskNo Known Reaction RiskNo known risk of allergy or intolerance reaction upon exposure to the specified substance.

CodeSystem:TestReportParticipantType

The type of participant.
CodeDisplayDefinition
test-engineTest EngineThe test execution engine.
clientClientA FHIR Client.
serverServerA FHIR Server.

CodeSystem:IdentifierUse

Identifies the purpose for this identifier, if known .
CodeDisplayDefinition
usualUsualThe identifier recommended for display and use in real-world interactions.
officialOfficialThe identifier considered to be most trusted for the identification of this item. Sometimes also known as "primary" and "main". The determination of "official" is subjective and implementation guides often provide additional guidelines for use.
tempTempA temporary identifier.
secondarySecondaryAn identifier that was assigned in secondary use - it serves to identify the object in a relative context, but cannot be consistently assigned to the same object again in a different context.
oldOldThe identifier id no longer considered valid, but may be relevant for search purposes. E.g. Changes to identifier schemes, account merges, etc.

CodeSystem:SearchComparator

What Search Comparator Codes are supported in search.
CodeDisplayDefinition
eqEqualsthe value for the parameter in the resource is equal to the provided value.
neNot Equalsthe value for the parameter in the resource is not equal to the provided value.
gtGreater Thanthe value for the parameter in the resource is greater than the provided value.
ltLess Thanthe value for the parameter in the resource is less than the provided value.
geGreater or Equalsthe value for the parameter in the resource is greater or equal to the provided value.
leLess of Equalthe value for the parameter in the resource is less or equal to the provided value.
saStarts Afterthe value for the parameter in the resource starts after the provided value.
ebEnds Beforethe value for the parameter in the resource ends before the provided value.
apApproximatelythe value for the parameter in the resource is approximately the same to the provided value.

CodeSystem:HL7Workgroup

An HL7 administrative unit that owns artifacts in the FHIR specification.
CodeDisplayDefinition
cbccCommunity Based Collaborative CareCommunity Based Collaborative Care (http://www.hl7.org/Special/committees/cbcc/index.cfm).
cdsClinical Decision SupportClinical Decision Support (http://www.hl7.org/Special/committees/dss/index.cfm).
cqiClinical Quality InformationClinical Quality Information (http://www.hl7.org/Special/committees/cqi/index.cfm).
cgClinical GenomicsClinical Genomics (http://www.hl7.org/Special/committees/clingenomics/index.cfm).
devHealth Care DevicesHealth Care Devices (http://www.hl7.org/Special/committees/healthcaredevices/index.cfm).
ehrElectronic Health RecordsElectronic Health Records (http://www.hl7.org/special/committees/ehr/index.cfm).
fhirFHIR InfrastructureFHIR Infrastructure (http://www.hl7.org/Special/committees/fiwg/index.cfm).
fmFinancial ManagementFinancial Management (http://www.hl7.org/Special/committees/fm/index.cfm).
hsiHealth Standards IntegrationHealth Standards Integration (http://www.hl7.org/Special/committees/hsi/index.cfm).
iiImaging IntegrationImaging Integration (http://www.hl7.org/Special/committees/imagemgt/index.cfm).
inmInfrastructure And MessagingInfrastructure And Messaging (http://www.hl7.org/special/committees/inm/index.cfm).
itsImplementable Technology SpecificationsImplementable Technology Specifications (http://www.hl7.org/special/committees/xml/index.cfm).
mnmModeling and MethodologyModeling and Methodology (http://www.hl7.org/Special/committees/mnm/index.cfm).
ooOrders and ObservationsOrders and Observations (http://www.hl7.org/Special/committees/orders/index.cfm).
paPatient AdministrationPatient Administration (http://www.hl7.org/Special/committees/pafm/index.cfm).
pcPatient CarePatient Care (http://www.hl7.org/Special/committees/patientcare/index.cfm).
pherPublic Health and Emergency ResponsePublic Health and Emergency Response (http://www.hl7.org/Special/committees/pher/index.cfm).
phxPharmacyPharmacy (http://www.hl7.org/Special/committees/medication/index.cfm).
brrBiomedical Research and RegulationBiomedical Research and Regulation (http://www.hl7.org/Special/committees/rcrim/index.cfm).
sdStructured DocumentsStructured Documents (http://www.hl7.org/Special/committees/structure/index.cfm).
secSecuritySecurity (http://www.hl7.org/Special/committees/secure/index.cfm).
usUS Realm TaskforceUS Realm Taskforce (http://www.hl7.org/Special/committees/usrealm/index.cfm).
vocabVocabularyVocabulary (http://www.hl7.org/Special/committees/Vocab/index.cfm).
aidApplication Implementation and DesignApplication Implementation and Design (http://www.hl7.org/Special/committees/java/index.cfm).

CodeSystem:ExpansionParameterSource

Declares what the source of a parameter is.
CodeDisplayDefinition
inputClient InputThe parameter was supplied by the client in the $expand request.
serverServer EngineThe parameter was added by the expansion engine on the server.
codesystemCode SystemThe parameter was added from one the code systems used in the $expand operation.

CodeSystem:GuideParameterCode

Code of parameter that is input to the guide.
CodeDisplayDefinition
applyApply Metadata ValueIf the value of this string 0..* parameter is one of the metadata fields then all conformance resources will have any specified [Resource].[field] overwritten with the ImplementationGuide.[field], where field is one of: version, date, status, publisher, contact, copyright, experimental, jurisdiction, useContext.
path-resourceResource PathThe value of this string 0..* parameter is a subfolder of the build context's location that is to be scanned to load resources. Scope is (if present) a particular resource type.
path-pagesPages PathThe value of this string 0..1 parameter is a subfolder of the build context's location that contains files that are part of the html content processed by the builder.
path-tx-cacheTerminology Cache PathThe value of this string 0..1 parameter is a subfolder of the build context's location that is used as the terminology cache. If this is not present, the terminology cache is on the local system, not under version control.
expansion-parameterExpansion ProfileThe value of this string 0..* parameter is a parameter (name=value) when expanding value sets for this implementation guide. This is particularly used to specify the versions of published terminologies such as SNOMED CT.
rule-broken-linksBroken Links RuleThe value of this string 0..1 parameter is either "warning" or "error" (default = "error"). If the value is "warning" then IG build tools allow the IG to be considered successfully build even when there is no internal broken links.
generate-xmlGenerate XMLThe value of this boolean 0..1 parameter specifies whether the IG publisher creates examples in XML format. If not present, the Publication Tool decides whether to generate XML.
generate-jsonGenerate JSONThe value of this boolean 0..1 parameter specifies whether the IG publisher creates examples in JSON format. If not present, the Publication Tool decides whether to generate JSON.
generate-turtleGenerate TurtleThe value of this boolean 0..1 parameter specifies whether the IG publisher creates examples in Turtle format. If not present, the Publication Tool decides whether to generate Turtle.
html-templateHTML TemplateThe value of this string singleton parameter is the name of the file to use as the builder template for each generated page (see templating).

CodeSystem:XPathUsageType

How a search parameter relates to the set of elements returned by evaluating its xpath query.
CodeDisplayDefinition
normalNormalThe search parameter is derived directly from the selected nodes based on the type definitions.
phoneticPhoneticThe search parameter is derived by a phonetic transform from the selected nodes.
nearbyNearbyThe search parameter is based on a spatial transform of the selected nodes.
distanceDistanceThe search parameter is based on a spatial transform of the selected nodes, using physical distance from the middle.
otherOtherThe interpretation of the xpath statement is unknown (and can't be automated).

CodeSystem:ExamplePharmacyServiceCodes

This value set includes a smattering of Pharmacy Service codes.
CodeDisplayDefinition
smokecessSmoking cessationSmoking cessation
flushotFlu ShotFlu Shot
drugcostDrug CostThe wholesale price of the medication.
markupMarkupThe additional cost assessed on the drug.
dispensefeeDispense FeeThe professional fee charged for dispensing the product or service.
compoundfeeCompounding FeeThe professional fee charged for compounding the medication.

CodeSystem:BundleType

Indicates the purpose of a bundle - how it is intended to be used.
CodeDisplayDefinition
documentDocumentThe bundle is a document. The first resource is a Composition.
messageMessageThe bundle is a message. The first resource is a MessageHeader.
transactionTransactionThe bundle is a transaction - intended to be processed by a server as an atomic commit.
transaction-responseTransaction ResponseThe bundle is a transaction response. Because the response is a transaction response, the transaction has succeeded, and all responses are error free.
batchBatchThe bundle is a set of actions - intended to be processed by a server as a group of independent actions.
batch-responseBatch ResponseThe bundle is a batch response. Note that as a batch, some responses may indicate failure and others success.
historyHistory ListThe bundle is a list of resources from a history interaction on a server.
searchsetSearch ResultsThe bundle is a list of resources returned as a result of a search/query interaction, operation, or message.
collectionCollectionThe bundle is a set of resources collected into a single package for ease of distribution that imposes no processing obligations or behavioral rules beyond persistence.

CodeSystem:StructureMapModelMode

How the referenced structure is used in this mapping.
CodeDisplayDefinition
sourceSource Structure DefinitionThis structure describes an instance passed to the mapping engine that is used a source of data.
queriedQueried Structure DefinitionThis structure describes an instance that the mapping engine may ask for that is used a source of data.
targetTarget Structure DefinitionThis structure describes an instance passed to the mapping engine that is used a target of data.
producedProduced Structure DefinitionThis structure describes an instance that the mapping engine may ask to create that is used a target of data.

CodeSystem:StatisticsCode

The statistical operation parameter -"statistic" codes.
CodeDisplayDefinition
averageAverageThe [mean](https://en.wikipedia.org/wiki/Arithmetic_mean) of N measurements over the stated period.
maximumMaximumThe [maximum](https://en.wikipedia.org/wiki/Maximal_element) value of N measurements over the stated period.
minimumMinimumThe [minimum](https://en.wikipedia.org/wiki/Minimal_element) value of N measurements over the stated period.
countCountThe [number] of valid measurements over the stated period that contributed to the other statistical outputs.
total-countTotal CountThe total [number] of valid measurements over the stated period, including observations that were ignored because they did not contain valid result values.
medianMedianThe [median](https://en.wikipedia.org/wiki/Median) of N measurements over the stated period.
std-devStandard DeviationThe [standard deviation](https://en.wikipedia.org/wiki/Standard_deviation) of N measurements over the stated period.
sumSumThe [sum](https://en.wikipedia.org/wiki/Summation) of N measurements over the stated period.
varianceVarianceThe [variance](https://en.wikipedia.org/wiki/Variance) of N measurements over the stated period.
20-percent20th PercentileThe 20th [Percentile](https://en.wikipedia.org/wiki/Percentile) of N measurements over the stated period.
80-percent80th PercentileThe 80th [Percentile](https://en.wikipedia.org/wiki/Percentile) of N measurements over the stated period.
4-lowerLower QuartileThe lower [Quartile](https://en.wikipedia.org/wiki/Quartile) Boundary of N measurements over the stated period.
4-upperUpper QuartileThe upper [Quartile](https://en.wikipedia.org/wiki/Quartile) Boundary of N measurements over the stated period.
4-devQuartile DeviationThe difference between the upper and lower [Quartiles](https://en.wikipedia.org/wiki/Quartile) is called the Interquartile range. (IQR = Q3-Q1) Quartile deviation or Semi-interquartile range is one-half the difference between the first and the third quartiles.
5-11st QuintileThe lowest of four values that divide the N measurements into a frequency distribution of five classes with each containing one fifth of the total population.
5-22nd QuintileThe second of four values that divide the N measurements into a frequency distribution of five classes with each containing one fifth of the total population.
5-33rd QuintileThe third of four values that divide the N measurements into a frequency distribution of five classes with each containing one fifth of the total population.
5-44th QuintileThe fourth of four values that divide the N measurements into a frequency distribution of five classes with each containing one fifth of the total population.
skewSkewSkewness is a measure of the asymmetry of the probability distribution of a real-valued random variable about its mean. The skewness value can be positive or negative, or even undefined. Source: [Wikipedia](https://en.wikipedia.org/wiki/Skewness).
kurtosisKurtosisKurtosis is a measure of the "tailedness" of the probability distribution of a real-valued random variable. Source: [Wikipedia](https://en.wikipedia.org/wiki/Kurtosis).
regressionRegressionLinear regression is an approach for modeling two-dimensional sample points with one independent variable and one dependent variable (conventionally, the x and y coordinates in a Cartesian coordinate system) and finds a linear function (a non-vertical straight line) that, as accurately as possible, predicts the dependent variable values as a function of the independent variables. Source: [Wikipedia](https://en.wikipedia.org/wiki/Simple_linear_regression) This Statistic code will return both a gradient and an intercept value.

CodeSystem:ProcedureProgressStatusCodes

This value set is provided as an example. The value set to instantiate this attribute should be drawn from a robust terminology code system that consists of or contains concepts to support the procedure performance process.
CodeDisplayDefinition
in-operating-roomIn Operating RoomA patient is in the Operating Room.
preparedPreparedThe patient is prepared for a procedure.
anesthesia-inducedAnesthesia InducedThe patient is under anesthesia.
open-incisionOpen IncisionThe patient has open incision(s).
closed-incisionClosed IncisionThe patient has incision(s) closed.
in-recovery-roomIn Recovery RoomThe patient is in the recovery room.

CodeSystem:Implant Status

A set codes that define the functional status of an implanted device.
CodeDisplayDefinition
functionalFunctionalThe implanted device is working normally.
non-functionalNon-FunctionalThe implanted device is not working.
disabledDisabledThe implanted device has been turned off.
unknownUnknownthe functional status of the implant has not been determined.

CodeSystem:ConceptMapEquivalence

The degree of equivalence between concepts.
CodeDisplayDefinition
relatedtoRelated ToThe concepts are related to each other, and have at least some overlap in meaning, but the exact relationship is not known.
unmatchedUnmatchedThere is no match for this concept in the target code system.

CodeSystem:DICOM Audit Message Record Lifecycle Events

Attached is vocabulary for the record lifecycle events, as per DICOM Audit Message,
CodeDisplayDefinition
1Origination / Creationundefined
2Import / Copyundefined
3Amendmentundefined
4Verificationundefined
5Translationundefined
6Access / Useundefined
7De-identificationundefined
8Aggregation / summarization / derivationundefined
9Reportundefined
10Exportundefined
11Disclosureundefined
12Receipt of disclosureundefined
13Archivingundefined
14Logical deletionundefined
15Permanent erasure / Physical destructionundefined

CodeSystem:FlagPriorityCodes

This value set is provided as an exemplar. The value set is driven by IHE Table B.8-4: Abnormal Flags, Alert Priority.
CodeDisplayDefinition
PNNo alarmNo alarm.
PLLow priorityLow priority.
PMMedium priorityMedium priority.
PHHigh priorityHigh priority.

CodeSystem:ChoiceListOrientation

Direction in which lists of possible answers should be displayed.
CodeDisplayDefinition
horizontalHorizontalList choices along the horizontal axis.
verticalVerticalList choices down the vertical axis.

CodeSystem:RestfulSecurityService

Types of security services used with FHIR.
CodeDisplayDefinition
OAuthOAuthOAuth (unspecified version see oauth.net).
SMART-on-FHIRSMART-on-FHIROAuth2 using SMART-on-FHIR profile (see http://docs.smarthealthit.org/).
NTLMNTLMMicrosoft NTLM Authentication.
BasicBasicBasic authentication defined in HTTP specification.
KerberosKerberossee http://www.ietf.org/rfc/rfc4120.txt.
CertificatesCertificatesSSL where client must have a certificate registered with the server.

CodeSystem:ExpansionProcessingRule

Defines how concepts are processed into the expansion when it's for UI presentation.
CodeDisplayDefinition
all-codesAll CodesThe expansion (when in UI mode) includes all codes *and* any defined groups (in extensions).
ungroupedGroups + Ungrouped codesThe expanion (when in UI mode) lists the groups, and then any codes that have not been included in a group.
groups-onlyGroups OnlyThe expansion (when in UI mode) only includes the defined groups.

CodeSystem:AlternativeCodeKind

Indicates the type of use for which the code is defined.
CodeDisplayDefinition
alternateAlternate CodeThe code is an alternative code that can be used in any of the circumstances that the primary code can be used.
deprecatedDeprecatedThe code should no longer be used, but was used in the past.
case-insensitiveCase InsensitiveThe code is an alternative to be used when a case insensitive code is required (when the primary codes are case sensitive).
case-sensitiveCase SensitiveThe code is an alternative to be used when a case sensitive code is required (when the primary codes are case insensitive).
expressionExpressionThe code is an alternative for the primary code that is built using the expression grammar defined by the code system.

CodeSystem:DiscriminatorType

How an element value is interpreted when discrimination is evaluated.
CodeDisplayDefinition
valueValueThe slices have different values in the nominated element.
existsExistsThe slices are differentiated by the presence or absence of the nominated element.
patternPatternThe slices have different values in the nominated element, as determined by testing them against the applicable ElementDefinition.pattern[x].
typeTypeThe slices are differentiated by type of the nominated element.
profileProfileThe slices are differentiated by conformance of the nominated element to a specified profile. Note that if the path specifies .resolve() then the profile is the target profile on the reference. In this case, validation by the possible profiles is required to differentiate the slices.

CodeSystem:FeedingDeviceCodes

Materials used or needed to feed the patient.
CodeDisplayDefinition
standard-nippleStandard nippleStandard nipple definition:
preemie-nipplePreemie nipplePreemie nipple definition:
ortho-nippleOrthodontic nippleOrthodontic nipple definition:
sloflo-nippleSlow flow nippleSlow flow nipple definition:
midflo-nippleMiddle flow nippleMiddle flow nipple definition:
bigcut-nippleEnlarged, cross-cut nippleEnlarged, cross-cut nipple definition:
haberman-bottleHaberman bottleHaberman bottle definition:
sippy-valveSippy cup with valveSippy cup with valve definition:
sippy-no-valveSippy cup without valveSippy cup without valve definition:
provale-cupProvale CupProvale Cup definition:
glass-lidGlass with lid/sippy cupGlass with lid/sippy cup definition:
handhold-cupDouble handhold on glass/cupDouble handhold on glass/cup definition:
rubber-matRubber matting under trayRubber matting under tray definition:
strawStrawStraw definition:
nose-cupNose cupNose cup definition:
scoop-plateScoop plateScoop plate definition:
utensil-holderHand wrap utensil holderHand wrap utensil holder definition:
foam-handleFoam handle utensilsFoam handle utensils definition:
angled-utensilAngled utensilsAngled utensils definition:
spout-cupSpout cupSpout cup definition:
autofeeding-deviceAutomated feeding devicesAutomated feeding devices definition:
rocker-knifeRocker knifeRocker knife definition:

CodeSystem:ISO 21089-2017 Health Record Lifecycle Events

Attached is vocabulary for the 27 record lifecycle events, as per ISO TS 21089-2017, Health Informatics - Trusted End-to-End Information Flows, Section 3, Terms and Definitions (2017, at ISO Central Secretariat, passed ballot and ready for publication). This will also be included in the FHIR EHR Record Lifecycle Event Implementation Guide, balloted and (to be) published with FHIR STU-3.
CodeDisplayDefinition
accessAccess/View Record Lifecycle EventOccurs when an agent causes the system to obtain and open a record entry for inspection or review.
holdAdd Legal Hold Record Lifecycle EventOccurs when an agent causes the system to tag or otherwise indicate special access management and suspension of record entry deletion/destruction, if deemed relevant to a lawsuit or which are reasonably anticipated to be relevant or to fulfill organizational policy under the legal doctrine of “duty to preserve”.
amendAmend (Update) Record Lifecycle EventOccurs when an agent makes any change to record entry content currently residing in storage considered permanent (persistent).
archiveArchive Record Lifecycle EventOccurs when an agent causes the system to create and move archive artifacts containing record entry content, typically to long-term offline storage.
attestAttest Record Lifecycle EventOccurs when an agent causes the system to capture the agent’s digital signature (or equivalent indication) during formal validation of record entry content.
decryptDecrypt Record Lifecycle EventOccurs when an agent causes the system to decode record entry content from a cipher.
deidentifyDe-Identify (Anononymize) Record Lifecycle EventOccurs when an agent causes the system to scrub record entry content to reduce the association between a set of identifying data and the data subject in a way that might or might not be reversible.
deprecateDeprecate Record Lifecycle EventOccurs when an agent causes the system to tag record entry(ies) as obsolete, erroneous or untrustworthy, to warn against its future use.
destroyDestroy/Delete Record Lifecycle EventOccurs when an agent causes the system to permanently erase record entry content from the system.
discloseDisclose Record Lifecycle EventOccurs when an agent causes the system to release, transfer, provision access to, or otherwise divulge record entry content.
encryptEncrypt Record Lifecycle EventOccurs when an agent causes the system to encode record entry content in a cipher.
extractExtract Record Lifecycle EventOccurs when an agent causes the system to selectively pull out a subset of record entry content, based on explicit criteria.
linkLink Record Lifecycle EventOccurs when an agent causes the system to connect related record entries.
mergeMerge Record Lifecycle EventOccurs when an agent causes the system to combine or join content from two or more record entries, resulting in a single logical record entry.
originateOriginate/Retain Record Lifecycle EventOccurs when an agent causes the system to: a) initiate capture of potential record content, and b) incorporate that content into the storage considered a permanent part of the health record.
pseudonymizePseudonymize Record Lifecycle EventOccurs when an agent causes the system to remove record entry content to reduce the association between a set of identifying data and the data subject in a way that may be reversible.
reactivateRe-activate Record Lifecycle EventOccurs when an agent causes the system to recreate or restore full status to record entries previously deleted or deprecated.
receiveReceive/Retain Record Lifecycle EventOccurs when an agent causes the system to a) initiate capture of data content from elsewhere, and b) incorporate that content into the storage considered a permanent part of the health record.
reidentifyRe-identify Record Lifecycle EventOccurs when an agent causes the system to restore information to data that allows identification of information source and/or information subject.
unholdRemove Legal Hold Record Lifecycle EventOccurs when an agent causes the system to remove a tag or other cues for special access management had required to fulfill organizational policy under the legal doctrine of “duty to preserve”.
reportReport (Output) Record Lifecycle EventOccurs when an agent causes the system to produce and deliver record entry content in a particular form and manner.
restoreRestore Record Lifecycle EventOccurs when an agent causes the system to recreate record entries and their content from a previous created archive artefact.
transformTransform/Translate Record Lifecycle EventOccurs when an agent causes the system to change the form, language or code system used to represent record entry content.
transmitTransmit Record Lifecycle EventOccurs when an agent causes the system to send record entry content from one (EHR/PHR/other) system to another.
unlinkUnlink Record Lifecycle EventOccurs when an agent causes the system to disconnect two or more record entries previously connected, rendering them separate (disconnected) again.
unmergeUnmerge Record Lifecycle EventOccurs when an agent causes the system to reverse a previous record entry merge operation, rendering them separate again.
verifyVerify Record Lifecycle EventOccurs when an agent causes the system to confirm compliance of data or data objects with regulations, requirements, specifications, or other imposed conditions based on organizational policy.

CodeSystem:ExampleUseCodesForList

Example use codes for the List resource - typical kinds of use.
CodeDisplayDefinition
alertsAlertsA list of alerts for the patient.
adverserxnsAdverse ReactionsA list of part adverse reactions.
allergiesAllergiesA list of Allergies for the patient.
medicationsMedication ListA list of medication statements for the patient.
problemsProblem ListA list of problems that the patient is known of have (or have had in the past).
worklistWorklistA list of items that constitute a set of work to be performed (typically this code would be specialized for more specific uses, such as a ward round list).
waitingWaiting ListA list of items waiting for an event (perhaps a surgical patient waiting list).
protocolsProtocolsA set of protocols to be followed.
plansCare PlansA set of care plans that apply in a particular context of care.

CodeSystem:ConditionalDeleteStatus

A code that indicates how the server supports conditional delete.
CodeDisplayDefinition
not-supportedNot SupportedNo support for conditional deletes.
singleSingle Deletes SupportedConditional deletes are supported, but only single resources at a time.
multipleMultiple Deletes SupportedConditional deletes are supported, and multiple resources can be deleted in a single interaction.

CodeSystem:SortDirection

The possible sort directions, ascending or descending.
CodeDisplayDefinition
ascendingAscendingSort by the value ascending, so that lower values appear first.
descendingDescendingSort by the value descending, so that lower values appear last.

CodeSystem:AssertionOperatorType

The type of operator to use for assertion.
CodeDisplayDefinition
equalsequalsDefault value. Equals comparison.
notEqualsnotEqualsNot equals comparison.
ininCompare value within a known set of values.
notInnotInCompare value not within a known set of values.
greaterThangreaterThanCompare value to be greater than a known value.
lessThanlessThanCompare value to be less than a known value.
emptyemptyCompare value is empty.
notEmptynotEmptyCompare value is not empty.
containscontainsCompare value string contains a known value.
notContainsnotContainsCompare value string does not contain a known value.
evalevaluateEvaluate the FHIRPath expression as a boolean condition.

CodeSystem:GuidePageGeneration

A code that indicates how the page is generated.
CodeDisplayDefinition
htmlHTMLPage is proper xhtml with no templating. Will be brought across unchanged for standard post-processing.
markdownMarkdownPage is markdown with templating. Will use the template to create a file that imports the markdown file prior to post-processing.
xmlXMLPage is xml with templating. Will use the template to create a file that imports the source file and run the nominated XSLT transform (see parameters) if present prior to post-processing.
generatedGeneratedPage will be generated by the publication process - no source to bring across.

CodeSystem:SubscriptionChannelType

The type of method used to execute a subscription.
CodeDisplayDefinition
rest-hookRest HookThe channel is executed by making a post to the URI. If a payload is included, the URL is interpreted as the service base, and an update (PUT) is made.
websocketWebsocketThe channel is executed by sending a packet across a web socket connection maintained by the client. The URL identifies the websocket, and the client binds to this URL.
emailEmailThe channel is executed by sending an email to the email addressed in the URI (which must be a mailto:).
smsSMSThe channel is executed by sending an SMS message to the phone number identified in the URL (tel:).
messageMessageThe channel is executed by sending a message (e.g. a Bundle with a MessageHeader resource etc.) to the application identified in the URI.

CodeSystem:ReferenceHandlingPolicy

A set of flags that defines how references are supported.
CodeDisplayDefinition
literalLiteral ReferencesThe server supports and populates Literal references (i.e. using Reference.reference) where they are known (this code does not guarantee that all references are literal; see 'enforced').
logicalLogical ReferencesThe server allows logical references (i.e. using Reference.identifier).
resolvesResolves ReferencesThe server will attempt to resolve logical references to literal references - i.e. converting Reference.identifier to Reference.reference (if resolution fails, the server may still accept resources; see logical).
enforcedReference Integrity EnforcedThe server enforces that references have integrity - e.g. it ensures that references can always be resolved. This is typically the case for clinical record systems, but often not the case for middleware/proxy systems.
localLocal References OnlyThe server does not support references that point to other servers.

CodeSystem:LanguagePreferenceType

This value set defines the set of codes for describing the type or mode of the patient's preferred language.
CodeDisplayDefinition
verbalverbalThe patient prefers to verbally communicate with the associated language.
writtenwrittenThe patient prefers to communicate in writing with the associated language.

CodeSystem:SecurityRoleType

This CodeSystem contains Additional FHIR-defined Security Role types not defined elsewhere
CodeDisplayDefinition
authserverauthorization serverAn entity providing authorization services to enable the electronic sharing of health-related information based on resource owner's preapproved permissions. For example, an UMA Authorization Server[UMA]
datacollectordata collectorAn entity that collects information over which the data subject may have certain rights under policy or law to control that information's management and distribution by data collectors, including the right to access, retrieve, distribute, or delete that information.
dataprocessordata processorAn entity that processes collected information over which the data subject may have certain rights under policy or law to control that information's management and distribution by data processors, including the right to access, retrieve, distribute, or delete that information.
datasubjectdata subjectA person whose personal information is collected or processed, and who may have certain rights under policy or law to control that information's management and distribution by data collectors or processors, including the right to access, retrieve, distribute, or delete that information.
humanuserhuman userThe human user that has participated.

CodeSystem:ObservationCategoryCodes

Codes to denote a guideline or policy statement.when a genetic test result is being shared as a secondary finding.
CodeDisplayDefinition
acmg-version1ACMG Version 1First release (2013): ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3727274/
acmg-version2ACMG Version 2Second release (2016): Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. https://www.ncbi.nlm.nih.gov/pubmed/27854360

CodeSystem:SearchModifierCode

A supported modifier for a search parameter.
CodeDisplayDefinition
missingMissingThe search parameter returns resources that have a value or not.
exactExactThe search parameter returns resources that have a value that exactly matches the supplied parameter (the whole string, including casing and accents).
containsContainsThe search parameter returns resources that include the supplied parameter value anywhere within the field being searched.
notNotThe search parameter returns resources that do not contain a match.
textTextThe search parameter is processed as a string that searches text associated with the code/value - either CodeableConcept.text, Coding.display, or Identifier.type.text.
inInThe search parameter is a URI (relative or absolute) that identifies a value set, and the search parameter tests whether the coding is in the specified value set.
not-inNot InThe search parameter is a URI (relative or absolute) that identifies a value set, and the search parameter tests whether the coding is not in the specified value set.
belowBelowThe search parameter tests whether the value in a resource is subsumed by the specified value (is-a, or hierarchical relationships).
aboveAboveThe search parameter tests whether the value in a resource subsumes the specified value (is-a, or hierarchical relationships).
typeTypeThe search parameter only applies to the Resource Type specified as a modifier (e.g. the modifier is not actually :type, but :Patient etc.).
identifierIdentifierThe search parameter applies to the identifier on the resource, not the reference.
ofTypeOf TypeThe search parameter has the format system|code|value, where the system and code refer to an Identifier.type.coding.system and .code, and match if any of the type codes match. All 3 parts must be present.

CodeSystem:SignatureTypeCodes

The Digital Signature Purposes, an indication of the reason an entity signs a document. This is included in the signed information and can be used when determining accountability for various actions concerning the document. Examples include: author, transcriptionist/recorder, and witness.
CodeDisplayDefinition
1.2.840.10065.1.12.1.1Author's Signaturethe signature of the primary or sole author of a health information document. There can be only one primary author of a health information document.
1.2.840.10065.1.12.1.2Coauthor's Signaturethe signature of a health information document coauthor. There can be multiple coauthors of a health information document.
1.2.840.10065.1.12.1.3Co-participant's Signaturethe signature of an individual who is a participant in the health information document but is not an author or coauthor. (Example a surgeon who is required by institutional, regulatory, or legal rules to sign an operative report, but who was not involved in the authorship of that report.)
1.2.840.10065.1.12.1.4Transcriptionist/Recorder Signaturethe signature of an individual who has transcribed a dictated document or recorded written text into a digital machine readable format.
1.2.840.10065.1.12.1.5Verification Signaturea signature verifying the information contained in a document. (Example a physician is required to countersign a verbal order that has previously been recorded in the medical record by a registered nurse who has carried out the verbal order.)
1.2.840.10065.1.12.1.6Validation Signaturea signature validating a health information document for inclusion in the patient record. (Example a medical student or resident is credentialed to perform history or physical examinations and to write progress notes. The attending physician signs the history and physical examination to validate the entry for inclusion in the patient's medical record.)
1.2.840.10065.1.12.1.7Consent Signaturethe signature of an individual consenting to what is described in a health information document.
1.2.840.10065.1.12.1.8Signature Witness Signaturethe signature of a witness to any other signature.
1.2.840.10065.1.12.1.9Event Witness Signaturethe signature of a witness to an event. (Example the witness has observed a procedure and is attesting to this fact.)
1.2.840.10065.1.12.1.10Identity Witness Signaturethe signature of an individual who has witnessed another individual who is known to them signing a document. (Example the identity witness is a notary public.)
1.2.840.10065.1.12.1.11Consent Witness Signaturethe signature of an individual who has witnessed the health care provider counselling a patient.
1.2.840.10065.1.12.1.12Interpreter Signaturethe signature of an individual who has translated health care information during an event or the obtaining of consent to a treatment.
1.2.840.10065.1.12.1.13Review Signaturethe signature of a person, device, or algorithm that has reviewed or filtered data for inclusion into the patient record. ( Examples: (1) a medical records clerk who scans a document for inclusion in the medical record, enters header information, or catalogues and classifies the data, or a combination thereof; (2) a gateway that receives data from another computer system and interprets that data or changes its format, or both, before entering it into the patient record.)
1.2.840.10065.1.12.1.14Source Signaturethe signature of an automated data source. (Examples: (1) the signature for an image that is generated by a device for inclusion in the patient record; (2) the signature for an ECG derived by an ECG system for inclusion in the patient record; (3) the data from a biomedical monitoring device or system that is for inclusion in the patient record.)
1.2.840.10065.1.12.1.15Addendum Signaturethe signature on a new amended document of an individual who has corrected, edited, or amended an original health information document. An addendum signature can either be a signature type or a signature sub-type (see 8.1). Any document with an addendum signature shall have a companion document that is the original document with its original, unaltered content, and original signatures. The original document shall be referenced via an attribute in the new document, which contains, for example, the digest of the old document. Whether the original, unaltered, document is always displayed with the addended document is a local matter, but the original, unaltered, document must remain as part of the patient record and be retrievable on demand.
1.2.840.10065.1.12.1.16Modification Signaturethe signature on an original document of an individual who has generated a new amended document. This (original) document shall reference the new document via an additional signature purpose. This is the inverse of an addendum signature and provides a pointer from the original to the amended document.
1.2.840.10065.1.12.1.17Administrative (Error/Edit) Signaturethe signature of an individual who is certifying that the document is invalidated by an error(s), or is placed in the wrong chart. An administrative (error/edit) signature must include an addendum to the document and therefore shall have an addendum signature sub-type (see 8.1). This signature is reserved for the highest health information system administrative classification, since it is a statement that the entire document is invalidated by the error and that the document should no longer be used for patient care, although for legal reasons the document must remain part of the permanent patient record.
1.2.840.10065.1.12.1.18Timestamp Signaturethe signature by an entity or device trusted to provide accurate timestamps. This timestamp might be provided, for example, in the signature time attribute.

CodeSystem:ExtensionContextType

How an extension context is interpreted.
CodeDisplayDefinition
fhirpathFHIRPathThe context is all elements that match the FHIRPath query found in the expression.
elementElement IDThe context is any element that has an ElementDefinition.id that matches that found in the expression. This includes ElementDefinition Ids that have slicing identifiers. The full path for the element is [url]#[elementid]. If there is no #, the Element id is one defined in the base specification.
extensionExtension URLThe context is a particular extension from a particular StructureDefinition, and the expression is just a uri that identifies the extension.

CodeSystem:ConformanceExpectation

Indicates the degree of adherence to a specified behavior or capability expected for a system to be deemed conformant with a specification.
CodeDisplayDefinition
SHALLSHALLSupport for the specified capability is required to be considered conformant.
SHOULDSHOULDSupport for the specified capability is strongly encouraged, and failure to support it should only occur after careful consideration.
MAYMAYSupport for the specified capability is not necessary to be considered conformant, and the requirement should be considered strictly optional.
SHOULD-NOTSHOULD-NOTSupport for the specified capability is strongly discouraged and should occur only after careful consideration.

CodeSystem:ResourceSecurityCategory

Provides general guidance around the kind of access Control to Read, Search, Create, Update, or Delete a resource.
CodeDisplayDefinition
anonymousAnonymous READ Access ResourceThese resources tend to not contain any individual data, or business sensitive data. Most often these Resources will be available for anonymous access, meaning there is no access control based on the user or system requesting. However these Resources do tend to contain important information that must be authenticated back to the source publishing them, and protected from integrity failures in communication. For this reason server authenticated https (TLS) is recommended to provide authentication of the server and integrity protection in transit. This is normal web-server use of https.
businessBusiness Sensitive ResourceThese Resources tend to not contain any individual data, but do have data that describe business or service sensitive data. The use of the term Business is not intended to only mean an incorporated business, but rather the more broad concept of an organization, location, or other group that is not identifable as individuals. Often these resources will require some for of client authentication to assure that only authorized access is given. The client access control may be to individuals, or may be to system identity. For this purpose possible client authentication methods such as: mutual-authenticated-TLS, APIKey, App signed JWT, or App OAuth client-id JWT For example: a App that uses a Business protected Provider Directory to determine other business endpoint details.
individualIndividual Sensitive ResourceThese Resources do NOT contain Patient data, but do contain individual information about other participants. These other individuals are Practitioners, PractionerRole, CareTeam, or other users. These identities are needed to enable the practice of healthcare. These identities are identities under general privacy regulations, and thus must consider Privacy risk. Often access to these other identities are covered by business relationships. For this purpose access to these Resources will tend to be Role specific using methods such as RBAC or ABAC.
patientPatient SensitiveThese Resources make up the bulk of FHIR and therefore are the most commonly understood. These Resources contain highly sesitive health information, or are closely linked to highly sensitive health information. These Resources will often use the security labels to differentiate various confidentiality levels within this broad group of Patient Sensitive data. Access to these Resources often requires a declared Purpose Of Use. Access to these Resources is often controlled by a Privacy Consent.
not-classifiedNot classifiedSome Resources can be used for a wide scope of use-cases that span very sensitive to very non-sensitive. These Resources do not fall into any of the above classifications, as their sensitivity is highly variable. These Resources will need special handling. These Resources often contain metadata that describes the content in a way that can be used for Access Control decisions.

CodeSystem:QuantityComparator

How the Quantity should be understood and represented.
CodeDisplayDefinition
<Less thanThe actual value is less than the given value.
<=Less or Equal toThe actual value is less than or equal to the given value.
>=Greater or Equal toThe actual value is greater than or equal to the given value.
>Greater thanThe actual value is greater than the given value.

CodeSystem:DocumentMode

Whether the application produces or consumes documents.
CodeDisplayDefinition
producerProducerThe application produces documents of the specified type.
consumerConsumerThe application consumes documents of the specified type.

CodeSystem:AbstractType

A list of the base types defined by this version of the FHIR specification - types that are defined, but for which only specializations actually are created.
CodeDisplayDefinition
TypeTypeA place holder that means any kind of data type
AnyAnyA place holder that means any kind of resource

CodeSystem:QuestionnaireItemUIControlCodes

Starter set of user interface control/display mechanisms that might be used when rendering an item in a questionnaire.
CodeDisplayDefinition
groupundefinedUI controls relevant to organizing groups of questions
textundefinedUI controls relevant to rendering questionnaire text items
questionundefinedUI controls relevant to capturing question data

CodeSystem:FinancialTaskInputTypeCodes

This value set includes Financial Task Input Type codes.
CodeDisplayDefinition
includeIncludeThe name of a resource to include in a selection.
excludeExcludeThe name of a resource to not include in a selection.
origresponseOriginal ResponseA reference to the response resource to the original processing of a resource.
referenceReference NumberA reference value which must be quoted to authorize an action.
itemItem NumberThe sequence number associated with an item for reprocessing.
periodPeriodThe reference period for the action being requested.
statusStatus codeThe processing status from a check on the processing status of a resource such as the adjudication of a claim.

CodeSystem:SearchParamType

Data types allowed to be used for search parameters.
CodeDisplayDefinition
numberNumberSearch parameter SHALL be a number (a whole number, or a decimal).
dateDate/DateTimeSearch parameter is on a date/time. The date format is the standard XML format, though other formats may be supported.
stringStringSearch parameter is a simple string, like a name part. Search is case-insensitive and accent-insensitive. May match just the start of a string. String parameters may contain spaces.
tokenTokenSearch parameter on a coded element or identifier. May be used to search through the text, display, code and code/codesystem (for codes) and label, system and key (for identifier). Its value is either a string or a pair of namespace and value, separated by a "|", depending on the modifier used.
referenceReferenceA reference to another resource (Reference or canonical).
compositeCompositeA composite search parameter that combines a search on two values together.
quantityQuantityA search parameter that searches on a quantity.
uriURIA search parameter that searches on a URI (RFC 3986).
specialSpecialSpecial logic applies to this parameter per the description of the search parameter.

CodeSystem:ExampleService/ProductCodes

This value set includes a smattering of Service/Product codes.
CodeDisplayDefinition
examExamExam
flushotFlu shotFlu shot

CodeSystem:NameUse

The use of a human name.
CodeDisplayDefinition
usualUsualKnown as/conventional/the one you normally use.
officialOfficialThe formal name as registered in an official (government) registry, but which name might not be commonly used. May be called "legal name".
tempTempA temporary name. Name.period can provide more detailed information. This may also be used for temporary names assigned at birth or in emergency situations.
nicknameNicknameA name that is used to address the person in an informal manner, but is not part of their formal or usual name.
anonymousAnonymousAnonymous assigned name, alias, or pseudonym (used to protect a person's identity for privacy reasons).
oldOldThis name is no longer in use (or was never correct, but retained for records).

CodeSystem:DoseAndRateType

The kind of dose or rate specified.
CodeDisplayDefinition
calculatedCalculatedThe dose specified is calculated by the prescriber or the system.
orderedOrderedThe dose specified is as ordered by the prescriber.

CodeSystem:PractitionerSpecialty

This example value set defines a set of codes that can be used to indicate the specialty of a Practitioner.
CodeDisplayDefinition
cardioCardiologistundefined
dentDentistundefined
dietaryDietary consultantundefined
midwMidwifeundefined
sysarchSystems architectundefined

CodeSystem:FMConditionCodes

This value set includes sample Conditions codes.
CodeDisplayDefinition
123987HeadacheHeadache

CodeSystem:NarrativeStatus

The status of a resource narrative.
CodeDisplayDefinition
generatedGeneratedThe contents of the narrative are entirely generated from the core elements in the content.
extensionsExtensionsThe contents of the narrative are entirely generated from the core elements in the content and some of the content is generated from extensions. The narrative SHALL reflect the impact of all modifier extensions.
additionalAdditionalThe contents of the narrative may contain additional information not found in the structured data. Note that there is no computable way to determine what the extra information is, other than by human inspection.
emptyEmptyThe contents of the narrative are some equivalent of "No human-readable text provided in this case".

CodeSystem:ExampleScenarioActorType

The type of actor - system or human.
CodeDisplayDefinition
personPersonA person.
entitySystemA system.

CodeSystem:ContributorType

The type of contributor.
CodeDisplayDefinition
authorAuthorAn author of the content of the module.
editorEditorAn editor of the content of the module.
reviewerReviewerA reviewer of the content of the module.
endorserEndorserAn endorser of the content of the module.

CodeSystem:DICOM Controlled Terminology Definitions

DICOM Code Definitions (Coding Scheme Designator "DCM" Coding Scheme Version "01")
CodeDisplayDefinition
ARCHIVEArchiveArchive device
ARAutorefractionAutorefraction device
ASAngioscopyAngioscopy device
AUAudioAudio object
BDUSUltrasound Bone DensitometryUltrasound Bone Densitometry (modality)
BIBiomagnetic imagingBiomagnetic imaging device
BMDBone Mineral DensitometryBone Mineral Densitometry by X-Ray (modality), including dual-energy X-Ray absorptiometry (DXA) and morphometric X-Ray absorptiometry (MXA)
CADComputer Assisted Detection/DiagnosisComputer Assisted Detection/Diagnosis device
CAPTUREImage CaptureImage Capture Device, includes video capture
CDColor flow DopplerColor flow Doppler
CFCinefluorographyCinefluorography
COMPComputation ServerComputation Server; includes radiotherapy planning
CPCulposcopyCulposcopy
CRComputed RadiographyComputed Radiography device
CSCystoscopyCystoscopy
CTComputed TomographyComputed Tomography device
DDDuplex DopplerDuplex Doppler
DFDigital fluoroscopyDigital fluoroscopy
DGDiaphanographyDiaphanography device
DMDigital microscopyDigital microscopy
DOCDDocument Digitizer EquipmentEquipment that digitized hardcopy documents and imported them
DSDigital Subtraction AngiographyDigital Subtraction Angiography
DSSDepartment System SchedulerDepartment System Scheduler, workflow manager; includes RIS
DXDigital RadiographyDigital Radiography device
ECEchocardiographyEchocardiography
ECGElectrocardiographyElectrocardiography device
EPSCardiac ElectrophysiologyCardiac Electrophysiology device
ESEndoscopyEndoscopy device
FFemaleFemale sex
FAFluorescein angiographyFluorescein angiography
FCFemale changed to MaleFemale sex changed to Male sex
FILMDFilm DigitizerFilm Digitizer
FPFemale PseudohermaphroditeFemale Pseudohermaphrodite
FSFundoscopyFundoscopy
GMGeneral MicroscopyGeneral Microscopy device
HHermaphroditeHermaphrodite
HCHard CopyHard Copy
HDHemodynamic WaveformHemodynamic Waveform acquisition device
IOIntra-oral RadiographyIntra-oral Radiography device
IVOCTIntravascular Optical Coherence TomographyAn acquisition device, process or method that performs intravascular optical coherence tomography
IVUSIntravascular UltrasoundIntravascular Ultrasound device
KERKeratometryKeratometry device
KOKey Object SelectionKey Object Selection object
LENLensometryLensometry device
LOGProcedure LoggingProcedure Logging device; includes cath lab logging
LPLaparoscopyLaparoscopy
LSLaser surface scanLaser surface scan device
MMaleMale sex
MAMagnetic resonance angiographyMagnetic resonance angiography
MCMale changed to FemaleMale sex changed to Female sex
MCDMedia Creation DeviceA device that creates DICOM PS3.10 interchange media; e.g. a CD creator that is managed by the Media Creation Management Service Class
MEDIMPortable Media Importer EquipmentEquipment that retrieved and imported objects from interchange Media
MGMammographyMammography device
MPMale PseudohermaphroditeMale Pseudohermaphrodite
MRMagnetic ResonanceMagnetic Resonance device
MSMagnetic resonance spectroscopyMagnetic resonance spectroscopy
NEARLINENearlineInstances need to be retrieved from relatively slow media such as optical disk or tape
NMNuclear MedicineNuclear Medicine device
OAMOphthalmic Axial MeasurementsMeasurements of the axial length of the eye, which are done by various devices
OCTOptical Coherence TomographyModality device that uses an interferometric, non-invasive optical tomographic technique to image 2D slices and 3D volumes of tissue using visible and near visible frequencies
OFFLINEOfflineInstances need to be retrieved by manual intervention
ONLINEOnlineInstances are immediately available
OPOphthalmic photographyOphthalmic photography modality
OPMOphthalmic MappingModality device that measures corneal topography, corneal or retinal thickness, and other similar parameters that are typically displayed as maps
OPROphthalmic RefractionModality device that measures the refractive characteristics of the eye
OPTOphthalmic TomographyTomography of the eye acquired by a modality that is based on light and optical principles. Tomography based on other principles, such as ultrasound, is excluded
OPVOphthalmic Visual FieldModality device that measures visual fields and perform visual perimetry
OSSOptical Survace ScannerAn acquisition device, process or method that performs optical surface scanning
OTOther ModalityOther Modality device
PRPresentation StatePresentation State object
PRINTHard Copy Print ServerHard Copy Print Server; includes printers with embedded DICOM print server
PTPositron emission tomographyPositron emission tomography (PET) device
PXPanoramic X-RayPanoramic X-Ray device
REGRegistrationRegistration
RFRadiofluoroscopyRadiofluoroscopy device
RGRadiographic imagingRadiographic imaging (conventional film/screen)
RTRadiation Therapy DeviceRadiation Therapy Device; includes linear accelerator, proton therapy
RTDOSERadiotherapy DoseRadiotherapy Dose
RTIMAGERadiotherapy ImageRadiotherapy Imaging device; includes portal imaging
RTPLANRadiotherapy PlanRadiotherapy Plan
RTRECORDRadiotherapy Treatment RecordRadiotherapy Treatment Record
RTSTRUCTRadiotherapy Structure SetRadiotherapy Structure Set
SEGSegmentationSegmentation
SMSlide MicroscopySlide Microscopy
SMRStereometric RelationshipStereometric image pairing modality
SRStructured Report DocumentStructured Report Document
SRFSubjective RefractionSubjective Refraction device
STSingle-photon emission computed tomographySingle-photon emission computed tomography (SPECT) device
TGThermographyThermography device
UUnknown SexUnknown Sex
UNAVAILABLEUnavailableInstances cannot be retrieved
USUltrasoundUltrasound device
VAVisual AcuityVisual Acuity device
VFVideofluorographyVideofluorography
VIDDVideo Tape Digitizer EquipmentEquipment that digitizes video tape and imports it
WSDWorkstationWorkstation
XAX-Ray AngiographyX-Ray Angiography device
XCExternal-camera PhotographyExternal-camera Photography device
109001Digital timecode (NOS)A signal transmitted for the purpose of interchange of the current time, not specific to any source or methodology
109002ECG-based gating signal, processedA signal that is generated for each detection of a heart beat
109003IRIG-B timecodeA signal transmitted by the Inter-Range Instrumentation Group for the purpose of synchronizing time clocks
109004X-Ray Fluoroscopy On SignalA signal that indicated that X-Ray source has been activated for fluoroscopy use
109005X-Ray On TriggerA signal that indicated that the X-Ray source has been activated for image recording
109006Differential signalAn electrical signal derived from two electrodes
109007His bundle electrogramAn electrophysiological recording from the HIS nerve bundle
109008Monopole signalAn electrical signal from one electrode relative to an indifferent potential
109009Pacing (electrical) stimulus, voltageThe voltage stimulus during cardiac pacing
109010Radio frequency ablation, powerThe power injected during RF ablation procedure
109011Voltage measurement by basket catheterElectrophysiological signals acquired using a multi-splined catheter each equipped with multiple electrodes
109012Voltage measurement by mapping catheterElectrophysiological signals acquired using a steerable catheter
109013Voltage measurement, NOSA voltage measurement not otherwise specified
10901435% of thermal COA signal point that is 35% of the peak thermal cardiac output signal
10901570% of thermal COA signal point that is 70% of the peak thermal cardiac output signal
109016A wave peak pressureThe peak pressure of each heart beat in the atrium caused by the atrial contraction
109017A wave pressure, averageThe average of several A wave pressure measurements
109018Beat detected (accepted)An identified cardiac beat used in the determination of a measurement
109019Beat detected (rejected)An identified cardiac beat not used in the determination of a measurement
109020Diastolic pressure, averageThe average of several diastolic pressure measurements
109021Diastolic pressure nadirThe lowest pressure value excluding any undershoot artifact
109022End diastoleThe moment at the end of the diastolic phase of the cardiac cycle
109023End of expirationThe moment at the end of respiratory expiration
109024End of inspirationThe moment at the end of respiratory inspiration
109025Max dp/dtThe maximum positive rate of change of pressure
109026Max neg dp/dtThe maximum negative rate of change of pressure
109027Mean blood pressureThe average blood pressure value, generally over 2 or more seconds
109028Peak of thermal cardiac output bolusThe peak change in blood temperature during a thermal cardiac output measurement
109029Start of expirationThe moment respiratory expiration begins
109030Start of inspirationThe moment of respiratory inspiration begins
109031Start of thermal cardiac output bolusThe first discernible blood temperature change following the injectate during a thermal cardiac output measurement
109032Systolic pressure, averageThe average of several systolic blood pressure measurements
109033Systolic peak pressureThe highest systolic blood pressure value excluding any overshoot artifact
109034V wave peak pressureThe peak pressure of each heart beat in the atrium caused by the filling of the atrium
109035V wave pressure, averageThe average of several V wave pressure measurements
109036Valve closeThe moment at which a heart valve closes
109037Valve openThe moment at which a heart valve opens
109038Ablation offThe moment when RF ablation current is turned off
109039Ablation onThe moment when RF ablation current is turned on
109040HIS bundle waveThe moment in the cardiac cycle when the HIS bundle nerves depolarize
109041P waveThe surface electrocardiogram of the atrial contraction
109042Q waveThe first negative deflection of the electrocardiogram caused by ventricular depolarization
109043R waveThe first positive deflection the electrocardiogram caused by ventricular depolarization
109044S waveThe first negative deflection after the R wave
109045Start of atrial contractionThe beginning of the atrial contraction
109046Start of atrial contraction (subsequent)The beginning of the second atrial contraction of two consecutive beats
109047Stimulation at rate 1 intervalThe stimulation interval during cardiac stimulation first used in a pacing train
109048Stimulation at rate 2 intervalThe stimulation interval different from the first stimulation interval used in a pacing train
109049Stimulation at rate 3 intervalA stimulation interval different from and subsequent to the second interval in a pacing train
109050Stimulation at rate 4 intervalDescribes a stimulation interval different from and subsequent to the third interval in a pacing train
109051T waveThe electrocardiogram deflection caused by ventricular repolarization
109052V waveThe peak pressure of each heart beat monitored in the atrium caused by the filling of the atrium
109053V wave of next beatThe second V wave measurement of two consecutive beats
109054Patient StateA description of the physiological condition of the patient
109055Protocol StageThe exercise level during a progressive cardiac stress test
109056Stress ProtocolA series of physiological challenges designed to progressively increase the work of the heart
109057Catheterization Procedure PhaseA subpart of a cardiac catheterization procedure
109058Contrast PhaseThe subpart of a cardiac catheterization procedure in which a radio-opaque contrast medium is injected into the patient
109059Physiological challengesPhysical changes administered to a patient in order to elicit an physiological response
109060Procedure Step NumberEnumeration of a subpart of a catheterization procedure
109061EP Procedure PhaseA subpart of an electrophysiological procedure
109063Pulse train definitionA means of defining a series of cardiac stimulation pulses
109070End of systoleEnd of the contraction phase of the cardiac cycle
109071Indicator mean transit timeTime for a median particle to travel from point of injection to point of detection
109072TauThe time constant of isovolumic pressure fall
109073V max myocardialMaximum velocity of myocardial contractility
109080Real time acquisitionTotal time for the acquisition is shorter than cardiac cycle, no gating is applied; see Cardiac Synchronization Technique (0018,9037)
109081Prospective gatingCertain thresholds have been set for a gating window that defines the acceptance of measurement data during the acquisition; see Cardiac Synchronization Technique (0018,9037)
109082Retrospective gatingCertain thresholds have been set for a gating window that defines the acceptance of measurement data after the acquisition; see Cardiac Synchronization Technique (0018,9037)
109083PacedThere is a constant RR interval, which makes thresholding not required; see Cardiac Synchronization Technique (0018,9037); e.g. Pacemaker
109091Cardiac Stress StateImaging after injection of tracer during increased cardiac workload or increased myocardial blood flow, achieved by either exercise or pharmacologic means
109092Reinjection StateImaging after injection of additional tracer under resting conditions
109093Redistribution StateImaging after allowing a moderate amount of time for tracer to move from its initial sites of uptake. Example: For Thallium imaging this would correspond to imaging 2-6 hours after injection
109094Delayed Redistribution StateImaging after allowing an extended amount of time for tracer to move from its initial sites of uptake. Example: For Thallium imaging this would correspond to imaging more than 6 hours after injection
109095Peak stress statePeak cardiac stress state
109096Recovery stateRecovery from cardiac stress
109101Acquisition EquipmentEquipment that originally acquired the data stored within composite instances; e.g. a CT, MR or Ultrasound modality
109102Processing EquipmentEquipment that has processed composite instances to create new composite instances; e.g. a 3D Workstation
109103Modifying EquipmentEquipment that has modified existing composite instances (without creating new composite instances); e.g. a QA Station or Archive
109104De-identifying EquipmentEquipment that has modified an existing composite instance to remove patient identifying information
109105Frame Extracting EquipmentEquipment that has processed composite instances to create new composite instances by extracting selected frames from the original instance
109106Enhanced Multi-frame Conversion EquipmentEquipment that has processed composite instances to create new composite instances by converting classic single frame images to enhanced multi-frame image, or vice versa and updating other instances to maintain referential integrity
109110VoiceThe sound of a human's speech, recorded during a procedure
109111Operator's narrativeThe voice of a device operator, recorded during a procedure
109112Ambient room environmentThe ambient sound recorded during a procedure, which may or may not include voice and other types of sound
109113Doppler audioThe Doppler waveform recorded as an audible signal
109114PhonocardiogramThe sound of the human heart beating
109115Physiological audio signalAny sound made by the human body
109116Arterial Pulse WaveformA digitized signal from the patient arterial system collected through pulse oximetry or other means
109117Respiration WaveformA digitized signal from the patient respiratory system representing respiration
109120On admission to unitThe occasion on which a procedure was performed on admission to a specialist unit; e.g. intensive care
109121On dischargeThe occasion on which a procedure was performed on discharge from hospital as an in-patient
109122On discharge from unitThe occasion on which a procedure was performed on discharge from a specialist unit; e.g. intensive care
109123Pre-interventionThe occasion on which a procedure was performed immediately prior to non-surgical intervention; e.g, percutaneous angioplasty, biopsy
109124Post-interventionThe occasion on which a procedure was performed immediately after to non-surgical intervention; e.g, percutaneous angioplasty, biopsy
109125At last appointmentThe occasion on which a procedure was performed at the most recent outpatient visit
109132Joint position methodThe active or passive joint positioning during acquisition
109133Physical forceA physical force applied during acquisition
109134Prior to voidingPrior to voiding
109135Post voidingPost voiding
109136Neutral musculoskeletal positionNeutral musculoskeletal position
109200America Kennel ClubAmerica Kennel Club
109201America's Pet Registry Inc.America's Pet Registry Inc
109202American Canine AssociationAmerican Canine Association
109203American Purebred RegistryAmerican Purebred Registry
109204American Rare Breed AssociationAmerican Rare Breed Association
109205Animal Registry UnlimitedAnimal Registry Unlimited
109206Animal Research FoundationAnimal Research Foundation
109207Canadian Border Collie AssociationCanadian Border Collie Association
109208Canadian Kennel ClubCanadian Kennel Club
109209Canadian Livestock Records AssociationCanadian Livestock Records Association
109210Canine Federation of CanadaCanine Federation of Canada
109211Continental Kennel ClubContinental Kennel Club
109212Dog Registry of AmericaDog Registry of America
109213Federation of International CaninesFederation of International Canines
109214International Progressive Dog Breeders' AllianceInternational Progressive Dog Breeders' Alliance
109215National Kennel ClubNational Kennel Club
109216North American Purebred Dog RegistryNorth American Purebred Dog Registry
109217United All Breed RegistryUnited All Breed Registry
109218United Kennel ClubUnited Kennel Club
109219Universal Kennel Club InternationalUniversal Kennel Club International
109220Working Canine Association of CanadaWorking Canine Association of Canada
109221World Kennel ClubWorld Kennel Club
109222World Wide Kennel ClubWorld Wide Kennel Club
109701Overall image quality evaluationEvaluation of overall image quality as described in section 7.3.2 of [IEC 62563-1]
109702Grayscale resolution evaluationVisual verification of sufficient grayscale resolution based on 8 and 10-bit markers as described in section 7.3.3 of [IEC 62563-1]
109703Luminance response evaluationVisual evaluation of luminance response using the TG18-CT test pattern as described in section 7.3.4 of [IEC 62563-1]
109704Luminance uniformity evaluationVisual detection of luminance non-uniformities as described in section 7.3.5 of [IEC 62563-1]
109705Chromaticity evaluationVisual verification of color uniformity as described in section 7.3.6 of [IEC 62563-1]
109706Pixel faults evaluationVisual detection of defective pixels on dark (TG18-UN80) and bright (TG18-UN10) images as described in section 7.3.7 of [IEC 62563-1]
109707Veiling glare evaluationVisual evaluation of veiling glare by looking at low contrast objects on 2 test patterns as described in section 7.3.8 of [IEC 62563-1]
109708Geometrical image evaluationVisual evaluation of geometry, phase/clock correction and clipping as described in section 7.3.9 of [IEC 62563-1]
109709Angular viewing evaluationVisual evaluation of viewing angle as described in section 7.3.10 of [IEC 62563-1]
109710Clinical evaluationVisual evaluation of the appearance of clinical images as described in section 7.3.11 of [IEC 62563-1]
109801TG18-QC PatternAAPM TG18-QC Pattern used for evaluation of resolution, luminance, distortion, artifacts. See [AAPM OR 03]
109802TG18-BR PatternAAPM TG18-BR Pattern used for the evaluation of the display of low-contrast, fine-detail image structures See [AAPM OR 03]
109803TG18-PQC PatternAAPM TG18-PQC Pattern used for evaluation of resolution, luminance, contrast transfer for prints. See [AAPM OR 03]
109804TG18-CT PatternAAPM TG18-CT Pattern used for evaluation of luminance response. See [AAPM OR 03]
109805TG18-LN8-01 PatternThe 1st image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109806TG18-LN8-02 PatternThe 2nd image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109807TG18-LN8-03 PatternThe 3rd image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109808TG18-LN8-04 PatternThe 4th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109809TG18-LN8-05 PatternThe 5th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109810TG18-LN8-06 PatternThe 6th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109811TG18-LN8-07 PatternThe 7th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109812TG18-LN8-08 PatternThe 8th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109813TG18-LN8-09 PatternThe 9th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109814TG18-LN8-10 PatternThe 10th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration series. See [AAPM OR 03]
109815TG18-LN8-11 PatternThe 11th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109816TG18-LN8-12 PatternThe 12th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109817TG18-LN8-13 PatternThe 13th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109818TG18-LN8-14 PatternThe 14th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109819TG18-LN8-15 PatternThe 15th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109820TG18-LN8-16 PatternThe 16th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109821TG18-LN8-17 PatternThe 17th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109822TG18-LN8-18 PatternThe 18th image in the AAPM TG18-LN8- set used for DICOM grayscale calibration. See [AAPM OR 03]
109823TG18-LN12-01 PatternThe 1st image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109824TG18-LN12-02 PatternThe 2 nd image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109825TG18-LN12-03 PatternThe 3rd image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109826TG18-LN12-04 PatternThe 4th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109827TG18-LN12-05 PatternThe 5th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109828TG18-LN12-06 PatternThe 6th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109829TG18-LN12-07 PatternThe 7th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109830TG18-LN12-08 PatternThe 8th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109831TG18-LN12-09 PatternThe 9th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109832TG18-LN12-10 PatternThe 10th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109833TG18-LN12-11 PatternThe 11th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109834TG18-LN12-12 PatternThe 12th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109835TG18-LN12-13 PatternThe 13th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109836TG18-LN12-14 PatternThe 14th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109837TG18-LN12-15 PatternThe 15th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109838TG18-LN12-16 PatternThe 16th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109839TG18-LN12-17 PatternThe 17th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109840TG18-LN12-18 PatternThe 18th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109841TG18-UN10 PatternThe AAPM TG18-UN10 Pattern used for evaluation of luminance and color uniformity, and angular response. See [AAPM OR 03]
109842TG18-UN80 PatternThe AAPM TG18-UN80 Pattern used for evaluation of luminance and color uniformity, and angular response. See [AAPM OR 03]
109843TG18-UNL10 PatternThe AAPM TG18-UNL10 Pattern is the AAPM TG-18 UN10 Pattern with added defining lines. See [AAPM OR 03]
109844TG18-UNL80 PatternThe AAPM TG18-UNL80 Pattern is the AAPM TG-18 UN80 Pattern with added defining lines. See [AAPM OR 03]
109845TG18-AD PatternThe AAPM TG18-AD Pattern used for visual evaluation of the reflection of ambient light from the display. See [AAPM OR 03]
109846TG18-MP PatternThe AAPM TG18-MP Pattern used for evaluation of Luminance response (bit-depth resolution). See [AAPM OR 03]
109847TG18-RH10 PatternThe AAPM TG18-RH10 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 horizontal lines at 10% luminance level. See [AAPM OR 03]
109848TG18-RH50 PatternThe AAPM TG18-RH50 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 horizontal lines at 50% luminance level. See [AAPM OR 03]
109849TG18-RH89 PatternThe AAPM TG18-RH89 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 horizontal lines at 89% luminance level. See [AAPM OR 03]
109850TG18-RV10 PatternThe AAPM TG18-RV10 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 vertical lines at 10% luminance level. See [AAPM OR 03]
109851TG18-RV50 PatternThe AAPM TG18-RV50 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 vertical lines at 50% luminance level. See [AAPM OR 03]
109852TG18-RV89 PatternThe AAPM TG18-RV89 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 vertical lines at 89% luminance level. See [AAPM OR 03]
109853TG18-PX PatternThe AAPM TG18-PX Pattern used for the assessment of display resolution. See [AAPM OR 03]
109854TG18-CX PatternThe AAPM TG18-CX Pattern used to assess display resolution and resolution uniformity. See [AAPM OR 03]
109855TG18-LPH10 PatternThe AAPM TG18-LPH10 Pattern used to assess display resolution. This pattern has horizontal bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 10% background level of the maximum pixel value. See [AAPM OR 03]
109856TG18-LPH50 PatternThe AAPM TG18-LPH50 Pattern used to assess display resolution. This pattern has horizontal bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 50% positive contrast against 10% background level of the maximum pixel value. See [AAPM OR 03]
109857TG18-LPH89 PatternThe AAPM TG18-LPH89 Pattern used to assess display resolution. This pattern has horizontal bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 89% background level of the maximum pixel value. See [AAPM OR 03]
109858TG18-LPV10 PatternThe AAPM TG18-LPV10 Pattern used to assess display resolution. This pattern has vertical bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 10% background level of the maximum pixel value. See [AAPM OR 03]
109859TG18-LPV50 PatternThe AAPM TG18-LPV50 Pattern used to assess display resolution. This pattern has vertical bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 50% background level of the maximum pixel value. See [AAPM OR 03]
109860TG18-LPV89 PatternThe AAPM TG18-LPV89 Pattern used to assess display resolution. This pattern has vertical bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 89% background level of the maximum pixel value. See [AAPM OR 03]
109861TG18-AFC PatternThe AAPM TG18-AFC Pattern used to assess display noise. See [AAPM OR 03]
109862TG18-NS10 PatternThe AAPM TG18-NS10 Pattern is AAPM TG18-RV10/RH10 with only difference being the absence of the single line at the center of the measurement area. See [AAPM OR 03]
109863TG18-NS50 PatternThe AAPM TG18-NS50 Pattern is AAPM TG18-RV50/RH50 with only difference being the absence of the single line at the center of the measurement area. See [AAPM OR 03]
109864TG18-NS89 PatternThe AAPM TG18-NS89 Pattern is AAPM TG18-RV89/RH89 with only difference being the absence of the single line at the center of the measurement area. See [AAPM OR 03]
109865TG18-GV PatternThe TG18-GV Pattern used to assess display veiling. See [AAPM OR 03]
109866TG18-GVN PatternThe TG18-GVN Pattern used to assess display veiling. This pattern is identical to AAPM TG18-GV Pattern except that the large-diameter white circle is replaced with a black circle, creating a completely black pattern except for the presence of low-contrast targets. See [AAPM OR 03]
109867TG18-GQ PatternThe TG18-GQ Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GV except that is lacks the central low-contrast objects. See [AAPM OR 03]
109868TG18-GQN PatternTG18-GQN Pattern used for the quantitative assessment of veiling glare. This pattern is identical to AAPM TG18-GQ Pattern except that the large-diameter white circle is replaced with a black circle, creating a completely black pattern except for the presence of low-contrast targets. See [AAPM OR 03]
109869TG18-GQB PatternThe TG18-GQB Pattern used for the quantitative assessment of veiling glare. This pattern is identical to AAPM TG18-GQ Pattern except eliminating the central black circle. See [AAPM OR 03]
109870TG18-GA03 PatternThe TG18-GA03 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 3. See [AAPM OR 03]
109871TG18-GA05 PatternThe TG18-GA05 Pattern This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 5. See [AAPM OR 03]
109872TG18-GA08 PatternThe TG18-GA08 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 8. See [AAPM OR 03]
109873TG18-GA10 PatternThe TG18-GA10 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 10. See [AAPM OR 03]
109874TG18-GA15 PatternThe TG18-GA15 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 15
109875TG18-GA20 PatternThe TG18-GA20 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 20. See [AAPM OR 03]
109876TG18-GA25 PatternThe TG18-GA25 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 25. See [AAPM OR 03]
109877TG18-GA30 PatternThe TG18-GA30 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 30. See [AAPM OR 03]
109878TG18-CH ImageThe AAPM TG18-CH Image is a reference anatomical PA chest image. See [AAPM OR 03]
109879TG18-KN ImageThe AAPM TG18-KN Image is a reference anatomical knee image. See [AAPM OR 03]
109880TG18-MM1 ImageThe AAPM TG18-MM1 Image is a reference anatomical mammogram image. See [AAPM OR 03]
109881TG18-MM2 ImageThe AAPM TG18-MM2 Image is a reference anatomical mammogram image. See [AAPM OR 03]
109901OIQ PatternThe IEC OIQ Pattern is used as an alternative to the TG18-QC Pattern. See [IEC 62563-1]
109902ANG PatternThe IEC ANG Pattern used for angular viewing evaluation. See [IEC 62563-1]
109903GD PatternThe IEC GD Pattern used for geometrical image evaluation. See [IEC 62563-1]
109904BN01 PatternThe IEC BN01 Pattern is used as analternative to the TG18-LN-01 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109905BN02 PatternThe IEC BN02 Pattern is used as analternative to the TG18-LN-02 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109906BN03 PatternThe IEC BN03 Pattern is used as analternative to the TG18-LN-03 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109907BN04 PatternThe IEC BN04 Pattern is used as analternative to the TG18-LN-04 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109908BN05 PatternThe IEC BN05 Pattern is used as analternative to the TG18-LN-05 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109909BN06 PatternThe IEC BN06 Pattern is used as analternative to the TG18-LN-06 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109910BN07 PatternThe IEC BN07 Pattern is used as analternative to the TG18-LN-07 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109911BN08 PatternThe IEC BN08 Pattern is used as analternative to the TG18-LN-08 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109912BN09 PatternThe IEC BN09 Pattern is used as analternative to the TG18-LN-09 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109913BN10 PatternThe IEC BN10 Pattern is used as analternative to the TG18-LN-10 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109914BN11 PatternThe IEC BN11 Pattern is used as analternative to the TG18-LN-11 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109915BN12 PatternThe IEC BN12 Pattern is used as analternative to the TG18-LN-12 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109916BN13 PatternThe IEC BN13 Pattern is used as analternative to the TG18-LN-13 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109917BN14 PatternThe IEC BN14 Pattern is used as analternative to the TG18-LN-14 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109918BN15 PatternThe IEC BN15 Pattern is used as analternative to the TG18-LN-15 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109919BN16 PatternThe IEC BN16 Pattern is used as analternative to the TG18-LN-16 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109920BN17 PatternThe IEC BN17 Pattern is used as analternative to the TG18-LN-17 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109921BN18 PatternThe IEC BN18 Pattern is used as analternative to the TG18-LN-18 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109931DIN Grayscale PatternTest image "Bild 2" for the gray-scale reproduction of imaging devices. See [DIN 6868-57]
109932DIN Geometry PatternTest image "Bild 3" for the geometrical imaging properties of imaging devices. See [DIN 6868-57]
109933DIN Resolution PatternTest image "Bild 5" for displaying the spatial and contrast resolution as well as the line structure of imaging devices. See [DIN 6868-57]
109941White PatternAn alternative to AAPM TG18-UN80, specified at 100% of maximum pixel value
109943SMPTE PatternA standard display test pattern. See [SMPTE RP133]. A pattern is available at http://www.dclunie.com/images/smpte.512.512.8.gif
109991CRT DisplayA Display Device that displays images on a Cathode Ray Tube
109992Liquid Crystal DisplayA Display Device that displays images on a Liquid Crystal Display
109993Plasma DisplayA Display Device that displays images on a Plasma Display
109994OLEDA Display Device that displays images on an Organic Light Emitting Diode based display
109995DLP Rear Projection SystemA Display Device that projects images on a surface from behind using a Digital Light Processing Projector
109996DLP Front Projection SystemA Display Device that projects images on a surface from in front using a Digital Light Processing Projector
109997CRT Rear Projection SystemA Display Device that projects images on a surface from behind using a Cathode Ray Tube
109998CRT Front Projection SystemA Display Device that projects images on a surface from in front using a Cathode Ray Tube
109999Other Projection SystemA Display Device that projects images on a surface from an unspecified direction using an unspecified means
110001Image ProcessingImage processing work item
110002Quality ControlQuality control work item
110003Computer Aided DiagnosisComputer aided diagnosis work item
110004Computer Aided DetectionComputer aided detection work item
110005InterpretationInterpretation work item
110006TranscriptionTranscription work item
110007Report VerificationReport verification work item
110008PrintPrint work item
110009No subsequent WorkitemsThere will be no more work items scheduled
110010FilmFilm type of output
110011DictationDictation type of output
110012TranscriptionTranscription type of output
110013Media ImportThe procedure to read DICOM instances from DICOM interchange media, coerce identifying attributes into the local namespace if necessary, and make the instances available
110020Sheet Film DigitizedDigitization of Sheet Film
110021Cine Film DigitizedDigitization of Cine Film
110022Video Tape DigitizedDigitization of Video Tape
110023Paper DigitizedDigitization of pages of a paper document (Units may be specified as Pages, Documents)
110024CD ImportedImportation of CD
110025DVD ImportedImportation of DVD
110026MOD ImportedImportation of MOD
110027Studies ImportedImportation of DICOM Studies
110028Instances ImportedImportation of DICOM Composite Instances
110030USB Disk EmulationA device that connects using the USB hard drive interface. These may be USB-Sticks, portable hard drives, and other technologies
110031EmailEmail and email attachments used as a media for data transport
110032CDCD-R, CD-ROM, and CD-RW media used for data transport
110033DVDDVD, DVD-RAM, and other DVD formatted media used for data transport
110034Compact FlashMedia that comply with the Compact Flash standard
110035Multi-media CardMedia that comply with the Multi-media Card standard
110036Secure Digital CardMedia that comply with the Secure Digital Card standard
110037URIURI Identifier for network or other resource, see RFC 3968
110038Paper DocumentAny paper or similar document
110100Application ActivityAudit event: Application Activity has taken place
110101Audit Log UsedAudit event: Audit Log has been used
110102Begin Transferring DICOM InstancesAudit event: Storage of DICOM Instances has begun
110103DICOM Instances AccessedAudit event: DICOM Instances have been created, read, updated, or deleted
110104DICOM Instances TransferredAudit event: Storage of DICOM Instances has been completed
110105DICOM Study DeletedAudit event: Entire Study has been deleted
110106ExportAudit event: Data has been exported out of the system
110107ImportAudit event: Data has been imported into the system
110108Network EntryAudit event: System has joined or left network
110109Order RecordAudit event: Order has been created, read, updated or deleted
110110Patient RecordAudit event: Patient Record has been created, read, updated, or deleted
110111Procedure RecordAudit event: Procedure Record has been created, read, updated, or deleted
110112QueryAudit event: Query has been made
110113Security AlertAudit event: Security Alert has been raised
110114User AuthenticationAudit event: User Authentication has been attempted
110120Application StartAudit event: Application Entity has started
110121Application StopAudit event: Application Entity has stopped
110122LoginAudit event: User login has been attempted
110123LogoutAudit event: User logout has been attempted
110124AttachAudit event: Node has been attached
110125DetachAudit event: Node has been detached
110126Node AuthenticationAudit event: Node Authentication has been attempted
110127Emergency Override StartedAudit event: Emergency Override has started
110128Network ConfigurationAudit event: Network configuration has been changed
110129Security ConfigurationAudit event: Security configuration has been changed
110130Hardware ConfigurationAudit event: Hardware configuration has been changed
110131Software ConfigurationAudit event: Software configuration has been changed
110132Use of Restricted FunctionAudit event: A use of a restricted function has been attempted
110133Audit Recording StoppedAudit event: Audit recording has been stopped
110134Audit Recording StartedAudit event: Audit recording has been started
110135Object Security Attributes ChangedAudit event: Security attributes of an object have been changed
110136Security Roles ChangedAudit event: Security roles have been changed
110137User security Attributes ChangedAudit event: Security attributes of a user have been changed
110138Emergency Override StoppedAudit event: Emergency Override has Stopped
110139Remote Service Operation StartedAudit event: Remote Service Operation has Begun
110140Remote Service Operation StoppedAudit event: Remote Service Operation has Stopped
110141Local Service Operation StartedAudit event: Local Service Operation has Begun
110142Local Service Operation StoppedAudit event: Local Service Operation Stopped
110150ApplicationAudit participant role ID of software application
110151Application LauncherAudit participant role ID of software application launcher, i.e., the entity that started or stopped an application
110152Destination Role IDAudit participant role ID of the receiver of data
110153Source Role IDAudit participant role ID of the sender of data
110154Destination MediaAudit participant role ID of media receiving data during an export
110155Source MediaAudit participant role ID of media providing data during an import
110180Study Instance UIDParticipantObjectID type: Study Instance UID
110181SOP Class UIDParticipantObjectID type: SOP Class UID
110182Node IDID of a node that is a participant object of an audit message
110190Issuer of IdentifierSystem, organization, agency, or department that has assigned an instance identifier (such as placer or filler number, patient or provider identifier, etc.)
110500Doctor canceled procedureProcedure order canceled by requesting physician or other authorized physician
110501Equipment failureEquipment failure prevented completion of procedure
110502Incorrect procedure orderedProcedure discontinued due to incorrect procedure being ordered
110503Patient allergic to media/contrastProcedure discontinued due to patient allergy to media/contrast (reported or reaction)
110504Patient diedProcedure discontinued due to death of Patient
110505Patient refused to continue procedureProcedure discontinued due to patient refusal to continue procedure
110506Patient taken for treatment or surgeryProcedure discontinued due to patient being taken for treatment or surgery
110507Patient did not arrivePatient did not arrive for procedure
110508Patient pregnantProcedure discontinued due to patient pregnancy (reported or determined)
110509Change of procedure for correct chargingProcedure discontinued to restart with new procedure code for correct charging
110510Duplicate orderProcedure discontinued due to duplicate orders received for same procedure
110511Nursing unit cancelProcedure order canceled by nursing unit
110512Incorrect side orderedProcedure discontinued due to incorrect side (laterality) being ordered
110513Discontinued for unspecified reasonProcedure discontinued for unspecified reason
110514Incorrect worklist entry selectedProcedure discontinued due to incorrect patient or procedure step selected from modality worklist
110515Patient condition prevented continuingPatient condition prevented continuation of procedure
110516Equipment changeProcedure step is discontinued to change to other equipment or modality
110518Patient MovementA movement of the patient affecting test quality
110519Operator ErrorAn error of the operator affecting test quality
110521Objects incorrectly formattedOne or more of the objects is malformed
110522Object Types not supportedReceiving System is unable to accept the object type
110523Object Set incompleteOne or more objects associated with the object set is missing
110524Media FailureThe contents of the Media could not be accessed properly
110526Resource pre-emptedProcedure discontinued due to necessary equipment, staff or other resource becoming (temporarily) unavailable to the procedure
110527Resource inadequateProcedure discontinued due to necessary equipment, staff or other resource being inadequate to complete the procedure
110528Discontinued Procedure Step rescheduledA new Procedure Step has been scheduled to replace the Discontinued Procedure Step
110529Discontinued Procedure Step rescheduling recommendedIt is recommended that a new Procedure Step be scheduled to replace the Discontinued Procedure Step
110700Ventral DiencephalonVentral structures of the diencephalon that cannot readily be distinguished on MR imaging, including the hypothalamus, mammillary body, subthalamic nuclei, substantia nigra, red nucleus, lateral geniculate nucleus, medial geniculate nucleus, zona incerta, cerebral peduncle, lenticular fasciculus, medial lemniscus, and optic tract. See http://neuromorphometrics.org:8080/Seg/html/segmentation/ventral%20diencephalon.html
110701White Matter T1 HypointensityArea(s) of reduced intensity on T1 weighted images relative to the surrounding white matter. These may be indicative of age-related or neurodegenerative white matter lesions, and may be co-located with areas of white matter T2 hyperintensity, but the concept is specifically confined to the MR appearance on T1 weighted images
110702White Matter T2 HyperintensityArea(s) of increased intensity on T2 weighted images relative to the surrounding white matter. These may be indicative of age-related or neurodegenerative white matter lesions, and may be co-located with areas of white matter T1 hypointensity, but the concept is specifically confined to the MR appearance on T2 weighted images
110703superior longitudinal fasciculus IThe dorsal component of the SLF originating from the medial and dorsal parietal cortex and ending in the dorsal and medial part of the frontal lobe. See Makris N, et al. "Segmentation of Subcomponents within the Superior Longitudinal Fascicle in Humans: A Quantitative, In Vivo, DT-MRI Study." Cerebral Cortex 15, no. 6 (June 1, 2005): 854-69. doi:10.1093/cercor/bhh186
110704superior longitudinal fasciculus IIThe major component of the SLF, derived from the caudal-inferior parietal region corresponding to the angular gyrus in the human and terminating within the dorsolateral frontal region. See Makris N, et al. "Segmentation of Subcomponents within the Superior Longitudinal Fascicle in Humans: A Quantitative, In Vivo, DT-MRI Study." Cerebral Cortex 15, no. 6 (June 1, 2005): 854-69. doi:10.1093/cercor/bhh186
110705superior longitudinal fasciculus IIIThe ventral component of the SLF, originating from the supramarginal gyrus and terminating predominantly in the ventral premotor and prefrontal areas. See Makris N, et al. "Segmentation of Subcomponents within the Superior Longitudinal Fascicle in Humans: A Quantitative, In Vivo, DT-MRI Study." Cerebral Cortex 15, no. 6 (June 1, 2005): 854-69. doi:10.1093/cercor/bhh186
110706Perilesional White MatterWhite matter that surrounds a lesion of interest; e.g. to identify the otherwise unclassified white matter that surrounds a tumor to be surgically resected
110800Spin Tagging Perfusion MR Signal IntensitySignal intensity of a Spin tagging Perfusion MR image. Spin tagging is a technique for the measurement of blood perfusion, based on magnetically labeled arterial blood water as an endogenous tracer
110801Contrast Agent Angio MR Signal IntensitySignal intensity of a Contrast Agent Angio MR image
110802Time Of Flight Angio MR Signal IntensitySignal intensity of a Time-of-flight (TOF) MR image. Time-of-flight (TOF) is based on the phenomenon of flow-related enhancement of spins entering into an imaging slice. As a result of being unsaturated, these spins give more signal that surrounding stationary spins
110803Proton Density Weighted MR Signal IntensitySignal intensity of a Proton Density Weighted MR image. All MR images have intensity proportional to proton density. Images with very little T1 or T2 weighting are called 'PD-weighted'
110804T1 Weighted MR Signal IntensitySignal intensity of T1 Weighted MR image. A T1 Weighted MR image is created typically by using short TE and TR times
110805T2 Weighted MR Signal IntensitySignal intensity of a T2 Weighted MR image. T2 Weighted image contrast state is approached by imaging with a TR long compared to tissue T1 (to reduce T1 contribution to image contrast) and a TE between the longest and shortest tissue T2s of interest
110806T2* Weighted MR Signal IntensitySignal intensity of a T2* Weighted MR image. The T2* phenomenon results from molecular interactions (spin spin relaxation) and local magnetic field non-uniformities, which cause the protons to precess at slightly different frequencies
110807Field Map MR Signal IntensitySignal intensity of a Field Map MR image. A Field Map MR image provides a direct measure of the B 0 inhomogeneity at each point in the image
110808Fractional AnisotropyCoefficient reflecting the fractional anisotropy of the tissues, derived from a diffusion weighted MR image. Fractional anisotropy is proportional to the square root of the variance of the Eigen values divided by the square root of the sum of the squares of the Eigen values
110809Relative AnisotropyCoefficient reflecting the relative anisotropy of the tissues, derived from a diffusion weighted MR image
110810Volumetric Diffusion Dxx ComponentDxx Component of the diffusion tensor, quantifying the molecular mobility along the X axis
110811Volumetric Diffusion Dxy ComponentDxy Component of the diffusion tensor, quantifying the correlation of molecular displacements in the X and Y directions
110812Volumetric Diffusion Dxz ComponentDxz Component of the diffusion tensor, quantifying the correlation of molecular displacements in the X and Z directions
110813Volumetric Diffusion Dyy ComponentDyy Component of the diffusion tensor, quantifying the molecular mobility along the Y axis
110814Volumetric Diffusion Dyz ComponentDyz Component of the diffusion tensor, quantifying the correlation of molecular displacements in the Y and Z directions
110815Volumetric Diffusion Dzz ComponentDzz Component of the diffusion tensor, quantifying the molecular mobility along the Z axis
110816T1 Weighted Dynamic Contrast Enhanced MR Signal IntensitySignal intensity of a T1 Weighted Dynamic Contrast Enhanced MR image. A T1 Weighted Dynamic Contrast Enhanced MR image reflects the dynamics of diffusion of the exogenous contrast media from the blood pool into the extra vascular extracellular space (EES) of the brain at a rate determined by the blood flow to the tissue, the permeability of the Brain Blood Barrier (BBB), and the surface area of the perfusing vessels
110817T2 Weighted Dynamic Contrast Enhanced MR Signal IntensitySignal intensity of a T2 Weighted Dynamic Contrast Enhanced MR image. A T2 Weighted Dynamic Contrast Enhanced MR image reflects the T2 of tissue decrease as the Gd contrast agent bolus passes through the brain
110818T2* Weighted Dynamic Contrast Enhanced MR Signal IntensitySignal intensity of a T2* Weighted Dynamic Contrast Enhanced MR image. A T2* Weighted Dynamic Contrast Enhanced MR image reflects the T2* of tissue decrease as the Gd contrast agent bolus passes through the brain
110819Blood Oxygenation LevelSignal intensity of a Blood Oxygenation Level image. BOLD imaging is sensitive to blood oxygenation (but also to cerebral blood flow and volume). This modality is essentially used for detecting brain activation (functional MR)
110820Nuclear Medicine Projection ActivityAccumulated decay event counts in a nuclear medicine projection image
110821Nuclear Medicine Tomographic ActivityAccumulated decay event counts in a Nuclear Medicine Tomographic image (including PET)
110822Spatial Displacement X ComponentSpatial Displacement along axis X of a non-linear deformable spatial registration image. The X axis is defined in reference to the patient's orientation, and is increasing to the left hand side of the patient
110823Spatial Displacement Y ComponentSpatial Displacement along axis Y of a non-linear deformable spatial registration image. The Y axis is defined in reference to the patient's orientation, and is increasing to the posterior side of the patient
110824Spatial Displacement Z ComponentSpatial Displacement along axis Z of a non-linear deformable spatial registration image. The Z axis is defined in reference to the patient's orientation, and is increasing toward the head of the patient
110825Hemodynamic ResistanceMeasured resistance to the flow of blood; e.g. through the vasculature or through a heart value
110826Indexed Hemodynamic ResistanceMeasured resistance to the flow of blood; e.g. through the vasculature or through a heart value, normalized to a particular indexed scale
110827Tissue VelocityVelocity of tissue based on Doppler measurements
110828Flow VelocityVelocity of blood flow based on Doppler measurements
110829Flow VarianceStatistical variance of blood velocity relative to mean
110830ElasticityScalar value related to the elastic properties of the tissue
110831PerfusionScalar value related to the volume of blood perfusing into tissue
110832Speed of soundSpeed of sound in tissue
110833Ultrasound AttenuationReduction in strength of ultrasound signal as the wave
110834RGB R ComponentRed component of a true color image (RGB)
110835RGB G ComponentGreen component of a true color image (RGB)
110836RGB B ComponentBlue component of a true color image (RGB)
110837YBR FULL Y ComponentY (Luminance) component of a YBR FULL image, as defined in JPEG 2000
110838YBR FULL CB ComponentCB (Blue chrominance) component of a YBR FULL image, as defined in JPEG 2000
110839YBR FULL CR ComponentCR (Red chrominance) component of a YBR FULL image, as defined in JPEG 2000
110840YBR PARTIAL Y ComponentY (Luminance) component of a YBR PARTIAL image, as defined in JPEG 2000
110841YBR PARTIAL CB ComponentCB (Blue chrominance) component of a YBR PARTIAL image, as defined in JPEG 2000
110842YBR PARTIAL CR ComponentCR (Red chrominance) component of a YBR PARTIAL image, as defined in JPEG 2000
110843YBR ICT Y ComponentY (Luminance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000
110844YBR ICT CB ComponentCB (Blue chrominance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000
110845YBR ICT CR ComponentCR (Red chrominance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000
110846YBR RCT Y ComponentY (Luminance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000
110847YBR RCT CB ComponentCB (Blue chrominance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000
110848YBR RCT CR ComponentCR (Red chrominance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000
110849EchogenicityThe ability of a material to create an ultrasound return echo
110850X-Ray AttenuationDecrease in the number of photons in an X-Ray beam due to interactions with the atoms of a material substance. Attenuation is due primarily to two processes, absorption and scattering
110851X-Ray Attenuation CoefficientCoefficient that describes the fraction of a beam of X-Rays or gamma rays that is absorbed or scattered per unit thickness of the absorber. This value basically accounts for the number of atoms in a cubic cm volume of material and the probability of a photon being scattered or absorbed from the nucleus or an electron of one of these atoms
110852MR signal intensitySignal intensity of an MR image, not otherwise specified
110853Binary SegmentationBinary value denoting that the segmented property is present
110854Fractional Probabilistic SegmentationProbability, defined as a percentage, that the segmented property occupies the spatial area defined by the voxel
110855Fractional Occupancy SegmentationPercentage of the voxel area occupied by the segmented property
110856Linear DisplacementSpatial dimension, denoting a linear displacement
110857Photon EnergyDimension denoting the energy (frequency or wavelength) of photons
110858TimeDimension used to sequence events, to compare the duration of events and the intervals between events
110859AngleSpatial dimension, denoting an angle
110860Left-Right AxisA spatial dimension axis running along a line between the patient's left and right side
110861Head-Foot AxisA spatial dimension axis running along a line between the patient's head and foot
110862Anterior-Posterior AxisA spatial dimension axis running along a line between the patient's anterior and posterior sides
110863Apex-Base AxisA spatial dimension axis running along a line between the apex and base of an organ, object, or chamber
110864Anterior-Inferior AxisA spatial dimension axis running along a line between the anterior and inferior sides of an organ, object, or chamber
110865Septum-Wall AxisA spatial dimension axis running along a line between the septum and wall of a chamber
110866Right To LeftOrientation of a spatial dimension where increasing values run from the right to the left side of the patient
110867Left To RightOrientation of a spatial dimension where increasing values run from the left to the right side of the patient
110868Head To FootOrientation of a spatial dimension where increasing values run from the head to the foot of the patient
110869Foot To HeadOrientation of a spatial dimension where increasing values run from the foot to the head of the patient
110870Anterior To PosteriorOrientation of a spatial dimension where increasing values run from the anterior to the posterior side of the patient
110871Posterior To AnteriorOrientation of a spatial dimension where increasing values run from the posterior to the anterior side of the patient
110872Apex To BaseOrientation of a spatial dimension where increasing values run from the apex to the base
110873Base To ApexOrientation of a spatial dimension where increasing values run from the base to the apex
110874Anterior To InferiorOrientation of a spatial dimension where increasing values run from the anterior to the inferior
110875Inferior To AnteriorOrientation of a spatial dimension where increasing values run from the inferior to the anterior
110876Septum To WallOrientation of a spatial dimension where increasing values run from the septum of a chamber to the opposite wall
110877Wall To SeptumOrientation of a spatial dimension where increasing values run from the opposite wall to the septum of a chamber
110901Image Position (Patient) XThe x coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system
110902Image Position (Patient) YThe y coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system
110903Image Position (Patient) ZThe z coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system
110904Image Orientation (Patient) Row XThe x value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system
110905Image Orientation (Patient) Row YThe y value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system
110906Image Orientation (Patient) Row ZThe z value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system
110907Image Orientation (Patient) Column XThe x value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system
110908Image Orientation (Patient) Column YThe y value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system
110909Image Orientation (Patient) Column ZThe z value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system
110910Pixel Data RowsNumber of rows in the pixel data of the image
110911Pixel Data ColumnsNumber of columns in the pixel data of the image
111001Algorithm NameThe name assigned by a manufacturer to a specific software algorithm
111002Algorithm ParametersThe input parameters used by a manufacturer to configure the behavior of a specific software algorithm
111003Algorithm VersionThe software version identifier assigned by a manufacturer to a specific software algorithm
111004Analysis PerformedThe type of correlation applied to detection results; e.g. temporal, spatial
111005Assessment CategoryAssignment of intermediate or overall interpretation results to a general category
111006Breast compositionAssessment of annotating tissues in breast; generally including fatty, mixed or dense
111007Breast Outline including Pectoral Muscle TissuePurpose of reference for an SCOORD content item that is an outline of the breast that includes the pectoral muscle tissue
111008Calcification DistributionThe type of distribution associated with detected calcifications
111009Calcification TypeIdentification of the morphology of detected calcifications
111010CenterPurpose of reference for an SCOORD content item that identifies the central point of a finding or feature
111011Certainty of FeatureThe likelihood that the feature analyzed is in fact the type of feature identified
111012Certainty of FindingThe likelihood that the finding detected is in fact the type of finding identified
111013Certainty of ImpressionThe certainty that a device places on an impression, where 0 equals no certainty and 100 equals certainty
111014Clockface or regionA location identifier based on clock-face numbering or anatomic sub-region
111015Composite FeatureAn item that is an inferred correlation relating two or more individual findings or features
111016Composite typeThe inferred relationship between the findings or features making up a composite feature
111017CAD Processing and Findings SummaryGeneral assessment of whether or not CAD processing was successful, and whether any findings resulted
111018Content DateThe date the data creation started
111019Content TimeThe time the data creation started
111020DepthA location identifier based on a feature's inferred distance from the surface of the associated anatomy
111021Description of ChangeA textual description of the change that occurred over time in a qualitative characteristic of a feature
111022Detection PerformedThe type of finding sought after by a specific algorithm applied to one image
111023Differential Diagnosis/ImpressionA general change that occurred within an imaged area between a prior imaging procedure and the current imaging procedure
111024Failed AnalysesA group of analysis algorithms that were attempted, but failed
111025Failed DetectionsA group of detection algorithms that were attempted, but failed
111026Horizontal Pixel SpacingFor projection radiography, the horizontal physical distance measured at the front plane of an Image Receptor housing between the center of each pixel. For tomographic images, the horizontal physical distance in the patient between the center of each pixel
111027Image LateralityLaterality of (possibly paired) body part contained in an image
111028Image LibraryA container that references all image data used as evidence to produce a report
111029Image Quality RatingA numeric value in the range 0 to 100, inclusive, where 0 is worst quality and 100 is best quality
111030Image RegionPurpose of reference for an SCOORD content item that identifies a specific region of interest within an image
111031Image ViewThe projection of the anatomic region of interest on an image receptor
111032Image View ModifierModifier for Image View
111033Impression DescriptionFree-form text describing the overall or an individual impression
111034Individual Impression/RecommendationA container for a group of related results from interpretation of one or more images and associated clinical information
111035Lesion DensityThe X-Ray attenuation of a lesion relative to the expected attenuation of an equal volume of fibroglandular breast tissue
111036Mammography CAD ReportA structured report containing the results of computer-aided detection or diagnosis applied to breast imaging and associated clinical information
111037MarginsThe characteristic of the boundary, edges or border of a detected lesion
111038Number of calcificationsThe quantity of calcifications detected within an identified group or cluster
111039Object typeA non-lesion object identified within one or more images
111040Original SourcePurpose of reference for a COMPOSITE content item that identifies it as the original source of evidence for another content item in the report
111041OutlinePurpose of reference for an SCOORD content item that identifies the outline or bounding region of a finding or feature
111042PathologyThe inferred type of disease associated with an identified feature
111043Patient Orientation ColumnThe patient orientation relative to the image plane, specified by a value that designates the anatomical direction of the positive column axis (top to bottom)
111044Patient Orientation RowThe patient orientation relative to the image plane, specified by a value that designates the anatomical direction of the positive row axis (left to right)
111045Pectoral Muscle OutlinePurpose of reference for an SCOORD content item that is an outline of the pectoral muscle tissue only
111046Percent Fibroglandular TissuePercent of breast area that is mammographically dense, excluding pectoralis muscle
111047Probability of cancerThe likelihood that an identified finding or feature is cancerous
111048Quadrant locationA location identifier based on the division of an area into four regions
111049Qualitative DifferenceA qualitative characteristic of a feature that has changed over time
111050Quality AssessmentThe effect of the quality of an image on its usability
111051Quality Control StandardThe quality control standard used to make a quality assessment
111052Quality FindingA specific quality related deficiency detected within an image
111053Recommended Follow-upRecommended type of follow-up to an imaging procedure, based on interpreted results
111054Recommended Follow-up DateRecommended follow-up date to an imaging procedure, based on interpreted results
111055Recommended Follow-up IntervalRecommended follow-up interval to an imaging procedure, based on interpreted results
111056Rendering IntentThe recommendation of the producer of a content item regarding presentation of the content item by recipients of the report
111057Scope of FeatureAn indication of how widespread the detection of a feature is within the analyzed image data set
111058Selected Region DescriptionA textual description of the contents of a selected region identified within an image
111059Single Image FindingAn item that was detected on one image
111060Study DateDate on which the acquisition of the study information was started
111061Study TimeTime at which the acquisition of the study information was started
111062Successful AnalysesA group of analysis algorithms that were attempted and completed successfully
111063Successful DetectionsA group of detection algorithms that were attempted and completed successfully
111064Summary of DetectionsAn overall indication of whether the CAD detection algorithms applied were completed successfully
111065Summary of AnalysesAn overall indication of whether the CAD analysis algorithms applied were completed successfully
111066Vertical Pixel SpacingFor projection radiography, the vertical physical distance measured at the front plane of an Image Receptor housing between the center of each pixel. For tomographic images, the vertical physical distance in the patient between the center of each pixel
111069CrosstableA radiographic projection that has been with the patient lying on a table with the X-Ray source on one side of the table and the detector on the other; e.g. may describe a cross-table cervical spine, chest or pelvis X-Ray image
111071CAD Operating PointOne of a number of discrete points on the Receiver-Operator Characteristics (ROC) curve that reflects the expected sensitivity and specificity of a CAD algorithm, where zero indicates the highest specificity, lowest sensitivity operating point. The value should not exceed the Maximum CAD Operating Point
111072Maximum CAD Operating PointThe maximum value of CAD Operating Point for the specific CAD algorithm used
111081CAD Operating Point DescriptionThe intended interpretation of a CAD Operating Point
111086False Markers per ImageThe number of false CAD markers per image. Correlates to inverse of Image Specificity
111087False Markers per CaseThe number of false markers per collection of images that are CAD processed as a group. Correlates to inverse of Case Specificity
111088Case SensitivityThe percentage of cancers that should be detected by a CAD algorithm where CAD marks the cancers in at least one view
111089Lesion SensitivityThe percentage of cancers that should be detected by a CAD algorithm where CAD marks the cancers in each view
111090Case SpecificityThe percentage of cases (collections of images CAD processed as a group) without cancer that have no CAD findings whatsoever. Correlates to inverse of False Markers per Case
111091Image SpecificityThe percentage of images without cancer that have no CAD findings whatsoever. Correlates to inverse of False Markers per Image
111092Recommended CAD Operating PointThe CAD operating point that is recommended for initial display by the creator of the structured report
111093CAD Operating Point TableA list of CAD operating points including their corresponding characteristics
111099Selected regionA specific area of interest noted within an image
111100Breast geometryThe surface shape of all or a portion of breast related anatomy
111101Image QualityImage quality incorporates the following clinical image evaluation parameters: assessment of positioning, compression, artifacts, exposure, contrast, sharpness, and labeling
111102Non-lesionA finding or feature that is identified as a non-anatomic foreign object
111103DensityA space-occupying lesion identified in a single image or projection
111104Individual CalcificationA single identified calcification
111105Calcification ClusterMultiple calcifications identified as occupying a small area of tissue (less than 2 cc)
111111Cooper's ligament changesStraightening or thickening of Cooper's ligaments
111112Mass in the skinAn abnormality noted at imaging within the dermis of the breast
111113Mass on the skinAn abnormality noted at imaging on the epidermis of the breast
111120Post Procedure Mammograms for Marker PlacementAn assessment category to indicate that images have been acquired to assess marker placement following a breast interventional procedure
111121Follow-up post biopsy as directed by clinicianAn indication that the patient should seek post procedural follow-up directives from a clinical health care provider
111122Known biopsy proven malignancy - take appropriate actionA recommendation on a patient with known cancer to take steps appropriate to the diagnosis
111123Marker placementPositioning of a radiopaque marker
111124Personal history of breast cancer with mastectomyPatient has previous diagnosis of breast cancer resulting in mastectomy
111125Known biopsy proven malignancyPatient has had biopsy containing proven malignancy
111126Image detected massPatient has a finding of mass reported on a prior imaging exam
111127TargetedA breast imaging procedure performed on a specific area of the breast
111128SurveyA breast imaging procedure performed on the entire breast
111129Clustered microcystsA cluster of tiny anechoic foci each smaller than 2-3 mm in diameter with thin (less than 0.5 mm) intervening septations and no discrete solid components
111130Complicated cystA fluid filled mass most commonly characterized by homogeneous low-level internal echoes on ultrasound
111135Additional projectionsViews not inclusive of MLO and CC (BI-RADS®)
111136Spot magnification view(s)A spot or coned down compression of the breast providing a reduction in the thickness and a magnification of the localized area of interest and improved separation of breast tissue
111137UltrasoundUse of sound waves to visualize muscles, tendons, and many internal organs, to capture their size, structure and any pathological lesions with real time tomographic images.
111138Old films for comparisonObtain previous mammography studies to compare to present study
111139DuctographyA medical procedure used for the sampling of mammary duct tissue
111140Normal interval follow-upFollow up study at 12 months for women 40 years of age having a prior negative study and no mitigating risk factors for breast cancer
111141Any decision to biopsy should be based on clinical assessmentAny decision to perform tissue acquisition should be based on clinical assessment
111142Follow-up at short interval (1-11 months)Follow-up at short interval (1-11 months)
111143Biopsy should be consideredTissue acquisition should be considered
111144Needle localization and biopsyBreast tissue acquisition following the identification of an area of concern with the placement of a needle or needle-wire assembly
111145Histology using core biopsyPathologic analysis of breast tissue and lesions using core tissue samples
111146Suggestive of malignancy - take appropriate actionLesions that do not have the characteristic morphologies of breast cancer but have a definite probability of being malignant. There is a sufficient concern to urge a biopsy
111147Cytologic analysisCellular analysis of specimen
111148Biopsy should be strongly consideredTissue acquisition should be strongly considered
111149Highly suggestive of malignancy - take appropriate actionLesions have a high probability of being cancer, which require additional action
111150Presentation Required: Rendering device is expected to presentThe producer of a report intends for a recipient of the report to present or display the associated content item
111151Presentation Optional: Rendering device may presentThe producer of a report considers the presentation or display of the associated content item by a recipient to be optional
111152Not for Presentation: Rendering device expected not to presentThe producer of a report intends for a recipient of the report NOT to present or display the associated content item
111153Target content items are related temporallyThe associated content items are identified as being the same finding or feature at different points in time
111154Target content items are related spatiallyThe associated content items are identified as being the same finding or feature on different projections taken at the same point in time
111155Target content items are related contra-laterallyThe associated content items are identified as being related side-to-side
111156Feature detected on the only imageThere is one image in the interpreted data set
111157Feature detected on only one of the imagesThere is more than one image of the same modality in the interpreted data set
111158Feature detected on multiple imagesThere is more than one image of the same modality in the interpreted data set
111159Feature detected on images from multiple modalitiesThe interpreted data set contains images from multiple modalities
111168Scar tissueThe fibrous tissue replacing normal tissues destroyed by disease or injury
111170J WireA medical appliance used for localization of non palpable breast lesions to insure that the proper area is removed in a surgical biopsy
111171PacemakerA medical appliance used for regulating cardiac rhythms
111172PaddleA compression device used for obtaining mammographic images
111173CollimatorA device used for restricting an X-Ray beam
111174ID PlateAn area designated on a radiographic film for facility and patient ID information
111175Other MarkerSite specific markers
111176UnspecifiedThe value of the concept is not specified
111177View and Laterality Marker is missingImage quality deficiency according to MQSA
111178View and Laterality Marker does not have both view and lateralityImage quality deficiency according to MQCM
111179View and Laterality Marker does not have approved codesImage quality deficiency according to MQCM
111180View and Laterality Marker is not near the axillaImage quality deficiency according to MQCM
111181View and Laterality Marker overlaps breast tissueImage quality deficiency according to MQCM
111182View and Laterality Marker is partially obscuredImage quality deficiency according to MQCM
111183View and Laterality Marker is incorrectImage quality deficiency
111184View and Laterality Marker is off imageImage quality deficiency
111185Flash is not near edge of filmImage quality deficiency according to MQCM
111186Flash is illigible, does not fit, or is lopsidedImage quality deficiency according to MQSA
111187Flash doesn't include patient name and additional patient idImage quality deficiency according to MQCM
111188Flash doesn't include date of examinationImage quality deficiency according to MQCM
111189Flash doesn't include facility name and locationImage quality deficiency according to MQSA
111190Flash doesn't include technologist identificationImage quality deficiency according to MQCM
111191Flash doesn't include cassette/screen/detector identificationImage quality deficiency according to MQCM
111192Flash doesn't include mammography unit identificationImage quality deficiency according to MQCM
111193Date sticker is missingImage quality deficiency according to MQCM
111194Technical factors missingImage quality deficiency according to MQCM
111195Collimation too close to breastImage quality deficiency according to MQCM
111196Inadequate compressionImage quality deficiency according to MQCM
111197MLO Insufficient pectoral muscleImage quality deficiency according to MQCM
111198MLO No fat is visualized posterior to fibroglandular tissuesImage quality deficiency according to MQCM
111199MLO Poor separation of deep and superficial breast tissuesImage quality deficiency according to MQCM
111200MLO Evidence of motion blurImage quality deficiency according to MQCM
111201MLO Inframammary fold is not openImage quality deficiency according to MQCM
111202CC Not all medial tissue visualizedImage quality deficiency according to MQCM
111203CC Nipple not centered on imageImage quality deficiency according to MQCM
111204CC Posterior nipple line does not measure within 1 cm of MLOImage quality deficiency according to MQCM
111205Nipple not in profileImage quality deficiency
111206Insufficient implant displacement incorrectImage quality deficiency according to MQCM
111207Image artifact(s)Signals that do not faithfully reproduce actual anatomic structures because of distortion or of addition or deletion of information
111208Grid artifact(s)Feature(s) arising from the acquisition unit's anti-scatter grid mechanism. For two-dimensional systems, such features include those of mechanically damaged or incorrectly positioned grids. For moving or Bucky grids, artifacts may result from intentional grid motion that is inadequate in duration or velocity uniformity
111209PositioningInadequate arrangement of the anatomy of interest with respect to the X-Ray field and image detector sensitive area. Examples: 1) positioning is "cutoff" when the projection of anatomy of interest falls outside the sensitive area of the detector; 2) "cone cut", in which the X-Ray field does not adequately cover the anatomy of interest; 3) detector's sensitive surface is too small to cover the projection of the anatomy of interest; 4) improper angular orientation or "rotation" of anatomy of interest with respect to the X-Ray source, or detector; 5) projection of other anatomy or clothing over the anatomy of interest in the image
111210Motion blurUnacceptable image blur resulting from motion of the anatomy of interest during exposure or the inadequately compensated motion of X-Ray source with respect to the image detector during exposure
111211Under exposedInadequate number of quanta reached the detector during exposure. Reasons for under exposed images include low kVp, low mAs product, excess Source Image Distance. Under exposed images have inadequate signal and higher noise in the areas of interest
111212Over exposedAn excess number of quanta reached the detector during exposure. Reasons for over exposed images include high kVp, high mAs product, short Source Image Distance. Over exposed images have high signal and lower noise in the areas of interest. Over exposed area may demonstrate lack of contrast from over saturation of the detector
111213No imageNo evidence of a patient exposure
111214Detector artifact(s)Superposed features or flaws of the detector
111215Artifact(s) other than grid or detector artifactFeatures or discontinuities arising from causes other than the anti-scatter grid and image detector
111216Mechanical failureFailure of the device to operate according to mechanical design specifications
111217Electrical failureFailure of a device to operate according to electrical design specifications
111218Software failureAttributable to software used in generation or handling of image
111219Inappropriate image processingImages processed inappropriately, not following appropriate protocol
111220Other failureFailure that is not mechanical or electrical or otherwise described
111221Unknown failureUnidentified or unknown cause of failure
111222SucceededThe attempted process was completely successful
111223Partially SucceededThe attempted process succeeded in some ways, but failed in others
111224FailedThe attempted process completely failed
111225Not AttemptedNo process was performed
111233Individual Impression / Recommendation AnalysisAnalysis of a related group of findings or features detected during image data inspection, to produce a summary impression and/or recommendation
111234Overall Impression / Recommendation AnalysisAnalysis of all groups of findings or features, to produce a single impression and/or recommendation
111235Unusable - Quality renders image unusableThe usability of an image for diagnostic interpretation or CAD, based on a quality control standard
111236Usable - Does not meet the quality control standardThe usability of an image for diagnostic interpretation or CAD, based on a quality control standard
111237Usable - Meets the quality control standardThe usability of an image for diagnostic interpretation or CAD, based on a quality control standard
111238Mammography Quality Control Manual 1999, ACRAn image quality control standard specified by the American College of Radiology
111239Title 21 CFR Section 900, Subpart BAn image quality control standard in the US Code of Federal Regulations
111240Institutionally defined quality control standardAn image quality control standard specified or adopted by the institution responsible for the document
111241All algorithms succeeded; without findingsNo findings resulted upon successful completion of all attempted computer-aided detection and/or analysis
111242All algorithms succeeded; with findingsOne or more findings resulted upon successful completion of all attempted computer-aided detection and/or analysis
111243Not all algorithms succeeded; without findingsNo findings resulted from the attempted computer-aided detection and/or analysis, but one or more failures occurred in the process
111244Not all algorithms succeeded; with findingsOne or more findings resulted from the attempted computer-aided detection and/or analysis, but one or more failures occurred in the process
111245No algorithms succeeded; without findingsAll of the attempted computer-aided detection and/or analysis failed, so there could be no findings
111248AdenolipomaA benign tumor having glandular characteristics but composed of fat, with the presence of normal mammary ducts
111249Ductal hyperplasiaHyperplasia is also known as epithelial hyperplasia or proliferative breast disease. It's an overgrowth of the cells that line the ducts or the lobules. Based on how the cells look under a microscope, the hyperplasia is called either ductal hyperplasia (also called duct epithelial hyperplasia) or lobular hyperplasia. Based on the pattern of the cells, hyperplasia may be called usual or atypical. In usual hyperplasia, the pattern of cells is very close to normal. Atypical hyperplasia (or hyperplasia with atypia) is a term used when the cells are more distorted. FROM: http://www.cancer.org/healthy/findcancerearly/womenshealth/non-cancerousbreastconditions/non-cancerous-breast-conditions-hyperplasia
111250AdenomyoepitheliomaNeoplasms composed of myoepithelial cells
111251Normal axillary nodeAxillary node that is normal in appearance with no associated pathology
111252Axillary node with calcificationsAxillary node containing calcifications
111253Axillary node hyperplasiaExcessive proliferation of normal tissue arrangement of the axillary node
111254Asynchronous involutionundefined
111255Benign cyst with bloodCyst with benign morphology containing blood
111256Benign CalcificationsCalcifications having typically benign morphology. They are not of intermediate or high probability of concern for malignancy
111257Intracystic papillomaGrowing within a cystic adenoma, filling the cavity with a mass of branching epithelial processes
111258Ductal adenomaAdenoma located in mammary duct, present as discrete sclerotic nodules, solitary or multiple
111259Diabetic fibrous mastopathyThe occurrence of fibrous tumor-forming stromal proliferation in patients with diabetes mellitus
111260Extra abdominal desmoidA deep seated firm tumor frequently occurring on the chest consisting of collagenous tissue that infiltrates surround muscle; frequently recurs but does not metastasize
111262Epidermal inclusion cystA cyst formed of a mass of epithelial cells, as a result of trauma has been pushed beneath the epidermis. The cyst is lined with squamous epithelium and contains concentric layers or keratin
111263Fibroadenomatoid hyperplasiaExcessive proliferation of fibroadenoma tissue
111264FibroadenolipomaA lipoma with an abundant stroma of fibrous tissue
111265Foreign body (reaction)undefined
111269GalactoceleRetention cyst caused by occlusion of a lactiferous duct
111271Hemangioma - nonparenchymal, subcutaneousA congenital anomaly that leads to a proliferation of blood vessels leading to a mass that resembles a neoplasm, not located in parenchymal areas but subcutaneous
111273Hyperplasia, usualHyperplasia is also known as epithelial hyperplasia or proliferative breast disease. It's an overgrowth of the cells that line the ducts or the lobules. Based on how the cells look under a microscope, the hyperplasia is called either ductal hyperplasia (also called duct epithelial hyperplasia) or lobular hyperplasia. FROM: http://www.cancer.org/healthy/findcancerearly/womenshealth/non-cancerousbreastconditions/non-cancerous-breast-conditions-hyperplasia
111277Juvenile papillomatosisA form of fibrocystic disease in young woman with florid and sclerosing adenosis that microscopically may suggest carcinoma
111278Lactating adenomaEnlarging masses during lactation. A circumscribed benign tumor composed primarily of glandular structures with scanty stroma, with prominent secretory changes in the duct
111279Lactational changeChanges related to the process of lactation
111281Large duct papillomaA papilloma pertaining to large mammary duct
111283MyofibroblastomaSolitary or multiple tumors of muscles and fibrous tissues, or tumors composed of myofibroblasts
111284Microglandular adenosisIrregular clusters of small tubules are present in adipose or fibrous tissue, resembling tubular carcinoma but lacking stromal fibroblastic proliferation
111285Multiple Intraductal PapillomasPapilloma typically involving an aggregate of adjacent ducts in the periphery of the breast, likely representing involvement of several foci of one or two duct systems
111286No abnormalityNo abnormality
111287Normal breast tissueNormal breast tissue
111288NeurofibromatosisCondition in which there are tumors of various sizes on peripheral nerves. They may be neuromas or fibromas
111290Oil cyst (fat necrosis cyst)A cyst resulting from the loss of the epithelial lining of a sebaceous dermoid or lacteal cyst
111291Post reduction mammoplastyBreast tissue with characteristics of a benign nature, following breast reduction surgery
111292Pseudoangiomatous stromal hyperplasiaA benign stromal lesion composed of intermixed stromal and epithelial elements. The lobular and duct structures of the breast parenchyma are separated by an increased amount of stroma, non specific proliferative epithelial changes include hyperplasia of duct and lobular epithelium often with accentuation of myoepithelial cells and aprocine metaplasia with or without cyst formation
111293Radial scarAn nonencapsulated stellate lesion consisting of a fibroelastic core and radiating bands of fibrous connective tissue containing lobules manifesting adenosis and ducts with papillary or diffuse intraductal hyperplasia
111294Sclerosing adenosisProminent interductal fibrosis of the terminal ductules
111296Silicone granulomaNodular inflammatory lesions due to the presence of silicone in the breast tissue
111297Nipple CharacteristicThe morphologic status of the nipple
111298Virginal hyperplasiaSpontaneous excessive proliferation of breast tissue, usually found in younger women
111299Peripheral duct papillomasPapilloma(s) pertaining the peripheral ducts
111300Axillary node with lymphomaAxillary node with lymphoid tissue neoplasm
111301Axillary nodal metastasesMetastatic disease to the axillary node
111302AngiosarcomaA malignant neoplasm occurring most often in breast and skin, believed to originate from endothelial cells of blood vessels, microscopically composed of closely packed round or spindle shaped cells, some of which line small spaces resembling vascular clefts
111303Blood vessel (vascular) invasionHistological changes to the vascular system related to an invasive process
111304Carcinoma in childrenCarcinoma of the breast found in patients less than 20 years of age
111305Carcinoma in ectopic breastA carcinoma found in supernumerary breasts and aberrant breast tissue
111306Carcinoma with endocrine differentiationA carcinoma that synthesizes substances, including hormones, not considered to be normal products of the breast
111307Basal cell carcinoma of nippleA basal cell carcinoma that arises in the nipple of the breast
111308Carcinoma with metaplasiaMetaplastic carcinoma is cancer that begins in cells that have changed into another cell type (for example, a squamous cell of the esophagus changing to resemble a cell of the stomach). In some cases, metaplastic changes alone may mean there is an increased chance of cancer developing at the site. Metaplastic carcinoma is a relatively uncommon type of cancer with treatment generally similar to that of invasive ductal carcinoma of no special type.[1] FROM: https://en.wikipedia.org/wiki/Metaplastic_carcinoma
111309Cartilaginous and osseous changeTissue changes to bones and cartilage
111310Carcinoma in pregnancy and lactationCarcinoma of the breast presenting during pregnancy or lactation
111311CarcinosarcomaA malignant neoplasm that contains elements of carcinoma and sarcoma, so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue
111312Intraductal comedocarcinoma with necrosisComedocarcinoma of a duct with areas of necrotic tissue
111313Intraductal carcinoma, low gradeA non-invasive carcinoma restricted to the glandular lumen characterized by less aggressive malignant cytologic features and behavior
111314Intraductal carcinoma micro-papillaryPapillary and micropapillary Ductal Carcinoma In Situ (DCIS): the cancer cells arrange themselves in a fern-like pattern within the affected breast ducts; micropapillary DCIS cells are smaller than papillary DCIS cells. FROM: http://www.imaginis.com/breast-cancer-diagnosis/ductal-carcinoma-in-situ-dcis-3
111315Intracystic papillary carcinomaA malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells found in a cyst
111316Invasive and in-situ carcinomaCarcinoma with both characteristics of localized and spreading disease
111317Invasive lobular carcinomaInvasive lobular carcinoma is a type of breast cancer that begins in the milk-producing glands (lobules) of the breast. Invasive cancer means the cancer cells have broken out of the lobule where they began and have the potential to spread to the lymph nodes and other areas of the body. Invasive lobular carcinoma typically doesn't form a lump, which is common in breast cancer. Instead, there is a change in the breast that feels like a thickening or fullness in one part of the breast and is different from the surrounding breast tissue. FROM: http://www.mayoclinic.org/diseases-conditions/invasive-lobular-carcinoma/basics/definition/con-20033968
111318Leukemic infiltrationMammary infiltrates as a secondary manifestation in patients with established leukemia
111320Lympathic vessel invasionHistological changes to the lymphatic system related to an invasive process
111321LymphomaA heterogeneous group of neoplasms arising in the reticuloendoethelial and lymphatic systems
111322Occult carcinoma presenting with axillary lymph node metastasesA small carcinoma, either asymptomatic or giving rise to metastases without symptoms due to the primary carcinoma presenting with metastatic disease in the axillary lymph nodes
111323Metastatic cancer to the breastA malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a non-mammary malignant neoplasm
111324Metastatic cancer to the breast from the colonA malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the colon
111325Metastatic cancer to the breast from the lungA malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the lung
111326Metastatic melanoma to the breastA malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a melanoma
111327Metastatic cancer to the breast from the ovaryA malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the ovary
111328Metastatic sarcoma to the breastA malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a sarcoma
111329Multifocal intraductal carcinomaMultiple foci of non-invasive carcinoma restricted to the glandular lumen
111330Metastatic disease to axillary nodeA malignant lesion in an axillary node arising from a non-axillary neoplasm
111331Malignant fibrous histiocytomaPleomorphic undifferentiated sarcoma (abbreviated PUS), also undifferentiated pleomorphic sarcoma and previously malignant fibrous histiocytoma (abbreviated MFH), is a type of soft tissue sarcoma. FROM: https://en.wikipedia.org/wiki/Pleomorphic_undifferentiated_sarcoma
111332Multifocal invasive ductal carcinomaMultiple sites of ductal carcinoma
111333Metastasis to an intramammary lymph nodeA malignant lesion in a intramammary lymph node arising from a non-intramammary lymph node neoplasm
111334Malignant melanoma of nippleA malignant melanoma of the skin that arises in the nipple of the breast
111335Neoplasm of the mammary skinundefined
111336Papillary carcinoma in-situPapillary and micropapillary Ductal Carcinoma In Situ (DCIS): the cancer cells arrange themselves in a fern-like pattern within the affected breast ducts; micropapillary DCIS cells are smaller than papillary DCIS cells. FROM: http://www.imaginis.com/breast-cancer-diagnosis/ductal-carcinoma-in-situ-dcis-3
111338Recurrent malignancyRecurrent malignancy
111340Squamous cell carcinoma of the nippleSquamous cell carcinoma to the terminal portion of the alveolar
111341Intraductal carcinoma, high gradeA non-invasive carcinoma restricted to the glandular lumen characterized by more aggressive malignant cytologic features and behavior
111342Invasive cribriform carcinomaInvasive tumor with cribriform pattern similar to cribriform DCIS. Low grade, cribriform appearance (well defined spaces formed by arches of cells) similar to cribriform DCIS but with larger cells, more cytoplasm and more vesicular nuclei: Tumor cells are small, often have apical snouts, mild/moderate nuclear pleomorphism; Also stromal invasion by islands of cells, often angulated; May have predominantly solid appearance; Associated with cribriform DCIS; Often mixed with tubular carcinoma. FROM: http://www.pathologyoutlines.com/topic/breastmalignantcribriform.html
111343Angular marginsAn indication that some or all of the margin of a lesion has sharp corners, often forming acute angles
111344Fine pleomorphic calcificationCalcifications that vary in sizes and shapes and are usually smaller than0.5 mm in diameter
111345MacrocalcificationsCoarse calcifications that are 0.5 mm or greater in size
111346Calcifications within a massAn indicator that calcifications are imbedded within a mass
111347Calcifications outside of a massAn indicator that calcifications are imaged outside of a mass finding
111350Breast background echotextureTissue composition of the breast noted on sonography
111351Homogeneous fat echotextureFat lobules and uniformly echogenic bands of supporting structures comprise the bulk of breast tissue
111352Homogeneous fibroglandular echotextureA uniformly echogenic layer of fibroglandular tissue is seen beneath a thin layer of subcutaneous fat
111353Heterogeneous echotextureThe breast texture is characterized by multiple small areas of increased and decreased echogenicity
111354OrientationReferential relationship of the finding to the imaging device as noted on sonography
111355ParallelThe long axis of a lesion parallels the skin line ("wider-than-tall" or in a horizontal orientation)
111356Not parallelThe anterior-posterior or vertical dimension is greater than the transverse or horizontal dimension
111357Lesion boundaryThe lesion boundary describes the transition zone between themas and the surrounding tissue
111358Abrupt interfaceThe sharp demarcation between the lesion and surrounding tissue can be imperceptible or a distinct well-defined echogenic rim of any thickness
111359Echogenic haloThere is no sharp demarcation between the mass and the surrounding tissue, which is bridged by an echogenic transition zone
111360Echo patternAn imaging characteristic of resonance noted during sonography
111361AnechoicWithout internal echoes
111362HyperechoicHaving increased echogenicity relative to fat or equal to fibroglandular tissue
111363ComplexMass contains both anechoic and echogenic components
111364HypoechoicDefined relative to fat; masses are characterized by low-level echoes throughout; e.g. appearance of a complicated cyst or fibroadenoma
111365IsoechoicHaving the same echogenicity as fat (a complicated cyst or fibroadenoma may be isoechoic or hypoechoic)
111366Posterior acoustic featuresThe attenuation characteristics of a mass with respect to its acoustic transmission
111367No posterior acoustic featuresNo posterior shadowing or enhancement
111368Posterior enhancementIncreased posterior echoes
111369Posterior shadowingDecreased posterior echoes; edge shadows are excluded
111370Combined posterior enhancement and shadowingMore than one pattern of posterior attenuation, both shadowing and enhancement
111371Identifiable effect on surrounding tissuesSonographic appearance of adjacent structures relative to a mass finding
111372VascularityCharacterization of vascularization in region of interest
111373Vascularity not presentVascularity not evident, such as on ultrasound
111374Vascularity not assessedVascularity not evaluated
111375Vascularity present in lesionVascularity on imaging is seen within a lesion
111376Vascularity present immediately adjacent to lesionVascularity on imaging is seen immediately adjacent to a lesion
111377Diffusely increased vascularity in surrounding tissueVascularity on imaging is considered diffusely elevated within the surrounding breast tissue
111380Correlation to other FindingsRelationship of the new anomaly to other clinical or imaging anomalies
111381Correlates to physical exam findingsAn indication that the current imaging finding relates to a finding from a clinical breast exam
111382Correlates to mammography findingsAn indication that the current imaging finding relates to a finding from a mammography exam
111383Correlates to MRI findingsAn indication that the current imaging finding relates to a finding from a breast MRI exam
111384Correlates to ultrasound findingsAn indication that the current imaging finding relates to a finding from a breast ultrasound exam
111385Correlates to other imaging findingsAn indication that the current imaging finding relates to a finding from an imaging exam
111386No correlation to other imaging findingsAn indication that the current imaging finding has no relation to findings from any other imaging exam
111387No correlation to clinical findingsAn indication that the current imaging finding has no relation to any other clinical findings
111388Malignancy TypeClassification of the cancer as invasive, DCIS, or other
111389Invasive breast carcinomaA malignancy that has spread beyond an area of focus
111390Other malignancy typeA breast cancer with malignant pathology findings that are not classified as invasive or in situ
111391Menstrual Cycle PhaseA specific timeframe during menses
1113921st weekIn the first week of the menstrual cycle phase, that is, one week following menses
1113932nd weekIn the second week of the menstrual cycle phase, that is, two weeks following menses
1113943rd weekIn the third week of the menstrual cycle phase, that is, three weeks following menses
111395Estimated TimeframeAn estimated period of time
111396< 3 months agoAn event occurred less than 3 months ago
1113974 months to 1 year agoAn event occurred between 4 months and 1 year ago
111398> 1 year agoAn event occurred longer than 1 year ago
111399Timeframe uncertainThe timing of an event is not recalled
111400Breast Imaging ReportReport title for the diagnostic report for one or more breast imaging or intervention procedures
111401Reason for procedureConcept name for the description of why a procedure has been performed
111402Clinical FindingA finding during clinical examination (i.e., history and physical examination) such as pain, palpable mass or discharge
111403Baseline screening mammogramFirst screening mammogram taken for patient that is used as a comparison baseline for further examinations
111404First mammogram everFirst mammogram taken for a patient without regard to whether it was for screening or a diagnostic procedure
111405Implant typeConcept name for the material of which a breast prosthetic device is constructed
111406Number of similar findingsA numeric count of findings classified as similar in nature
111407Implant findingConcept name for the status of a breast prosthetic device as noted by imaging
111408Film Screen MammographyMammogram using traditional X-Ray film
111409Digital MammographyMammogram using a digital image acquisition system
111410Surgical consultReferred for evaluation by a surgeon
111411Mammography CADComputer aided detection and/or computer aided diagnosis for mammography
111412Narrative SummaryConcept name for a text-based section of a report
111413Overall AssessmentA title for a report section that summarizes all interpretation results for a report with one overriding assessment; e.g. benign or negative
111414Supplementary DataConcept name for a collection of supporting evidence for a report
111415Additional evaluation requested from prior studyPrior study indicates that additional imaging be performed to further evaluate a suspicious or questionable anatomic region
111416Follow-up at short interval from prior studyThe prior study recommended a follow-up breast imaging exam in 1 to 11 months (generally in 6 months)
111417History of breast augmentation, asymptomaticPrior breast augmentation (breast enlargement) and is not presenting with any symptoms
111418Review of an outside studyReview or second opinion made on an image performed outside of the facility
111419Additional evaluation requested from abnormal screening examAdditional breast imaging performed at the time of the patient's screening mammogram
111420History of benign breast biopsyPatient has had previous benign breast biopsies
111421Personal history of breast cancer with breast conservation therapyPatient has had a prior surgery such as a lumpectomy or quadrantectomy to remove malignant breast tissue, but breast tissue remains
111423Physical Examination ResultsThe results of a physical examination performed on the patient, possibly including the results of inspection, palpation, auscultation, or percussion
111424Comparison to previous findingsThe result of assessing the current imaging exam in comparison to previous imaging exams
111425Intraluminal filling defectAn abnormality observed during ductography where the ductal system within the breast fills in an abnormal pattern. Ductography is an imaging exam in which a radio opaque contrast media is introduced into the ductal system of the breast through the nipple and images of the ductal system are obtained
111426Multiple filling defectDuring ductography an observation of more than one filling abnormality within the breast ductal system
111427Abrupt duct terminationAn abnormality observed during ductography where the ductal system within the breast terminates in an unusual fashion
111428ExtravasationAbnormal flowage of contrast media within the breast noted on ductography
111429Duct narrowingAn abnormality observed during ductography where the ductal system within the breast appears narrow
111430Cyst fillDuring ductography an observation of the contrast media filling a cyst within the breast
111431Instrument ApproachThe area and line within the anatomy through which a needle or instrument passes during an interventional procedure
111432Inferolateral to superomedialThe line within the anatomy from the lower outer to the upper inner aspect; e.g. through which a needle or instrument passes in an interventional procedure
111433Inferomedial to superolateralThe line within the anatomy from the lower inner to the upper outer aspect; e.g. through which a needle or instrument passes in an interventional procedure
111434Superolateral to inferomedialThe line within the anatomy from the upper outer to the lower inner aspect; e.g. through which a needle or instrument passes in an interventional procedure
111435Superomedial to inferolateralThe line within the anatomy from the upper inner to the lower outer aspect; e.g. through which a needle or instrument passes in an interventional procedure
111436Number of passesThe number of times a biopsy instrument is passed through an area of interest
111437Number of specimensThe number of biopsy specimens obtained from an interventional procedure
111438Needle in targetAn indicator of whether or not a biopsy or localizing needle in an interventional procedure is seen to be in the area of interest
111439Number of needles around targetThe number of localizing needles placed around the area of interest in an interventional procedure
111440Incision madeAn indicator of whether or not an incision was made in the anatomy during an interventional procedure
111441Microclip placedAn indicator of whether or not a radio opaque microclip was placed in the anatomy during an interventional procedure
111442Confirmation of targetAn indicator of the degree of success of an interventional procedure
111443Target completely contained in the specimenAn indicator that during an interventional procedure the area of interest was fully excised and is noted in the resultant biopsy specimen
111444Target partially obtained in the specimenAn indicator that during an interventional procedure the area of interest was partially excised and is noted in the resultant biopsy specimen
111445Target not in the specimenAn indicator that following an interventional procedure the area of interest is not seen in the resultant biopsy specimen
111446Calcifications seen in the coreAn indicator that following an interventional procedure the targeted calcifications are noted in the resultant biopsy specimen
111447Lesion completely removedAn indicator that during an interventional procedure the area of interest was fully excised and is noted in the resultant biopsy specimen
111448Lesion partially removedAn indicator that during an interventional procedure the area of interest was partially excised and is noted in the resultant biopsy specimen
111449Fluid obtainedAn indicator that during an interventional procedure fluid was successfully aspirated
111450Light brown colorColor that is a light shade of brown
111451Dark red colorColor that is a dark shade of red
111452Dark brown colorColor that is a dark shade of brown
111453Bright red colorColor that is a bright shade of red
111454Blood tinged colorColor that is tinged with the color of blood
111455Occult blood test resultAn indicator of whether or not the fluid obtained during an interventional procedure contains red blood cells
111456Action on fluidAn indicator of whether or not fluid during an interventional procedure was sent for cytological analysis or simply discarded
111457Sent for analysisAn indicator that fluid obtained during an interventional procedure was sent to a laboratory for analysis
111458DiscardedAn indicator that fluid obtained during an interventional procedure was discarded
111459Mass with calcificationsA radiopaque density noted during diagnostic imaging that has associated calcific densities
111460Complex cystA fluid-filled sac with greater than normal characteristics
111461Intracystic lesionA tumor within a cyst
111462Solid massA tumor or lesion
111463Supplementary Data for InterventionSupporting evidence for interpretation results of an interventional procedure
111464Procedure ModifierA descriptor that further qualifies or characterizes a type of procedure
111465Needle GaugeNeedle size (diameter) characterization; e.g. of a biopsy needle
111466Severity of ComplicationAn indicator of the gravity of a problem experienced by a patient, related to a procedure that was performed
111467Needle LengthDistance from the hub or bushing to the tip of the needle
111468Pathology ResultsThe collection of observations and findings from pathologic analysis
111469Sampling DateTimeThe date and time that the sample was collected from the patient
111470UninvolvedIndicates that the margin of the biopsy specimen was not involved with the tumor
111471InvolvedIndicates that the margin of the biopsy specimen was involved with the tumor
111472Nipple involvedIndicates whether the nipple was involved in an interventional procedure or pathologic analysis
111473Number of nodes removedIndicates the number of lymph nodes removed
111474Number of nodes positiveIndicates the number of lymph nodes removed that contain cancer cells
111475Estrogen receptorThe result of a test for the presence of a protein that binds with estrogen
111476Progesterone receptorThe result of a test for the presence of a protein that binds with progesterone
111477S PhaseIndicates the percentage of cells in S phase. Cell division is defined by phases; the S phase is the stage during which DNA replicates
111478Non-bloody discharge (from nipple)The visible emission of non-bloody fluid from the nipple
111479Difficult physical/clinical examinationThe inability to discern normal versus abnormal breast tissue during palpation
111480Cancer elsewhereAn indication that a patient has or had a malignant occurrence in an area of the body other than the breast
111481Saline implantA salt water filled prosthetic device implanted in the breast
111482Polyurethane implantA polymer based (plastic) prosthetic device implanted in the breast
111483Percutaneous silicone injectionThe introduction of polymeric organic silicon based material through the skin, as for breast augmentation or reconstruction
111484Combination implantA prosthetic device that contains more than one material implanted in the breast
111485Pre-pectoral implantA breast implant placed in front of the pectoralis major muscle
111486Retro-pectoral implantA breast implant placed behind the pectoralis major muscle
111487Mammographic (crosshair)Using X-Ray technique and a superimposed set of crossed lines for detection or placement
111488Mammographic (grid)Using X-Ray technique and a superimposed aperture for detection or placement
111489Palpation guidedUsing physical touch for detection or placement
111490Vacuum assistedThe performance of a biopsy procedure using a vacuum device attached to the biopsy needle
111491Abnormal dischargeUnusual or unexpected emission of fluid
111492No complicationsHaving experienced no adverse medical conditions related to or resulting from an interventional procedure
111494Stage 0TNM grouping of tumor stage, from AJCC, where primary tumor is Tis, regional lymph node is N0, and distant metastasis is M0
111495Stage ITNM grouping of tumor stage, from AJCC, where primary tumor is T1, regional lymph node is N0, and distant metastasis is M0
111496Stage IIATNM grouping of tumor stage, from AJCC, where primary tumor is T0 or T1, with regional lymph node N1 and distant metastasis is M0, or T2 with N0 and M0
111497Stage IIBTNM grouping of tumor stage, from AJCC, where primary tumor is T2, with regional lymph node N1 and distant metastasis is M0, or T3 with N0 and M0
111498Stage IIIATNM grouping of tumor stage, from AJCC, where primary tumor is T0, T1 or T2, with regional lymph node N2 and distant metastasis is M0, or T3 with N1 or N2 and M0
111499Stage IIIBTNM grouping of tumor stage, from AJCC, where primary tumor is T4, regional lymph node is N0, N1 or N2, and distant metastasis is M0
111500Stage IIICTNM grouping of tumor stage, from AJCC, where primary tumor is any T value, regional lymph node is N3, and distant metastasis is M0
111501Stage IVTNM grouping of tumor stage, from AJCC, where primary tumor is any T value, regional lymph node is any N value, and distant metastasis is M1
111502Bloom-Richardson GradeHistologic tumor grade (sometimes called Scarff-Bloom-Richardson grade) is based on the arrangement of the cells in relation to each other -- whether they form tubules, how closely they resemble normal breast cells (nuclear grade) and how many of the cancer cells are in the process of dividing (mitotic count)
111503Normal implantsBreast prosthetic devices are intact, not leaking, and are in a normal shape and form
111504Asymmetric implantsBreast prosthetic devices are not symmetric, equal, corresponding in form, or are in one breast (unilateral)
111505Calcified implantFibrous or calcific contracture of the tissue capsule that forms around a breast prosthetic device
111506Distorted implantBreast prosthetic device is twisted out of normal shape or form
111507Silicone-laden lymph nodesSilicone from breast prosthetic device found in lymphatic tissue
111508Free siliconeSilicone found in breast tissue outside of the prosthetic capsule or implant membrane
111509Herniated implantProtrusion of part of the structure normally encapsulating the content of the breast prosthetic device
111510ExplantationEvidence of removal of a breast prosthetic device
111511Relevant Patient Information for Breast ImagingHistorical patient health information of interest to the breast health clinician
111512Medication HistoryInformation regarding usage by the patient of certain medications, such as hormones
111513Relevant Previous ProceduresInterventional or non-interventional procedures previously performed on the patient, such as breast biopsies
111514Relevant Indicated ProblemsAbnormal conditions experienced by the patient that serve as the reason for performing a procedure, such as a breast exam
111515Relevant Risk FactorsPersonal, familial, and other health factors that may indicate an increase in the patient's chances of developing a health condition or disease, such as breast cancer
111516Medication TypeA classification of a medicinal substance, such as hormonal contraceptive or antibiotic
111517Relevant Patient InformationHistorical patient health information for general purpose use
111518Age when first menstrual period occurredThe age of the patient at the first occurrence of menses
111519Age at First Full Term PregnancyThe age of the patient at the time of her first full term pregnancy
111520Age at MenopauseThe age of the patient at the cessation of menses
111521Age when hysterectomy performedThe age of the patient at the time her uterus was removed
111522Age when left ovary removedThe age of the patient at the time she had her left ovary removed
111523Age when right ovary removedThe age of the patient at the time she had her right ovary removed
111524Age StartedThe age of a patient on the first occurrence of an event, such as the first use of a medication
111525Age EndedThe age of a patient on the last occurrence of an event, such as the last use of a medication
111526DateTime StartedThe date and time of the first occurrence of an event, such as the first use of a medication
111527DateTime EndedThe date and time of the last occurrence of an event, such as the last use of a medication
111528OngoingAn indicator of whether an event is still in progress, such as the use of a medication or substance, or environmental exposure
111529Brand NameProduct name of a device or substance, such as medication, to identify it as the product of a single firm or manufacturer
111530Risk Factor modifierA descriptor that further qualifies or characterizes a risk factor
111531Previous ProcedureA prior non-interventional exam or interventional procedure performed on a patient
111532Pregnancy StatusDescribes the pregnancy state of a referenced subject
111533Indicated ProblemA symptom experienced by a patient that is used as the reason for performing an exam or procedure
111534Role of person reportingThe function of the individual who is reporting information on a patient, which could be a specific health care related profession, the patient him/herself, or a relative or friend
111535DateTime problem observedThe date and time that a symptom was noted
111536DateTime of last evaluationThe date and time of the most recent evaluation of an indicated problem
111537Family Member with Risk FactorA patient's biological relative who exhibits a health factor that may indicate an increase in the patient's chances of developing a particular disease or medical problem
111538Age at OccurrenceThe age at which an individual experienced a specific event, such as breast cancer
111539Menopausal phaseThe current stage of an individual in her gynecological development
111540Side of FamilyAn indicator of paternal or maternal relationship
111541MaternalRelating to biological female parentage
111542Unspecified gynecological hormoneA gynecological hormone for which the specific type is not specified; e.g. contraceptive, estrogen, Tamoxifen
111543Breast feeding historyAn indicator of whether or not a patient ever provided breast milk to her offspring
111544Average breast feeding periodThe average length of time that a patient provided breast milk to her offspring
111545Substance Use HistoryInformation regarding usage by the patient of certain legal or illicit substances
111546Used Substance TypeA classification of a substance, such as alcohol or a legal or illicit drug
111547Environmental Exposure HistoryInformation regarding exposure of the patient to potentially harmful environmental factors
111548Environmental FactorA classification of a potentially harmful substance or gas in a subject's environment, such as asbestos, lead, or carcinogens
111549Previous ReportsPrevious Structured Reports that could have relevant information for a current imaging service request
111550Personal breast cancer historyAn indication that a patient has had a previous malignancy of the breast
111551History of endometrial cancerIndicates a previous occurrence of cancer of the lining of the uterus
111552History of ovarian cancerIndicates a previous occurrence of cancer of the lining of the ovary
111553History of high risk lesion on previous biopsyIndicates a prior diagnosis of pre-cancerous cells or tissue removed for pathologic evaluation
111554Post menopausal patientA female patient whose menstrual periods have ceased
111555Late child bearing (after 30)A female patient whose first child was born after the patient was 30 years old
111556BRCA1 breast cancer geneThe first level genetic marker indicating risk for breast cancer
111557BRCA2 breast cancer geneThe second level genetic marker indicating risk for breast cancer
111558BRCA3 breast cancer geneThe third level genetic marker indicating risk for breast cancer
111559Weak family history of breast cancerA patient's biological aunt, grandmother, or female cousin was diagnosed with breast cancer. Definition from BI-RADS®
111560Intermediate family history of breast cancerA patient's biological mother or sister was diagnosed with breast cancer after they had gone through menopause. Definition from BI-RADS®
111561Very strong family history of breast cancerA patient's biological mother or sister was diagnosed with breast cancer before they had gone through menopause, or more than one of the patient's first-degree relatives (biological mother or sister) were diagnosed with breast cancer after they had gone through menopause. Definition from BI-RADS®
111562Family history of prostate cancerPrevious diagnosis of a malignancy of the prostate gland in a biological relative
111563Family history unknownThe health record of a patient's biological relatives is not known
111564Nipple discharge cytologyThe study of cells obtained from fluid emitted from the breast
111565Uterine malformationsA developmental abnormality resulting in an abnormal shape of the uterus
111566Spontaneous AbortionA naturally occurring premature expulsion from the uterus of the products of conception - the embryo or a nonviable fetus
111567Gynecologic conditionAn ailment/abnormality or state of the female reproductive tract
111568Gynecologic surgeryA surgical operation performed on any portion of the female reproductive tract
111569Previous LBW or IUGR birthPrior pregnancy with a low birth weight baby or a fetus with Intrauterine Growth Restriction or Retardation
111570Previous fetal malformation/syndromeHistory of at least one prior pregnancy with fetal anatomic abnormality(s)
111571Previous RH negative or blood dyscrasia at birthHistory of delivering a Rhesis Isoimmunization affected child(ren) or a child(ren) with another blood disorder
111572History of multiple fetusesHistory of at least one pregnancy that contained more than one fetus; e.g. twins, triplets, etc.
111573Current pregnancy, known or suspected malformations/syndromesAt least one fetus of this pregnancy has an anatomic abnormality(s) that is known to exist, or a "marker" is present that suggests the abnormality(s) may be present
111574Family history, fetal malformation/syndromeBiological relatives have previously conceived a fetus with an anatomic abnormality(s)
111575HighA subjective descriptor for an elevated amount of exposure, use, or dosage, incurring high risk of adverse effects
111576MediumA subjective descriptor for a moderate amount of exposure, use, or dosage, incurring medium risk of adverse effects
111577LowA subjective descriptor for a limited amount of exposure, use, or dosage, incurring low risk of adverse effects
111578Dose frequencyA measurement of the rate of occurrence of which a patient takes a certain medication
111579Rate of exposureThe quantity per unit of time that a patient was or is being exposed to an environmental irritant
111580Volume of useThe quantity per unit of time that a medication or substance was or is being used
111581Relative dose amountA qualitative descriptor for the amount of a medication that was or is being taken
111582Relative amount of exposureA qualitative descriptor for the amount of present or past exposure to an environmental irritant
111583Relative amount of useA qualitative descriptor for the amount of a medication or substance that was or is being used
111584Relative dose frequencyA qualitative descriptor for the frequency with which a medication was or is being taken
111585Relative frequency of exposureA qualitative descriptor for the frequency of present or past exposure to an environmental irritant
111586Relative frequency of useA qualitative descriptor for the frequency with which a medication or substance was or is being used
111587No known exposurePatient is not known to have been exposed to or used the substance or medication
111590Recall for technical reasonsPatient returns for additional images to improve the quality of the most recent exam
111591Recall for imaging findingsPatient returns for additional images to clarify findings from the most recent exam
111592Recall for patient symptoms/ clinical findingsPatient returns for additional images to clarify symptoms or signs reported by the patient or a healthcare professional at the time of the most recent exam
111593LBW or IUGRNumber of births with low birth weight or intrauterine growth restriction
111601Green filterFilter that transmits green light while blocking the other colors, typically centered at 510-540 nm
111602Red filterFilter that transmits red light while blocking the other colors, typically centered at 630-680 nm
111603Blue filterFilter that transmits blue while blocking the other colors, typically centered at 460-480 nm
111604Yellow-green filterA filter of 560nm that is used for retinal imaging and can provide good contrast and good visibility of the retinal vasculature
111605Blue-green filterA filter of 490nm that is used for retinal imaging because of excessive scattering of some retinal structures at very short wavelengths
111606Infrared filterFilter that transmits the infrared spectrum, which is light that lies outside of the visible spectrum, with wavelengths longer than those of red light, while blocking visible light
111607Polarizing filterA filter that reduces reflections from non-metallic surfaces such as glass or water by blocking light waves that are vibrating at selected angles to the filter
111609No filterNo filter used
111621Field 1 for Joslin 3 fieldJoslin NM-1 is a 45 degree field focused centrally between the temporal margin of optic disc and the center of the macula: Center the camera on the papillomacular bundle midway between the temporal margin of the optic disc and the center of the macula. The horizontal centerline of the image should pass directly through the center of the disc
111622Field 2 for Joslin 3 fieldJoslin NM-2 is a 45 degree field focused superior temporal to the optic disc: Center the camera laterally approximately one-half disc diameter temporal to the center of the macula. The lower edge of the field is tangent to a horizontal line passing through the upper edge of the optic disc. The image is taken temporal to the macula but includes more retinal nasal and superior to the macula than standard field 2
111623Field 3 for Joslin 3 fieldJoslin NM-3 is a 45 degree field focused nasal to the optic disc: This field is nasal to the optic disc and may include part of the optic disc. The horizontal centerline of the image should pass tangent to the lower edge of the optic disc
111625Diffuse direct illuminationA broad or "soft" light supplied from a single source
111626Scheimpflug CameraA slit reflected light microscope, which has the ability to form an image of the back scattered light from the eye in a sagittal plane. Scheimpflug cameras are able to achieve a wide depth of focus by employing the "Sheimpflug principle" where the lens and image planes are not parallel with each other. Rotating Sheimplug cameras are able to generate three-dimensional images and calculate measurements of the anterior chamber of the eye
111627Scotopic lightLighting condition approximately 0.04 lux
111628Mesopic lightLighting condition approximately 4 lux
111629Photopic lightLighting condition approximately 40 lux
111630Dynamic lightAcquisition preceded by intense light
111631Average Glandular DoseCalculated from values of entrance exposure in air, the X-Ray beam quality (half-value layer), and compressed breast thickness, is the energy deposited per unit mass of glandular tissue averaged over all the glandular tissue in the breast
111632Anode Target MaterialThe primary material in the anode of an X-Ray source
111633Compression ThicknessThe average thickness of the body part examined when compressed, if compression has been applied during X-Ray exposure
111634Half Value LayerThickness of Aluminum required to reduce the X-Ray output at the patient entrance surface by a factor of two
111635X-Ray GridAn anti-scatter device based on radiation absorbing strips above the detector; e.g. in the patient support
111636Entrance Exposure at RPExposure measurement in air at the reference point that does not include back scatter, according to MQCM 1999
111637Accumulated Average Glandular DoseAverage Glandular Dose to a single breast accumulated over multiple images
111638Patient Equivalent ThicknessValue of the control variable used to parametrize the Automatic Exposure Control (AEC) closed loop; e.g. "Water Value"
111641Fixed gridAn X-Ray Grid that does not move during exposure
111642Focused gridAn X-Ray Grid with radiation absorbing strips that are focused toward the focal spot, to eliminate grid cutoff
111643Reciprocating gridAn X-Ray Grid that is designed to move during exposure, to eliminate the appearance of grid lines on the image
111644Parallel gridAn X-Ray Grid with radiation absorbing strips that are parallel to each other and that is used only with long source to image distances
111645Crossed gridAn X-Ray Grid with crossed radiation absorbing strips used for more complete cleanup of scatter radiation
111646No gridNo X-Ray Grid was used due to low scatter conditions
111671Spectacle Prescription ReportThe spectacle prescription for a patient
111672Add NearRefractive measurements of the eye to correct for inability to focus at near while wearing the distance prescription
111673Add IntermediateRefractive measurements of the eye to correct for inability to focus at intermediate distance while wearing the distance prescription
111674Add OtherRefractive measurements of the eye to correct for inability to focus at the specified distance while wearing the distance prescription
111675Horizontal Prism PowerThe power of a prism to bend light in the horizontal direction, in prism diopters
111676Horizontal Prism BaseDirection of the base of a horizontal prism -- either in (toward the nose), or out (away from the nose)
111677Vertical Prism PowerThe power of a prism to bend light in the vertical direction, in prism diopters
111678Vertical Prism BaseDirection of the base of a vertical prism -- either up, or down
111679Distance Pupillary DistanceDistance in mm between the pupils when the patient's object of regard is in the distance
111680Near Pupillary DistanceDistance in mm between the pupils when the patient's object of regard is at near
111685Autorefraction Visual AcuityA patient's vision with the correction measured by an autorefractor in place
111686Habitual Visual AcuityA patient's vision with whichever vision correction the patient customarily wears
111687Prescription Visual AcuityA patient's vision with the final spectacle prescription in place
111688Right Eye RxThe spectacle prescription for the right eye
111689Left Eye RxThe spectacle prescription for the left eye
111690Macular Grid Thickness and Volume ReportA macular grid thickness and volume report for a patient. The macular grid is an analytic tool described in PS3.1
111691Number of Images Used for Macular MeasurementsNumber of images used for the macular grid measurement
111692Number of Samples Used per ImageNumber of samples used per Image for analysis
111693Analysis Quality RatingA numeric rating of the quality of the entire analysis with respect to grading and diagnostic purposes. Higher numbers indicate greater quality
111694Image Set Quality RatingA numeric rating of the quality of an entire image set with respect to grading and diagnostic purposes. Higher numbers indicate greater quality
111695Interfering Tears or DropsTear film or drops affecting test quality
111696Visual Fixation Quality During AcquisitionThe assessment of the centricity and persistence of the visual fixation (direction of gaze) during the acquisition
111697Visual Fixation Quality ProblemThe reason why the patient's visual fixation was not steady or was indeterminate
111698Ophthalmic Macular Grid ProblemThe reason why the macular grid measurements may be questionable
111700Specimen Container IdentifierIdentifier of container (box, block, microscope slide, etc.) for the specimen under observation
111701Processing typeType of processing that tissue specimen underwent
111702DateTime of processingDate and time of processing step
111703Processing step descriptionDescription of the individual step in the tissue processing sequence
111704Sampling MethodMethod of sampling used to derive specimen from its parent
111705Parent Specimen IdentifierIdentifier of the parent specimen that gave rise to the current specimen
111706Issuer of Parent Specimen IdentifierAssigning authority for parent specimen's identifier
111707Parent specimen typeParent specimen type that gave rise to current specimen
111708Position Frame of ReferenceDescription of coordinate system and origin reference point on parent specimen, or parent specimen container, or image used for localizing the sampling site or location within container or image
111709Location of sampling siteReference to image of parent specimen localizing the sampling site; may include referenced Presentation State object
111710Location of sampling site X offsetLocation of sampling site of specimen (nominal center) relative to the Position Frame of Reference in the X dimension
111711Location of sampling site Y offsetLocation of sampling site of specimen (nominal center) relative to the Position Frame of Reference in the Y dimension
111712Location of sampling site Z offsetLocation of sampling site of specimen (nominal center) relative to the Position Frame of Reference in the Z dimension
111718Location of SpecimenDescription of specimen location, either in absolute terms or relative to the Position Frame of Reference
111719Location of Specimen X offsetLocation of specimen (nominal center) relative to the Position Frame of Reference in the X dimension
111720Location of Specimen Y offsetLocation of specimen (nominal center) relative to the Position Frame of Reference in the Y dimension
111721Location of Specimen Z offsetLocation of specimen (nominal center) relative to the Position Frame of Reference in the Z dimension
111723Visual Marking of SpecimenDescription of visual distinguishing identifiers; e.g. ink, or a particular shape of the specimen
111724Issuer of Specimen IdentifierAssigning authority for specimen identifier
111726Dissection with entire specimen submissionDissection of specimen with submission of all its sections for further processing or examination
111727Dissection with representative sections submissionDissection of specimen with submission of representative sections for further processing or examination
111729Specimen storageA workflow step, during which tissue specimens are stored in a climate-controlled environment
111741Transmission illuminationTransmission illumination method for specimen microscopy
111742Reflection illuminationReflection illumination method for specimen microscopy
111743Epifluorescence illuminationEpifluorescence illumination method for specimen microscopy
111744Brightfield illuminationBrightfield illumination method for specimen microscopy
111745Darkfield illuminationDarkfield illumination method for specimen microscopy
111746Oblique illuminationOblique illumination method for specimen microscopy
111747Phase contrast illuminationPhase contrast illumination method for specimen microscopy
111748Differential interference contrastDifferential interference contrast method for specimen microscopy
111749Total internal reflection fluorescenceTotal internal reflection fluorescence method for specimen microscopy
111750Ultrasound ContactA method of obtaining ophthalmic axial measurements that uses ultrasound, and that requires applanation of the cornea
111751Ultrasound ImmersionA method of obtaining ophthalmic axial measurements that uses ultrasound, and that requires immersion of the patient's eye in fluid as he lies in a supine position
111752OpticalA method of obtaining ophthalmic axial measurements that uses light
111753Manual KeratometryMeasurements taken of the corneal curvature using a manual keratometer
111754Auto KeratometryMeasurements taken of the corneal curvature using an automated keratometer
111755Simulated KeratometrySimulated Keratometry measurements derived from corneal topography
111756Equivalent K-readingCorneal power measurements using Scheimpflug camera
111760HaigisThe Haigis IOL calculation formula. Haigis W, Lege B, Miller N, Schneider B. Comparison of immersion ultrasound biometry and partial coherence interferometry for intraocular lens calculation according to Haigis. Graefes Arch Clin Exp Ophthalmol 2000;238:765-73
111761Haigis-LThe Haigis-L IOL calculation formula. Haigis W. Intraocular lens calculation after refractive surgery for myopia: Haigis-L formula. J Cataract Refract Surg. 2008 Oct;34(10):1658-63
111762Holladay 1The Holladay 1 IOL calculation formula. Holladay JT, Prager TC, Chandler TY, Musgrove KH, Lewis JW, Ruiz RS. A three-part system for refining intraocular lens power calculations. J Cataract Refract Surg. 1988; 14:17-24
111763Holladay 2The Holladay 2 IOL calculation formula
111764Hoffer QThe Hoffer Q IOL calculation formula. Hoffer KJ. The Hoffer Q formula: a comparison of theoretic and regression formulas. J Cataract Refract Surg 1993;19:700-12. Errata. J Cataract Refract Surg 1994;20:677 and 2007;33:2-3
111765OlsenThe Olsen IOL calculation formula. Olsen T. Calculation of intraocular lens power: a review. Acta Ophthalmol. Scand. 2007: 85: 472-485
111766SRKIIThe SRKII IOL calculation formula. Sanders DR, Retzlaff J, Kraff MC. Comparison of the SRK II formula and other second generation formulas. J Cataract Refract Surg. 1988 Mar;14(2):136-41
111767SRK-TThe SRK-T IOL calculation formula. Retzlaff JA, Sanders DR, Kraff MC. Development of the SRK/T intraocular lens implant power calculation formula. J Cataract Refract Surg 1990;16:333-40. Erratum 1990;16:528
111768ACD ConstantThe "ACD Constant" used in IOL calculation
111769Haigis a0The "Haigis a0" constant used in IOL calculation
111770Haigis a1The "Haigis a1" constant used in IOL calculation
111771Haigis a2The "Haigis a2" constant used in IOL calculation
111772Hoffer pACD ConstantThe "Hoffer pACD Constant" used in IOL calculation
111773Surgeon FactorThe "Surgeon Factor" constant used in IOL calculation
111776Front Of Cornea To Front Of LensAnterior chamber depth defined as the front of the cornea to the front of the lens
111777Back Of Cornea To Front Of LensAnterior chamber depth defined as the back of the cornea to the front of the lens
111778Single or Anterior LensRefers to the anterior lens when there are two lenses in the eye. The distance, in mm, from the anterior surface of the lens to the posterior surface of the lens
111779Posterior LensRefers to the posterior lens when there are two lenses in the eye. The distance, in mm, from the anterior surface of the lens to the posterior surface of the lens
111780Measurement From This DeviceValue obtained from measurements taken by the device creating this SOP Instance
111781External Data SourceValue obtained by data transfer from an external source - not from measurements taken by the device providing the value
111782Axial Measurements SOP InstanceAxial Measurements DICOM SOP Instance
111783Refractive Measurements SOP InstanceRefractive Measurements DICOM SOP Instance
111786Standard Deviation of measurements usedStandard Deviation is a simple measure of the variability of a data set
111787Signal to Noise RatioSignal to Noise Ratio of the data samples taken to create a measurement
111791Spherical projectionProjection from 2D image pixels to 3D Cartesian coordinates based on a spherical mathematical model
111792Surface contour mappingMapping from 2D image pixels to 3D Cartesian coordinates based on measurements of the retinal surface; e.g. of the retina, derived via a measurement technology such as Optical Coherence Tomography, Ultrasound etc.
111800Visual Field 24-2 Test PatternTest pattern, nominally covering an area within 24° of fixation. Consists of 54 test points a minimum of 3° from each meridian and placed 6° apart. The "-2" distinguishes this from another 24° pattern (no longer supported)
111801Visual Field 10-2 Test PatternTest pattern, nominally covering an area within 10° of fixation. Consists of 68 test points a minimum of 1° from each meridian and placed 2° apart. The "-2" in this case indicates its point layout to be similar to the 30-2 and 24-2
111802Visual Field 30-2 Test PatternTest pattern consisting of test point locations within 30° of fixation. Consists of 76 test points a minimum of 3° from each meridian and placed 6° apart. The "-2" distinguishes this from another 30° pattern (no longer supported)
111803Visual Field 60-4 Test PatternTest pattern consisting of 60 test point locations between 30° and 60° of fixation a minimum of 6° from each meridian and placed 12° apart. The "-4" distinguishes this from a similar 60° pattern having 4 additional points
111804Visual Field Macula Test PatternTest pattern consisting of 16 test point locations within 10° of fixation a minimum of 1° from each meridian and placed 2° apart
111805Visual Field Central 40 Point Test PatternTest pattern consisting of 40 test point locations within 30° of fixation that spread out radially from fixation
111806Visual Field Central 76 Point Test PatternTest pattern consisting of 76 test point locations within 30° of fixation a minimum of 3° from each meridian and placed 6° apart
111807Visual Field Peripheral 60 Point Test PatternTest pattern consisting of 60 test point locations between 30° and 60° of fixation a minimum of 6° from each meridian and placed 12° apart
111808Visual Field Full Field 81 Point Test PatternTest pattern consisting of 81 test point locations within 60° of fixation that spread out radially from fixation
111809Visual Field Full Field 120 Point Test PatternTest pattern consisting of 120 test point locations within 60° of fixation that spread out radially from fixation, concentrated in the nasal hemisphere
111810Visual Field G Test PatternTest pattern for Glaucoma and general visual field assessment with 59 test locations of which 16 test locations are in the macular area (up to 10° eccentricity) and where the density of test location is reduced with eccentricity. The test can be extended with the inclusion of 14 test locations between 30° and 60° eccentricity, 6 of which are located at the nasal step
111811Visual Field M Test PatternTest pattern for the macular area. Orthogonal test pattern with 0.7° spacing within the central 4° of eccentricity and reduced density of test locations between 4 and 10, 5° of eccentricity. 81 test locations over all. The test can be extended to include the test locations of the Visual Field G Test Pattern between 10, 5° and 60°
111812Visual Field 07 Test PatternFull field test pattern with 48 test locations from 0-30° and 82 test locations from 30-70°. Reduced test point density with increased eccentricity. Can be combined with screening and threshold strategies
111813Visual Field LVC Test PatternLow Vision Central. Orthogonal off-center test pattern with 6° spacing. 75 test locations within the central 30°. Corresponds with the 32/30-2 excluding the 2 locations at the blind spot, including a macular test location. The LVC is linked with a staircase threshold strategy starting at 0 dB intensity and applies stimulus area V
111814Visual Field Central Test PatternGeneral test corresponding to the 30-2 but excluding the 2 test locations in the blind spot area, hence with 74 instead of 76 test locations
111815Visual Field SITA-Standard Test StrategySwedish Interactive Thresholding Algorithm (SITA). Strategy gains testing efficiency through use of visual field and information theory models. In: Bengtsson B, Olsson J, Heijl A, Rootzen H. A new generation of algorithms for computerized threshold perimetry, SITA. Acta Ophthalmologica Scandinavica, 1997, 75: 368-375
111816Visual Field SITA-SWAP Test StrategyAdaptation of SITA testing methods to Blue-Yellow testing
111817Visual Field SITA-Fast Test StrategySimilar to SITA-Standard but with less strict criteria for closing test points. Intended for patients who must be tested in the shortest possible time. In: Bengtsson B, Hejl A. SITA Fast, a new rapid perimetric threshold test. Description of methods and evaluation in patients with manifest and suspect glaucoma. Acta Ophthalmologica Scandinavica, 1998, 76: 431-437
111818Visual Field Full Threshold Test StrategyThreshold test algorithm that determines a patient's sensitivity at each test point in the threshold test pattern by adjusting intensity by 4 dB steps until the patient changes their response, and then adjusts the intensity in the opposite direction by 2 dB steps until the patient changes their response again. The last stimulus seen by the patient is recognized as the threshold for that point. The starting values are determined by first thresholding a "primary" point in each quadrant then using the results of each primary point to determine the starting values for neighboring points
111819Visual Field FastPac Test StrategySimilar to the Full Threshold algorithm except that it steps by 3 dB and only crosses the threshold only once. In: Flanagan JG, Wild JM, Trope GE. Evaluation of FASTPAC, a new strategy for threshold estimation with the Humphrey Field Analyzer, in a glaucomatous population. Ophthalmology, 1993, 100: 949-954
111820Visual Field Full From Prior Test StrategyIdentical to Full Threshold except that starting values are determined by the results of a previous test performed using the same test pattern and the Full Threshold test strategy
111821Visual Field Optima Test StrategySimilar to FastPac except that the steps are pseudo-dynamic (differ based on the intensity of the last presentation)
111822Visual Field Two-Zone Test StrategySuprathreshold testing strategy, in which each point is initially tested using stimulus that is 6 dB brighter than the expected hill of vision. If the patient does not respond, the stimulus is presented a second time at the same brightness. If the patient sees either presentation, the point is marked as "seen"; otherwise it is marked as "not seen"
111823Visual Field Three-Zone Test StrategyAn extension of the two-zone strategy in which test points where the second stimulus is not seen are presented with a third stimulus at maximum brightness
111824Visual Field Quantify-Defects Test StrategyAn extension of the two-zone strategy, in which test points where the second stimulus is not seen receive threshold testing to quantify the depth of any detected scotomas
111825Visual Field TOP Test StrategyTendency Oriented Perimetry. Fast thresholding algorithm. Test strategy makes use of the interaction between neighboring test locations to reduce the test time compared to normal full threshold strategy by 60-80%. In: Morales J, Weitzman ML, Gonzalez de la Rosa M. Comparison between Tendency-Oriented Perimetry (TOP) and octopus threshold perimetry. Ophthalmology, 2000, 107: 134-142
111826Visual Field Dynamic Test StrategyDynamic strategy is a fast thresholding strategy reducing test duration by adapting the dB step sizes according to the frequency-of-seeing curve of the threshold. Reduction of test time compared to normal full threshold strategy 30-50%
111827Visual Field Normal Test StrategyTraditional full threshold staircase strategy. Initial intensities are presented, based on anchor point sensitivities in each quadrant and based on already known neighboring sensitivities. In a first run, thresholds are changed in 4dB steps until the first response reversal. Then the threshold is changed in 2 dB steps until the second response reversal. The threshold is calculated as the average between the last seen and last not-seen stimulus, supposed to correspond with the 50% point in the frequency-of-seeing curve
111828Visual Field 1-LT Test StrategyOne level screening test: Each test location is tested with a single intensity. The result is shown as seen or not-seen. The intensity can either be a 0 dB stimulus or a predefined intensity
111829Visual Field 2-LT Test StrategyTwo level screening test: Each test location is initially tested 6 dB brighter than the age corrected normal value
111830Visual Field LVS Test StrategyLow Vision Strategy is a full threshold normal strategy with the exception that it starts at 0 dB intensity and applies stimulus area V
111831Visual Field GATE Test StrategyGerman Adaptive Threshold Estimation is a fast strategy based on a modified 4-2 staircase algorithm, using prior visual fields to calculate the starting intensity. In: Chiefer U, Pascual JP, Edmunds B, Feudner E, Hoffmann EM, Johnson CA, Lagreze WA, Pfeiffer N, Sample PA, Staubach F, Weleber RG, Vonthein R, Krapp E, Paetzold J. Comparison of the new perimetric GATE strategy with conventional full-threshold and SITA standard strategies. Investigative Ophthalmology and Visual Science, 2009, 51: 488-494
111832Visual Field GATEi Test StrategySimilar to GATE. The i stands for initial. If there was no prior visual field test to calculate the starting values, an anchor point method is used to define the local start values
111833Visual Field 2LT-Dynamic Test StrategyA test started as two level screening test. In the course of the test, the threshold of relative defects and/or normal test locations has been quantified using the dynamic threshold strategy
111834Visual Field 2LT-Normal Test StrategyA test started as two level screening test. In the course of the test, the threshold of relative defects and/or normal test locations has been quantified using the normal full threshold strategy
111835Visual Field Fast Threshold Test StrategyTakes neighborhood test point results into account and offers stimuli with an adapted value to save time
111836Visual Field CLIP Test StrategyContinuous Luminance Incremental Perimetry, which measures at first the individual reaction time of the patient and threshold values in every quadrant. The starting value for the main test is slightly below in individual threshold
111837Visual Field CLASS StrategyA supra threshold screening strategy. The starting stimuli intensities depend on the classification of the patient's visual hill by measuring the central (fovea) or peripheral (15° meridian) threshold. The result of each dot slightly underestimates the sensitivity value (within 5 dB)
111838Age correctedMode for determining the starting luminance for screening test points - the starting luminance s is chosen based on the age of the patient
111839Threshold relatedMode for determining the starting luminance for screening test points - the starting luminance is chosen based on the results of thresholding a set of "primary" test points (one in each quadrant)
111840Single luminanceMode for determining the starting luminance for screening test points - in this case, all starting luminance is set to the same value
111841Foveal sensitivity relatedMode for determining the starting luminance for screening test points - the starting luminance is chosen based on the result of the foveal threshold value
111842Related to non macular sensitivityMode for determining the starting luminance for screening test points - the starting luminance is chosen based on the result of four threshold values measured near the 15° meridian (one in each quadrant)
111843Automated OpticalReal time evaluation of the camera image to recognize blinks and fixation losses with influence on the test procedure. Blinks that interfere with stimuli presentation cause the automated repetition of such stimulus presentations. Fixation losses can be used to delay the stimulus presentation until correct fixation is regained
111844Blind Spot MonitoringA method of monitoring the patient's fixation by periodically presenting stimulus in a location on the background surface that corresponds to the patient's blind spot
111845Macular Fixation TestingA method of monitoring the patient's fixation by presenting the stimulus to the patient's macula
111846Observation by ExaminerA method of monitoring the patient's fixation by observation from the examiner of the patient
111847Outside normal limitsAnalysis Results are outside normal limits
111848BorderlineAnalysis Results are borderline
111849Abnormally high sensitivityAnalysis Results identify abnormally high sensitivity
111850General reduction in sensitivityAnalysis Results identify general reduction in sensitivity
111851Borderline and general reduction in sensitivityAnalysis Results identify Borderline and general reduction in sensitivity
111852Visual Field IndexIndex of a patient's remaining visual field normalized for both age and generalized defect
111853Visual Field Loss Due to Diffuse DefectEstimate of the portion of a patient's visual field loss that is diffuse (i.e., spread evenly across all portions of the visual field)
111854Visual Field Loss Due to Local DefectEstimate of the portion of a patient's visual field loss that is local (i.e., not spread evenly across all portions of the visual field)
111855Glaucoma Hemifield Test AnalysisAn analysis of asymmetry between zones of the superior and inferior visual field. It is designed to be specific for defects due to glaucoma
111856Optical Fixation MeasurementsThe data output of an optical fixation monitoring process, consisting of a list of positive and negative numbers indicating the quality of patient fixation over the course of a visual field test. The value 0 represents the initial fixation. Negative numbers indicate a measuring error (i.e., the patient blinked). Positive numbers quantify the degree of eccentricity from initial fixation
111900Macula centeredAn image of at least 15° angular subtend that is centered on the macula; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111901Disc centeredAn image of at least 15° angular subtend that is centered on the optic disc; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111902Lesion centeredAn image of any angular subtend that is centered on a lesion located in any region of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111903Disc-macula centeredAn image of at least 15° angular subtend centered midway between the disc and macula and containing at least a portion of the disc and both the disc and the macula; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111904Mid-peripheral-superiorAn image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the superior-temporal and superior-nasal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111905Mid-peripheral-superior temporalAn image of at least 15° angular subtend positioned between the central zone and the equator in the superior-temporal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111906Mid-peripheral-temporalAn image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the superior-temporal and inferior-temporal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111907Mid-peripheral-inferior temporalAn image of at least 15° angular subtend positioned between the central zone and the equator in the inferior-temporal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111908Mid-peripheral-inferiorAn image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the inferior-temporal and inferior-nasal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111909Mid-peripheral-inferior nasalAn image of at least 15° angular subtend positioned between the central zone and the equator in the inferior-nasal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111910Mid-peripheral-nasalAn image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the superior-nasal and inferior-nasal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111911Mid-peripheral-superior nasalAn image of at least 15° angular subtend positioned between the central zone and the equator in the superior-nasal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111912Peripheral-superiorAn image of at least 15° angular subtend positioned between the equator and the ora serrata, and spanning both the superior temporal and superior nasal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111913Peripheral-superior temporalAn image of at least 15° angular subtend positioned between the equator and ora serrata in the superior-temporal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111914Peripheral-temporalAn image of at least 15° angular subtend positioned between the equator and ora serrata, and spanning both the superior-temporal and inferior-temporal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111915Peripheral-inferior temporalAn image of at least 15° angular subtend positioned between the equator and ora serrata in the inferior-temporal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111916Peripheral-inferiorAn image of at least 15° angular subtend positioned between the equator and ora serrata, and spanning both the inferior-temporal and inferior-nasal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111917Peripheral-inferior nasalAn image of at least 15° angular subtend positioned between the equator and ora serrata in the inferior-nasal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111918Peripheral-nasalAn image of at least 15° angular subtend positioned between the equator and ora serrata, and spanning both the superior-nasal and inferior-nasal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111919Peripheral-superior nasalAn image of at least 15° angular subtend positioned between the equator and ora serrata in the superior-nasal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111920Time domainIdentifies the use of physical signals with respect to time to capture information
111921Spectral domainIdentifies the use of physical signals with respect to multiple frequencies to capture information
111922No corneal compensationNo compensation algorithm for corneal birefringence
111923Corneal birefringence compensationAlgorithm to compensate for variability in corneal birefringence
111924Retinal topographyMeasurement of the retinal surface contour relative to an assigned datum plane
111925Retinal nerve fiber layer thicknessMeasurement approximating the distance related to the structure between the internal limiting membrane (ILM) and the outer boarder of the retinal nerve fiber layer (RNFL); see Section III.6 "Retinal Thickness Definition" in PS3.17
111926Ganglion cell complex thicknessMeasurement approximating the distance related to the structure between the ILM and the outer border of the inner plexiform layer (IPL), called the ganglion cell complex (GCC); see Section III.6 "Retinal Thickness Definition" in PS3.17
111927Total retinal thickness (ILM to IS-OS)Measurement approximating the distance related to the structure between the ILM and the inner-outer segment junction (IS-OS); see Section III.6 "Retinal Thickness Definition" in PS3.17
111928Total retinal thickness (ILM to RPE)Measurement approximating the distance related to the structure between the ILM and the retinal pigment epithelium (RPE); see Section III.6 "Retinal Thickness Definition" in PS3.17
111929Total retinal thickness (ILM to BM)Measurement approximating the distance related to the structure between the ILM and the Bruch's membrane (BM); see Section III.6 "Retinal Thickness Definition" in PS3.17
111930Absolute ophthalmic thicknessThickness of a component of the posterior segment of the eye; e.g. thickness of retina, choroid, etc.
111931Thickness deviation category from normative dataOphthalmic Thickness map based upon statistical significance category (such as percentile) from a normative data set
111932Thickness deviation from normative dataOphthalmic Thickness map based upon deviation (such as microns) from a normative data set
111933Related ophthalmic thickness mapOphthalmic Thickness Map related to another Ophthalmic Thickness Map or another SOP Instance
111934Disc-FoveaAn anatomic point centered midway between the disc and fovea centralis
111935p>5%Assuming the null hypothesis is true, the conditional percent probability of observing this result is not statistically significant
111936p<5%Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 95% unlikely to happen by chance
111937p<2%Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 98% unlikely to happen by chance
111938p<1%Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 99% unlikely to happen by chance
111939p<0.5%Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 99.5% unlikely to happen by chance
111940Corneal axial power mapA two dimensional representation of the axial curvature of the cornea. Axial curvature is calculated from the reciprocal of the distance from a point on a meridian normal at the point to the corneal topographer axis. Also known as sagittal curvature
111941Corneal instantaneous power mapA two dimensional representation of the instantaneous curvature of the cornea. Instantaneous curvature is calculated from the reciprocal of the distance from a point on a meridian normal at the point to the center of curvature of that point. Also called tangential curvature
111942Corneal refractive power mapA two dimensional representation of the refractive power of the cornea. Corneal refractive power is calculated using Snell's Law
111943Corneal elevation mapA two dimensional representation of the elevation of the cornea. Elevation is calculated as the distance from a point on the corneal surface to a point on a reference surface along a line parallel to the corneal topographer axis. For the purpose of visualization the reference surface is usually a sphere or an ellipse
111944Corneal wavefront mapA two dimensional representation of a wavefront aberration surface of the cornea. Wavefront aberration surface is calculated from the corneal elevation data fit with either the Zernike polynomial series or the Fourier Series. Maps generally display total aberrations and selectable higher order aberrations
111945Elevation-based corneal tomographerA device that measures corneal anterior surface shape using elevation-based methods (stereographic and light slit-based). Rasterstereography images a grid pattern illuminating the fluorescein dyed tear film with 2 cameras to produce 3D. Slit-based devices scan the cornea, usually by rotation about the instrument axis centered on the cornea vertex
111946Reflection-based corneal topographerA reflection-based device that projects a pattern of light onto the cornea and an image of the reflection of that pattern from the tear film is recorded in one video frame. Light patterns include the circular mire pattern (Placido disc) and spot matrix patterns. Sequential scanning of light spots reflected from the corneal surface is also used requiring multiple video frames for recording
111947Interferometry-based corneal tomographerAn Interference-based device that projects a beam of light onto and through the cornea. Light reflected from within the cornea is combined with a reference beam giving rise to an interference pattern. Appropriately scanned, this imaging is used to construct 3-dimensional images of the cornea from anterior to posterior surfaces; e.g. swept source OCT
112000Chest CAD ReportA structured report containing the results of computer-aided detection or diagnosis applied to chest imaging and associated clinical information
112001OpacityThe shadow of an absorber that attenuates the X-Ray beam more effectively than do surrounding absorbers. In a radiograph, any circumscribed area that appears more nearly white (of lesser photometric density) than its surround [Fraser and Pare]
112002Series Instance UIDA unique identifier for a series of DICOM SOP instances
112003Associated Chest ComponentA named anatomic region within the chest cavity
112004Abnormal interstitial patternA collection of opacities detected within the continuum of loose connective tissue throughout the lung, that is not expected in a diagnostically normal radiograph
112005Radiographic anatomyA type of anatomy that is expected to be detectable on a radiographic (X-Ray based) image
112006Distribution DescriptorCharacteristic of the extent of spreading of a finding or feature
112007Border definitionCharacteristic of the clarity of the boundary or edges of a finding or feature
112008Site involvementThe part(s) of the anatomy affected or encompassed by a finding or feature
112009Type of ContentCharacteristic of the matter or substance within a finding or feature
112010Texture DescriptorCharacteristic of the surface or consistency of a finding or feature
112011Positioner Primary AnglePosition of the X-Ray beam about the patient from the RAO to LAO direction where movement from RAO to vertical is positive
112012Positioner Secondary AnglePosition of the X-Ray beam about the patient from the caudal to cranial direction where movement from caudal to vertical is positive
112013Location in ChestThe zone, lobe or segment within the chest cavity in which a finding or feature is situated
112014Orientation DescriptorVertical refers to orientation parallel to the superior-inferior (cephalad-caudad) axis of the body, with horizontal being perpendicular to this, and an oblique orientation having projections in both the horizontal and vertical
112015Border shapeCharacteristic of the shape formed by the boundary or edges of a finding or feature
112016Baseline CategoryIndicates whether a finding was considered a target lesion, non-target lesion, or non-lesion during evaluation of a baseline series, according to a method such as RECIST
112017Cavity extent as percent of volumeThe extent of a detected cavity, represented as the percent of the surrounding volume that it occupies
112018Calcification extent as percent of surfaceThe extent of a detected calcification, represented as the percent of the surrounding surface that it occupies
112019Calcification extent as percent of volumeThe extent of a detected calcification, represented as the percent of the surrounding volume that it occupies
112020Response EvaluationA heading for the reporting of response evaluation for treatment of solid tumors
112021Response Evaluation MethodThe system applied in the reporting of response evaluation for treatment of solid tumors
112022RECISTResponse Evaluation Criteria In Solid Tumors; see Normative References
112023Composite Feature ModifierA term that further specifies the name of an item that is an inferred correlation relating two or more individual findings or features
112024Single Image Finding ModifierA term that further specifies the name of an item that was detected on one image
112025Size DescriptorA qualitative descriptor for the extent of a finding or feature
112026Width DescriptorA qualitative descriptor for the thickness of tubular structures, such as blood vessels
112027Opacity DescriptorA characteristic that further describes the nature of an opacity
112028Abnormal Distribution of Anatomic StructureThe type of adverse affect that a finding or feature is having on the surrounding anatomy
112029WHOResponse evaluation method as defined in chapter 5, "Reporting of Response" of the WHO Handbook for Reporting Results for Cancer Treatment; see Normative References
112030Calcification DescriptorIdentification of the morphology of detected calcifications
112031Attenuation CoefficientA quantitative numerical statement of the relative attenuation of the X-Ray beam at a specified point. Coefficient that describes the fraction of a beam of X-Rays or gamma rays that is absorbed or scattered per unit thickness of the absorber. This value basically accounts for the number of atoms in a cubic cm volume of material and the probability of a photon being scattered or absorbed from the nucleus or an electron of one of these atoms. Usually expressed in Hounsfield units [referred to as CT Number in Fraser and Pare]
112032Threshold Attenuation CoefficientAn X-Ray attenuation coefficient that is used as a threshold; e.g. in calcium scoring
112033Abnormal opacityAn opacity that is not expected in a diagnostically normal radiograph
112034Calculation DescriptionA textual description of the mathematical method of calculation that resulted in a calculated value
112035Performance of Pediatric and Adult Chest Radiography, ACRAmerican College of Radiology. ACR Standard for the Performance of Pediatric and Adult Chest Radiography. In: Standards. Reston, Va: 2001:95-98
112036ACR Position StatementAmerican College of Radiology. ACR Position Statement for Quality Control and Improvement, Safety, Infection Control, and Patient Concerns. In: Practice Guidelines and Technical Standards. Reston, Va: 2001:iv
112037Non-lesion ModifierA descriptor for a non-lesion object finding or feature, used to indicate whether the object was detected as being internal or external to the patient's body
112038Osseous ModifierA concept modifier for an Osseous Anatomy, or bone related, finding
112039Tracking IdentifierA text label used for tracking a finding or feature, potentially across multiple reporting objects, over time. This label shall be unique within the domain in which it is used
112040Tracking Unique IdentifierA unique identifier used for tracking a finding or feature, potentially across multiple reporting objects, over time
112041Target Lesion Complete ResponseDisappearance of all target lesions
112042Target Lesion Partial ResponseAt least a 30% decrease in the sum of the Longest Diameter of target lesions, taking as reference the baseline sum Longest Diameter
112043Target Lesion Progressive DiseaseAt least a 20% increase in the sum of the Longest Diameter of target lesions, taking as reference the smallest sum Longest Diameter recorded since the treatment started, or the appearance of one or more new lesions
112044Target Lesion Stable DiseaseNeither sufficient shrinkage to qualify for Partial Response nor sufficient increase to qualify for Progressive Disease, taking as reference the smallest sum Longest Diameter since the treatment started
112045Non-Target Lesion Complete ResponseDisappearance of all non-target lesions and normalization of tumor marker level
112046Non-Target Lesion Incomplete Response or Stable DiseasePersistence of one or more non-target lesions and/or maintenance of tumor marker level above the normal limits
112047Non-Target Lesion Progressive DiseaseAppearance of one or more new lesions and/or unequivocal progression of existing non-target lesions
112048Current ResponseThe current response evaluation for treatment of solid tumors, according to a method such as RECIST
112049Best Overall ResponseBest response recorded from the start of the treatment until disease progression/recurrence, taking as reference for Progressive Disease the smallest measurements recorded since the treatment started, according to a method such as RECIST
112050Anatomic IdentifierA text identifier of an anatomic feature when a multiplicity of features of that type may be present, such as "Rib 1", "Rib 2" or thoracic vertebrae "T1" or "T2"
112051Measurement of ResponseA measured or calculated evaluation of response; e.g. according to a method such as RECIST, the value would be the calculated sum of the lengths of the longest axes of a set of target lesions
112052BronchovascularOf or relating to a bronchial (lung) specific channel for the conveyance of a body fluid
112053OsseousOf, relating to, or composed of bone
112054Secondary pulmonary lobuleThe smallest unit of lung surrounded by connective tissue septa; the unit of lung subtended by any bronchiole that gives off three to five terminal bronchioles [Fraser and Pare]
112055Agatston scoring methodA method of calculating an overall calcium score, reflecting the calcification of coronary arteries, based on the maximum X-Ray attenuation coefficient and the area of calcium deposits
112056Volume scoring methodA method of calculating an overall calcium score, reflecting the calcification of coronary arteries, based on the volume of each calcification, typically expressed in mm3
112057Mass scoring methodA method of calculating an overall calcium score, reflecting the calcification of coronary arteries, based on the total mass of calcification, typically expressed in mg
112058Calcium scoreA measure often arrived at through calculation of findings from CT examination, which is a common predictor of significant stenosis of the coronary arteries
112059Primary complexThe combination of a focus of pneumonia due to a primary infection with granulomas in the draining hilar or mediastinal lymph nodes [Fraser and Pare]
112060OligemiaGeneral or local decrease in the apparent width of visible pulmonary vessels, suggesting less than normal blood flow (reduced blood flow) [Fraser and Pare]
112061Abnormal lines (1D)Linear opacity of very fine width, i.e., a nearly one dimensional opacity
112062Abnormal lucencyArea of abnormal very low X-Ray attenuation, typically lower than aerated lung when occurring in or projecting over lung, or lower than soft tissue when occurring in or projecting over soft tissue
112063Abnormal calcificationsA calcific opacity within the lung that may be organized, but does not display the trabecular organization of true bone [Fraser and Pare]
112064Abnormal textureRelatively homogeneous, extended, pattern of abnormal opacity in the lung, typically low in contrast
112065Reticulonodular patternA collection of innumerable small, linear, and nodular opacities that together produce a composite appearance resembling a net with small superimposed nodules. The reticular and nodular elements are dimensionally of similar magnitude [Fraser and Pare]
112066Beaded septum signIrregular septal thickening that suggests the appearance of a row of beads; usually a sign of lymphangitic carcinomatosis, but may also occur rarely in sarcoidosis [Fraser and Pare]
112067Nodular patternA collection of innumerable, small discrete opacities ranging in diameter from 2-10 mm, generally uniform in size and widespread in distribution, and without marginal spiculation [Fraser and Pare]
112068PseudoplaqueAn irregular band of peripheral pulmonary opacity adjacent to visceral pleura that simulates the appearance of a pleural plaque and is formed by coalescence of small nodules [Fraser and Pare]
112069Signet-ring signA ring of opacities (usually representing a dilated, thick-walled bronchus) in association with a smaller, round, soft tissue opacity (the adjacent pulmonary artery) suggesting a "signet ring" [Fraser and Pare]
112070Air bronchiologramEquivalent of air bronchogram, but in airways assumed to be bronchioles because of peripheral location and diameter [Fraser and Pare]
112071Air bronchogramRadiographic shadow of an air-containing bronchus; presumed to represent an air-containing segment of the bronchial tree (identity often inferred) [Fraser and Pare]
112072Air crescentAir in a crescentic shape in a nodule or mass, in which the air separates the outer wall of the lesion from an inner sequestrum, which most commonly is a fungus ball of Aspergillusspecies [Fraser and Pare]
112073Halo signGround-glass opacity surrounding the circumference of a nodule or mass. May be a sign of invasive aspergillosis or hemorrhage of various causes [Fraser and Pare]
112074Target Lesion at BaselineFlag denoting that this lesion was identified, at baseline, as a target lesion intended for tracking over time [RECIST]
112075Non-Target Lesion at BaselineFlag denoting that this lesion was not identified, at baseline, as a target lesion, and was not intended for tracking over time [RECIST]
112076Non-Lesion at BaselineFlag denoting that this finding was identified, at baseline, as a category other than a lesion, and was not intended for tracking over time [RECIST]
112077VasoconstrictionLocal or general reduction in the caliber of visible pulmonary vessels, presumed to result from decreased flow occasioned by contraction of muscular pulmonary arteries [Fraser and Pare]
112078VasodilationLocal or general increase in the width of visible pulmonary vessels resulting from increased pulmonary blood flow [Fraser and Pare]
112079Architectural distortionA manifestation of lung disease in which bronchi, pulmonary vessels, a fissure or fissures, or septa of secondary pulmonary lobules are abnormally displaced [Fraser and Pare]
112080Mosaic perfusionA patchwork of regions of varied attenuation, interpreted as secondary to regional differences in perfusion [Fraser and Pare]
112081PleonemiaIncreased blood flow to the lungs or a portion thereof, manifested by a general or local increase in the width of visible pulmonary vessels [Fraser and Pare]
112082InterfaceThe common boundary between the shadows of two juxtaposed structures or tissues of different texture or opacity (edge, border) [Fraser and Pare]
112083LineA longitudinal opacity no greater than 2 mm in width [Fraser and Pare]
112084LucencyThe shadow of an absorber that attenuates the primary X-Ray beam less effectively than do surrounding absorbers. In a radiograph, any circumscribed area that appears more nearly black (of greater photometric density) than its surround [Fraser and Pare]
112085Midlung windowA midlung region, characterized by the absence of large blood vessels and by a paucity of small blood vessels, that corresponds to the minor fissure and adjacent peripheral lung [Fraser and Pare]
112086Carina angleThe angle formed by the right and left main bronchi at the tracheal bifurcation [Fraser and Pare]
112087Centrilobular structuresThe pulmonary artery and its immediate branches in a secondary lobule; HRCT depicts these vessels in certain cases; a.k.a. core structures or lobular core structures [Fraser and Pare]
112088Anterior junction lineA vertically oriented linear or curvilinear opacity approximately 1-2 mm wide, commonly projected on the tracheal air shadow [Fraser and Pare]
112089Posterior junction lineA vertically oriented, linear or curvilinear opacity approximately 2 mm wide, commonly projected on the tracheal air shadow, and usually slightly concave to the right [Fraser and Pare]
112090Azygoesophageal recess interfaceA space in the right side of the mediastinum into which the medial edge of the right lower lobe extends [Fraser and Pare]
112091Paraspinal lineA vertically oriented interface usually seen in a frontal chest radiograph to the left of the thoracic vertebral column [Fraser and Pare]
112092Posterior tracheal stripeA vertically oriented linear opacity ranging in width from 2-5 mm, extending from the thoracic inlet to the bifurcation of the trachea, and visible only on lateral radiographs of the chest [Fraser and Pare]
112093Right tracheal stripeA vertically oriented linear opacity approximately 2-3 mm wide extending from the thoracic inlet to the right tracheobronchial angle [Fraser and Pare]
112094StripeA longitudinal composite opacity measuring 2-5 mm in width; acceptable when limited to anatomic structures within the mediastinum [Fraser and Pare]
112095HiatusA gap or passage through an anatomical part or organ; especially : a gap through which another part or organ passes
112096Rib Scalene TubercleA small rounded elevation or eminence on the first rib for the attachment of the scalenus anterior
112097Vertebral Intervertebral NotchA groove that serves for the transmission of the vertebral artery
112098Subscapular FossaThe concave depression of the anterior surface of the scapula
112099Scapular SpineA sloping ridge dividing the dorsal surface of the scapula into the supraspinatous fossa (above), and the infraspinatous fossa (below)
112100Scapular Supraspinatus FossaThe portion of the dorsal surface of the scapula above the scapular spine
112101Scapular Infraspinatus FossaThe portion of the dorsal surface of the scapula below the scapular spine
112102Aortic knobThe portion of the aortic arch that defines the transition between its ascending and descending limbs
112103Arch of the Azygos veinSection of Azygos vein near the fourth thoracic vertebra, where it arches forward over the root of the right lung, and ends in the superior vena cava, just before that vessel pierces the pericardium
112104Air-fluid levelA local collection of gas and liquid that, when traversed by a horizontal X-Ray beam, creates a shadow characterized by a sharp horizontal interface between gas density above and liquid density below [Fraser and Pare]
112105Corona radiataA circumferential pattern of fine linear spicules, approximately 5 mm long, extending outward from the margin of a solitary pulmonary nodule through a zone of relative lucency [Fraser and Pare]
112106Honeycomb patternA number of closely approximated ring shadows representing air spaces 5-10 mm in diameter with walls 2-3 mm thick that resemble a true honeycomb; implies "end-stage" lung [Fraser and Pare]
112107Fleischner's line(s)A straight, curved, or irregular linear opacity that is visible in multiple projections; usually situated in the lower half of the lung; vary markedly in length and width [Fraser and Pare]
112108Intralobular linesFine linear opacities present in a lobule when the intralobular interstitium is thickened. When numerous, they may appear as a fine reticular pattern [Fraser and Pare]
112109Kerley A lineEssentially straight linear opacity 2-6 cm in length and 1-3 mm in width, usually in an upper lung zone [Fraser and Pare]
112110Kerley B lineA straight linear opacity 1.5-2 cm in length and 1-2 mm in width, usually at the lung base [Fraser and Pare]
112111Kerley C linesA group of branching, linear opacities producing the appearing of a fine net, at the lung base [Fraser and Pare]
112112Parenchymal bandElongated opacity, usually several millimeters wide and up to about 5 cm long, often extending to the pleura, which may be thickened and retracted at the site of contact [Fraser and Pare]
112113Reticular patternA collection of innumerable small linear opacities that together produce an appearance resembling a net [Fraser and Pare]
112114Septal line(s)Usually used in the plural, a generic term for linear opacities of varied distribution produced when the interstitium between pulmonary lobules is thickened [Fraser and Pare]
112115Subpleural lineA thin curvilinear opacity, a few millimeters or less in thickness, usually less than 1 cm from the pleural surface and paralleling the pleura [Fraser and Pare]
112116Tramline shadowParallel or slightly convergent linear opacities that suggest the planar projection of tubular structures and that correspond in location and orientation to elements of the bronchial tree [Fraser and Pare]
112117Tubular shadowPaired, parallel, or slightly convergent linear opacities presumed to represent the walls of a tubular structure seen en face; used if the anatomic nature of a shadow is obscure [Fraser and Pare]
112118DensityThe opacity of a radiographic shadow to visible light; film blackening; the term should never be used to mean an "opacity" or "radiopacity" [Fraser and Pare]
112119Dependent opacitySubpleural increased attenuation in dependent lung. The increased attenuation disappears when the region of lung is nondependent; a.k.a. dependent increased attenuation [Fraser and Pare]
112120Ground glass opacityHazy increased attenuation of lung, but with preservation of bronchial and vascular margins; caused by partial filling of air spaces, interstitial thickening, partial collapse of alveoli, normal expiration, or increased capillary blood volume [Fraser and Pare]
112121InfiltrateAny ill-defined opacity in the lung [Fraser and Pare]
112122MicronoduleDiscrete, small, round, focal opacity of at least soft tissue attenuation and with a diameter no greater than 7 mm [Fraser and Pare]
112123Phantom tumor (pseudotumor)A shadow produced by a local collection of fluid in one of the interlobar fissures, usually elliptic in one radiographic projection and rounded in the other, resembling a tumor [Fraser and Pare]
112124ShadowAny perceptible discontinuity in film blackening attributed to the attenuation of the X-Ray beam by a specific anatomic absorber or lesion on or within the body of the patient; to be employed only when more specific identification is not possible [Fraser and Pare]
112125Small irregular opacitiesTerm used to define a reticular pattern specific to pneumoconioses [Fraser and Pare]
112126Small rounded opacitiesTerm used to define a nodular pattern specific to pneumoconioses [Fraser and Pare]
112127Tree-in-bud signNodular dilation of centrilobular branching structures that resembles a budding tree and represents exudative bronchiolar dilation [Fraser and Pare]
112128Granular patternAny extended, finely granular pattern of pulmonary opacity within which normal anatomic details are partly obscured [Fraser and Pare]
112129Miliary patternA collection of tiny discrete opacities in the lungs, each measuring 2 mm or less in diameter, generally uniform in size and widespread in distribution [Fraser and Pare]
112130Mosaic patternGeneralized pattern of relatively well defined areas in the lung having different X-Ray attenuations due to a longstanding underlying pulmonary disease
112131Extremely smallA qualitative descriptor of a size that is dramatically less than typical
112132Very smallA qualitative descriptor of a size that is considerably less than typical
112133Too smallA qualitative descriptor of a size that is so small as to be abnormal versus expected size
112134EllipticShaped like an ellipse (oval)
112135LobulatedA border shape that is made up of, provided with, or divided into lobules (small lobes, curved or rounded projections or divisions)
112136SpiculatedRadially orientated border shape
112137Sharply definedThe border of a shadow (opacity) is sharply defined [Fraser and Pare]
112138Distinctly definedThe border of a shadow (opacity) is distinctly defined [Fraser and Pare]
112139Well demarcatedThe border of a shadow (opacity) is well distinct from adjacent structures [Fraser and Pare]
112140Sharply demarcatedThe border of a shadow (opacity) is sharply distinct from adjacent structures [Fraser and Pare]
112141Poorly demarcatedThe border of a shadow (opacity) is poorly distinct from adjacent structures [Fraser and Pare]
112142CircumscribedA shadow (opacity) possessing a complete or nearly complete visible border [Fraser and Pare]
112143AirInspired atmospheric gas. The word is sometimes used to describe gas within the body regardless of its composition or site [Fraser and Pare]
112144Soft tissueMaterial having X-Ray attenuation properties similar to muscle
112145CalciumMaterial having X-Ray attenuation properties similar to calcium, a silver-white bivalent metallic element occurring in plants and animals
112146AcinarA pulmonary opacity 4-8 mm in diameter, presumed to represent anatomic acinus, or a collection of opacities in the lung, each measuring 4-8 mm in diameter, and together producing an extended, homogeneous shadow [Fraser and Pare]
112147Air spaceThe gas-containing portion of the lung parenchyma, including the acini and excluding the interstitium [Fraser and Pare]
112148FibronodularSharply defined, approximately circular opacities occurring singly or in clusters, usually in the upper lobes [Fraser and Pare]
112149FluffyA shadow (opacity) that is ill-defined, lacking clear-cut margins [Fraser and Pare]
112150LinearA shadow resembling a line; any elongated opacity of approximately uniform width [Fraser and Pare]
112151ProfusionThe number of small opacities per unit area or zone of lung. In the International Labor Organization (ILO) classification of radiographs of the pneumoconioses, the qualifiers 0 through 3 subdivide the profusion into 4 categories. The profusion categories may be further subdivided by employing a 12-point scale [Fraser and Pare]
112152Silhouette signThe effacement of an anatomic soft tissue border by either a normal anatomic structure or a pathologic state such as airlessness of adjacent lung or accumulation of fluid in the contiguous pleural space; useful in detecting and localizing an opacity along the axis of the X-Ray beam [Fraser and Pare]
112153SubpleuralSituated or occurring between the pleura and the body wall
112154Bat's wing distributionSpatial arrangement of opacities that bears vague resemblance to the shape of a bat in flight; bilaterally symmetric [Fraser and Pare]
112155Butterfly distributionSpatial arrangement of opacities that bears vague resemblance to the shape of a butterfly in flight; bilaterally symmetric [Fraser and Pare]
112156CentrilobularReferring to the region of the bronchioloarteriolar core of a secondary pulmonary lobule [Fraser and Pare]
112157CoalescentThe joining together of a number of opacities into a single opacity [Fraser and Pare]
112158LobarOf or relating to a lobe (a curved or rounded projection or division); e.g. involving an entire lobe of the lung
112159Hyper-acuteExtremely or excessively acute, as a qualitative measure of severity
112160Homogeneous (uniform opacity)Of uniform opacity or texture throughout [Fraser and Pare]
112161InhomogeneousLack of homogeneity in opacity or texture
112162TargetDiscrete opacity centrally within a larger opacity, as a calcification descriptor
112163FibrocalcificPertaining to sharply defined, linear, and/or nodular opacities containing calcification(s) [Fraser and Pare]
112164FlocculentCalcifications made up of loosely aggregated particles, resembling wool
112165Difference in border shapeA change in the shape formed by the boundary or edges of a finding or feature
112166Difference in border definitionA change in the clarity of the boundary or edges of a finding or feature
112167Difference in distributionA change in the extent of spreading of a finding or feature
112168Difference in site involvementA change in the part(s) of the anatomy affected or encompassed by a finding or feature
112169Difference in Type of ContentA change in the matter or substance within a finding or feature
112170Difference in TextureA change in the surface or consistency of a finding or feature
112171Fiducial markA location in image space, which may or may not correspond to an anatomical reference, which is often used for registering data sets
112172PortacathConnected to an injection chamber placed under the skin in the upper part of the chest. When it is necessary to inject some drug, a specific needle is put in the chamber through the skin and a silicon membrane. The advantage of a portacath is that it may be left in place several months contrarily of "classical" catheters
112173Chest tubeA tube inserted into the chest wall from outside the body, for drainage. Sometimes used for collapsed lung. Usually connected to a receptor placed lower than the insertion site
112174Central lineA tube placed into the subclavian vein to deliver medication directly into the venous system
112175Kidney stentA stent is a tube inserted into another tube. Kidney stent is a tube that is inserted into the kidney, ureter, and bladder, to help drain urine. Usually inserted through a scoping device presented through the urethra
112176Pancreatic stentA stent is a tube inserted into another tube. Pancreatic stent is inserted through the common bile duct to the pancreatic duct, to drain bile
112177Nipple ringA non-lesion object that appears to be a circular band, attached to the body via pierced nipple
112178CoinA non-lesion object that appears to be a flat round piece of metal
112179Minimum Attenuation CoefficientThe least quantity assignable, admissible, or possible; the least of a set of X-Ray attenuation coefficients
112180Maximum Attenuation CoefficientThe greatest quantity or value attainable or attained; the largest of a set of X-Ray attenuation coefficients
112181Mean Attenuation CoefficientThe value that is computed by dividing the sum of a set of X-Ray attenuation coefficients by the number of values
112182Median Attenuation CoefficientThe value in an ordered set of X-Ray attenuation coefficients, below and above which there is an equal number of values
112183Standard Deviation of Attenuation CoefficientFor a set of X-Ray attenuation coefficients: 1) a measure of the dispersion of a frequency distribution that is the square root of the arithmetic mean of the squares of the deviation of each of the class frequencies from the arithmetic mean of the frequency distribution; 2) a parameter that indicates the way in which a probability function or a probability density function is centered around its mean and that is equal to the square root of the moment in which the deviation from the mean is squared
112184Performance of Pediatric and Adult Thoracic CTAmerican College of Radiology. ACR Standard for the Performance of Pediatric and Adult Thoracic Computed Tomography (CT). In: Standards. Reston, Va: 2001:103-107
112185Performance of CT for Detection of Pulmonary Embolism in AdultsAmerican College of Radiology. ACR Standard for the Performance of Computed Tomography for the Detection of Pulmonary Embolism in Adults. In: Standards. Reston, Va: 2001:109-113
112186Performance of High-Resolution CT of the Lungs in AdultsAmerican College of Radiology. ACR Standard for the Performance of High-Resolution Computed Tomography (HRCT) of the Lungs in Adults. In: Standards. Reston, Va: 2001:115-118
112187Unspecified method of calculationThe method of calculation of a measurement or other type of numeric value is not specified
112188Two-dimensional methodThe calculation method was performed in two-dimensional space
112189Three-dimensional methodThe calculation method was performed in three-dimensional space
112191Breast tissue densityThe relative density of parenchymal tissue as a proportion of breast volume
112192Volume of parenchymal tissueThe volume of parenchymal tissue
112193Volume of breastThe volume of the breast
112194Mass of parenchymal tissueThe mass of parenchymal tissue
112195Mass of breastThe mass of the breast
112196Area of Vascular CalcificationA measured or calculated area of vascular calcification
112197Volume of Vascular CalcificationA measured or calculated volume of vascular calcification
112198Percentage of Vascular CalcificationA measured or calculated percentage of vascular calcification
112199Mass of Vascular CalcificationA measured or calculated mass of vascular calcification
112200Average calcification distance in a calcification clusterThe average nearest neighbor distance of all individual microcalcifications in a cluster
112201Standard deviation distance of calcifications in a clusterThe standard deviation of nearest neighbor distance of all individual microcalcifications in a cluster
112220Colon CAD ReportA structured report containing the results of computer-aided detection or diagnosis applied to colon imaging and associated clinical information
112222Colon Overall AssessmentOverall interpretation of the colon using C-RADS categorization system
112224Image Set PropertiesCharacteristics of a set of images
112225Slice ThicknessNominal slice thickness, in mm
112226Spacing between slicesDistance between contiguous images, measured from the center-to-center of each image
112227Frame of Reference UIDUniquely identifies groups of composite instances that have the same coordinate system that conveys spatial and/or temporal information
112228Recumbent Patient Position with respect to gravityPatient orientation with respect to downward direction (gravity)
112229Identifying SegmentDistinguishes a part of a segmentation
112232Polyp stalk widthThe diameter of a polyp stalk measured perpendicular to the axis of the stalk
112233Distance from anusThe length of the path following the centerline of the colon from the anus to the area of interest
112238Anatomic non-colonA location in the body that is outside the colon
112240C0 - Inadequate Study/Awaiting Prior ComparisonsAn inadequate study or a study that is awaiting prior comparisons. The study may have inadequate preparation and cannot exclude lesions greater than or equal to ten millimeters owing to presence of fluid or feces. The study may have inadequate insufflation where one or more colonic segments collapsed on both views. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9
112241C1 - Normal Colon or Benign LesionThe study has a normal colon or benign lesion, with the recommendation to continue routine screening. The study has no visible abnormalities of the colon. The study has no polyps greater than six millimeters. The study may have lipoma, inverted diverticulum, or nonneoplastic findings, such as colonic diverticula. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9
112242C2 - Intermediate Polyp or Indeterminate FindingThe study has an intermediate polyp or indeterminate finding and surveillance or colonoscopy is recommended. There may be intermediate polyps between six and nine millimeters and there are less than three in number. The study may have an intermediate finding and cannot exclude a polyp that is greater than or equal to six millimeters in a technically adequate exam. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9
112243C3 - Polyp, Possibly Advanced AdenomaThe study has a polyp, possibly advanced adenoma, and a follow-up colonoscopy is recommended. The study has a polyp greater than or equal to ten millimeters or the study has three or more polyps that are each between six to nine millimeters. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9
112244C4 - Colonic Mass, Likely MalignantThe study has a colonic mass, likely malignant, and surgical consultation is recommended. The lesion compromises bowel lumen and demonstrates extracolonic invasion. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9
112248ACR Guideline, Performance of Adult CT ColonographyAmerican College of Radiology Practice Guideline for the Performance of Computed Tomography (CT) Colonography in Adults. In: Practice Guidelines and Technical Standards.Reston, Va: American College of Radiology;2006:371-376
112249ACR Standard, CT medical physics performance monitoringAmerican College of Radiology Technical Standard for Diagnostic Medical Physics Performance Monitoring of Computed Tomography (CT) Equipment. In: Practice Guidelines and Technical Standards.Reston, Va: American College of Radiology;2006:945-948
112300AP+45View Orientation Modifier indicates that the view orientation of the imaging plane is rotated +45° along the cranial-caudal axis
112301AP-45View Orientation Modifier indicates that the view orientation of the imaging plane is rotated -45° along the cranial-caudal axis
112302Anatomical axis of femurThe axis following the shaft of the femur
112303Acetabular Center of RotationCenter of Rotation of the natural Acetabulum
112304Femur Head Center of RotationCenter of Rotation of the natural femur head
112305Acetabular Cup ShellProsthetic component implanted into the acetabulum. Provides hold for the insert that is mounted inside the cup
112306Acetabular Cup InsertProsthetic pelvic joint component. Inserted into the cup, takes in the femoral head replacement
112307Acetabular Cup MonoblockProsthetic pelvic joint cup including insert
112308Femoral Head Ball ComponentComponent for Femoral Head Prosthesis where the conic intake for the stem neck can be exchanged. Combined with a Femoral Head Cone Taper Component
112309Femoral Head Cone Taper ComponentExchangeable neck intake for composite femoral head prosthesis. Combined with a Femoral Head Ball Component
112310Femoral StemProsthesis Implanted into the femoral bone to provide force transmission between joint replacement and bone. On the proximal end a conic neck holds the femoral head replacement
112311Femoral Stem Distal ComponentDistal half of a modular stem prosthesis system. Combined with a Stem Proximal Component
112312Femoral Stem Proximal ComponentProximal half of a modular stem prosthesis system. Combined with a Stem Distal Component
112313Femoral Stem ComponentStem prosthetic component with a modular insert for an exchangeable neck component. Combined with a Neck Component
112314Neck ComponentProsthetic Neck to be combined with a Stem Component
112315Monoblock StemProsthetic Stem and Femoral Head in one piece
112316Prosthetic Shaft AugmentA proximal attachment to the shaft used to compensate for bone deficiencies or bone loss
112317Femoral Head Resurfacing ComponentArtificial femur head surface needed for the partial replacement of the femoral head where only the surface is replaced
112318PinningFixation using a pin
112319SewingFixation sewing several objects together
112320BoltingFixation using a bolt
112321WedgingFixation due to forcing an object into a narrow space
112325Distal CentralizerAttachment to the distal end of a cemented stem assuring that the stem is in a central position inside the drilled femoral canal before cementation
112340Generic 2D PlanningPlanning by an unspecified 2D method
112341Generic 3D PlanningPlanning by an unspecified 3D method
112342Generic Planning for Hip ReplacementPlanning of a Hip Replacement, by an unspecified method
112343Generic Planning for Knee ReplacementPlanning of Knee Replacement, by an unspecified method
112344Müller Method Planning for Hip ReplacementPlanning of Hip Replacement according to the procedure of M. E. Müller [Eggli et. al.1998]
112345Implantation PlanA Report containing the results of an Implantation Planning Activity
112346Selected Implant ComponentA selection of one Implant Component
112347Component IDIdentification ID of an Implant Component
112348Implant TemplateAn implant template describing the properties (2D/3D geometry and other data) of one Implant Component
112350Component ConnectionA connection of two Connected Implantation Plan Components
112351Mating Feature Set IDID of a Mating Feature Set in an Implant Component
112352Mating Feature IDID of the Mating Feature in a Mating Feature Set in an Implant Component
112353Spatial RegistrationThe Spatial Registration of one or more Implant Components
112354Patient ImagePatient Images used for an implantation planning activity
112355AssemblyA collection of Component Connections of Implant Components
112356User Selected FiducialFiducials that are selected by the user and may or may not belong to anatomical landmarks
112357Derived FiducialFiducials that represent geometric characteristics, such as center of rotation, and are derived from other fiducials
112358Information used for planningAll parameters and data that were used for the planning activity
112359Supporting InformationA description of the plan as encapsulated PDF SOP Instance
112360Implant Component ListA list of all Implant Components selected for an implantation
112361Patient Data Used During PlanningReference to objects containing patient data that is used for planning
112362Degrees of Freedom SpecificationA specification of the values from one or more Degrees of Freedom
112363Degree of Freedom IDID of one Degree of Freedom
112364Related Patient Data Not Used During PlanningReference to objects containing patient data that were not used for planning but are somehow related
112365Related Implantation ReportsImplantation Reports that are somehow related; e.g. contemporaneous implantations that are independent
112366Implant Assembly TemplateImplant Assembly Template
112367Planning Information for Intraoperative UsageInformation that is intended to be used intra-operatively
112368Implantation Patient PositioningPosition of the patient on the operating room table
112369Fiducial IntentIntended use of the fiducial
112370Component TypeType of an Implant Component
112371Manufacturer Implant TemplateImplant Template released by the Manufacturer
112372Derived Planning ImagesImages that are created by a planning application
112373Other Derived Planning DataData that is created by a planning application
112374Connected Implantation Plan ComponentOne Implant Component that is connected to another Implant Component
112375Planning MethodThe method used for planning
112376Degree of Freedom Exact Translational ValueDefines the exact value that was planned for translation
112377Degree of Freedom Minimum Translational ValueDefines the minimum value that was planned for translation
112378Degree of Freedom Maximum Translational ValueDefines the maximum value that was planned for translation
112379Degree of Freedom Exact Rotational Translation ValueDefines the exact value that was planned for rotation
112380Degree of Freedom Minimum Rotational ValueDefines the minimum value that was planned for rotation
112381Degree of Freedom Maximum Rotational ValueDefines the maximum value that was planned for rotation
112700Peri-operative Photographic ImagingProcedure step protocol for photographic imaging of surgical procedures, including photography of specimens collected
112701Gross Specimen ImagingProcedure step protocol for imaging gross specimens, typically with a photographic camera (modality XC), and planning further dissection
112702Slide MicroscopyProcedure step protocol for imaging slide specimens
112703Whole Slide ImagingProcedure step protocol for imaging slide specimens using a whole slide scanner
112704WSI 20X RGBProcedure step protocol for imaging slide specimens using a whole slide scanner with a 20X nominal objective lens, in full color, with a single imaging focal plane across the image
112705WSI 40X RGBProcedure step protocol for imaging slide specimens using a whole slide scanner with a 40X nominal objective lens, in full color, with a single imaging focal plane across the image
112706Illumination MethodTechnique of illuminating specimen
112707Number of focal planesNumber of focal planes for a microscopy image acquisition
112708Focal plane Z offsetNominal distance above a reference plane (typically a slide glass substrate top surface) of the focal plane
112709Magnification selectionMicroscope magnification based on nominal objective lens power
112710Illumination wavelengthNominal center wavelength for an imaging spectral band
112711Illumination spectral bandName (coded) for an imaging spectral band
112712Optical filter typeType of filter inserted into the optical imaging path
112713Tissue selection methodTechnique for identifying tissue to be imaged versus area of slide not to be imaged
112714Multiple planesImaging performed at multiple imaging (focal) planes
1127155XNominal 5 power objective lens, resulting in a digital image at approximately 2 um/pixel spacing
11271610XNominal 10 power objective lens, resulting in a digital image at approximately 1 um/pixel spacing
11271720XNominal 20 power microscope objective lens, resulting in a digital image at approximately 0.5 um/pixel spacing
11271840XNominal 40 power microscope objective lens, with a combined condenser and objective lens numerical aperture of approximately 1.3, resulting in a digital image at approximately 0.25 um/pixel spacing
112719Nominal empty tile suppressionEquipment-specific nominal or default method for identifying tiles without tissue imaged for suppression from inclusion in image object
112720High threshold empty tile suppressionEquipment-specific high threshold method for identifying tiles without tissue imaged for suppression from inclusion in image object
112721No empty tile suppressionTiles without tissue imaged are not suppressed from inclusion in image object
113000Of InterestOf Interest
113001Rejected for Quality ReasonsRejected for Quality Reasons
113002For Referring ProviderFor Referring Provider
113003For SurgeryFor Surgery
113004For TeachingFor Teaching
113005For ConferenceFor Conference
113006For TherapyFor Therapy
113007For PatientFor Patient
113008For Peer ReviewFor Peer Review
113009For ResearchFor Research
113010Quality IssueQuality Issue
113011Document Title ModifierDocument Title Modifier
113012Key Object DescriptionKey Object Description
113013Best In SetA selection that represents the "best" chosen from a larger set of items; e.g. the best images within a Study or Series. The criteria against which "best" is measured is not defined. Contrast this with the more specific term "Best illustration of finding"
113014StudyA study is a collection of one or more series of medical images, presentation states, and/or SR documents that are logically related for the purpose of diagnosing a patient. A study may include composite instances that are created by a single modality, multiple modalities or by multiple devices of the same modality. [From Section A.1.2.2 "Study IE" in PS3.3 ]
113015SeriesA distinct logical set used to group composite instances. All instances within a Series are of the same modality, in the same Frame of Reference (if any), and created by the same equipment. [See Section A.1.2.3 "Series IE" in PS3.3 ]
113016Performed Procedure StepAn arbitrarily defined unit of service that has actually been performed (not just scheduled). [From Section 7.3.1.9 "Modality Performed Procedure Step" in PS3.3 ]
113017Stage-ViewAn image or set of images illustrating a specific stage (phase in a stress echo exam protocol) and view (combination of the transducer position and orientation at the time of image acquisition)
113018For PrintingFor Printing
113020For Report AttachmentSelection of information objects for attachment to the clinical report of the Current Requested Procedure
113021For LitigationList of objects that are related to litigation and should be specially handled; e.g. may apply if a complaint has been received regarding a patient, or a specific set of images has been the subject of a subpoena, and needs to be sequestered or excluded from automatic purging according to retention policy
113026Double exposureDouble exposure
113030ManifestA list of objects that have been exported out of one organizational domain into another domain. Typically, the first domain has no direct control over what the second domain will do with the objects
113031Signed ManifestA signed list of objects that have been exported out of one organizational domain into another domain, referenced securely with either Digital Signatures or MACs. Typically, the first domain has no direct control over what the second domain will do with the objects
113032Complete Study ContentThe list of objects that constitute a study at the time that the list was created
113033Signed Complete Study ContentThe signed list of objects that constitute a study at the time that the list was created, referenced securely with either Digital Signatures or MACs
113034Complete Acquisition ContentThe list of objects that were generated in a single procedure step
113035Signed Complete Acquisition ContentThe signed list of objects that were generated in a single procedure step, referenced securely with either Digital Signatures or MACs
113036Group of Frames for DisplayA list of frames or single-frame or entire multi-frame instances that together constitute a set for some purpose, such as might be displayed together in the same viewport, as distinct from another set that might be displayed in a separate viewport
113037Rejected for Patient Safety ReasonsList of objects whose use is potentially harmful to the patient; e.g. an improperly labeled image could lead to dangerous surgical decisions
113038Incorrect Modality Worklist EntryList of objects that were acquired using an incorrect modality worklist entry, and that should not be used, since they may be incorrectly identified
113039Data Retention Policy ExpiredList of objects that have expired according to a defined data retention policy
113040Lossy CompressionLossy compression has been applied to an image
113041Apparent Diffusion CoefficientValues are derived by calculation of the apparent diffusion coefficient
113042Pixel by pixel additionValues are derived by the pixel by pixel addition of two images
113043Diffusion weightedValues are derived by calculation of the diffusion weighting
113044Diffusion AnisotropyValues are derived by calculation of the diffusion anisotropy
113045Diffusion AttenuatedValues are derived by calculation of the diffusion attenuation
113046Pixel by pixel divisionValues are derived by the pixel by pixel division of two images
113047Pixel by pixel maskValues are derived by the pixel by pixel masking of one image by another
113048Pixel by pixel MaximumValues are derived by calculating the pixel by pixel maximum of two or more images
113049Pixel by pixel meanValues are derived by calculating the pixel by pixel mean of two or more images
113050Metabolite Maps from spectroscopy dataValues are derived by calculating from spectroscopy data pixel values localized in two dimensional space based on the concentration of specific metabolites (i.e, at specific frequencies)
113051Pixel by pixel MinimumValues are derived by calculating the pixel by pixel minimum of two or more images
113052Mean Transit TimeThe time required for blood to pass through a region of tissue
113053Pixel by pixel multiplicationValues are derived by the pixel by pixel multiplication of two images
113054Negative Enhancement IntegralValues are derived by calculating negative enhancement integral values
113055Regional Cerebral Blood FlowThe flow rate of blood perfusing a region of the brain as volume per mass per unit of time
113056Regional Cerebral Blood VolumeThe volume of blood perfusing a region of brain as volume per mass
113057R-CoefficientCorrelation Coefficient, r
113058Proton DensityValues are derived by calculating proton density values
113059Signal ChangeValues are derived by calculating signal change values
113060Signal to NoiseValues are derived by calculating the signal to noise ratio
113061Standard DeviationValues are derived by calculating the standard deviation of two or more images
113062Pixel by pixel subtractionValues are derived by the pixel by pixel subtraction of two images
113063T1Values are derived by calculating T1 values
113064T2*Values are derived by calculating T2* values
113065T2Values are derived by calculating T2 values
113066Time Course of SignalValues are derived by calculating values based on the time course of signal
113067Temperature encodedValues are derived by calculating values based on temperature encoding
113068Student's T-TestValues are derived by calculating the value of the Student's T-Test statistic from multiple image samples
113069Time To PeakThe time from the start of the contrast agent injection to the maximum enhancement value
113070Velocity encodedValues are derived by calculating values based on velocity encoded; e.g. phase contrast
113071Z-ScoreValues are derived by calculating the value of the Z-Score statistic from multiple image samples
113072Multiplanar reformattingValues are derived by reformatting in a flat plane other than that originally acquired
113073Curved multiplanar reformattingValues are derived by reformatting in a curve plane other than that originally acquired
113074Volume renderingValues are derived by volume rendering of acquired data
113075Surface renderingValues are derived by surface rendering of acquired data
113076SegmentationValues are derived by segmentation (classification into tissue types) of acquired data
113077Volume editingValues are derived by selectively editing acquired data (removing values from the volume), such as in order to remove obscuring structures or noise
113078Maximum intensity projectionValues are derived by maximum intensity projection of acquired data
113079Minimum intensity projectionValues are derived by minimum intensity projection of acquired data
113080Glutamate and glutamineFor single-proton MR spectroscopy, the resonance peak corresponding to glutamate and glutamine
113081Choline/Creatine RatioFor single-proton MR spectroscopy, the ratio between the Choline and Creatine resonance peaks
113082N-acetylaspartate /Creatine RatioFor single-proton MR spectroscopy, the ratio between the N-acetylaspartate and Creatine resonance peaks
113083N-acetylaspartate /Choline RatioFor single-proton MR spectroscopy, the ratio between the N-acetylaspartate and Choline resonance peaks
113085Spatial resamplingValues are derived by spatial resampling of acquired data
113086Edge enhancementValues are derived by edge enhancement
113087SmoothingValues are derived by smoothing
113088Gaussian blurValues are derived by Gaussian blurring
113089Unsharp maskValues are derived by unsharp masking
113090Image stitchingValues are derived by stitching two or more images together
113091Spatially-related frames extracted from the volumeSpatially-related frames in this image are representative frames from the referenced 3D volume data set
113092Temporally-related frames extracted from the set of volumesTemporally-related frames in this image are representative frames from the referenced 3D volume data set
113093Polar to Rectangular Scan ConversionConversion of a polar coordinate image to rectangular (Cartesian) coordinate image
113094Creatine and CholineFor single-proton MR spectroscopy, the resonance peak corresponding to creatine and choline
113095Lipid and LactateFor single-proton MR spectroscopy, the resonance peak corresponding to lipid and lactate
113096Creatine+Choline/ Citrate RatioFor single-proton MR spectroscopy, the ratio between the Choline and Creatine resonance peak and the Citrate resonance peak
113097Multi-energy proportional weightingImage pixels created through proportional weighting of multiple acquisitions at distinct X-Ray energies
113100Basic Application Confidentiality ProfileDe-identification using a profile defined in PS3.15 that requires removing all information related to the identity and demographic characteristics of the patient, any responsible parties or family members, any personnel involved in the procedure, the organizations involved in ordering or performing the procedure, additional information that could be used to match instances if given access to the originals, such as UIDs, dates and times, and private attributes, when that information is present in the non-Pixel Data Attributes, including graphics or overlays
113101Clean Pixel Data OptionAdditional de-identification according to an option defined in PS3.15 that requires any information burned in to the Pixel Data corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed
113102Clean Recognizable Visual Features OptionAdditional de-identification according to an option defined in PS3.15 that requires that sufficient removal or distortion of the Pixel Data shall be applied to prevent recognition of an individual from the instances themselves or a reconstruction of a set of instances
113103Clean Graphics OptionAdditional de-identification according to an option defined in PS3.15 that requires that any information encoded in graphics, text annotations or overlays corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed
113104Clean Structured Content OptionAdditional de-identification according to an option defined in PS3.15 that requires that any information encoded in SR Content Items or Acquisition Context Sequence Items corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed
113105Clean Descriptors OptionAdditional de-identification according to an option defined in PS3.15 that requires that any information that is embedded in text or string Attributes corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed
113106Retain Longitudinal Temporal Information Full Dates OptionRetention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that any dates and times be retained,
113107Retain Longitudinal Temporal Information Modified Dates OptionRetention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that any dates and times be modified in a manner that preserves temporal relationships; e.g. Study Date and Time
113108Retain Patient Characteristics OptionRetention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that any physical characteristics of the patient, which are descriptive rather than identifying information per se, be retained; e.g. Patient's Age, Sex, Size (height) and Weight
113109Retain Device Identity OptionRetention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that any information that identifies a device be retained; e.g. Device Serial Number
113110Retain UIDs OptionRetention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that UIDs be retained; e.g. SOP Instance UID
113111Retain Safe Private OptionRetention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that private attributes that are known not to contain identity information be retained; e.g. private SUV scale factor
113500Radiopharmaceutical Radiation Dose ReportThe procedure report is a Radiopharmaceutical Radiation Dose report
113502Radiopharmaceutical AdministrationInformation pertaining to the administration of a radiopharmaceutical
113503Radiopharmaceutical Administration Event UIDUnique identification of a single radiopharmaceutical administration event
113505Intravenous Extravasation SymptomsInitial signs or symptoms of extravasation
113506Estimated Extravasation ActivityThe estimated percentage of administered activity lost at the injection site. The estimation includes extravasation, paravenous administration and leakage at the injection site
113507Administered activityThe calculated activity at the Radiopharmaceutical Start Time when the radiopharmaceutical is administered to the patient. The residual activity (i.e. radiopharmaceutical not administered) , if measured, is reflected in the calculated value. The estimated extravasation is not reflected in the calculated value
113508Pre-Administration Measured ActivityRadioactivity measurement of radiopharmaceutical before or during the administration
113509Post-Administration Measured ActivityRadioactivity measurement of radiopharmaceutical after the administration
113510Drug Product IdentifierRegistered drug establishment code for product, coding scheme example is NDC or RxNorm
113511Radiopharmaceutical Dispense Unit IdentifierThe human readable identification of the specific radiopharmaceutical dispensed quantity or dose ("dose" as unit of medication delivery, not radiation dose measure) to be administered to the patient
113512Radiopharmaceutical Lot IdentifierIdentifies the vial, batch or lot number from which the individual dispense radiopharmaceutical quantity (dose) is produced. The Radiopharmaceutical Dispense Unit Identifier records the identification for each individual dose
113513Reagent Vial IdentifierIdentifies the lot or unit serial number for the reagent component for the radiopharmaceutical
113514Radionuclide Vial IdentifierIdentifies the lot or unit serial number for the radionuclide component for the radiopharmaceutical
113516Prescription IdentifierAdministered Product's Prescription Number
113517Organ Dose InformationInformation pertaining to the estimated absorbed radiation dose to an organ
113518Organ DoseThe absorbed radiation dose to organ
113520MIRD Pamphlet 1Reference authority MIRD Pamphlet No.1 (rev) ,Society of Nuclear Medicine, 1976
113521ICRP Publication 53Reference authority ICRP, 1988. Radiation Dose to Patients from Radiopharmaceuticals. ICRP Publication 53. Ann. ICRP 18 (1-4)
113522ICRP Publication 80Reference authority ICRP, 1998. Radiation Dose to Patients from Radiopharmaceuticals (Addendum to ICRP Publication 53). ICRP Publication 80. Ann. ICRP 28 (3)
113523ICRP Publication 106Reference authority ICRP, 2008. Radiation Dose to Patients from Radiopharmaceuticals - Addendum 3 to ICRP Publication 53. ICRP Publication 106. Ann. ICRP 38 (1-2)
113526MIRDOSEReference authority Stabin MG, Sparks RB, Crowe E (1994) MIRDOSE: personal computer software for internal dose assessment in nuclear medicine [Computer program]
113527OLINDA-EXMReference authority Stabin MG, Sparks RB, Crowe E (2005) OLINDA/EXM: The Second-Generation Personal Computer Software for Internal Dose Assessment in Nuclear Medicine [Computer program]
113528Package InsertReference authority The reported organ dose is based on radiopharmaceutical's package insert
113529Institutionally Approved EstimatesReference authority The reported organ dose is based on Institutionally approved estimates from the Radioactive Drug Research Committee (RDRC) of the institution itself
113530Investigational New DrugReference authority The reported organ dose is based on an Investigation new drug
113540Activity Measurement DeviceThe type of device that performed the activity measurement
113541Dose CalibratorThe device that measures the radiation activity of the radiopharmaceutical
113542Infusion SystemRadiopharmaceutical Infusion System
113543GeneratorRadioisotope Generator
113550Fasting DurationThe number hours the patient has gone without food
113551Hydration VolumeThe amount of fluids the patient has consumed before the procedure
113552Recent Physical ActivityA description of physical activity the patient performed before the start of the procedure, such as that which may affect imaging agent biodistribution
113560Acute unilateral renal blockageBlockage in one of the tubes (ureters) that drain urine from the kidneys
113561Low Thyroid Uptake5% or less Thyroid Uptake of Iodine
113562High Thyroid Uptake25% or higher Thyroid Uptake of Iodine
113563Severely JaundicedThe patient exhibits symptoms severe of jaundice and/or has a Bilirubin >10 mg/dL
113568Extravasation visible in imageExtravasation or paravenous administration of the product is visible in the images
113570Cockroft-Gault Formula estimation of GFRThe measurement method of the Glomerular Filtration Rate is Cockroft-Gault Formula
113571CKD-EPI Formula estimation of GFRThe measurement method of the Glomerular Filtration Rate is CKD-EPI Formula
113572Glomerular Filtration Rate (MDRD)The measurement method of the Glomerular Filtration Rate is MDRD
113573Glomerular Filtration Rate non-black (MDRD)The measurement method of the Glomerular Filtration Rate is non-black MDRD
113574Glomerular Filtration Rate black (MDRD)The measurement method of the Glomerular Filtration Rate is black (MDRD)
113575Glomerular Filtration Rate female (MDRD)The measurement method of the Glomerular Filtration Rate is female (MDRD)
113576Glomerular Filtration Rate Cystatin-based formulaThe measurement method of the Glomerular Filtration Rate is Cystatin-based formula
113577Glomerular Filtration Rate Creatinine-based formula (Schwartz)The measurement method of the Glomerular Filtration Rate is Creatinine-based formula (Schwartz)
113601Small: < 32.0 cm lateral thicknessSmall body thickness for calcium scoring adjustment. Lateral thickness is measured from skin-to-skin, at the level of the proximal ascending aorta, from an A/P localizer image
113602Medium: 32.0-38.0 cm lateral thicknessMedium body thickness for calcium scoring adjustment. Lateral thickness is measured from skin-to-skin, at the level of the proximal ascending aorta, from an A/P localizer image
113603Large: > 38.0 cm lateral thicknessLarge body thickness for calcium scoring adjustment. Lateral thickness is measured from skin-to-skin, at the level of the proximal ascending aorta, from an A/P localizer image
113605Irradiation Event LabelA human-readable label identifying an irradiation event
113606Label TypeThe type of a human-readable label
113607Series NumberA number that identifies a Series. Corresponds to (0020,0011) in PS3.3
113608Acquisition NumberA number that identifies an Acquisition. Corresponds to (0020,0012) in PS3.3
113609Instance NumberA number that identifies an Instance. Corresponds to (0020,0013) in PS3.3
113611Stationary AcquisitionAcquisition where the X-Ray source does not move in relation to the patient
113612Stepping AcquisitionAcquisition where the X-Ray source moves laterally in relation to the patient
113613Rotational AcquisitionAcquisition where the X-Ray source moves angularly in relation to the patient
113620Plane APrimary plane of a Biplane acquisition equipment
113621Plane BSecondary plane of a Biplane acquisition equipment
113622Single PlaneSingle plane acquisition equipment
113630ContinuousContinuous X-Ray radiation is applied during an irradiation event
113631PulsedPulsed X-Ray radiation is applied during an irradiation event
113650Strip filterFilter with uniform thickness
113651Wedge filterFilter with variation in thickness from one edge to the opposite edge
113652Butterfly filterFilter with two triangular sections
113653Flat filterFilter with uniform thickness that is for spectral filtering only; e.g. filter out low energy portion of the X-Ray that would only contribute to skin dose, but not to image
113661Outline of lobulationsA polyline defining the outline of a lobulated finding
113662Inner limits of fuzzy marginA polyline defining the inner limits of a finding with fuzzy margin
113663Outer limits of fuzzy marginA polyline defining the outer limits of a finding with fuzzy margin
113664Outline of spiculationsA polyline defining the outline of the spiculations of a finding
113665Linear spiculationA polyline segment graphically indicating the location and direction of a spiculation of a finding
113666Pixelated spiculationsA collection of points indicating the pixel locations of the spiculations of a finding
113669Orthogonal location arcConnected line segments indicating the center of location of a finding on an orthogonal view
113670Orthogonal location arc inner marginConnected line segments indicating the inner margin of the location of a finding on an orthogonal view
113671Orthogonal location arc outer marginConnected line segments indicating the outer location of a finding on an orthogonal view
113680Quality Control IntentThis procedure is intended to gather data that is used for calibration or other quality control purposes
113681PhantomAn artificial subject of an imaging study
113682ACR Accreditation Phantom - CTA phantom acceptable for the ACR Computed Tomography Accreditation program
113683ACR Accreditation Phantom - MRA phantom acceptable for the ACR Magnetic Resonance Imaging Accreditation program
113684ACR Accreditation Phantom - MammographyA phantom acceptable for the ACR Mammography Accreditation program
113685ACR Accreditation Phantom - Stereotactic Breast BiopsyA phantom acceptable for the ACR Stereotactic Breast Biopsy Accreditation program
113686ACR Accreditation Phantom - ECTA phantom acceptable for the ACR SPECT Accreditation program (but not for PET)
113687ACR Accreditation Phantom - PETA phantom acceptable for the ACR PET Accreditation program (but not for SPECT)
113688ACR Accreditation Phantom - ECT/PETA SPECT phantom with a PET faceplate acceptable for both the ACR SPECT and PET Accreditation programs
113689ACR Accreditation Phantom - PET FaceplateA PET faceplate (made to fit an existing flangeless or flanged ECT phantom) acceptable for the ACR PET Accreditation program
113690IEC Head Dosimetry PhantomA phantom used for CTDI measurement in head modes according to IEC 60601-2-44, Ed.2.1 (Head 16 cm diameter Polymethyl methacrylate PMMA)
113691IEC Body Dosimetry PhantomA phantom used for CTDI measurement in body modes according to IEC 60601-2-44, Ed.2.1 (Body 32cm diameter Polymethyl methacrylate PMMA)
113692NEMA XR21-2000 PhantomA phantom in accordance with NEMA standard XR-21-2000
113701X-Ray Radiation Dose ReportX-Ray Radiation Dose Report
113702Accumulated X-Ray Dose DataX-Ray dose data accumulated over multiple irradiation events; e.g. for a study or a performed procedure step
113704Projection X-RayImaging using a point X-Ray source with a diverging beam projected onto a 2 dimensional detector
113705Scope of AccumulationEntity over which dose accumulation values are integrated
113706Irradiation Event X-Ray DataX-Ray dose data for a single Irradiation Event
113710Niobium or Niobium compoundMaterial containing Niobium or a Niobium compound
113711Europium or Europium compoundMaterial containing Europium or a Europium compound
113720Calibration ProtocolDescribes the method used to derive the calibration factor
113721Irradiation Event TypeDenotes the type of irradiation event recorded
113722Dose Area Product TotalTotal calculated Dose Area Product (in the scope of the including report)
113723Calibration DateLast calibration Date for the integrated dose meter or dose calculation
113724Calibration Responsible PartyIndividual or organization responsible for calibration
113725Dose (RP) TotalTotal Dose related to Reference Point (RP). (in the scope of the including report)
113726Fluoro Dose Area Product TotalTotal calculated Dose Area Product applied in Fluoroscopy Modes (in the scope of the including report)
113727Acquisition Dose Area Product TotalTotal calculated Dose Area Product applied in Acquisition Modes (in the scope of the including report)
113728Fluoro Dose (RP) TotalDose applied in Fluoroscopy Modes, related to Reference Point (RP). (in the scope of the including report)
113729Acquisition Dose (RP) TotalDose applied in Acquisition Modes, related to Reference Point (RP). (in the scope of the including report)
113730Total Fluoro TimeTotal accumulated clock time of Fluoroscopy in the scope of the including report (i.e., the sum of the Irradiation Duration values for accumulated fluoroscopy irradiation events)
113731Total Number of Radiographic FramesAccumulated Count of exposure pulses (single or multi-frame encoded) created from irradiation events performed with high dose (acquisition)
113732Fluoro ModeMode of application of X-Rays during Fluoroscopy
113733KVPApplied X-Ray Tube voltage at peak of X-Ray generation, in kilovolts; Mean value if measured over multiple peaks (pulses)
113734X-Ray Tube CurrentMean value of applied Tube Current
113735Exposure TimeCumulative time the patient has received X-Ray exposure during the irradiation event
113736ExposureMean value of X-Ray Current Time product
113737Distance Source to Reference PointDistance to the Reference Point (RP) defined according to IEC 60601-2-43 or equipment defined
113738Dose (RP)Dose applied at the Reference Point (RP)
113739Positioner Primary End AnglePositioner Primary Angle at the end of an irradiation event. For further definition see (112011, DCM, "Positioner Primary Angle")
113740Positioner Secondary End AnglePositioner Secondary Angle at the end of an irradiation event. For further definition see (112012, DCM, "Positioner Secondary Angle")
113742Irradiation DurationClock time from the start of loading time of the first pulse until the loading time trailing edge of the final pulse in the same irradiation event. Note Loading time is defined in IEC 60601-1-3:2008, 3.37, and described in IEC 60601-2-54:2009, 203.4.101.3
113743Patient OrientationOrientation of the Patient with respect to Gravity
113744Patient Orientation ModifierEnhances or modifies the Patient orientation specified in Patient Orientation
113745Patient Table RelationshipOrientation of the Patient with respect to the Head of the Table
113748Distance Source to IsocenterDistance from the X-Ray Source to the Equipment C-Arm Isocenter.(Center of Rotation)
113750Distance Source to DetectorMeasured or calculated distance from the X-Ray source to the detector plane in the center of the beam
113751Table Longitudinal PositionTable Longitudinal Position with respect to an arbitrary chosen reference by the equipment. Table motion towards LAO is positive assuming that the patient is positioned supine and its head is in normal position
113752Table Lateral PositionTable Lateral Position with respect to an arbitrary chosen reference by the equipment. Table motion towards CRA is positive assuming that the patient is positioned supine and its head is in normal position
113753Table Height PositionTable Height Position with respect to an arbitrary chosen reference by the equipment in (mm). Table motion downwards is positive
113754Table Head Tilt AngleAngle of the head-feet axis of the table in degrees relative to the horizontal plane. Positive values indicate that the head of the table is upwards
113755Table Horizontal Rotation AngleRotation of the table in the horizontal plane (clockwise when looking from above the table)
113756Table Cradle Tilt AngleAngle of the left-right axis of the table in degrees relative to the horizontal plane. Positive values indicate that the left of the table is upwards
113757X-Ray Filter MaterialX-Ray absorbing material used in the filter
113758X-Ray Filter Thickness MinimumThe minimum thickness of the X-Ray absorbing material used in the filters
113759Table Longitudinal End PositionTable Longitudinal Position at the end of an irradiation event; see (113751, DCM, "Table Longitudinal Position")
113760Table Lateral End PositionTable Lateral Position at the end of an irradiation event; see (113752, DCM, "Table Lateral Position")
113761Table Height End PositionTable Height Position at the end of an irradiation event; see (113753, DCM, "Table Height Position")
113763Calibration UncertaintyUncertainty of the 'actual' value
113764Acquisition PlaneIdentification of Acquisition Plane with Biplane systems
113766Focal Spot SizeNominal Size of Focal Spot of X-Ray Tube
113767Average X-Ray Tube CurrentAverage X-Ray Tube Current averaged over time for pulse or for continuous Fluoroscopy
113768Number of PulsesNumber of pulses applied by X-Ray systems during an irradiation event (acquisition run or pulsed fluoro)
113769Irradiation Event UIDUnique identification of a single irradiation event
113770Column AngulationAngle of the X-Ray beam in degree relative to an orthogonal axis to the detector plane
113771X-Ray FiltersDevices used to modify the energy or energy distribution of X-Rays
113772X-Ray Filter TypeType of filter(s) inserted into the X-Ray beam; e.g. wedges
113773X-Ray Filter Thickness MaximumThe maximum thickness of the X-Ray absorbing material used in the filters
113780Reference Point DefinitionSystem provided definition of the Reference Point used for Dose calculations
113788Collimated Field HeightDistance between the collimator blades in pixel column direction as projected at the detector plane
113789Collimated Field WidthDistance between the collimator blades in pixel row direction as projected at the detector plane
113790Collimated Field AreaCollimated field area at image receptor. Area for compatibility with IEC 60601-2-43
113791Pulse RatePulse rate applied by equipment during Fluoroscopy
113792Distance Source to Table PlaneMeasured or calculated distance from the X-Ray source to the table plane in the center of the beam
113793Pulse Width(Average) X-Ray pulse width
113794Dose Measurement DeviceCalibrated device to perform dose measurements
113795Acquired ImageImage acquired during a specified event
113800DLP to E conversion via MC computationEffective Dose evaluation from the product of Dose Length Product (DLP) and the Effective Dose Conversion Factor (E/DLP in units of mSv/mGy-cm), where the ratio is derived by means of Monte Carlo computations
113801CTDIfreeair to E conversion via MC computationEffective Dose evaluation from the product of the Mean CTDIfreeair and the ratio E/CTDIfreeair (mSv/mGy), where the ratio is derived by means of Monte Carlo computations
113802DLP to E conversion via measurementEffective Dose evaluation from the product of Dose Length Product (DLP) and the Effective Dose Conversion Factor (E/DLP in units of mSv/mGy-cm), where the ratio is derived by means of dosimetric measurements with an anthropomorphic phantom
113803CTDIfreeair to E conversion via measurementEffective Dose evaluation from the product of the Mean CTDIfreeair and the ratio E/CTDIfreeair (mSv/mGy), where the ratio is derived by means of dosimetric measurements with an anthropomorphic phantom
113804Sequenced AcquisitionThe CT acquisition was performed by acquiring single or multi detector data while rotating the source about the gantry while the table is not moving. Additional slices are acquired by incrementing the table position and again rotating the source about the gantry while the table is not moving
113805Constant Angle AcquisitionThe CT acquisition was performed by holding the source at a constant angle and moving the table to obtain a projection image; e.g. localizer
113806Stationary AcquisitionThe CT acquisition was performed by holding the table at a constant position and acquiring multiple slices over time at the same location
113807Free AcquisitionThe CT acquisition was performed while rotating the source about the gantry while the table movement is under direct control of a human operator or under the control of an analysis application; e.g. fluoro
113808ICRP Pub 60Reference authority 1990 Recommendations of the International Commission on Radiological Protection (ICRP Publication 60, published as the Annals of the ICRP Vol. 21, No. 1-3, Pergamon Press,1991)
113809Start of X-Ray IrradiationStart, DateTime of the first X-Ray Irradiation Event of the accumulation within a Study
113810End of X-Ray IrradiationEnd, DateTime of the last X-Ray Irradiation Event of the accumulation within a Study
113811CT Accumulated Dose DataX-Ray dose accumulated over multiple CT irradiation events; e.g. for a study or a performed procedure step
113812Total Number of Irradiation EventsTotal number of events during the defined scope of accumulation
113813CT Dose Length Product TotalThe total dose length product defined scope of accumulation
113814CT Effective Dose TotalThe total Effective Dose at the defined scope of accumulation
113815Patient ModelIdentification of the reference-patient model used when Effective Dose is evaluated via Monte Carlo calculations or from a Dose Length Product conversion factor based on Monte Carlo calculations
113816Condition Effective Dose measuredReferences the physical phantom and the type of dosimeter used when measurements are done to establish Effective Dose Conversion Factors (E/DLP) or ratios E/CTDIfreeair
113817Effective Dose Phantom TypeType of Effective Dose phantom used
113818Dosimeter TypeType of dosimeter used
113819CT AcquisitionGeneral description of the CT Irradiation event
113820CT Acquisition TypeMethod of the CT acquisition
113821X-Ray Filter Aluminum EquivalentThickness of an equivalent filter in mm in Aluminum
113822CT Acquisition ParametersGeneral description of the acquisition parameters
113823Number of X-Ray SourcesNumber of X-Ray sources
113824Exposure TimeTotal time the patient has received X-Ray exposure during the irradiation event
113825Scanning LengthLength of the table travel during the entire tube loading, according to IEC 60601-2-44 Note Scanning Length might be longer than the programmed acquisition length (Length of Reconstructable Volume)
113826Nominal Single Collimation WidthThe value of the nominal width referenced to the location of the isocenter along the z axis of a single row of acquired data in mm
113827Nominal Total Collimation WidthThe value of the nominal width referenced to the location of the isocenter along the z axis of the total collimation in mm over the area of active X-Ray detection
113828Pitch FactorFor Spiral scanning: Pitch Factor = (Table Feed per Rotation (mm)) /(Nominal Total Collimation Width (mm)) For Sequenced scanning: Pitch Factor = (Table Feed per single Sequenced scan (mm)) /(Nominal Total Collimation Width (mm))
113829CT DoseGeneral description of CT dose values
113830Mean CTDIvol"Mean CTDIvol" refers to the average value of the CTDIvol associated with this acquisition
113831CT X-Ray Source ParametersIdentification, tube-potential, tube-current, and exposure-time parameters associated with an X-Ray source during an acquisition
113832Identification of the X-Ray SourceIdentifies the particular X-Ray source (in a multi-source CT system) for which the set of X-Ray source parameter values is reported
113833Maximum X-Ray Tube CurrentMaximum X-Ray tube current
113834Exposure Time per RotationThe exposure time for one rotation of the source around the object in s
113835CTDIw Phantom TypeA label describing the type of phantom used for CTDIW measurement according to IEC 60601-2-44 (Head 16 cm diameter PMMA, Body 32 cm diameter PMMA)
113836CTDIfreeair Calculation FactorThe CTDIfreeair Calculation Factor is the CTDIfreeair per mAs, expressed in units of mGy/mAs. The CTDIfreeair Calculation Factor may be used in one method calculating Dose
113837Mean CTDIfreeairThe average value of the free-in-air CTDI associated with this acquisition
113838DLPDose Length Product (DLP), expressed in mGy-cm, is an index characterizing the product of the CTDIvol and the length scanned. For Spiral scanning, DLP = CTDIvol x Scanning Length. For Sequenced scanning, DLP = CTDIvol x Nominal Total Collimation Width x Cumulative Exposure Time / Exposure Time per Rotation. For Stationary and Free scanning, DLP = CTDIvol x Nominal Total Collimation Width
113839Effective DoseEffective dose in mSv
113840Effective Dose Conversion FactorEffective Dose per DLP, reference value for Effective Dose calculation, expressed in mSv/mGY.cm
113841ICRP Pub 103Effective Dose Reference authority 2007 Recommendations of the International Commission on Radiological Protection (ICRP Publication 103, published as the Annals of the ICRP Vol. 37, No. 2-4, Elsevier, 2007)
113842X-Ray Modulation TypeThe type of exposure modulation used for the purpose of limiting the dose
113845Exposure IndexMeasure of the detector response to radiation in the relevant image region of an image acquired with a digital X-Ray imaging system as defined in IEC 62494-1; see PS3.3 definition of Exposure Index Macro
113846Target Exposure IndexThe target value used to calculate the Deviation Index as defined in IEC 62494-1; see PS3.3 definition of Exposure Index Macro
113847Deviation IndexA scaled representation of the accuracy of the Exposure Index compared to the Target Exposure Index as defined in IEC 62494-1; see PS3.3 definition of Exposure Index Macro
113850Irradiation AuthorizingThe clinician responsible for determining that the irradiating procedure was appropriate for the indications
113851Irradiation AdministeringThe person responsible for the administration of radiation
113852Irradiation EventAn irradiation event is the loading of X-Ray equipment caused by a single continuous actuation of the equipment's irradiation switch, from the start of the loading time of the first pulse until the loading time trailing edge of the final pulse. Any automatic on-off switching of the irradiation source during the event is not treated as separate events, rather the event includes the time between start and stop of irradiation as triggered by the user; e.g. a pulsed fluoro X-Ray acquisition shall be treated as a single irradiation event
113853Irradiation Event UIDUnique Identifier of an Irradiation Event
113854Source of Dose InformationMethod by which dose-related details of an Irradiation Event were obtained
113855Total Acquisition TimeTotal accumulated acquisition clock time in the scope of the including report (i.e., the sum of the Irradiation Duration values for accumulated acquisition irradiation events)
113856Automated Data CollectionDirect recording of data by a relevant system
113857Manual EntryRecording of data by a human operator, including manual transcription of electronic data
113858MPPS ContentThe data is taken from an MPPS SOP Instance
113859Irradiating DeviceA device exposing a patient to ionizing radiation
11386015cm from Isocenter toward Source15cm from the isocenter towards the X-Ray source; See IEC 60601-2-43
11386130cm in Front of Image Input Surface30cm in front (towards the tube) of the input surface of the image receptor; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d) (7)
1138621cm above Tabletop1cm above the patient tabletop or cradle; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d) (7)
11386330cm above Tabletop30cm above the patient tabletop of cradle; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d) (7)
11386415cm from Table Centerline15cm from the centerline of the X-Ray table and in the direction of the X-Ray source; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d) (7)
113865Entrance exposure to a 4.2 cm breast thicknessStandard breast means a 4.2 centimeter (cm) thick compressed breast consisting of 50 percent glandular and 50 percent adipose tissue. See Department of Health and Human Services, Food and Drug Administration. Mammography quality standards; final rule. Federal Register. Oct. 28, 1997; 68(208):55852-55994; see 900.2(uu)
113866Copied From Image AttributesThe data is copied from information present in the image attributes; e.g. dose attributes such as CTDIvol (0018,9345)
113867Computed From Image AttributesThe data is computed from information present in the image attributes; e.g. by using dosimetry information for the specific irradiating device make and model, applied to technique information such as KVP and mAs
113868Derived From Human-Readable ReportsThe data is derived from human-readable reports; e.g. by natural language parsing of text reports, or optical character recognition from reports saved as images by the irradiating device
113870Person NameThe name of a specific person
113871Person IDAn identification number or code for a specific person
113872Person ID IssuerThe organization that issued a Person ID
113873Organization NameThe name of an organization
113874Person Role in OrganizationThe role played by a person in an organization
113875Person Role in ProcedureThe role played by a person in a procedure
113876Device Role in ProcedureThe role played by a device in a procedure
113877Device NameThe name used to refer to a device; usually locally unique
113878Device ManufacturerManufacturer of a device
113879Device Model NameModel Name of a device
113880Device Serial NumberSerial Number of a device
113890All PlanesAll planes of a multi-plane acquisition equipment
113893Length of Reconstructable VolumeThe length from which images may be reconstructed (i.e., excluding any overranging performed in a spiral acquisition that is required for data interpolation). Value is distinct from (1113825, DCM, "Scanning Length"), which is the actual length of the table travel during the entire tube loading, according to IEC 60601-2-44, and includes overranging. Also distinct from any actual Reconstructed Volume, which may depend on the slice thickness chosen for a particular reconstruction
113895Top Z Location of Reconstructable VolumeThe Z location that is the top (highest Z value) of the Reconstructable Volume. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference
113896Bottom Z Location of Reconstructable VolumeThe Z location that is the bottom (lowest Z value) of the Reconstructable Volume. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference
113897Top Z Location of Scanning LengthThe Z location that is the top (highest Z value) of the scanning length. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference
113898Bottom Z Location of Scanning LengthThe Z location that is the bottom (lowest Z value) of the scanning length. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference
113899Exposed RangeThe range along the z axis of the total volume irradiated, per IEC 60601-2-44, Ed. 3, 203.115(b). The start and stop of loading corresponding to the outer edge of the full width half maximum of the free-in-air dose profile for the beam collimation used
113900Dose Check Alert DetailsReport section about cumulative dose alerts during an examination
113901DLP Alert Value ConfiguredFlag denoting whether a DLP Alert Value was configured
113902CTDIvol Alert Value ConfiguredFlag denoting whether a CTDIvol Alert Value was configured
113903DLP Alert ValueCumulative Dose Length Product value configured to trigger an alert; see NEMA XR 25-2010 Dose Check Standard
113904CTDIvol Alert ValueCumulative CTDIvol value configured to trigger an alert; see NEMA XR 25-2010 Dose Check Standard
113905Accumulated DLP Forward EstimateA forward estimate of the accumulated DLP plus the estimated DLP for the next Protocol Element Group; see NEMA XR 25-2010 Dose Check Standard
113906Accumulated CTDIvol Forward EstimateA forward estimate at a given location of the accumulated CTDIvol plus the estimated CTDIvol for the next Protocol Element Group; see NEMA XR 25-2010 Dose Check Standard
113907Reason for ProceedingReason provided for proceeding with a procedure that is projected to exceed a configured dose value
113908Dose Check Notification DetailsReport section about dose notifications during a protocol element
113909DLP Notification Value ConfiguredFlag denoting whether a DLP Notification Value was configured
113910CTDIvol Notification Value ConfiguredFlag denoting whether a CTDIvol Notification Value was configured
113911DLP Notification ValueDose Length Product value configured to trigger a notification for a given protocol element
113912CTDIvol Notification ValueCTDIvol value configured to trigger a notification for a given protocol element
113913DLP Forward EstimateA forward estimate of the DLP for the next Protocol Element Group; see NEMA XR 25-2010 Dose Check Standard
113914CTDIvol Forward EstimateA forward estimate of the CTDIvol for the next Protocol Element Group; see NEMA XR 25-2010 Dose Check Standard
113921Radiation ExposureThe amount of ionizing radiation to which the patient was exposed
113922Radioactive Substance AdministeredType, amount and route of radioactive substance administered
113923Radiation Exposure and Protection InformationExposure to ionizing radiation and associated preventive measures used to reduce the exposure of parts of the body like lead apron or eye, thyroid gland or gonad protection
113930Size Specific Dose EstimationThe Size-Specific Dose Estimate is a patient dose estimate that takes into account the size of the patient, such as described in AAPM Report 204 by using linear dimensions measured on the patient or patient images or estimated from patient age
113931Measured Lateral DimensionThe side-to-side (left to right) dimension of the body part being scanned (per AAPM Report 204)
113932Measured AP DimensionThe thickness of the body part being scanned, in the antero-posterior dimension (per AAPM Report 204)
113933Derived Effective DiameterThe diameter of the patient at a given location along the Z-axis of the patient, assuming that the patient has a circular cross-section (per AAPM Report 204)
113934AAPM 204 Lateral DimensionThe Size Specific Dose Estimation is computed using Table 1B (32cm phantom) or Table 2B (16cm phantom) of AAPM Report 204
113935AAPM 204 AP DimensionThe Size Specific Dose Estimation is computed using Table 1C (32cm phantom) or Table 2C (16cm phantom) of AAPM Report 204
113936AAPM 204 Sum of Lateral and AP DimensionThe Size Specific Dose Estimation is computed using Table 1A (32cm phantom) or Table 2A (16cm phantom) of AAPM Report 204
113937AAPM 204 Effective Diameter Estimated From Patient AgeThe Size Specific Dose Estimation is computed using Table 1D (32cm phantom) or Table 2D (16cm phantom) using an effective diameter estimated from the patient's age using Table 3 of AAPM Report 204
113940System CalculatedValues calculated from other existing parameters
113941In Detector PlaneA segmented region of the detector surface within the irradiated area (but might not be near the center of the detector)
113942X-Ray Reading DeviceA device that creates digital images from X-Ray detectors (Direct, Indirect or Storage)
113943X-Ray Source Data AvailableParameters related to the X-Ray source (generator, tube, etc.) are available to the recording application
113944X-Ray Mechanical Data AvailableParameters related to the X-Ray Mechanical System (Stand, Table) are available to the recording application
113945X-Ray Detector Data AvailableParameters related to the X-Ray Detector are available to the recording application
113946Projection Eponymous NameDescribes the radiographic method of patient, tube and detector positioning to achieve a well described projection or view
113947Detector TypeType of Detector used to acquire data; e.g. Images
113948Direct DetectorDetector that directly transforms the input signal to pixel values
113949Indirect DetectorDetector that transforms an intermediate signal into pixel values; e.g. a scintillator-based detector
113950Storage DetectorStorage detector that stores a signal that is later transformed by a reader into pixel values; e.g. a phosphor-based detector
113951FilmFilm that is scanned to create pixel values
113952Table MountThe cassette/detector is mounted in the patient table
113953Unmounted DetectorThe cassette/detector is not mounted.; e.g. a cassette placed underneath the patient
113954Upright Stand MountThe cassette/detector is mounted in an upright stand
113955C-Arm MountThe cassette/detector is mounted on a c-arm
113956CR/DR Mechanical ConfigurationMethod of mounting or positioning a CR/DR cassette or detector
113957Fluoroscopy-Guided Projection Radiography SystemAn integrated projection radiography system capable of fluoroscopy
113958Integrated Projection Radiography SystemA projection radiography system where the X-Ray detector, X-Ray Source and gantry components are integrated and the managing system is able to access details of each component
113959Cassette-based Projection Radiography SystemA projection radiography system where the X-Ray detector, X-Ray Source and gantry components are not integrated; e.g. cassette-based CR and DR systems
113961Reconstruction AlgorithmDescription of the algorithm used when reconstructing the image from the data acquired during the acquisition process
113962Filtered Back ProjectionAn algorithm for reconstructing an image from multiple projections by back-projecting the measured values along the line of the projection and filtering the result to reduce blurring
113963Iterative ReconstructionAn algorithm for reconstructing an image from multiple projections by starting with an assumed reconstructed image, computing projections from the image, comparing the original projection data and updating the reconstructed image based upon the difference between the calculated and the actual projections
113970Procedure Step To This PointThe period of time from the start of a Procedure Step until the time point established by the context of the reference
114000Not a numberMeasurement not available: Not a number (per IEEE 754)
114001Negative InfinityMeasurement not available: Negative Infinity (per IEEE 754)
114002Positive InfinityMeasurement not available: Positive Infinity (per IEEE 754)
114003Divide by zeroMeasurement not available: Divide by zero (per IEEE 754)
114004UnderflowMeasurement not available: Underflow (per IEEE 754)
114005OverflowMeasurement not available: Overflow (per IEEE 754)
114006Measurement failureMeasurement not available: Measurement failure
114007Measurement not attemptedMeasurement not available: Measurement not attempted
114008Calculation failureMeasurement not available: Calculation failure
114009Value out of rangeMeasurement not available: Value out of range
114010Value unknownMeasurement not available: Value unknown
114011Value indeterminateMeasurement not available: Value indeterminate
114201Time of flightMeasures the time-of-flight of a light signal between the camera and the subject for each point of the image
114202InterferometryInterferometry is a family of techniques in which waves are superimposed in order to extract depth information about the scanned object
114203Laser scanningLaser scanning describes the general method to sample or scan a surface using laser technology
114204Pattern projectionProjecting a narrow band of light onto a three-dimensionally shaped surface produces a line of illumination that appears distorted from other perspectives than that of the projector. It can be used for an exact geometric reconstruction of the surface shape
114205Shape from shadingA technique for estimating the surface normal of an object by observing that object under different lighting conditions
114206Shape from motionA technique for estimating the surface normal of an object by observing that object under different motions
114207Confocal imagingAn optical imaging technique used to increase optical resolution and contrast of a micrograph by using point illumination and a spatial pinhole to eliminate out-of-focus light in specimens that are thicker than the focal plane. It enables the reconstruction of 3D structures from the obtained images
114208Point Cloud AlgorithmicPoint cloud that was calculated by an algorithm
114209Turntable Scan MethodScanning the object from different views by placing it on a rotating table
114210High resolutionHigher resolution with a longer acquisition time
114211Fast modeLower resolution with a shorter acquisition time
114213Iterative Closest PointAn algorithm employed to minimize the difference between two clouds of points. It iteratively revises the transformation (translation, rotation) needed to minimize the distance between the points of two point clouds
114215FreehandHuman controlled minimization of the distance between the points of two point clouds
114216CheckerboardScanning the object from different views by placing it in front of a checkerboard pattern
121001Quotation ModeType of source for observations quoted from an external source
121002Quoted SourceReference to external source of quoted observations
121003DocumentDocumentary source of quoted observations
121004VerbalVerbal source of quoted observations
121005Observer TypeType of observer that created the observations
121006PersonHuman observer created the observations
121007DeviceAutomated device created the observations
121008Person Observer NameName of human observer that created the observations
121009Person Observer's Organization NameOrganization or institution with which the human observer is affiliated for the context of the current observation
121010Person Observer's Role in the OrganizationOrganizational role of human observer for the context of the current observation
121011Person Observer's Role in this ProcedureProcedural role of human observer for the context of the current observation
121012Device Observer UIDUnique identifier of automated device that created the observations
121013Device Observer NameInstitution-provided identifier of automated device that created the observations
121014Device Observer ManufacturerManufacturer of automated device that created the observations
121015Device Observer Model NameManufacturer-provided model name of automated device that created the observations
121016Device Observer Serial NumberManufacturer-provided serial number of automated device that created the observations
121017Device Observer Physical Location During ObservationLocation of automated device that created the observations whilst the observations were being made
121018Procedure Study Instance UIDUnique identifier for the Study or Requested Procedure
121019Procedure Study Component UIDUnique identifier for the Performed Procedure Step
121020Placer NumberIdentifier for the Order (or Service Request) assigned by the order placer system
121021Filler NumberIdentifier for the Order (or Service Request) assigned by the order filler system
121022Accession NumberIdentifier for the Order (or Service Request) assigned by the department information system
121023Procedure CodeType of procedure scheduled or performed
121024Subject ClassType of observation subject
121025PatientA patient is the subject of observations
121026FetusFetus of patient is the subject of observations
121027SpecimenSpecimen is the subject of observations
121028Subject UIDUnique Identifier of patient or fetus who is the subject of observations
121029Subject NameName of patient who is the subject of observations
121030Subject IDIdentifier of patient or fetus who is the subject of observations
121031Subject Birth DateBirth Date of patient who is the subject of observations
121032Subject SexSex of patient who is the subject of observations
121033Subject AgeAge of patient who is the subject of observations
121034Subject SpeciesSpecies of patient who is the subject of observations
121035Subject BreedThe breed of the subject
121036Mother of fetusName of mother of fetus that is the subject of observations
121037Fetus numberundefined
121038Number of Fetusesundefined
121039Specimen UIDUnique Identifier of specimen that is the subject of observations
121040Specimen Accession NumberAccession Number of specimen that is the subject of observations
121041Specimen IdentifierIdentifier of specimen that is the subject of observations
121042Specimen TypeCoded category of specimen that is the subject of observations
121043Slide IdentifierIdentifier of specimen microscope slide that is the subject of observations
121044Slide UIDUnique Identifier of specimen microscope slide that is the subject of observations
121045LanguageThe language of the content, being a language that is primarily used for human communication; e.g. English, French
121046Country of LanguageThe country-specific variant of language; e.g. Canada for Candadian French
121047Language of ValueThe language of the value component of a name-value pair
121048Language of Name and ValueThe language of both the name component and the value component of a name-value pair
121049Language of Content Item and DescendantsThe language of the current content item (node in a tree of content) and all its descendants
121050Equivalent Meaning of Concept NameThe human readable meaning of the name component of a name-value pair that is equivalent to the post-coordinated meaning conveyed by the coded name and its concept modifier children
121051Equivalent Meaning of ValueThe human readable meaning of the value component of a name-value pair that is equivalent to the post-coordinated meaning conveyed by the coded value and its concept modifier children
121052Presence of propertyWhether or not the property concept being modified is present or absent
121053Presentundefined
121054Absentundefined
121055PathA set of points on an image, that when connected by line segments, provide a polyline from which a linear measurement was inferred
121056Area outlineA set of points on an image, that when connected by line segments, provide a closed polyline that is the border of a defined region from which an area, or two-dimensional measurement, was inferred
121057Perimeter outlineA set of points on an image, that when connected by line segments, provide a closed polyline that is a two-dimensional border of a three-dimensional region's intersection with, or projection into the image
121058Procedure reportedThe imaging procedure whose results are reported
121059Presence UndeterminedPresence or absence of a property is undetermined
121060Historyundefined
121062Requestundefined
121064Current Procedure Descriptionsundefined
121065Procedure DescriptionA description of the imaging procedure
121066Prior Procedure Descriptionsundefined
121068Previous Findingsundefined
121069Previous FindingAn observation found on a prior imaging study
121070Findingsundefined
121071FindingAn observation found on an imaging study
121072Impressionsundefined
121073ImpressionAn interpretation in the clinical context of the finding(s) on an imaging study
121074Recommendationsundefined
121075RecommendationA recommendation for management or investigation based on the findings and impressions of an imaging study
121076Conclusionsundefined
121077ConclusionAn interpretation in the clinical context of the finding(s) on an imaging study
121078Addendumundefined
121079BaselineInitial images used to esyablish a beginning condition that is used for comparison over time to look for changes. [Paraphrases NCI-PT (C1442488, UMLS, "Baseline"), which is defined as "An initial measurement that is taken at an early time point to represent a beginning condition, and is used for comparison over time to look for changes. For example, the size of a tumor will be measured before treatment (baseline) and then afterwards to see if the treatment had an effect. A starting point to which things may be compared."]
121080Best illustration of findingA selection of composite instances that best illustrates a particular finding; e.g. an image slice at the location of the largest extent of a tumor
121081Physicianundefined
121082Nurseundefined
121083Technologistundefined
121084Radiographerundefined
121085Internundefined
121086Residentundefined
121087Registrarundefined
121088FellowA medical practitioner undergoing sub-specialty training; e.g. during the period after specialty training (residency)
121089Attending [Consultant]undefined
121090Scrub nurseundefined
121091Surgeonundefined
121092SonologistA medical practitioner with sub-specialty training in Ultrasound
121093Sonographerundefined
121094PerformingThe person responsible for performing the procedure
121095ReferringThe person responsible for referring the patient for the procedure
121096RequestingThe person responsible for requesting the procedure
121097RecordingThe person responsible for recording the procedure or observation
121098VerifyingThe person responsible for verifying the recorded procedure or observation
121099AssistingThe person responsible for assisting with the procedure
121100CirculatingThe person responsible for making preparations for and monitoring the procedure
121101StandbyThe person responsible for standing by to assist with the precedure if required
121102Other sexOther sex
121103Undetermined sexSex of subject undetermined at time of encoding
121104Ambiguous sexAmbiguous sex
121105Radiation PhysicistRadiation Physicist
121106CommentComment
121109Indications for ProcedureIndications for Procedure
121110Patient PresentationPatient condition at the beginning of a healthcare encounter
121111SummarySummary of a procedure, including most significant findings
121112Source of MeasurementImage or waveform used as source for measurement
121113ComplicationsComplications from a procedure
121114Performing PhysicianPhysician who performed a procedure
121115Discharge SummarySummary of patient condition upon Discharge from a healthcare facility
121116Proximal Finding SiteProximal Anatomic Location for a differential measurement; may be considered subtype of term (G-C0E3, SRT, "Finding Site"); e.g. distance or pressure gradient
121117Distal Finding SiteDistal Anatomic Location for a differential measurement; may be considered subtype of term (G-C0E3, SRT, "Finding Site"); e.g. distance or pressure gradient
121118Patient CharacteristicsPatient Characteristics (findings)
121120Cath Lab Procedure LogTime-stamped record of events that occur during a catheterization procedure
121121Room identificationRoom identification
121122Equipment IdentificationEquipment identification
121123Patient Status or EventA recorded Patient Status or an event involving a patient
121124Procedure Action Item IDIdentification of a step, action, or phase of a procedure
121125DateTime of Recording of Log EntryDateTime of Recording of an Entry in an Event Log
121126Performed Procedure Step SOP Instance UIDSOP Instance UID of a Performed Procedure Step
121127Performed Procedure Step SOP Class UIDSOP Class UID of a Performed Procedure Step
121128Procedure Action DurationDuration of a step, action, or phase of a procedure
121130Start Procedure Action ItemBeginning of a step, action, or phase of a procedure
121131End Procedure Action ItemEnd of a step, action, or phase of a procedure
121132Suspend Procedure Action ItemSuspension of a step, action, or phase of a procedure
121133Resume Procedure Action ItemResumption of a step, action, or phase of a procedure
121135Observation DateTime QualifierConcept modifier for the DateTime of Recording of an Entry in an Event Log
121136DateTime UnsynchronizedRecorded DateTime had its source in a system clock not synchronized to other recorded DateTimes
121137DateTime EstimatedRecorded DateTime is estimated
121138Image AcquiredEvent of the acquisition of an image
121139ModalityType of data acquisition device
121140Number of FramesNumber of Frames in a multi-frame image
121141Image TypeDescriptor of an Image
121142Acquisition DurationDuration of the acquisition of an image or a waveform
121143Waveform AcquiredEvent of the acquisition of an image
121144Document TitleDocument Title
121145Description of MaterialDescription of Material used in a procedure
121146Quantity of MaterialQuantity of Material used in a procedure
121147Billing CodeBilling Code for materials used in a procedure
121148Unit Serial IdentifierUnit or Device Serial Identifier
121149Lot IdentifierLot Identifier
121150Device CodeVendor or local coded value identifying a device
121151Lesion IdentifierIdentification of a Lesion observed during an imaging procedure
121152Person administering drug/contrastPerson administering drug/contrast
121153Lesion RiskAssessment of the risk a coronary lesion presents to the health of a patient
121154Intervention attempt identifierIdentifier for an attempted Intervention
121155DeploymentUse of a device to deploy another device
121156Percutaneous Entry ActionAction of a clinical professional at the site of percutaneous access to a patient's cardiovascular system
121157Begin Circulatory SupportThe action or event of beginning circulatory support for a patient
121158End Circulatory SupportThe action or event of ending circulatory support for a patient
121160Oxygen Administration RateRate of Oxygen Administration
121161Begin Oxygen AdministrationThe action or event of beginning administration of oxygen to a patient
121162End oxygen administrationThe action or event of ending administration of oxygen to a patient
121163By ventilatorMethod of administration of oxygen to a patient by ventilator
121165Patient Assessment PerformedThe action or event of assessing the clinical status of a patient
121166Begin PacingThe action or event of beginning pacing support for a patient
121167End PacingThe action or event of ending pacing support for a patient
121168Begin VentilationThe action or event of beginning ventilation support for a patient
121169End VentilationThe action or event of ending ventilation support for a patient
121171Tech NoteProcedural note originated by a technologist
121172Nursing NoteProcedural note originated by a nurse
121173Physician NoteProcedural note originated by a Physician
121174Procedure NoteGeneral procedural note
121180Key ImagesList of references to images considered significant
121181DICOM Object CatalogList of references to DICOM SOP Instances
121190Referenced FramesIndividual frames selected as a subset of a multi-frame image
121191Referenced SegmentSegment selected as a subset of a segmentation image, specifically the pixels/voxels identified as belonging to the classification of the identified segment
121192Device SubjectA device is the subject of observations
121193Device Subject NameName or other identifier of a device that is the subject of observations
121194Device Subject ManufacturerManufacturer of a device that is the subject of observations
121195Device Subject Model NameModel Name of a device that is the subject of observations
121196Device Subject Serial NumberSerial Number of a device that is the subject of observations
121197Device Subject Physical Location during observationPhysical Location of a device that is the subject of observations during those observations
121198Device Subject UIDUnique Identifier of a device that is the subject of observations
121200Illustration of ROIIllustration of a region of interest
121201Area Outlineundefined
121202Area of Defined Regionundefined
121206DistanceA one dimensional, or linear, numeric measurement
121207HeightVertical measurement value
121208Inter-Marker DistanceDistance between marks on a device of calibrated size; e.g. a ruler
121210Pathundefined
121211Path lengthA one dimensional, or linear, numeric measurement along a polyline
121213Perimeter Outlineundefined
121214Referenced Segmentation FrameFrame selected from a segmentation image, specifically the pixels/voxels identified as belonging to the classification of the segment encompassing the identified frame
121216Volume estimated from single 2D regionA three-dimensional numeric measurement that is approximate, based on a two-dimensional region in a single image
121217Volume estimated from three or more non-coplanar 2D regionsA three-dimensional numeric measurement that is approximate, based on three or more non-coplanar two-dimensional image regions
121218Volume estimated from two non-coplanar 2D regionsA three-dimensional numeric measurement that is approximate, based on two non-coplanar two-dimensional image regions
121219Volume of bounding three dimensional regionA three-dimensional numeric measurement of the bounding region of a three-dimensional region of interest in an image set
121220Volume of circumscribed sphereA three-dimensional numeric measurement of the bounding sphere of a three-dimensional region of interest in an image set
121221Volume of ellipsoidA three-dimensional numeric measurement of an ellipsoid shaped three-dimensional region of interest in an image set
121222Volume of sphereA three-dimensional numeric measurement of a sphere shaped three-dimensional region of interest in an image set
121230Path VertexCoordinates of a point on a defined path
121231Volume SurfaceSurface of an identified or measured volume
121232Source series for segmentationSeries of image instances used as source data for a segmentation
121233Source image for segmentationImage instances used as source data for a segmentation
121242Distance from nippleIndicates the location of the area of interest as measured from the nipple of the breast
121243Distance from skinIndicates the location of the area of interest as measured from the most direct skin point of the breast
121244Distance from chest wallIndicates the location of the area of interest as measured from the chest wall
121290Patient exposure to ionizing radiationPatient exposure to ionizing radiation (procedure)
121291Results communicatedThe act of communicating actionable findings to a responsible receiver
121301Simultaneous DopplerReference is to a Doppler waveform acquired simultaneously with an image
121302Simultaneous HemodynamicReference is to a Hemodynamic waveform acquired simultaneously with an image
121303Simultaneous ECGReference is to a ECG waveform acquired simultaneously with an image
121304Simultaneous Voice NarrativeReference is to a voice narrative recording acquired simultaneously with an image
121305Simultaneous Respiratory WaveformA waveform representing chest expansion and contraction due to respiratory activity, measured simultaneously with the acquisition of this Image
121306Simultaneous Arterial Pulse WaveformArterial pulse waveform obtained simultaneously with acquisition of a referencing image
121307Simultaneous Phonocardiographic WaveformPhonocardiographic waveform obtained simultaneously with acquisition of a referencing image
121311LocalizerImage providing an anatomical reference on the patient under examination, for the purpose of defining the location of the ensuing imaging
121312Biopsy localizerImage providing an anatomical reference on the patient under examination, for the purpose of planning or documenting a biopsy
121313Other partial viewsImage providing a partial view of the target anatomy, when the target anatomy is too large for a single image
121314Other image of biplane pairImage providing a view of the target anatomy in a different imaging plane, typically from a near perpendicular angle
121315Other image of stereoscopic pairImage providing a view of the target anatomy in a different imaging plane, typically with a small angular difference
121316Images related to standalone objectImage related to a non-image information object
121317SpectroscopyImage where signals are identified and separated according to their frequencies; e.g. to identify individual chemicals, or individual nuclei in a chemical compound
121318Spectroscopy Data for Water Phase CorrectionMR spectroscopy data acquired to correct the phase of the diagnostic data for the phase signal of the Water
121320Uncompressed predecessorAn image that has not already been lossy compressed that is used as the source for creation of a lossy compressed image
121321Mask image for image processing operationImage used as the mask for an image processing operation, such as subtraction
121322Source image for image processing operationImage used as the source for an image processing operation
121323Source series for image processing operationSeries used as the source for an image processing operation
121324Source ImageImage used as the source for a derived or compressed image
121325Lossy compressed imageImage encoded with a lossy compression transfer syntax
121326Alternate SOP Class instanceSOP Instance encoded with a different SOP Class but otherwise equivalent data
121327Full fidelity imageFull fidelity image, uncompressed or lossless compressed
121328Alternate Photometric Interpretation imageImage encoded with a different photometric interpretation
121329Source image for montageImage used as a source for a montage (stitched) image
121330Lossy compressed predecessorAn image that has previously been lossy compressed that is used as the source for creation of another lossy compressed image
121331Equivalent CDA DocumentHL7 Document Architecture (CDA) Document that contains clinical content equivalent to the referencing Instance
121332Complete Rendering for PresentationInstance that contains a displayable complete rendering of the referencing Instance
121333Partial Rendering for PresentationInstance that contains a displayable partial rendering of the referencing Instance
121334Extended Rendering for PresentationInstance that contains a displayable complete rendering of the referencing Instance, plus additional content such as inline rendering of referenced images
121335Source DocumentDocument whose content has been wholly or partially transformed to create the referencing document
121338Anatomic imageImage showing structural anatomic features
121339Functional imageImage showing physical or chemical activity
121340Spectral filtered imageImage providing the same view of the target anatomy acquired using only a specific imaging wavelength, frequency or energy
121341Device localizerImage providing an anatomical reference on the patient under examination, for the purpose of documenting the location of device such as a diagnostic or therapeutic catheter
121342Dose ImageImage providing a graphic view of the distribution of radiation dose
121346Acquisition frames corresponding to volumeThe referenced image is the source of spatially-related frames from which the referencing 3D volume data set was derived
121347Volume corresponding to spatially-related acquisition frames3D Volume containing the spatially-related frames in the referencing instance
121348Temporal PredecessorInstance acquired prior to the referencing instance in a set of consecutively acquired instances
121349Temporal SuccessorInstance acquired subsequent to the referencing instance in a set of consecutively acquired instances
121350Same acquisition at lower resolutionImage of the same target area at lower resolution acquired in the same acquisition process
121351Same acquisition at higher resolutionImage of the same target area at higher resolution acquired in the same acquisition process
121352Same acquisition at different focal depthImage of the same target area at different focal depth (Z-plane) acquired in the same acquisition process
121353Same acquisition at different spectral bandImage of the same target area at different spectral band acquired in the same acquisition process
121354Imaged container labelImage specifically targeting the container label
121358For Processing predecessorSource image from which FOR PRESENTATION images were created
121360Replaced reportThe reference is to a predecessor report that has been replaced by the current report
121361Addended reportThe reference is to a predecessor report to which the current report provides and addendum
121362Preliminary reportA report that precedes the final report and may contain only limited information; it may be time sensitive, and it is not expected to contain all the reportable findings
121363Partial reportA report that is not complete
121370Composed from prior dosesThe dose object created was calculated by summation of existing, previously calculated, RT Dose instances
121371Composed from prior doses and current planThe dose object created was calculated by summation of existing, previously calculated, RT Dose instances and dose newly calculated by the application. The newly calculated dose may or may not exist as an independent object
121372Source dose for composing current doseRT Dose Instances used as source for calculated dose
121380Active Ingredient Undiluted ConcentrationConcentration of the chemically or physically interesting (active) ingredient of a drug or contrast agent as delivered in product form from the manufacturer, typically in mg/ml
121381Contrast/Bolus Ingredient OpaqueX-Ray absorption of the active ingredient of a contrast agent ingredient is greater than the absorption of water (tissue)
121382Quantity administeredNumber of units of substance administered to a patient; e.g. tablets
121383Mass administeredMass of substance administered to a patient
121401DerivationMethod of deriving or calculating a measured value; e.g. mean, or maximum of set
121402NormalityAssessment of a measurement relative to a normal range of values; may be considered subtype of term (G-C0F2, SRT, "has interpretation")
121403Level of SignificanceSignificance of a measurement
121404Selection StatusStatus of selection of a measurement for further processing or use
121405Population descriptionDescription of a population of measurements
121406Reference AuthorityBibliographic or clinical reference for a Description of a population of measurements
121407Normal Range descriptionDescription of a normal range of values for a measurement concept
121408Normal Range AuthorityBibliographic or clinical reference for a Description of a normal range of values
121410User chosen valueObservation value selected by user for further processing or use, or as most representative
121411Most recent value chosenObservation value is the recently obtained, and has been selected for further processing or use
121412Mean value chosenObservation value is the mean of several measurements, and has been selected for further processing or use
121414Standard deviation of populationStandard deviation of a measurement in a reference population
121415Percentile Ranking of measurementPercentile Ranking of an observation value with respect a reference population
121416Z-Score of measurementZ-score of an observation value with respect a reference population, expressed as the dimensionless quantity (x-m) /s, where (x-m) is the deviation of the observation value (x) from the population mean (m), and s is the standard deviation of the population
1214172 Sigma deviation of population2 Sigma deviation of a measurement in a reference population
121420EquationFormula used to compute a derived measurement
121421Equation CitationBibliographic reference to a formula used to compute a derived measurement; reference may be to a specific equation in a journal article
121422Table of Values CitationBibliographic reference to a Table of Values used to look up a derived measurement
121423Method CitationBibliographic reference to a method used to compute a derived measurement
121424Table of ValuesA Table of Values used to look up a derived measurement
121425IndexFactor (divisor or multiplicand) for normalizing a measurement; e.g. body surface area used for normalizing hemodynamic measurements
121427EstimatedMeasurement obtained by observer estimation, rather than with a measurement tool or by calculation
121428CalculatedMeasurement obtained by calculation
121430ConcernIdentified issue about a state or process that has the potential to require intervention or management
121431DateTime Concern NotedDateTime concern noted (noted by whom is determined by context of use)
121432DateTime Concern ResolvedDateTime the concern was resolved
121433DateTime Problem ResolvedDateTime the problem was resolved
121434Service Delivery LocationPlace at which healthcare services may be provided
121435Service PerformerIdentification of a healthcare provider who performed a healthcare service; may be either a person or an organization
121436Medical Device UsedType or identifier of a medical device used on, in, or by a patient
121437Pharmacologic and exercise stress testCardiac stress test using pharmacologic and exercise stressors
121438Paced stress testCardiac stress test using an implanted or external cardiac pacing device
121439Correction of congenital cardiovascular deformityProcedure for correction of congenital cardiovascular deformity
121701RT Patient SetupProcess of placing patient in the anticipated treatment position, including specification and location of positioning aids, and other treatment delivery accessories
121702RT Patient Position Acquisition, single plane MVAcquisition of patient positioning information prior to treatment delivery, using single-plane megavoltage imaging
121703RT Patient Position Acquisition, dual plane MVAcquisition of patient positioning information prior to treatment delivery, using dual-plane megavoltage imaging
121704RT Patient Position Acquisition, single plane kVAcquisition of patient positioning information prior to treatment delivery, using single-plane kilovoltage imaging
121705RT Patient Position Acquisition, dual plane kVAcquisition of patient positioning information prior to treatment delivery, using dual-plane kilovoltage imaging
121706RT Patient Position Acquisition, dual plane kV/MVAcquisition of patient positioning information prior to treatment delivery, using dual-plane combination kilovoltage and megavoltage imaging
121707RT Patient Position Acquisition, CT kVAcquisition of patient positioning information prior to treatment delivery, using kilovoltage CT imaging
121708RT Patient Position Acquisition, CT MVAcquisition of patient positioning information prior to treatment delivery, using megavoltage CT imaging
121709RT Patient Position Acquisition, OpticalAcquisition of patient positioning information prior to treatment delivery, using optical imaging
121710RT Patient Position Acquisition, UltrasoundAcquisition of patient positioning information prior to treatment delivery, using ultrasound imaging
121711RT Patient Position Acquisition, Spatial FiducialsAcquisition of patient positioning information prior to treatment delivery, using spatial fiducials
121712RT Patient Position Registration, single planeRegistration of intended and actual patient position prior to treatment delivery, using single-plane images
121713RT Patient Position Registration, dual planeRegistration of intended and actual patient position prior to treatment delivery, using dual-plane images
121714RT Patient Position Registration, 3D CT generalRegistration of intended and actual patient position prior to treatment delivery, using 3D CT images and an unspecified registration approach
121715RT Patient Position Registration, 3D CT marker-basedRegistration of intended and actual patient position prior to treatment delivery, using 3D CT images and a marker-based registration approach
121716RT Patient Position Registration, 3D CT volume-basedRegistration of intended and actual patient position prior to treatment delivery, using 3D CT images and a volume-based registration approach
121717RT Patient Position Registration, 3D on 2D referenceRegistration of intended and actual patient position prior to treatment delivery, using 3D verification images and 2D reference images
121718RT Patient Position Registration, 2D on 3D referenceRegistration of intended and actual patient position prior to treatment delivery, using 2D verification images and 3D reference images
121719RT Patient Position Registration, OpticalRegistration of intended and actual patient position prior to treatment delivery, using optical images
121720RT Patient Position Registration, UltrasoundRegistration of intended and actual patient position prior to treatment delivery, using ultrasound images
121721RT Patient Position Registration, Spatial FiducialsRegistration of intended and actual patient position prior to treatment delivery, using spatial fiducials
121722RT Patient Position AdjustmentAdjustment of patient position such that the patient is correctly positioned for treatment
121723RT Patient Position In-treatment-session ReviewReview of patient positioning information in the process of delivering a treatment session
121724RT Treatment Simulation with Internal VerificationSimulated radiotherapy treatment delivery using verification integral to the Treatment Delivery System
121725RT Treatment Simulation with External VerificationSimulated radiotherapy treatment delivery using verification by a external Machine Parameter Verifier
121726RT Treatment with Internal VerificationRadiotherapy treatment delivery using verification integral to the Treatment Delivery System
121727RT Treatment with External VerificationRadiotherapy treatment delivery using verification by an external Machine Parameter Verifier
121728RT Treatment QA with Internal VerificationQuality assurance of a radiotherapy treatment delivery using verification integral to the Treatment Delivery System
121729RT Treatment QA with External VerificationQuality assurance of a radiotherapy treatment delivery using verification by an external Machine Parameter Verifier
121730RT Machine QAQuality assurance of a Treatment Delivery Device
121731RT Treatment QA by RT Plan Dose CheckPerform Quality Assurance on an RT Plan by evaluating dosimetric content of the current RT Plan
121732RT Treatment QA by RT Plan Difference CheckPerform Quality Assurance on an RT Plan by comparing the content of previously quality-assessed RT Plans with the current RT Plan
121733RT Treatment QA by RT Ion Plan Dose CheckPerform Quality Assurance on an RT Ion Plan by evaluating dosimetric content of the current RT Ion Plan
121734RT Treatment QA with RT Ion Plan Difference CheckPerform Quality Assurance on an RT Ion Plan by comparing the content of previously quality-assessed RT Ion Plans with the current RT Ion Plan
121740Treatment Delivery TypeIndicates whether the treatment to be delivered is a complete fraction or a continuation of previous incompletely treated fraction
122001Patient called to procedure roomPatient called to procedure room
122002Patient admitted to procedure roomPatient admitted to procedure room
122003Patient given pre-procedure instructionPatient given pre-procedure instruction
122004Patient informed consent givenPatient informed consent given
122005Patient advance directive givenPatient advance directive given
122006Nil Per Os (NPO) status confirmedNil Per Os (NPO) status confirmed
122007Patient assisted to tablePatient assisted to table
122008Patient prepped and drapedPatient prepped and draped
122009Patient connected to continuous monitoringPatient connected to continuous monitoring
122010Patient transferred to holding areaPatient transferred to holding area
122011Patient transferred to surgeryPatient transferred to surgery
122012Patient transferred to CCUPatient transferred to CCU
122020Patient disorientedPatient disoriented
122021Patient reports nauseaPatient reports nausea
122022Patient reports discomfortPatient reports discomfort
122023Patient reports chest painPatient reports chest pain
122024Patient reports no painPatient reports no pain
122025Patient alertPatient alert
122026Patient restlessPatient restless
122027Patient sedatedPatient sedated
122028Patient asleepPatient asleep
122029Patient unresponsivePatient unresponsive
122030Patient has respiratory difficultyPatient has respiratory difficulty
122031Patient coughedPatient coughed
122032Patient disconnected from continuous monitoringPatient disconnected from continuous monitoring
122033Hemostasis achievedHemostasis achieved
122034Hemostasis not achieved - oozingHemostasis not achieved - oozing
122035Hemostasis not achieved - actively bleedingHemostasis not achieved - actively bleeding
122036Patient given post-procedure instructionPatient given post-procedure instruction
122037Patient discharged from departmentPatient discharged from department or laboratory
122038Patient pronounced deadPatient pronounced dead
122039Patient transferred to morguePatient transferred to morgue
122041Personnel ArrivedIdentified personnel or staff arrived in procedure room
122042Personnel DepartedIdentified personnel or staff departed procedure room
122043Page Sent ToPage sent to identified personnel or staff
122044Consultation WithConsultation with identified personnel or staff
122045Office calledOffice of identified personnel or staff was called
122046Equipment failureEquipment failure
122047Equipment brought to procedure roomEquipment brought to procedure room
122048Equipment readyEquipment ready for procedure
122049Equipment removedEquipment removed from procedure room
122052BioptomeDevice for obtaining biopsy sample
122053Valvular InterventionValvular Intervention
122054Aortic InterventionAortic Intervention
122055Septal Defect InterventionSeptal Defect Intervention
122056Vascular InterventionVascular Intervention
122057Myocardial biopsyMyocardial biopsy
122058Arterial conduit angiographyArterial conduit angiography
122059Single plane AngiographySingle plane Angiography
122060Bi-plane AngiographyBi-plane Angiography
122061Percutaneous Coronary InterventionPercutaneous Coronary Intervention
12206215-Lead ECG15-Lead electrocardiography
122072Pre-procedure logLog of events occurring prior to the current procedure
122073Current procedure evidenceAnalysis or measurements for current procedure (purpose of reference to evidence document)
122075Prior report for current patientPrior report for current patient
122076Consumable taken from inventoryIdentifier of Consumable taken from inventory
122077Consumable returned to inventoryIdentifier of Consumable returned to inventory
122078Remaining consumable disposedIdentifier of consumable whose remaining content has been disposed
122079Consumable unusableIdentifier of Consumable determined to be unusable
122081Drug startIdentifier of Drug whose administration has started
122082Drug endIdentifier of Drug whose administration has ended
122083Drug administeredIdentifier of Drug administered as part of procedure
122084Contrast startIdentifier of Contrast agent whose administration has started
122085Contrast endIdentifier of Contrast agent whose administration has ended
122086Contrast administeredIdentifier of Contrast agent administered
122087Infusate startIdentifier of Infusate whose administration has started
122088Infusate endIdentifier of Infusate whose administration has ended
122089Device crossed lesionAction of a device traversing a vascular lesion
122090Intervention ActionAction of a clinical professional performed on a patient for therapeutic purpose
122091Volume administeredVolume of Drug, Contrast agent, or Infusate administered
122092Undiluted dose administeredUndiluted dose of Drug, Contrast agent, or Infusate administered
122093ConcentrationConcentration of Drug, Contrast agent, or Infusate administered
122094Rate of administrationRate of Drug, Contrast agent, or Infusate administration
122095Duration of administrationDuration of Drug, Contrast agent, or Infusate administration
122096Volume unadministered or discardedVolume of Drug, Contrast agent, or Infusate unadministered or discarded
122097Catheter CurveNumeric parameter of Curvature of Catheter
122098Transmit FrequencyTransmit Frequency
122099ST change from baselineMeasured change of patient electrocardiographic ST level relative to baseline measurement
122101Aneurysm on cited vesselAnatomic term modifier indicating aneurysm on cited vessel is the subject of the finding
122102Graft to cited segment, proximal sectionAnatomic term modifier indicating proximal section of graft to cited vessel is the subject of the finding
122103Graft to cited segment, mid sectionAnatomic term modifier indicating mid section of graft to cited vessel is the subject of the finding
122104Graft to cited segment, distal sectionAnatomic term modifier indicating distal section of graft to cited vessel is the subject of the finding
122105DateTime of InterventionDateTime of Intervention
122106Duration of InterventionDuration of Intervention
122107Baseline Stenosis MeasurementLesion stenosis measured prior to any interventional procedure
122108Post-Intervention Stenosis MeasurementLesion stenosis measured after an interventional procedure
122109Baseline TIMI FlowAssessment of perfusion across a coronary lesion measured prior to any interventional procedure
122110Post-Intervention TIMI FlowAssessment of perfusion across a coronary lesion measured after an interventional procedure
122111Primary Intervention DeviceIndication that device is the primary (first and/or most significant) device used for interventional therapy of a particular pathology; e.g. lesion
122112Normal MyocardiumNormal Myocardium
122113Sacrred MyocardialSacrred Myocardial
122114Thinning MyocardiumThinning Myocardium
122120Hemodynamics ReportHemodynamics Report
122121Atrial pressure measurementsAtrial pressure measurements, report section
122122Ventricular pressure measurementsVentricular pressure measurements, report section
122123Gradient assessmentGradient assessment, report section
122124Blood velocity measurementsBlood velocity measurements, report section
122125Blood lab measurementsBlood lab measurements, report section
122126Derived Hemodynamic MeasurementsDerived Hemodynamic Measurements, report section
122127Clinical ContextClinical Context, report section
122128Patient Transferred FromLocation from which the patient was transferred
122129PCI during this procedureIndication that the procedure includes a percutaneous coronary intervention
122130Dose Area ProductRadiation dose times area of exposure
122131Degree of ThrombusFinding of probability and/or severity of thrombus
122132Severity of CalcificationSeverity of Calcification, property of lesion
122133Lesion MorphologyLesion Morphology; form and/or structural properties of lesion
122134Vessel MorphologyVessel Morphology; form and/or structural properties of vessel
122138Circulatory SupportTechnique (device or procedure) of support for patient circulatory system; hemodynamic support
122139Reason for ExamReason for Exam
122140Comparison with Prior Exam DoneIndication that the current exam data has been compared with prior exam data
122141Electrode PlacementElectrocardiographic electrode placement technique
122142Acquisition Device TypeAcquisition Device Type
122143Acquisition Device IDAcquisition Device ID
122144Quantitative AnalysisQuantitative Analysis, report section
122145Qualitative AnalysisQualitative Analysis, report section
122146Procedure DateTimeThe date and time on which a procedure was performed on a patient
122147Clinical InterpretationClinical Interpretation, report section
122148Lead IDECG Lead Identifier
122149Beat NumberBeat Number; ordinal of cardiac cycle within an acquisition
122150Compound StatementComplex coded semantic unit, consisting of several coded components
122151TrendTrend (temporal progression) of a clinical condition, finding, or disease
122152StatementCoded semantic unit
122153Statement ModifierCoded modifier for a semantic unit
122154Conjunctive TermConjunctive term between semantic units
122157ProbabilityProbability
122158ECG Global MeasurementsECG Global Measurements, report section
122159ECG Lead MeasurementsECG Lead Measurements, report section
122160Derived Area, Non-ValveDerived cross-sectional area of a vessel or anatomic feature, other than a cardiac valve
122161Pulmonary FlowRate of blood flow through Pulmonary artery
122162Systemic FlowRate of blood flow through the aorta
122163Discharge DateTimeDateTime of patient discharge from hospital admission
122164Coronary Artery Bypass During This AdmissionIndication that a Coronary Artery Bypass operation was performed during the current hospital admission
122165Date of DeathDate of Death
122166Death During This AdmissionIndication that the patient died during the current hospital admission
122167Death During CatheterizationIndication that the patient died during the current Catheterization procedure
122170Type of Myocardial InfarctionFinding of type of Myocardial Infarction
122171Coronary lesion > = 50% stenosisFinding of Coronary lesion with greater than 50% stenosis
122172Acute MI PresentFinding of Acute Myocardial Infarction Presence as indication for interventional procedure
122173ST Elevation Onset DateTimeDateTime of first determination of elevated ECG ST segment, as indication of Myocardial Infarction
122175Number of lesion interventions attemptedNumber of lesion interventions attempted during current procedure
122176Number of lesion interventions successfulNumber of lesion interventions successful during current procedure, where the residual post intervention stenosis is less than or equal to 50% of the arterial luminal diameter, TIMI Flow is 3 and the minimal decrease in stenosis was 20%
122177Procedure ResultOverall success of interventional procedure
122178Lesion Intervention InformationLesion Intervention Information, report section
122179Peri-procedural MI occurredIndication that Myocardial Infarction occurred during current procedure
122180CK-MB baselineCreatine Kinase-MB value at baseline (start of procedure)
122181CK-MB peakCreatine Kinase-MB highest value measured during procedure
122182R-R intervalTime interval between ECG R-wave peaks in subsequent cardiac cycles
122183Blood temperatureBlood temperature
122185Blood Oxygen contentBlood Oxygen content
122187Blood Carbon dioxide saturationBlood Carbon dioxide saturation
122188Pulmonary Arterial Content (FCpa)Pulmonary Arterial Content (FCpa)
122189Pulmonary Venous Content (FCpv)Pulmonary Venous Content (FCpv)
122190Max dp/dt/PMax dp/dt/P
122191Ventricular End Diastolic pressureVentricular End Diastolic pressure
122192Indicator appearance timeElapsed time from injection of an indicator bolus until it is observed at another location
122193Maximum pressure accelerationMaximum pressure acceleration
122194Ventricular Systolic blood pressureVentricular Systolic blood pressure
122195Pulse StrengthPulse Strength; palpable strength of systolic flow
122196C wave pressureThe secondary peak pressure in the atrium during atrial contraction
122197Gradient pressure, averageGradient pressure, average
122198Gradient pressure, peakGradient pressure, peak
122199Pressure at dp/dt maxPressure at dp/dt max
122201Diastolic blood velocity, meanDiastolic blood velocity, mean
122202Diastolic blood velocity, peakDiastolic blood velocity, peak
122203Systolic blood velocity, meanSystolic blood velocity, mean
122204Systolic blood velocity, peakSystolic blood velocity, peak
122205Blood velocity, meanBlood velocity, mean
122206Blood velocity, minimumBlood velocity, minimum
122207Blood velocity, peakBlood velocity, peak
122208x-descent pressureVenous or atrial pressure minimum during ventricular systole, after A-wave
122209y-descent pressureVenous or atrial pressure minimum when tricuspid valve opens during diastole, after V-wave
122210z-point pressureAtrial pressure upon closure of tricuspid and mitral valves
122211Left Ventricular ejection timeLeft Ventricular ejection time
122212Left Ventricular filling timeLeft Ventricular filling time
122213Right Ventricular ejection timeRight Ventricular ejection time
122214Right Ventricular filling timeRight Ventricular filling time
122215Total Pulmonary ResistanceTotal Pulmonary Resistance
122216Total Vascular ResistanceTotal Vascular Resistance
122217Coronary Flow reserveCoronary Flow reserve
122218Diastolic/Systolic velocity ratioDiastolic/Systolic velocity ratio
122219Hyperemic ratioHyperemic ratio
122220Hemodynamic Resistance IndexHemodynamic Resistance Index
122221Thorax diameter, sagittalThorax diameter, sagittal
122222Procedure Environmental CharacteristicsEnvironmental characteristics in the procedure room
122223Room oxygen concentrationOxygen concentration in the procedure room
122224Room temperatureTemperature in the procedure room
122225Room Barometric pressureBarometric pressure in the procedure room
122227Left to Right FlowLeft to Right Flow
122228Right to Left FlowRight to Left Flow
122229Arteriovenous differenceArteriovenous oxygen content difference
12223010 Year CHD RiskFramingham Study 10 Year CHD Risk
122231Comparative Average10 Year CHD RiskFramingham Study Comparative Average10 Year CHD Risk
122232Comparative Low10 Year CHD RiskFramingham Study Comparative Low10 Year CHD Risk
122233LDL Cholesterol Score Sheet for MenFramingham Study LDL Cholesterol Score Sheet for Men
122234LDL Cholesterol Score Sheet for WomenFramingham Study LDL Cholesterol Score Sheet for Women
122235Total Cholesterol Score Sheet for MenFramingham Study Total Cholesterol Score Sheet for Men
122236Total Cholesterol Score Sheet for WomenFramingham Study Total Cholesterol Score Sheet for Women
122237Corrected Sinus Node Recovery TimeCorrected Sinus Node Recovery Time
122238Max volume normalized to 50mmHg pulse pressureMax volume normalized to 50mmHg pulse pressure
122239Oxygen ConsumptionOxygen Consumption
122240BSA = 3.207*WT^(0.7285-0.0188 log (WT)) *HT^0.3Body Surface Area computed from patient height and weight: BSA = 3.207*WT[g]^(0.7285-0.0188 log (WT[g])) *HT[cm] ^ 0.3 [Boyd E, The growth of the surface area of the human body. Minneapolis: University of Minnesota Press, 1935, eq. (36) ]
122241BSA = 0.007184*WT^ 0.425*HT^0.725Body Surface Area computed from patient height and weight: BSA = 0.007184* WT[kg] ^ 0.425*HT[cm] ^ 0.725 [Dubois and Dubois, Arch Int Med 1916 17:863-71]
122242BSA = 0.0235*WT^0.51456*HT^ 0.42246Body Surface Area computed from patient height and weight: BSA = 0.0235* WT[kg] ^0.51456*HT[cm]^ 0.42246 [Gehan EA, George SL, 'Estimation of human body surface area from height and weight', Cancer Chemother Rep 1970 54:225-35]
122243BSA = 0.024265*WT^0.5378*HT^0.3964Body Surface Area computed from patient height and weight: BSA = 0.024265 * WT[kg] ^ 0.5378 * HT[cm] ^ 0.3964 [Haycock G.B., Schwartz G.J., Wisotsky D.H. 'Geometric method for measuring body surface area: A height weight formula validated in infants, children and adults.' The Journal of Pediatrics 1978 93:1:62-66]
122244BSA = (HT * WT/36) ^0.5Body Surface Area computed from patient height and weight: BSA = (HT[m] * WT[kg] / 36) ^ 0.5 [Mosteller, R.D. 'Simplified Calculation of Body Surface Area.' N Engl J Med 1987 Oct 22;317(17):1098]
122245BSA = 1321+0.3433*WTBody Surface Area computed from patient weight:BSA = 1321 + 0.3433 * WT[kg] (for pediatrics 3-30 kg) [Current, J.D. 'A Linear Equation For Estimating The Body Surface Area In Infants And Children', The Internet Journal of Anesthesiology. 1998. 2:2]
122246BSA = 0.0004688 * WT ^ (0.8168 - 0.0154 * log(WT))BSA = 0.0004688 * (1000 * WT) ^ (0.8168 - 0.0154 * log(1000 * WT)) Where (WT is weight in kilogram) Units = m2 Boyd, Edith. The Growth of the Surface Area of the Human Body(originally published in 1935 by the University of Minnesota Press), Greenwood Press, Westport, Connecticut, 1975, p. 102.Equation (35)
122247VO2male = BSA (138.1 - 11.49 * loge(age) + 0.378 * HRf)Equation for estimated oxygen consumption: VO2male = BSA (138.1 - 11.49 * loge(age) + 0.378 * HRf)
122248VO2female = BSA (138.1 - 17.04 * loge(age) + 0.378 * HRf)Equation for estimated oxygen consumption: VO2female = BSA (138.1 - 17.04 * loge(age) + 0.378 * HRf)
122249VO2 = VeSTPD * 10 * (FIO2 - FE02)Equation for estimated oxygen consumption: VO2 = VeSTPD * 10 * (FIO2 - FE02)
122250VO2 = 152 * BSAEquation for estimated oxygen consumption: VO2 = 152 * BSA
122251VO2 = 175 * BSAEquation for estimated oxygen consumption: VO2 = 175 * BSA
122252VO2 = 176 * BSAEquation for estimated oxygen consumption: VO2 = 176 * BSA
122253Robertson & Reid tableRobertson & Reid Table for estimated oxygen consumption
122254Fleisch tableFleisch table for estimated oxygen consumption
122255Boothby tableBoothby table for estimated oxygen consumption
122256if (prem age< 3days) P50 = 19.9Estimate of Oxygen partial pressure at 50% saturation for premature infants less than 3 days old: P50 = 19.9
122257if (age < 1day) P50 = 21.6Estimate of Oxygen partial pressure at 50% saturation for infants less than 1 day old: P50 = 21.6
122258if (age < 30day) P50 = 24.6Estimate of Oxygen partial pressure at 50% saturation for infants less than 30 days old: P50 = 24.6
122259if (age < 18y) P50 = 27.2Estimate of Oxygen partial pressure at 50% saturation for patients less than 18 years old: P50 = 27.2
122260if (age < 40y) P50 = 27.4Estimate of Oxygen partial pressure at 50% saturation for patients less than 40 years old: P50 = 27.4
122261if (age > 60y) P50 = 29.3Estimate of Oxygen partial pressure at 50% saturation for patients more than 60 years old: P50 = 29.3
122262Area = Flow / 44.5 * sqrt(Gradient[mmHg])Cardiac valve area computed from flow and pressure gradient: Area = Flow / 44.5 * sqrt(Gradient[mmHg]) [Gorlin and Gorlin, Am Heart J, 1951]
122263MVA = Flow / 38.0 * sqrt(Gradient[mmHg])Mitral valve area computed from flow and pressure gradient: Mitral valve Area = Flow / 38.0 * sqrt(Gradient[mmHg]) [Gorlin and Gorlin, Am Heart J, 1951]
122265BMI = Wt / Ht ^ 2Body Mass Index computed from weight and height: BMI = Wt/Ht^2
122266BSA = 0.007358 * WT ^ 0.425 * HT ^ 0.725Body Surface Area computed from patient height and weight: BSA = 0.007358 * WT[kg] ^ 0.425 * HT[cm] ^ 0.725 (for East Asian adult, aged 15+ years) [Kanai Izumi, Masamitsu Kanai, 'Clinical examination method summary']
122267BSA = 0.010265 * WT ^ 0.423 * HT ^ 0.651Body Surface Area computed from patient height and weight: BSA = 0.010265 * WT[kg] ^ 0.423 * HT[cm] ^ 0.651 (For East Asian child aged 12-14 years)
122268BSA = 0.008883 * WT ^ 0.444 * HT ^ 0.663Body Surface Area computed from patient height and weight: BSA = 0.008883* WT[kg] ^ 0.444 * HT[cm] ^ 0.663 (For East Asian child aged 6-11 years)
122269BSA = 0.038189 * WT ^ 0.423 * HT ^ 0.362Body Surface Area computed from patient height and weight: BSA = 0.038189 * WT[kg] ^ 0.423 * HT[cm] ^ 0.362 (For East Asian child aged 1-5 years)
122270BSA = 0.009568 * WT ^ 0.473 * HT ^ 0.655Body Surface Area computed from patient height and weight: BSA = 0.009568* WT[kg] ^ 0.473 * HT[cm] ^ 0.655 (For East Asian child aged 0-12 months)
122271Skin Condition WarmSkin Condition Warm
122272Skin Condition CoolSkin Condition Cool
122273Skin Condition ColdSkin Condition Cold
122274Skin Condition DrySkin Condition Dry
122275Skin Condition ClammySkin Condition Clammy
122276Skin Condition DiaphoreticSkin Condition Diaphoretic
122277Skin Condition FlushSkin Condition Flush
122278Skin Condition MottledSkin Condition Mottled
122279Skin Condition PaleSkin Condition Pale
122281Airway unobstructedAirway unobstructed
122282Airway partially obstructedAirway partially obstructed
122283Airway severely obstructedAirway severely obstructed
122288Not VisualizedAnatomy could not be visualized for the purpose of evaluation
122291Quantitative Arteriography ReportQuantitative Arteriography Report
122292Quantitative Ventriculography ReportQuantitative Ventriculography Report
122301Guidewire crossing lesion unsuccessfulGuidewire crossing lesion unsuccessful
122302Guidewire crossing lesion successfulGuidewire crossing lesion successful
122303Angioplasty balloon inflatedAngioplasty balloon inflated
122304Angioplasty balloon deflatedAngioplasty balloon deflated
122305Device deployedDevice deployed
122306Stent re-expandedStent re-expanded
122307Object removedObject removed
122308Radiation appliedRadiation applied
122309Radiation removedRadiation removed
122310Interventional device placement unsuccessfulInterventional device placement unsuccessful
122311Interventional device placedInterventional device placed
122312Intervention performedIntervention performed
122313Interventional device withdrawnInterventional device withdrawn
122319Catheter SizeCatheter Size
122320Injectate TemperatureInjectate Temperature
122321Injectate VolumeInjectate Volume
122322Calibration FactorFactor by which a measured or calculated value is multiplied to obtain the estimated real-world value
122325IVUS ReportIntravascular Ultrasound Report
122330EEM DiameterExternal Elastic Membrane (EEM) diameter measured through the center point of the vessel. Center point of the vessel is defined as the center of gravity of the EEM area. The EEM is a discrete interface at the border between the media and the adventitia
122331Plaque Plus Media ThicknessThe distance from intimal leading edge to the external elastic membrane along any line passing through the luminal center, which is defined as the center of gravity of the lumen area
122332Lumen PerimeterPlanimetered perimeter of the lumen
122333EEM Cross-Sectional AreaVessel area measured at the External Elastic Membrane (EEM), a discrete interface at the border between the media and the adventitia
122334Plaque plus Media Cross-Sectional AreaArea within the EEM occupied by atheroma, regardless of lumen compromise. Plaque plus Media Area = EEM cross-sectional area - vessel lumen cross-sectional area
122335In-Stent Neointimal Cross-Sectional AreaMeasurement of in-stent restenosis. In-Stent Intimal Area = Stent cross-sectional area - vessel lumen cross-sectional area
122336Vascular Volume measurement lengthLongitudinal extent of the Vascular Volume Measurement. This is the distance from the distal edge to the proximal edge of the Volume measurement
122337Relative positionLongitudinal distance from the closest edge of a fiducial feature or reference location to the start of the vascular measurement. This value will be a positive if the measurement is distal to the fiducial feature or reference location, or negative if the measurement is proximal to the fiducial feature or reference location
122339Stent Volume ObstructionIn-Stent Neointimal Volume / Stent Volume
122340Fiducial featureReference, normally anatomical, which is used for locating the position of a measurement
122341Calcium LengthLongitudinal calcium length measurement
122343Lumen Eccentricity IndexMeasurement of vessel lumen eccentricity. Lumen Eccentricity Index = (maximum vessel lumen diameter - minimum vessel lumen diameter) / maximum vessel lumen diameter. Lumen diameters are measured through the center point of the lumen, which is defined as the center of gravity of the lumen area
122344Plaque plus Media Eccentricity IndexPlaque plus Media Eccentricity Index = (maximum Plaque plus media thickness - minimum Plaque plus media thickness) / maximum Plaque plus media thickness
122345Remodeling IndexMeasurement of increase or decrease in EEM area that occurs during the development of atherosclerosis. Remodeling Index = Lesion EEM area / reference EEM area
122346Stent Symmetry IndexMeasurement of stent circularity. Stent Symmetry Index = (maximum stent diameter - minimum stent diameter) / maximum stent diameter
122347Stent Expansion IndexMeasurement of stent area relative to the reference lumen area. Stent Expansion Index = Minimum stent area / reference vessel lumen cross-sectional area
122348Lumen Shape IndexMeasurement of vessel lumen eccentricity. Lumen Shape Index = (2p * sqrt(Vessel lumen cross-sectional area / p) / Lumen Perimeter) 2 Reference: Tobis & Yock, "Intravascular Ultrasound Imaging", Chapter 7
122350Lumen Diameter RatioLumen diameter ratio = minimum vessel lumen diameter / maximum vessel lumen diameter, measured at the same cross section in the vessel. Lumen diameters are measured through the center point of the lumen, which is defined as the center of gravity of the lumen area
122351Stent Diameter RatioStent diameter ratio = Minimum stent diameter / Maximum stent diameter, measured at the same cross section in the vessel. Stent diameters are measured through the center point of the stent, which is defined as the center of gravity of the stent area
122352EEM Diameter RatioEEM diameter ratio = minimum EEM diameter / maximum EEM diameter. Measured at the same cross section in the vessel
122354Plaque BurdenFractional area within the External Elastic Membrane (EEM) occupied by atheroma. Plaque Burden = (EEM area - vessel lumen cross-sectional area) / EEM area
122355Arc of CalciumAngular measurement of a Calcium deposit with the apex located at the center of the lumen, which is defined as the center of gravity of the lumen area
122356Soft plaquePlaque characterized by low density or echogenicity
122357In-Stent NeointimaAbnormal thickening of the intima within the stented segment
122360True LumenLumen surrounded by all three layers of the vessel-intima, media, and adventitia
122361False LumenA channel, usually parallel to the true lumen, which does not communicate with the true lumen over a portion of its length
122363Plaque RupturePlaque ulceration with a tear detected in a fibrous cap
122364Stent GapLength of gap between two consecutive stents
122367T-1 WorstWorst stenosis - the stenosis with the smallest lumen size within a vessel segment
122368T-2 Secondary2nd most severe stenosis within a vessel segment
122369T-3 Secondary3rd most severe stenosis within a vessel segment
122370T-4 Secondary4th most severe stenosis within a vessel segment
122371EEM VolumeExternal Elastic Membrane (EEM) volume measured within a specified region. The EEM is a discrete interface at the border between the media and the Adventitia
122372Lumen VolumeLumen volume measured within a specified region
122374In-Stent Neointimal VolumeThe amount of plaque between the lumen and stent, within the stent region; In-stent restenosis. In-Stent Neointimal Volume = Stent Volume - Lumen Volume
122375Native Plaque VolumeThe amount of plaque between the stent and the EEM, within the stent region. Native Plaque Volume = EEM Volume - Stent Volume
122376Total Plaque VolumeTotal amount of plaque between the EEM and the Lumen, over the entire region that is measured. Total Plaque Volume = EEM Volume - Lumen Volume
122380Proximal ReferenceProximal reference segment measurement site. Typically the site with the largest lumen proximal to a stenosis but within the same segment (usually within 10 mm of the stenosis with no major intervening branches)
122381Distal ReferenceDistal reference segment measurement site. Typically the site with the largest lumen distal to a stenosis but within the same segment (usually within 10 mm of the stenosis with no major intervening branches)
122382Site of Lumen MinimumSite of the smallest lumen in a vessel; e.g. due to a stenotic lesion
122383Entire PullbackMeasurement region that encompasses the entire vessel imaged in a single pullback acquisition
122384Stented RegionMeasurement region occupied by the stent
122385Proximal Stent MarginRegion starting at the proximal edge of the Stent and extending several millimeters (usually 5 mm) proximal to the Stent edge
122386Distal Stent MarginRegion starting at the distal edge of the Stent and extending several millimeters (usually 5 mm) distal to the Stent edge
122387Dissection ClassificationClassification of dissections in a vessel
122388Intra-stent DissectionSeparation of neointimal hyperplasia from stent struts, usually seen only after treatment of in-stent restenosis
122389Vulnerable PlaquePlaque with a thin cap fibrous atheroma that is at increased risk of rupture and thrombosis (or re-thrombosis) and rapid stenosis progression
122390Eroded PlaquePlaque erosions with no structural defect (beyond endothelial injury) or gap in the plaque
122391Relative Stenosis SeverityStenosis severity classifications of multiple lesions in a vessel
122393Restenotic LesionA finding of a previously treated lesion in which stenosis has reoccurred
122394Fibro-Lipidic PlaqueLoosely packed bundles of collagen fibers with regions of lipid deposition present. Region is cellular and no cholesterol clefts or necrosis are present. Some macrophage infiltration. Increase in extra cellular matrix
122395Necrotic-Lipidic PlaqueArea within the plaque with very low echogenicity separated from the lumen and surrounded by more echogenic structures (fibrous cap). Highly lipidic necrotic region with remnants of foam cells and dead lymphocytes present. No collagen fibers are visible and mechanical integrity is poor. Cholesterol clefts and micro calcifications are visible
122398Intimal DissectionDissection limited to the intima or atheroma, and not extending to the media
122399Medial DissectionDissection in the arterial Media, extending into the media
122400Simultaneously AcquiredThe referenced information was acquired simultaneously with the information in the object in which the reference occurs
122401Same AnatomyInformation acquired for the same anatomic region
122402Same IndicationInformation acquired for the same indication; e.g. to elucidate the same diagnostic question
122403For Attenuation CorrectionThe referenced information was used to correct the data for differential attenuation through different anatomic tissue
122404ReconstructedValue estimated for a vessel in the absence of a stenosis
122405Algorithm ManufacturerManufacturer of application used
122406Left Atrial Ejection Fraction by AngiographyLeft Atrial Ejection Fraction by Angiography
122407Left Atrial ED VolumeLeft Atrial End Diastolic Volume
122408Left Atrial ES VolumeLeft Atrial End Systolic Volume
122410Contour RealignmentContour repositioning of End Diastolic relative to End Systolic contour
122411Threshold ValueThe minimum standard deviation to define the hypokinesis and hyperkinesis
122417Regional Abnormal Wall MotionReport of differentiation of wall motion compared to normal
122421Calibration ObjectObject used for Calibration
122422Calibration MethodMethod used for Calibration
122423Calibration Object SizeSize of calibration object
122428Area Length MethodMethod how long axis is positioned
122429Volume MethodModel for cardiac chamber volume calculation
122430Reference MethodMethod to define original diameter of the artery
122431Regression Slope EDRelation between calculated End Diastolic volume and ventricular End Diastolic volume. The specific meaning is dependent on volume method used
122432Regression Offset EDCorrection factor for the calculated End Diastolic volume and ventricular End Diastolic volume. The specific meaning is dependent on volume method used
122433Regression Slope ESRelation between calculated End Systolic volume and ventricular End Systolic volume. The specific meaning is dependent on volume method used
122434Regression Offset ESCorrection factor for the calculated End Systolic volume and ventricular End Systolic volume. The specific meaning is dependent on volume method used
122435Regression Volume ExponentExponent of volume in regression formula
122438Reference PointsContainer for spatial locations or coordinates used for calculation
122445Wall ThicknessAverage thickness of the chamber wall in the current view
122446Wall VolumeVolume of the chamber wall estimated from the current view
122447Wall MassMass of the chamber wall (myocardium)
122448Wall StressPeak systolic stress of chamber wall
122449Centerline Wall Motion AnalysisMethod to calculate wall motion [example: Sheehan, 1986]
122450Normalized Chord LengthThe length between End Diastolic and End Systolic contour perpendicular on the centerline normalized by a method dependent ventricular perimeter length. The centerline is the line equidistant between the End Diastolic and End Systolic contour [example: Sheehan, 1986]
122451Abnormal RegionThe report of the boundaries of the abnormal (hyperkinetic, hypokinetic, a-kinetic) regions associated with the territory of the artery [example: Sheehan, 1986]
122452First Chord of Abnormal RegionThe chord number specifying the begin of abnormal region [example: Sheehan, 1986]
122453Last Chord of Abnormal RegionThe chord number specifying the end of abnormal region [example: Sheehan, 1986]
122459Territory Region SeveritySeverity at the regional abnormality extent [example: Sheehan, 1986]
122461Opposite Region SeveritySeverity at the opposite regional abnormality extent [example: Sheehan, 1986]
122464LAD Region in RAO ProjectionBased on a total number of chords of 100 and RAO project the range of chords belonging to this circumferential extent lies between 5 - 85. [Sheehan, 1986]
122465RCA Region in ROA ProjectionBased on a total number of chords of 100 and RAO project the range of chords belonging to this circumferential extent lies between 25 - 85. [Sheehan, 1986]
122466Single LAD Region in RAO ProjectionBased on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 10 - 66 (hypokinetic) and 67 - 80 (hyperkinetic). [Sheehan, 1986]
122467Single RCA Region in RAO ProjectionBased on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 51 - 80 (hypokinetic) and 10 - 50 (hyperkinetic). [Sheehan, 1986]
122468Multiple LAD Region in RAO ProjectionBased on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 10 - 58 (hypokinetic) and 59 -80 (hyperkinetic). [Sheehan, 1986]
122469Multiple RCA Region in RAO ProjectionBased on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 59 - 80 (hypokinetic) and 10 - 58 (hyperkinetic). [Sheehan, 1986]
122470LAD Region in LAO ProjectionBased on a total number of chords of 100 and LAO projection the range of chords belonging to this regional extent lies between 50 -100 (hypokinetic) and 20 - 49 (hyperkinetic). [Sheehan, 1986]
122471RCA Region in LAO ProjectionBased on a total number of chords of 100 and LAO projection the range of chords belonging to this regional extent lies between 19 - 67 (hypokinetic) and 68 - 100 (hyperkinetic). [Sheehan, 1986]
122472CFX Region in LAO ProjectionBased on a total number of chords of 100 and LAO projection the range of chords belonging to this regional extent lies between 38 -74 (hypokinetic) and 75 - 100 (hyperkinetic). [Sheehan, 1986]
122473Circular MethodMethod based on assumption that the image object is circular
122474Densitometric MethodMethod based on the gray value distribution of the image
122475Center of GravityEnd Systolic contour realigned to End Diastolic contour based on the center of gravity
122476Long Axis BasedEnd Systolic contour realigned to End Diastolic contour based on the mid point of the long axis. The long axis end-points are defined as the posterior and apex
122477No RealignmentNo Contour Realignment applied
122480Vessel Lumen Cross-Sectional AreaCalculated Vessel Lumen Cross-Sectional Area based on the referenced method
122481Contour StartLocation of the beginning of a contour
122482Contour EndLocation of the end of a contour
122485SphereSphere is used as calibration object
122486Geometric IsocenterObject of interest in isocenter of image and pixel separation is calculated from geometric data
122487Geometric Non-IsocenterObject of interest not in isocenter of image and pixel separation is calculated from geometric data and out of isocenter distances
122488Calibration Object UsedObject used for calibration; e.g. sphere
122489Curve Fitted ReferenceApplication dependent method to calculate the reference diameter based on the multiple diameter values
122490Interpolated Local ReferenceApplication dependent method to calculate reference by interpolation, based on the diameter of two or more user defined reference positions
122491Mean Local ReferenceApplication dependent method to calculate by averaging the reference, based on the diameter of one or more user defined reference positions
122493Radial Based Wall Motion AnalysisMethod to calculate wall motion based on the lengths of the radials in the predefined regions [Ingels]
122495Regional Contribution to Ejection FractionContribution of Region to global Ejection factor based on radial or landmark based wall motion method
122496Radial ShorteningThe reduction of area between End Systolic and End Diastolic based on radial wall motion analysis
122497Landmark Based Wall Motion AnalysisMethod to calculate wall motion based on the move of landmarks on the wall [Slager]
122498Slice Contribution to Ejection FractionContribution to the ejection fraction of a specific slice region [Slager]
122499Frame to Frame AnalysisMethod to calculate volumes of heart chambers for every image in a range
122501Area of closed irregular polygonThe area is derived by considering a set of coordinates as a closed irregular polygon, accounting for inner angles. The exact method, such as by decomposition into triangles or quadrilaterals, is not specified, since it does not affect the numeric result, apart from the effect of numeric precision during computation of intermediate results
122502Area of a closed NURBSThe area is derived by using a set of coordinates as control points for a Non Uniform Rational B-Spline (NURBS)
122503Integration of sum of closed areas on contiguous slicesThe volume derived by integrating the sum of the areas on adjacent slices across the slice interval; each area is defined by a regular planar shape or by considering a set of coordinates as a closed irregular polygon, accounting for inner angles
122505CalibrationProcedure used to calibrate measurements or measurement devices
122507Left ContourLeft contour of lumen (direction proximal to distal)
122508Right ContourRight contour of lumen (direction proximal to distal)
122509Diameter GraphOrdered set of diameters values derived from contours (direction proximal to distal)
122510Length Luminal SegmentLength Luminal Segment
122511Graph IncrementIncrement value along X-axis in Diameter Graph
122516Site of Maximum LuminalLocation of the maximum lumen area in a lesion or vessel
122517Densitometric Luminal Cross-sectional Area GraphOrdered set of cross-sectional Vessel Lumen Cross-Sectional Area values derived from contours (direction proximal to distal) based on densitometric method
122528Position of Proximal BorderPosition of proximal border of segment relative to the contour start (proximal end of analysis area)
122529Position of Distal BorderPosition of distal border of segment relative to the contour start (proximal end of analysis area)
122542Plaque AreaLongitudinal cross sectional area of plaque
122544Diameter SymmetrySymmetry of stenosis (0 = complete asymmetry, 1 = complete symmetry); see Section T.2 "Definition of Diameter Symmetry with Arterial Plaques" in PS3.17
122545Area SymmetrySymmetry of plaque (0 = complete asymmetry, 1 = complete symmetry); see Section T.2 "Definition of Diameter Symmetry with Arterial Plaques" in PS3.17
122546Inflow AngleThe average slope of the diameter function between the position of the minimum luminal diameter and the position of the proximal border of the segment
122547Outflow AngleThe average slope of the diameter function between the position of the minimum luminal diameter and the position of the distal border of the segment
122548Stenotic Flow ReserveThe relation between coronary pressure and coronary flow
122549Poiseuille ResistancePoiseuille Resistance at the location of the stenosis
122550Turbulence ResistanceTurbulence Resistance at the location of the stenosis
122551Pressure Drop at SFRPressure drop over the stenosis at maximum heart output
122554Segmentation MethodMethod for selection of vessel sub-segments
122555Estimated Normal FlowEstimate of the volume of blood flow in the absence of stenosis
122558Area Length KennedyArea Length method defined by Kennedy [Kennedy, 1970]
122559Area Length DodgeArea Length method defined by Dodge [Dodge, 1960]
122560Area Length WynneArea Length method defined by Wynne [Wynne]
122562Multiple SlicesVolume method based on multiple slice
122563BoakVolume method defined by Boak [Boak]
122564TS PyramidVolume method defined by Ferlinz [Ferlinz]
122565Two ChamberVolume method defined by Graham [Graham]
122566ParallelepipedVolume method defined by Arcilla [Arcilla]
122572BSA^1.219Corrected Body Surface area for indexing the hemodynamic measurements for a pediatric patient
122574Equidistant methodMethod for selecting sub-segments that are all of the same length
122575User selected methodManually selected start and end of sub-segment
122582Left ventricular posterobasal segmentLeft ventricular posterobasal segment
122600Cardiovascular Analysis ReportReport of a Cardiovascular Analysis, typically from a CT or MR study
122601Ventricular AnalysisVentricular Analysis
122602Myocardial Perfusion AnalysisMyocardial Perfusion Analysis
122603Calcium Scoring AnalysisCalcium Scoring Analysis
122604Flow QuantificationFlow Quantification Analysis
122605Vascular Morphological AnalysisVascular Morphological Analysis
122606Vascular Functional AnalysisVascular Functional Analysis
122607Thickening AnalysisAnalysis of myocardial wall thickening
122608Absolute Values Of Ventricular MeasurementsSection Heading for absolute values of ventricular measurements
122609Normalized Values Of Ventricular MeasurementsResults of normalizing ventricular measurements
122611Reference PointReference Point of a measurement
122612Central breathing positionCentral breathing position between inspiration and expiration
122616Peak Ejection RatePeak of the ventricular ejection rate
122617Peak Ejection TimeTime of the peak of ventricular ejection
122618Peak Filling RatePeak of the fluid filling rate
122619Peak Filling TimeTime interval until time of peak filling from a given reference point; e.g. end systole
122620Papillary Muscle ExcludedPapillary muscle was excluded from the measurement
122621Papillary Muscle IncludedPapillary muscle was included in the measurement
122624Wall Thickness Ratio end-systolic to end-diastolicThe ratio of the end-systolic wall thickness compared to the end-diastolic wall thickness
122627Curve Fit MethodThe method to smooth a ventricular volume as a function of time
122628Baseline Result CorrectionBaseline correction used in the calculation of the results
122631Signal Earliest Peak TimeThe time in a dynamic set of images at which the first peak of the signal is observed for the analyzed myocardial wall segments
122633Signal Increase Start TimeThis is the time at which the signal begins to increase
122634Signal Time to PeakTime interval between the beginning of the signal increase to the time at which the signal intensity reaches its first maximum in a dynamic set of images
122635MR Perfusion PeakPeak of the MR perfusion signal
122636MR Perfusion SlopeSignal intensity as a function of time. It is the change in the signal intensity divided by the change in the time
122637MR Perfusion Time IntegralMR perfusion time integral from baseline (foot time) to earliest peak
122638Signal Baseline StartFirst time point in a dynamic set of images used in the calculation of the baseline signal intensity for each myocardial wall segment
122639Signal Baseline EndLast time point in a dynamic set of images used in the calculation of the baseline signal intensity for each myocardial wall segment
122640Image IntervalThe time delta between images in a dynamic set of images
122642Velocity Encoding Minimum ValueThe minimum velocity encoded by the phase encoding gradient
122643Velocity Encoding Maximum ValueThe maximum velocity encoded by the phase encoding gradient
122645Net Forward VolumeForward volume-reverse volume
122650Area Based MethodArea Based Method for estimating volume or area
122651Diameter Based MethodDiameter Based Method for estimating volume, area or diameter
122652Volume Based MethodVolume Based Method for estimating volume
122655NASCETA method of diameter measurements according to NASCET (North American Symptomatic Carotid Endarterectomy Trial)
122656ECSTA method of diameter measurements according to ECST (European Carotid Surgery Trial)
122657Agatston Score ThresholdAgatston Score Threshold
122658Calcium Mass ThresholdCalcium Mass Threshold
122659Calcium Scoring CalibrationCalcium Scoring Calibration
122660Calcium VolumeCalcium Volume
122661Calcium MassCalcium Mass
122664Late Contrast EnhancementDelayed hyperenhancement of a tissue observed in an image acquired after injection of contrast media
122665Time interval since injection of contrast mediaTime interval since injection of contrast media
122666Time relative to R-wave peakTime relative to R-wave peak
122667Blood velocity vs. time of cardiac cycleRelationship between blood velocity and time relative to R-wave peak
122668Time interval since detection of contrast bolusTime interval since detection of contrast bolus
122670Papillary Muscle Included/ExcludedIndicates if the papillary muscle was included or excluded in the measurement
122675Anterior-PosteriorAnterior to Posterior direction
122680endoleakPersistent flow of blood into the stent-grafting
122683Stent FractureFracture of a stent
122684Stent DisintegrationDisintegration of a stent
122685Stent CompositionMaterial that a stent consists of
122686Parent Vessel FindingFinding about the characteristics of the parent vessel of a vessel
122687Site of Lumen MaximumSite of Maximal lumen diameter of a vessel
122698X-ConceptThe physical domain (time, space, etc.) to the horizontal axis of the graphical presentation
122699Y-ConceptThe physical domain (time, space, etc.) to the vertical axis of the graphical presentation
122700Indications for Pharmacological StressIndications for Pharmacological Stress
122701Procedure time baseReference time for measurement of elapsed time in a procedure
122702Treadmill speedTreadmill speed
122703Treadmill gradientTreadmill gradient
122704Ergometer powerErgometer power
122705Pharmacological Stress Agent Dose RatePharmacological Stress Agent Dose Rate
122706Rating of Perceived ExertionRating of Perceived Exertion
122707Number of Ectopic BeatsNumber of ectopic beats during a period of collection
122708Double ProductHeart rate times systolic blood pressure
122709Activity workloadPhysical activity workload (intensity) measurement
122710Time since start of stageElapsed time at stage
122711Exercise duration after stress agent injectionExercise duration after stress agent injection
122712Imaging Start TimeImaging Start Time
122713Attenuation correction methodAttenuation correction method
122715Pharmacological Stress Agent DosePharmacological Stress Agent Dose
122716Maximum Power Output AchievedMaximum power output achieved during course of procedure
122717Peak activity workloadPeak physical activity intensity measurement during course of procedure
122718Peak Double ProductPeak Double Product measurement during course of procedure
122720OSEM algorithmOrdered subsets expectation maximization reconstruction algorithm
122721Chang methodChang attenuation correction method
122726Algorithmic attenuation correctionAttenuation correction not based on image-based attenuation maps
122727NM transmission attenuation correctionNM transmission attenuation correction
122728CT-based attenuation correctionCT-based attenuation correction
122729No Attenuation CorrectionNo attenuation correction
122730Bazett QTc AlgorithmBazett QT Correction Algorithm; QT/(RR ^ 0.5); Bazett HC. "An analysis of the time-relations of electrocardiograms" Heart7:353-370 (1920)
122731Hodges QTc AlgorithmHodges QT Correction Algorithm; QT + 1.75 (heart rate-60); Hodges M, Salerno Q, Erlien D. "Bazett's QT correction reviewed. Evidence that a linear QT correction for heart rate is better." J Am Coll Cardiol1:694 (1983)
122732Fridericia QTc AlgorithmFridericia QT Correction Algorithm; QT/(RR ^ 0.333); Fridericia LS. "The duration of systole in the electrocardiogram of normal subjects and of patients with heart disease" Acta Med Scand53:469-486 (1920)
122733Framingham QTc AlgorithmFramingham QT Correction Algorithm; QT + 0.154 (1- RR); Sagie A, Larson MG, Goldberg RJ, et al. "An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)." Am J Cardiol70:797-801(1992)
122734Borg RPE ScaleBorg Rating of Perceived Exertion Scale, range 6:20
122735Borg CR10 ScaleBorg category ratio scale, open ended range with nominal range 0:10
122739Overall study qualityOverall study quality
122740Excellent image qualityExcellent image quality
122741Good image qualityGood image quality
122742Poor image qualityPoor image quality
122743Body habitus attenuationImage attenuation due to body physique (overweight)
122744Breast attenuationImage attenuation due to breast tissue
122745Diaphragmatic attenuationImage attenuation due to diaphragm
122748False positive defect findingFinding of a defect is incorrect; e.g. from automated analysis
122750Non-diagnostic - low heart rateECG is non-diagnostic due to low heart rate
122751Non-diagnostic - resting ST abnormalitiesECG is non-diagnostic due to resting ST abnormalities
122752Non-diagnostic - ventricular pacing or LBBBECG is non-diagnostic due to ventricular pacing or Left Bundle Branch Block
122753Non-diagnostic ECGECG is non-diagnostic for presence of acute coronary syndrome
122755Strongly positiveStrongly positive finding
122756Strongly positive - ST elevationStrongly positive finding - ST elevation
122757ST Depression - HorizontalFinding of ST segment depression with no slope
122758ST Depression - UpslopingFinding of ST segment depression with upslope
122759ST Depression - DownslopingFinding of ST segment depression with downslope
122760Stress test scoreStress test score
122762Number of diseased vessel territoriesNumber of diseased vessel territories
122764Weight exceeds equipment limitPatient weight exceeds equipment limit
122768Difference in Ejection FractionDifference in Ejection Fraction
122769Difference in ED LV VolumeDifference in End Diastolic Left Ventricular Volume
122770Ratio of achieved to predicted maximal oxygen consumptionRatio of achieved to predicted maximal oxygen consumption
122771Ratio of achieved to predicted functional capacityRatio of achieved to predicted functional capacity
122772Aerobic indexWorkload (Watts) at target heart rate divided by body weight
122773ST/HR IndexST depression at peak exercise divided by the exercise-induced increase in heart rate [Kligfield P, Ameisen O, Okin PM. "Heart rate adjustment of ST segment depression for improved detection of coronary artery disease." Circulation 1989;79:245-55.]
122775Agreement with prior findingsAgreement with prior findings
122776Disagreement with prior findingsDisagreement with prior findings
122781Rest thallium/stress technetium procedureNuclear Medicine Rest thallium/stress technetium procedure
122782Rest technetium/stress technetium 1 day procedureNuclear Medicine Rest technetium/stress technetium 1 day procedure
122783Rest technetium/stress technetium 2 day procedureNuclear Medicine Rest technetium/stress technetium 2 day procedure
122784Stress technetium/rest technetium 1 day procedureNuclear Medicine Stress technetium/rest technetium 1 day procedure
122785NM Myocardial Viability procedureNuclear Medicine Myocardial Viability procedure
122791PET Myocardial Perfusion, Rest onlyPositron Emission Tomography Perfusion Imaging procedure, rest only
122792PET Myocardial Perfusion, Stress onlyPositron Emission Tomography Perfusion Imaging procedure, stress only
122793PET Myocardial Perfusion, Rest and StressPositron Emission Tomography Perfusion Imaging procedure, rest and stress
122795PET Myocardial Viability, Rest onlyPositron Emission Tomography Myocardial Viability procedure, rest only
122796PET Myocardial Viability, Stress onlyPositron Emission Tomography Myocardial Viability procedure, stress only
122797PET Myocardial Viability, Rest and StressPositron Emission Tomography Myocardial Viability procedure, rest and stress
122799Anginal EquivalentGroup of symptoms heralding angina pectoris that does not include chest pain (dyspnea, diaphoresis, profuse vomiting in a diabetic patient, or arm or jaw pain)
123001RadiopharmaceuticalActive ingredient (molecular) used for radioactive tracing
123003Radiopharmaceutical Start TimeTime of radiopharmaceutical administration to the patient for imaging purposes
123004Radiopharmaceutical Stop TimeEnding time of radiopharmaceutical administration to the patient for imaging purposes
123005Radiopharmaceutical VolumeVolume of radiopharmaceutical administered to the patient
123006Radionuclide Total DoseTotal amount of radionuclide administered to the patient at Radiopharmaceutical Start Time
123007Radiopharmaceutical Specific ActivityActivity per unit mass of the radiopharmaceutical at Radiopharmaceutical Start Time
123009Radionuclide Syringe CountsPre-injection syringe acquisition count rate
123010Radionuclide Residual Syringe CountsSyringe acquisition count rate following patient injection
123011Contrast/Bolus AgentContrast or bolus agent
123012Pre-MedicationMedication to be administered at the beginning of the Scheduled Procedure Step
123014Target RegionAnatomic Region to be imaged
123015Imaging DirectionDirection of imaging (includes view, transducer orientation, patient orientation, and/or projection)
123016Imaging ConditionsImaging condition for refinement of protocol (includes secondary posture, instruction, X-Ray / electron beam energy or nuclide, and ultrasound modes), as used in JJ1017 v3.0
123019Caudal 10 degree distal-cranioproximal obliqueCaudal 10 degree distal-cranioproximal oblique radiographic projection, defined per Smallwood et al
123101Neighborhood AnalysisSurface processing utilizing predefined weighting factors (i.e., kernels) applied to different data values depending on their location relative to other data values within the data domain. Includes Low Pass, High Pass, Gaussian, Laplacian, etc.
123102Adaptive FilteringSurface processing applied non-uniformly utilizing a priori knowledge of the system and/or relative locations of the data values within the data domain. Example: Neighborhood analysis where weighting factors are modified continuously based on predefined criteria
123103Edge DetectionSurface processing through the exploitation of discontinuities in the data values within their domain. Includes Gradient filters
123104Morphological OperationsSurface processing based on the connectivity of values based on the shape or structure of the data values within their domain. Includes erode, dilate, etc.
123105Histogram AnalysisSurface processing applied to the distribution of the data values. Includes thresholding, Bayesian Classification, etc.
123106Multi-Scale/Resolution FilteringSurface processing accomplished through varying the data domain size. Include deformable models
123107Cluster AnalysisSurface processing accomplished by combining data values based on their relative location within their domain or value distribution. Includes K- and C-means, Fuzzy Analysis, Watershed, Seed Growing, etc.
123108Multispectral ProcessingSurface processing accomplished through the weighted combination of multiple data sets. Includes Principle Component Analysis, linear and non-linear weighed combinations, etc.
123109Manual ProcessingSurface processing accomplished through human interaction. Region drawing
123110Artificial IntelligenceSurface processing using Artificial Intelligence techniques, such as Machine Learning, Neural Networks, etc.
123111Deformable ModelsSurface processing using Deformable Model techniques, such as Point Distribution Models, Level Sets, Simplex Meshes, etc.
125000OB-GYN Ultrasound Procedure ReportDocument Title of OB-GYN procedure report
125001Fetal Biometry RatiosReport section for assessment of fetal growth using ratios and indexes
125002Fetal BiometryReport section for assessment of fetal growth
125003Fetal Long BonesReport section for assessment of fetal growth by long bone measurements
125004Fetal CraniumReport section for assessment of fetal cranium growth
125005Biometry GroupBiometric assessment of
125006Biophysical ProfileReport section for assessment of biophysical observations that evaluate fetal well-being according to Manning, Antepartum Fetal Evaluation: Development of a Fetal Biophysical Profile Score, Am. J Obstet Gynecol, 1980;136:787
125007Measurement GroupA grouping of related measurements and calculations that share a common context
125008Fetus SummaryReport section for fetus specific procedure summary observations
125009Early GestationReport section for assessment of early gestation fetus
125010IdentifierA name to differentiate between multiple instances of some item
125011Pelvis and UterusReport section for assessment of pelvis and uterus
125012Growth Percentile rankThe rank of a measured growth indicator relative to a normal distribution expressed as a percentage
125013Growth Z-scoreThe rank of a measured growth indicator relative to a normal distribution expressed as the dimensionless quantity z = (x-m) /s where (x-m) is the deviation of the value x, from the distribution mean, m, and s is the standard deviation of the distribution
125015Fetus CharacteristicsFetus characteristics (findings section title)
125016Fetal MeasurementsFetal Measurements (findings section title)
125021Frame of Reference IdentityThere is a defined equivalence between the Frame of Reference of the Registration SOP instance and the Frame of Reference of the referenced images
125022Fiducial AlignmentThe registration is based on fiducials that represent patient or specimen features identified in each data set
125023Acquisition Equipment AlignmentRegistration based on a-priori knowledge of the acquisition geometry. This is not an object registration as in fiducial registration. Rather, it specifies a known spatial relationship
125024Image Content-based AlignmentComputed registration based on global image information
125025Visual AlignmentRegistration by visually guided manipulation
125030Inter-Hemispheric PlaneA plane fiducial that specifies the location of the plane separating the two hemispheres of the brain
125031Right Hemisphere Most AnteriorA point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the anterior limit of the right brain hemisphere
125032Right Hemisphere Most PosteriorA point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the posterior limit of the right brain hemisphere
125033Right Hemisphere Most SuperiorA point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the superior limit of the right brain hemisphere
125034Right Hemisphere Most InferiorA point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the inferior limit of the Right brain hemisphere
125035Left Hemisphere Most AnteriorA point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the anterior limit of the left brain hemisphere
125036Left Hemisphere Most PosteriorA point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the posterior limit of the left brain hemisphere
125037Left Hemisphere Most SuperiorA point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the superior limit of the left brain hemisphere
125038Left Hemisphere Most InferiorA point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the inferior limit of the left brain hemisphere
125040BackgroundThat which is not part of an object
125041Registration InputA segment for use as an input to an image registration process; e.g. to specify the bounding region for determining a Frame of Reference Transformation Matrix
125100Vascular Ultrasound Procedure ReportRoot Document Title for ultrasound vascular evidence reports (worksheets)
125101Vessel BranchThe particular vessel branch, such as the inferior, medial or lateral
125102Graft TypeA descriptor or elaboration of the type of graft
125105Measurement OrientationA modifier to a 2D distance measurement to describe its orientation; e.g. a vascular distance measurement for a vessel plague could have a modifier Transverse or Longitudinal
125106Doppler AngleThe angle formed between the Doppler beam line and the direction of blood flow within a region of interest in the body defined by the sample volume
125107Sample Volume DepthThe depth of the center of the Doppler sample volume measured from skin line along the Doppler line
125195Pediatric Cardiac Ultrasound ReportPediatric Cardiac Ultrasound Report (document title)
125196Fetal Cardiac Ultrasound ReportFetal Cardiac Ultrasound Report (document title)
125197Adult Congenital Cardiac Ultrasound ReportAdult Congenital Cardiac Ultrasound Report (document title)
125200Adult Echocardiography Procedure ReportDocument title of adult echocardiography procedure (evidence) report
125201Illustration of FindingAn image that is a pictorial representation of findings. The concept is typically used as a purpose of reference to an image, such as a depiction of myocardium segments depicting wall motion function
125202LV Wall Motion Score IndexThe average of all scored (non-zero) Left Ventricle segment wall motion scores
125203Acquisition ProtocolA type of clinical acquisition protocol for creating images or image-derived measurements. Acquisition protocols may be specific to a manufacturer's product
125204Area-length biplaneMethod for calculating left ventricular volume from two orthogonal views containing the true long axis (usually the apical 4 and 2 chamber views). Volume = [pL1 / 6] * [(4A1) ÷ (pL1) ] * [(4A2) ÷ (pL2) ]
125205Area-Length Single PlaneMethod for calculating left ventricular volume from a view containing the true long axis (usually the apical 4-chamber view). Volume = [8(A)2]÷[3pL]
125206CubeMethod (formula) for calculating left ventricle volumes and function derivatives (EF, SV, SI, etc.) that estimates the volume as the cube of diameter
125207Method of Disks, BiplaneMethod of calculating volume based on the summation of disk volumes. The disk axis is parallel to the left ventricular long axis and using a disk diameter averaged from the two chamber and four chamber views
125208Method of Disks, Single PlaneMethod of calculating volume based on the summation of disk volumes. The disk axis is parallel to the left ventricular long axis with disk diameter taken from the four-chamber view
125209TeichholzMethod (formula) for calculating left ventricle volumes and function derivatives (EF, SV, SI, etc.) Volume = [7.0/(2.4+D) ]*D3
125210Area by Pressure Half-TimeMitral valve area (cm2) by Pressure Half-time = 220 (cm2.ms) / PHT (ms)
125211Biplane EllipseArea = P/4 X d1 X d2 d1 = anterior/posterior axis d2 = medial/lateral axis Hagen-Ansert, Sandra L., Textbook of Diagnostic Ultrasound, ed. 3, The C.V.Mosby Co., 1989, p. 73.
125212Continuity EquationFor conduits in series ("in continuity"), volume flow is equal: A1*V1 = A2*V2. where V is the velocity
125213Continuity Equation by Mean VelocityFor conduits in series ("in continuity"), volume flow is equal: A1*V1 = A2*V2. where V is the mean velocity
125214Continuity Equation by Peak VelocityFor conduits in series ("in continuity"), volume flow is equal: A1*V1 = A2*V2. where V is the peak velocity
125215Continuity Equation by Velocity Time IntegralFor conduits in series ("in continuity"), volume flow is equal: A1*V1 = A2*V2. where V is the velocity time integral
125216Proximal Isovelocity Surface AreaUtilizes aliasing velocity (by color Doppler) of flow into an orifice (often regurgitant or stenotic) to measure instantaneous flow rate, orifice area, and flow volume. The instantaneous flow rate = (2πr2vav ) * (α / π) where vav is the constant velocity known as aliasing velocity at radius r, vp is the peak velocity at the orifice, and α is the angle in radians of the constant velocity surface. Estimated Orifice area = Flow rate / vp , where vp is the peak velocity at the orifice and the flow rate is the PISA peak flow rate. The volume flow is then the product of the orifice area and Velocity Time Integral
125217Full BernoulliΔP = 4*(V12 - V22)
125218Simplified BernoulliΔP = 4*V2
125219Doppler Volume FlowVolume flow = Conduit CSA * (Velocity Time Integral)
125220PlanimetryDirect measurement of an area by tracing an irregular perimeter
125221Left Ventricle Mass by M-modeMass = 1.04 * [(ST+LVID+PWT)3 - LVID3] * 0.8+ 0.6. Mass unit is grams and length in cm
125222Left Ventricle Mass by Truncated EllipseMass = 1.05P ((b + t)2 X (2/3 (a + t) + d - d3 /3(a + t)2) - b2 (2/3a + d - d3 /3a2)) a = Semi-major axis from widest minor axis radius to apex. b = Short axis radius calculated from short axis cavity area t = Myocardial thickness calculated from short axis epicardial and cavity areas d = Truncated semi-major axis from widest short axis diameter to plane of mitral annulus. Mass unit is grams and length in cm. Schiller NB et al: Recommendations for quantification of the left ventricle by two-dimensional echocardiography, American Society of Echocardiography 2:364, 1989.
1252234 Point Segment Finding ScaleA four point, echocardiographic numeric scoring scheme of myocardium segments based on evaluation of wall motion and ventricle morphology. Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography, Journal of the American Society of Echocardiography, 2:358-367, 1989
1252245 Point Segment Finding ScaleA five point, echocardiographic numeric scoring scheme of myocardium segments based on evaluation of wall motion and ventricle morphology. Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography, Journal of the American Society of Echocardiography, 2:358-367, 1989
1252255 Point Segment Finding Scale With Graded HypokinesisA five point, echocardiographic numeric scoring scheme of myocardium segments based on evaluation of wall motion and ventricle morphology, with severity of hypokinesis graded. Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography, Journal of the American Society of Echocardiography, 2:358-367, 1989
125226Single Plane EllipseMethod of estimating volume from a planar ellipse. Equivalent to Biplane Ellipse with an assumption that the ellipse in the orthogonal plane has identical major and minor diameters
125227Modified SimpsonModified Simpson's Method of estimating ventricular volume, based on the method of disks with paired apical views. Schiller NB, et al. "Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms". J Am Soc Echocardiogr.1989 2(5):358-367. Sep-Oct
125228Bullet MethodBullet method of estimating ventricular volume. Volume = 5/6 * L * S L: Left ventricle long axis length S: Left ventricle area, SAX view at level of Mitral Valve
125230Power DopplerColor coded ultrasound images of blood flow, which depict the amplitude, or power, of Doppler signals
1252313D modeVolumetric ultrasound imaging
125233Start of drug dose administrationOnset of administration of dose of a drug
125234Start of contrast agent administrationOnset of contrast agent administration
125235Destruction of microbubblesDestruction of ultrasonic contrast microbubbles by a high-energy ultrasound pulse
125236Onset of exerciseInstant at which exercise begins
125237Cessation of exerciseInstant at which exercise ends
125238Onset of stimulationInstant at which stimulation begins
125239Cessation of stimulationInstant at which stimulation ends
125240Line scan patternUltrasound transducer scan pattern in which information is gathered along a line
125241Plane scan patternUltrasound transducer scan pattern in which information is gathered within a plane
125242Volume scan patternUltrasound transducer scan pattern in which information is gathered within a volume
125251Non-imaging Doppler ultrasound transducer geometryUltrasound transducer geometry characterized by a single scan line used for PW or CW Doppler scanning
125252Linear ultrasound transducer geometryUltrasonic transducer geometry characterized by parallel lines
125253Curved linear ultrasound transducer geometryUltrasonic transducer geometry characterized by radial lines normal to the outside of a curved surface
125254Sector ultrasound transducer geometryUltrasonic transducer geometry characterized by lines originating from a common apex
125255Radial ultrasound transducer geometryUltrasonic transducer geometry characterized by lines emanating radially from a single point
125256Ring ultrasound transducer geometryUltrasonic transducer geometry characterized by a circular ring of transducer elements
125257Fixed beam directionUltrasonic steering technique consisting of a single beam normal to the transducer face steered by the orientation of the probe
125258Mechanical beam steeringUltrasonic steering technique consisting of mechanically directing the beam
125259Phased beam steeringUltrasonic steering technique consisting of electronically-steered beams
125261External TransducerTransducer is designed to be placed onto the surface of the subject
125262Transesophageal TransducerTransducer is designed for insertion into the esophagus
125263Endovaginal TransducerTransducer is designed for insertion into the vagina
125264Endorectal TransducerTransducer is designed for insertion into the rectum
125265Intravascular TransducerTransducer is designed for insertion via a catheter
125270Left Ventricle Mass by Area Lengthmethod to measure the mass of the Left Ventricle via the ASE area-length method at end diastole. LV Mass = 1.05*(5/6*(A1*(L+t)) - 5/6*(A2*L)) A1 = Left Ventricle epicardial SAX area at the level of the papillary muscle tips at end diastole. A2 = Left Ventricle endocardial SAX area cavity area at the level of the papillary muscle tips at end diastole. L = Left Ventricle apical view long axis length at end diastole. t = Myocardial thickness can be computed as: t = sqrt (A1/3.14) - sqrt (A2/3.14) Reference: 1) Schiller, N.B., et al. "Recommendations for Quantification of the LV by Two-dimensional Echocardiography." J Am Soc Echo, Vol. 2, No. 5: 358-367, Sep-Oct 1989. 2) Reichek, N., et al. "Anatomic Validation of Left Ventricular Mass Estimates from Clinical Two-dimensional Echocardiography: Initial Results." Circulation, Vol. 67, No. 2: 348-52, February 1983
125271Left Ventricle Mass by M-mode - adjusted by HeightEquation = Left Ventricle Mass by M-mode (in gram) / (Height (in meter)) ^2.7 Reference: Giovanni De Simone, et al. "Effect of Growth on Variability of Left Ventricular Mass: Assessment of Allometric Signals in Adults and Children and Their Capacity to Predict Cardiovascular Risk". New York, New York and Cincinnati, Ohio
125272Left Ventricle Mass by Truncated Ellipse - adjusted by HeightEquation = Left Ventricle Mass by Truncated Ellipse / Height^2.7 Reference: Giovanni De Simone, et al. "Effect of Growth on Variability of Left Ventricular Mass: Assessment of Allometric Signals in Adults and Children and Their Capacity to Predict Cardiovascular Risk". New York, New York and Cincinnati, Ohio
125273Left Ventricle Mass by Area Length - adjusted by HeightEquation = Left Ventricle Mass by Area Length / Height^2.7 Reference: Giovanni De Simone, et al. "Effect of Growth on Variability of Left Ventricular Mass: Assessment of Allometric Signals in Adults and Children and Their Capacity to Predict Cardiovascular Risk". New York, New York and Cincinnati, Ohio
125901CARDIOsphereCARDIOsphere™ ultrasonic contrast agent produced by POINT Biomedical
125902EchovistEchovist® ultrasonic contrast agent produced by Schering AG
125903ImagifyImagify™ ultrasonic contrast agent produced by Accusphere Inc
125904LevovistLevovist® ultrasonic contrast agent produced by Schering AG
125905SonazoidSonazoid™ ultrasonic contrast agent produced by Daiichi Pharmaceutical / General Electric
125906SonoVueSonoVue™ ultrasonic contrast agent produced by Bracco Diagnostics
125907Targestar-BTargestar™-B ultrasonic contrast agent produced by Targeson LLC
125908Targestar-PTargestar™-P ultrasonic contrast agent produced by Targeson LLC
126000Imaging Measurement ReportA structured report containing the quantitative results of human or machine analysis of images
126001Oncology Measurement ReportA structured report containing the quantitative results of human or machine analysis of images for oncology evaluation
126002Dynamic Contrast MR Measurement ReportA structured report containing the quantitative results of human or machine analysis of DCE-MR
126003PET Measurement ReportA structured report containing the quantitative results of human or machine analysis of PET images
126010Imaging MeasurementsMeasurements made on images
126011Derived Imaging MeasurementsMeasurements derived from measurements made on images
126020Multiparametric MRIAn MRI procedure in which multiple parameters including diffusion, dynamic contrast and T2 are measured
126021Multiparametric MRI of prostateAn MRI procedure of the prostate in which multiple parameters including diffusion, dynamic contrast and T2 are measured
126022Multiparametric MRI of whole bodyAn MRI procedure of the whole body in which multiple parameters including diffusion, dynamic contrast and T2 are measured
126030Sum of segmented voxel volumesThe volume derived by summing the volumes of all the voxels (and partial voxels if the segment contains partially occupied voxels) included in the segment
126031Peak Value Within ROIMaximum average gray value that is calculated from a 1 cubic centimeter sphere placed within the region of interest. Reference Wahl et al PERCIST article
126032Metabolic VolumeThe volume of a lesion (e.g. a tumor) ascertained through information about its metabolic activity (e.g. SUV on PET). Abbreviated "MV". Synonymous with Metabolic Tumor Volume (MTV)
126033Total Lesion GlycolysisThe total activity of a lesion obtained as the product of its volume and its glycolytic activity (on FDG-PET). The volume may be defined on the same modality (e.g. the MV on FDG-PET by some thresholding or other technique) or on another spatially registered modality (e.g. the lesion outline segmented on CT or MR). Does not apply to other radiopharmaceuticals than those involved in glucose metabolism. Abbreviated TLG. Synonymnous with "Tumor Lesion Glycolysis"
126034GlycolysisThe amount glycolytic activity summed across all voxels in a defined region or within a defined range of SUV (on FDG-PET)
126035Total Lesion ProliferationThe total activity of a lesion obtained as the product of its volume and its proliferative activity (on FLT-PET). The volume may be defined on the same modality (e.g. the MV on FDG-PET by some thresholding or other technique) or on another spatially registered modality (e.g. the lesion outline segmented on CT or MR). Does not apply to other radiopharmaceuticals than those involved in cellular proliferation. Abbreviated TLP. Synonymnous with "Tumor Lesion Proliferation"
126036Proliferative ActivityThe amount proliferative activity summed across all voxels in a defined region or within a defined range of SUV (on FLT-PET)
126037Standardized Added Metabolic Activity (SAM)A background-corrected, partial volume independent version of TLG. SAM is calculated by drawing a volume of interest (VOI1) around the tumour and a larger VOI (VOI2) around VOI1. Subtracting the background activity in VOI2-VOI1 from VOI1 yields SAM. See Mertens et al. "Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases". Eur J Nucl Med Mol Imaging (2012) 39:1441-1448
126038Standardized Added Metabolic Activity (SAM) BackgroundThe background value (VOI2-VOI1) used to calculate Standardized Added Metabolic Activity (SAM). SAM is calculated by drawing a volume of interest (VOI1) around the tumour and a larger VOI (VOI2) around VOI1. Subtracting the background activity in VOI2-VOI1 from VOI1 yields SAM. See Mertens et al. "Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases". Eur J Nucl Med Mol Imaging (2012) 39:1441-1448
126039Lesion to Background SUV RatioThe ratio of the SUV within a tumor to the SUV of a pre-defined background region. Need reference(s). A more general concept than Tumor to Background Ratio (TBR)
126040Background for Lesion to Background SUV RatioThe SUV of a pre-defined background region used to compute Lesion to Background SUV Ratio. Need reference(s)
126050Fractal DimensionA statistical index of complexity comparing how detail in a fractal pattern changes with the scale at which it is measured; a ratio of the change in detail to the change in scale
126051SkewnessMeasure of the asymmetry of the probability distribution of a real-valued random variable about its mean
126052KurtosisMeasure of the peakedness of the probability distribution of a real-valued random variable
126060Entropy of GLCMThe zero order entropy of a Gray Level Co-occurrence Matrix (GLCM). A measure of disorder. See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126061Energy of GLCMThe energy (uniformity) (square root of the Angular Second Moment (ASM)) of a Gray Level Co-occurrence Matrix (GLCM). A measure of orderliness. See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126062Homogeneity of GLCMThe Inverse Difference Moment of a Gray Level Co-occurrence Matrix (GLCM). See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126063Contrast of GLCMThe sum of squares variance of a Gray Level Co-occurrence Matrix (GLCM). See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126064Dissimilarity of GLCMThe dissimilarity of a Gray Level Co-occurrence Matrix (GLCM). See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126065ASM of GLCMThe Angular Second Moment of a Gray Level Co-occurrence Matrix (GLCM). See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126066Correlation of GLCMA measure of the linear dependency of grey levels on those of neighbouring pixels of a Gray Level Co-occurrence Matrix (GLCM). See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126067Gray Level Co-occurrence Matrix (GLCM)A tabulation of how often different combinations of pixel values (grey levels) occur in an image. See http://www.fp.ucalgary.ca/mhallbey/the_glcm.htm
126070Subject Time Point IdentifierAn identifier of a specific time point in a continuum, which is unique within an appropriate local context (such as an entire organization, system or treatment protocol), which identifies the time point for a specific patient
126071Protocol Time Point IdentifierAn identifier of a specific time point in a continuum, which is unique within an appropriate local context (such as an entire organization, system or treatment protocol), which identifies the time point "slot" within a treatment protocol using the same value for all patients in the protocol
126072Time Point TypeA pre-defined type of a specific time point in a continuum
126073Time Point OrderA number indicating the order of a time point relative to other time points in the same continuum
126074PosttreatmentThe time after the treatment of interest
126075EligibilityFor the purpose of determining eligibility for a protocol
126080RECIST 1.0Response Evaluation Criteria in Solid Tumors version 1.0. See [RECIST] in Normative References
126081RECIST 1.1Response Evaluation Criteria in Solid Tumors Version 1.1. See Eisenhauer et al. "New Response Evaluation Criteria in Solid Tumours: Revised RECIST Guideline (version 1.1)." European Journal of Cancer 45, no. 2 (n.d.): 228-47. doi:10.1016/j.ejca.2008.10.026.
126100Real World Value Map used for measurementA reference to the Real World Value Map applied to the stored image pixel values before their use for a measurement
126200Image Library GroupA container that groups common information about a set of images used as evidence to produce a report
126201Acquisition DateThe date the acquisition of data started
126202Acquisition TimeThe time the acquisition of data started
126203PET Radionuclide Incubation TimeThe time between the start of injection of the PET radionuclide and the start of acquisition of the PET data
126220R2-CoefficientCoefficient of determination, R2. An indication of goodness of fit
126300Perfusion analysis by Stable Xenon CT techniquePerfusion analysis by Stable Xenon CT technique
126301Perfusion analysis by IV Iodinated Contrast CT techniquePerfusion analysis by IV Iodinated Contrast CT technique
126302Perfusion analysis by Arterial Spin Labeling MR techniquePerfusion analysis by Arterial Spin Labeling (ASL) MR technique
126303Perfusion analysis by Susceptibility MR techniquePerfusion analysis by Susceptibility (T2*) MR technique
126310Least Mean Square (LMS) deconvolutionLeast Mean Square (LMS) deconvolution
126311Singular Value Decomposition (SVD) deconvolutionSingular Value Decomposition (SVD) deconvolution
126312KtransKtrans, the volume transfer constant of a tracer diffusion kinetic model, specifically the volume transfer constant between blood plasma and extravascular extracellular space (EES) See Tofts et al, "Estimating Kinetic Parameters From Dynamic Contrast-Enhanced T1-Weighted MRI of a Diffusable Tracer: Standardized Quantities and Symbols", Journal of Magnetic Resonance Imaging, vol. 10, pp. 223-232, 1999
126313kepkep, the rate constant between extravascular extracellular space (EES) and blood plasma See Tofts et al, "Estimating Kinetic Parameters From Dynamic Contrast-Enhanced T1-Weighted MRI of a Diffusable Tracer: Standardized Quantities and Symbols", Journal of Magnetic Resonance Imaging, vol. 10, pp. 223-232, 1999
126314veve, the fractional (not absolute) volume of extravascular extracellular space (EES) per unit volume of tissue See Tofts et al, "Estimating Kinetic Parameters From Dynamic Contrast-Enhanced T1-Weighted MRI of a Diffusable Tracer: Standardized Quantities and Symbols", Journal of Magnetic Resonance Imaging, vol. 10, pp. 223-232, 1999
126320IAUCThe intial area under the contrast agent concentration-time curve
126321IAUC60The intial area under the contrast agent concentration-time curve at 60 seconds after the onset time
126322IAUC90The intial area under the contrast agent concentration-time curve at 90 seconds after the onset time
126330tau_mτm. The mean intracellular water lifetime (τi). Used in the Shutter-Speed Model (SSM) of tracer kinetics
126331vpvp. The fractional (not absolute) blood plasma volume per unit volume of tissue. See Tofts et al, "Estimating Kinetic Parameters From Dynamic Contrast-Enhanced T1-Weighted MRI of a Diffusable Tracer: Standardized Quantities and Symbols", Journal of Magnetic Resonance Imaging, vol. 10, pp. 223-232, 1999
126340Standard Tofts ModelA tracer diffusion kinetic model in which the permeability is assumed to be isodirectional. See P. Tofts, "Modeling tracer kinetics in dynamic Gd-DTPA MR imaging", Journal of Magnetic Resonance Imaging, vol. 7, pp. 91-101, 1997
126341Extended Tofts ModelA tracer diffusion kinetic model in which the permeability is not assumed to be isodirectional, and which includes the contribution of tracer in the blood plasma to the total tissue concentration. See P. Tofts, "Modeling tracer kinetics in dynamic Gd-DTPA MR imaging", Journal of Magnetic Resonance Imaging, vol. 7, pp. 91-101, 1997
126342Model-free concentration-time quantitificationA semiquantitative analysis of the contrast-enhancement concentration versus time curve that avoids the use of a pharmacokinetic model; e.g. integration to compute the initial area under the curve
126343First Pass Leakage Profile (FPLP)A tracer diffusion kinetic model that accounts for the tumor leakage profile during the first pass of contrast. See Li, Ka-Loh, Xiao Ping Zhu, John Waterton, and Alan Jackson. "Improved 3D Quantitative Mapping of Blood Volume and Endothelial Permeability in Brain Tumors." Journal of Magnetic Resonance Imaging 12, no. 2 (2000): 347-357. doi:10.1002/1522-2586(200008)12:2<347::AID-JMRI19>3.0.CO;2-7
126344Shutter-Speed Model (SSM)A tracer diffusion kinetic model that does not assume that intercompartmental water molecule exchange is infinitely fast. See Li, Xin, Wei Huang, Thomas E. Yankeelov, Alina Tudorica, William D. Rooney, and Charles S. Springer. "Shutter-Speed Analysis of Contrast Reagent Bolus-Tracking Data: Preliminary Observations in Benign and Malignant Breast Disease." Magnetic Resonance in Medicine 53, no. 3 (2005): 724-29. doi:10.1002/mrm.20405
126350T1 by Multiple Flip AnglesT1 measurement by Multiple Flip Angles (MFA) (variable saturation) method
126351T1 by Inversion RecoveryT1 measurement by Inversion Recovery (IR) method
126352T1 by Fixed ValueCalculation was performed using a fixed value of T1 rather than a measured value. The value could be encoded as the value of (126353, DCM, "T1 Used For Calculation")
126353T1 Used For CalculationThe fixed value of T1 used for a calculation
126360AIF IgnoredNo Arterial Input Function was used
126361Population Averaged AIFA population-averaged Arterial Input Function
126362User-defined AIF ROIAn Arterial Input Function computed from a user-defined Region of Interest
126363Automatically Detected AIF ROIAn Arterial Input Function computed from an automatically detected Region of Interest
126364Blind Estimation of AIFA data-driven blind source separation (BSS) algorithm that estimates AIF from individuals without any presumed AIF model and initialization. See Lin, Yu-Chun, Tsung-Han Chan, Chong-Yung Chi, Shu-Hang Ng, Hao-Li Liu, Kuo-Chen Wei, Yau-Yau Wai, Chun-Chieh Wang, and Jiun-Jie Wang. "Blind Estimation of the Arterial Input Function in Dynamic Contrast-Enhanced MRI Using Purity Maximization." Magnetic Resonance in Medicine 68, no. 5 (November 1, 2012): 1439-49. doi:10.1002/mrm.24144
126370Time of Peak ConcentrationThe time at which the concentration-time curve achieves its peak for the first time. Used as a concept name for a value or as a method; e.g. used as a method of calculation for BAT. See Shpilfoygel Med Phys 2008. doi: 10.1118/1.1288669
126371Bolus Arrival TimeThe nominal time at which arrival of a contrast bolus is detected, which is used as a reference point for subsequent calculations. Used as a concept name for a value or as a method. No specific computational method is implied by this general definition. Abbreviated BAT
126372Time of Leading Half-Peak ConcentrationThe time at which the concentration-time curve achieves half of its peak density for the first time. Used as a concept name for a value or as a method; e.g. used as a method of calculation for BAT. See Shpilfoygel Med Phys 2008. doi: 10.1118/1.1288669
126373Temporal Derivative Exceeds ThresholdA method of determining BAT that involves computing the temporal derivative of the concentration-time curve and selecting the time when the temporal derivative exceeds a specified threshold. See Shpilfoygel Med Phys 2008. doi: 10.1118/1.1288669
126374Temporal Derivative ThresholdA threshold applied to the temporal derivative of the concentration-time curve; e.g. used to establish BAT. See Shpilfoygel Med Phys 2008. doi: 10.1118/1.1288669
126375Maximum SlopeThe maximum rate of signal intensity change within a measured region of a time-activity curve. See Boonsirikamchai, Piyaporn, Harmeet Kaur, Deborah A. Kuban, Edward Jackson, Ping Hou, and Haesun Choi. "Use of Maximum Slope Images Generated From Dynamic Contrast-Enhanced MRI to Detect Locally Recurrent Prostate Carcinoma After Prostatectomy: A Practical Approach." American Journal of Roentgenology 198, no. 3 (March 1, 2012): W228-W236. doi:10.2214/AJR.10.6387
126376Maximum DifferenceThe maximum degree of signal intensity change within a measured region of a time-activity curve. See Boonsirikamchai, Piyaporn, Harmeet Kaur, Deborah A. Kuban, Edward Jackson, Ping Hou, and Haesun Choi. "Use of Maximum Slope Images Generated From Dynamic Contrast-Enhanced MRI to Detect Locally Recurrent Prostate Carcinoma After Prostatectomy: A Practical Approach." American Journal of Roentgenology 198, no. 3 (March 1, 2012): W228-W236. doi:10.2214/AJR.10.6387
126377Tracer ConcentrationTracer concentration in tissue; e.g. in a DCE-MR experiment, the concentration of contrast agent in mmol/l
126380Contrast Longitudinal RelaxivityThe degree to which a paramagnetic contrast agent can enhance the proton longitudinal relaxation rate constant (R1, 1/T1), normalized to the concentration of the contrast agent. Also referred to as r1. Typically expressed in units of l/mmol/s
126390Regional Blood FlowThe flow rate of blood perfusing a region as volume per mass per unit of time
126391Regional Blood VolumeThe volume of blood perfusing a region as volume per mass
126392Oxygen Extraction FractionThe percent of the oxygen removed from the blood by tissue during its passage through the capillary network. For example, as measured by blood oxygenation level dependent (BOLD) MR. See He, Xiang, and Dmitriy A. Yablonskiy. "Quantitative BOLD: Mapping of Human Cerebral Deoxygenated Blood Volume and Oxygen Extraction Fraction: Default State." Magnetic Resonance in Medicine 57, no. 1 (2007): 115-26
126393R1The longitiudinal relaxation rate constant. The inverse of longitudinal relaxation time, i.e., R1 = 1/T1
126394R2The transverse relaxation rate constant. The inverse of transverse relaxation time, i.e., R2 = 1/T2
126400Standardized Uptake ValueA ratio of locally measured radioactivity concentration versus the injected radioactivity distributed evenly throughout the whole body. This general concept encompasses all specific methods of calculating the whole body volume of distribution, such as using body weight, lean body mass, body surface area, etc.
126401SUVbwStandardized Uptake Value calculated using body weight. The patient size correction factor for males and females is body weight. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126402SUVlbmStandardized Uptake Value calculated using lean body mass. The patient size correction factor for males is 1.10 * weight - 120 * (weight/height) ^2, and for females is 1.07 * weight - 148 * (weight/height) ^2. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126403SUVbsaStandardized Uptake Value calculated using body surface area. The patient size correction factor for males and females is weight^ 0.425 * height^0.725 * 0.007184. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126404SUVibwStandardized Uptake Value calculated using ideal body weight. The patient size correction factor for males is 48.0 + 1.06 * (height - 152) and for females is 45.5 + 0.91 * (height - 152). Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126410SUV body weight calculation methodMethod of calculating Standardized Uptake Value using body weight. The patient size correction factor for males and females is body weight. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126411SUV lean body mass calculation methodMethod of calculating Standardized Uptake Value using lean body mass. The patient size correction factor for males is 1.10 * weight - 120 * (weight/height) ^2, and for females is 1.07 * weight - 148 * (weight/height) ^2. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126412SUV body surface area calculation methodMethod of calculating Standardized Uptake Value using body surface area. The patient size correction factor for males and females is weight^ 0.425 * height^0.725 * 0.007184. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126413SUV ideal body weight calculation methodMethod of calculating Standardized Uptake Value using ideal body weight. The patient size correction factor for males is 48.0 + 1.06 * (height - 152) and for females is 45.5 + 0.91 * (height - 152). Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126500Pittsburgh compound B C^11^A beta-amyloid PET radiotracer that is an analog of thioflavin T
126501Florbetaben F^18^A beta-amyloid PET radiotracer
126502T807 F^18^A PHF-tau PET radiotracer
126503Flubatine F^18^A nicotinic α4β2 receptor (nAChR) PET radiotracer
126510Monoclonal Antibody (mAb) ^64^CuA Cu 64 Monoclonal Antibody (mAb) PET Radiotracer
126511Monoclonal Antibody (mAb) ^89^ZrA Zr 89 Monoclonal Antibody (mAb) PET Radiotracer
126512Trastuzumab ^89^ZrA Zr 89 Trastuzumab PET Radiotracer
126513Cetuximab ^89^ZrA Zr 89 Cetuximab PET Radiotracer
126514J591 ^89^ZrA Zr 89 J591 PET Radiotracer
126515cU36 ^89^ZrA Zr 89 cU36 PET Radiotracer
126516Bevacizumab ^89^ZrA Zr 89 Bevacizumab PET Radiotracer
126517cG250-F(ab')(2) ^89^ZrA Zr 89 cG250-F(ab')(2) PET Radiotracer
126518R1507 ^89^ZrA Zr 89 R1507 PET Radiotracer
126519E4G10 ^89^ZrA Zr 89 E4G10 PET Radiotracer
126520Df-CD45 ^89^ZrA Zr 89 Df-CD45 PET Radiotracer
126600^44^Scandium^44^Scandium
126601^51^Manganese^51^Manganese
126602^70^Arsenic^70^Arsenic
126603^90^Niobium^90^Niobium
126604^191m^Iridium^191m^Iridium
126605^43^Scandium^43^Scandium
126606^152^Terbium^152^Terbium
126700ATSM Cu^60^A Cu 60 ATSM PET radiotracer
126701ATSM Cu^61^A Cu 61 ATSM PET radiotracer
126702ATSM Cu^62^A Cu 62 ATSM PET radiotracer
126703Choline C^11^A C 11 Choline PET radiotracer
126704Fallypride C^11^A C 11 Fallypride PET radiotracer
126705Fallypride F^18^An F 18 Fallypride PET radiotracer
126706FLB 457 C^11^A C 11 FLB 457 PET radiotracer
126707Fluorotriopride F^18^An F 18 Fluorotriopride PET radiotracer
126708Fluoromisonidazole (FMISO) F^18^An F 18 Fluoromisonidazole PET radiotracer
126709Glutamine C^11^A C 11 Glutamine PET radiotracer
126710Glutamine C^14^A C 14 Glutamine PET radiotracer
126711Glutamine F^18^An F 18 Glutamine PET radiotracer
126712Flubatine F^18^An F 18 Flubatine PET radiotracer
1267132FA F^18^An F 18 2FA PET radiotracer
126714Nifene F^18^An F 18 Nifene PET radiotracer
126715CLR1404 I^124^An I 124 cancer targeted phospholipid ether PET radiotracer
126716CLR1404 I^131^An I 131 cancer targeted phospholipid ether PET radiotracer
126801IEC6127 Patient Support Continuous AnglePatient Support Continuous Angle in IEC PATIENT SUPPORT Coordinate System [IEC 61217]
126802IEC6127 Table Top Continuous Pitch AngleTable Top Continuous Pitch Angle in the direction of the IEC TABLE TOP Coordinate System [IEC 61217]
126803IEC6127 Table Top Continuous Roll AngleTable Top Continuous Roll Angle in the direction of the IEC TABLE TOP Coordinate System [IEC 61217]
126804IEC6127 Table Top Eccentric Axis DistanceTable Top Eccentric Axis Distance [IEC 61217]
126805IEC6127 Table Top Continuous Eccentric AngleTable Top Continuous Eccentric Angle in the direction of the IEC TABLE TOP ECCENTRIC Coordinate System [IEC 61217]
126806IEC6127 Table Top Lateral PositionTable Top Lateral Position IEC TABLE TOP Coordinate System [IEC 61217]
126807IEC6127 Table Top Longitudinal PositionTable Top Longitudinal Position IEC TABLE TOP Coordinate System [IEC 61217]
126808IEC6127 Table Top Vertical PositionTable Top Vertical Position in IEC TABLE TOP Coordinate System [IEC 61217]
126809IEC6127 Gantry Continuous Roll AngleGantry Continuous Roll Angle in degrees of the radiation source, i.e., the rotation about the Y-axis of the IEC GANTRY coordinate system [IEC 61217]
126810IEC6127 Gantry Continuous Pitch AngleGantry Pitch Continuous Angle in degrees of the radiation source, i.e., the rotation about the X-axis of the IEC GANTRY coordinate system [IEC 61217]
126811IEC6127 Gantry Continuous Yaw AngleGantry Yaw Continuous Angle in degrees of the radiation source, i.e., about the Z-axis of the IEC GANTRY coordinate system [IEC 61217]

CodeSystem:TestScriptRequestMethodCode

The allowable request method or HTTP operation codes.
CodeDisplayDefinition
deleteDELETEHTTP DELETE operation.
getGETHTTP GET operation.
optionsOPTIONSHTTP OPTIONS operation.
patchPATCHHTTP PATCH operation.
postPOSTHTTP POST operation.
putPUTHTTP PUT operation.
headHEADHTTP HEAD operation.

CodeSystem:MessageTransport

The protocol used for message transport.
CodeDisplayDefinition
httpHTTPThe application sends or receives messages using HTTP POST (may be over http: or https:).
ftpFTPThe application sends or receives messages using File Transfer Protocol.
mllpMLLPThe application sends or receives messages using HL7's Minimal Lower Level Protocol.

CodeSystem:StructureMapGroupTypeMode

If this is the default rule set to apply for the source type, or this combination of types.
CodeDisplayDefinition
noneNot a DefaultThis group is not a default group for the types.
typesDefault for Type CombinationThis group is a default mapping group for the specified types and for the primary source type.
type-and-typesDefault for type + combinationThis group is a default mapping group for the specified types.

CodeSystem:TestReportResult

The reported execution result.
CodeDisplayDefinition
passPassAll test operations successfully passed all asserts.
failFailOne or more test operations failed one or more asserts.
pendingPendingOne or more test operations is pending execution completion.

CodeSystem:SmartCapabilities

Codes that define what the server is capable of.
CodeDisplayDefinition
launch-ehrEHR Launch Modesupport for SMART’s EHR Launch mode.
launch-standaloneStandalone Launch Modesupport for SMART’s Standalone Launch mode.
client-publicPublic Client Profilesupport for SMART’s public client profile (no client authentication).
client-confidential-symmetricConfidential Client Profilesupport for SMART’s confidential client profile (symmetric client secret authentication).
sso-openid-connectSupports OpenID Connectsupport for SMART’s OpenID Connect profile.
context-passthrough-bannerAllows "Need Patient Banner"support for “need patient banner” launch context (conveyed via need_patient_banner token parameter).
context-passthrough-styleAllows "Smart Style Style"support for “SMART style URL” launch context (conveyed via smart_style_url token parameter).
context-ehr-patientAllows "Patient Level Launch Context (EHR)"support for patient-level launch context (requested by launch/patient scope, conveyed via patient token parameter).
context-ehr-encounterAllows "Encounter Level Launch Context (EHR)"support for encounter-level launch context (requested by launch/encounter scope, conveyed via encounter token parameter).
context-standalone-patientAllows "Patient Level Launch Context (STANDALONE)"support for patient-level launch context (requested by launch/patient scope, conveyed via patient token parameter).
context-standalone-encounterAllows "Encounter Level Launch Context (STANDALONE)"support for encounter-level launch context (requested by launch/encounter scope, conveyed via encounter token parameter).
permission-offlineSupports Refresh Tokensupport for refresh tokens (requested by offline_access scope).
permission-patientSupports Patient Level Scopessupport for patient-level scopes (e.g. patient/Observation.read).
permission-userSupports User Level Scopessupport for user-level scopes (e.g. user/Appointment.read).

CodeSystem:ContactPointUse

Use of contact point.
CodeDisplayDefinition
homeHomeA communication contact point at a home; attempted contacts for business purposes might intrude privacy and chances are one will contact family or other household members instead of the person one wishes to call. Typically used with urgent cases, or if no other contacts are available.
workWorkAn office contact point. First choice for business related contacts during business hours.
tempTempA temporary contact point. The period can provide more detailed information.
oldOldThis contact point is no longer in use (or was never correct, but retained for records).
mobileMobileA telecommunication device that moves and stays with its owner. May have characteristics of all other use codes, suitable for urgent matters, not the first choice for routine business.

CodeSystem:EventCapabilityMode

The mode of a message capability statement.
CodeDisplayDefinition
senderSenderThe application sends requests and receives responses.
receiverReceiverThe application receives requests and sends responses.

CodeSystem:IssueType

A code that describes the type of issue.
CodeDisplayDefinition
invalidInvalid ContentContent invalid against the specification or a profile.
securitySecurity ProblemAn authentication/authorization/permissions issue of some kind.
processingProcessing FailureProcessing issues. These are expected to be final e.g. there is no point resubmitting the same content unchanged.
transientTransient IssueTransient processing issues. The system receiving the message may be able to resubmit the same content once an underlying issue is resolved.
informationalInformational NoteA message unrelated to the processing success of the completed operation (examples of the latter include things like reminders of password expiry, system maintenance times, etc.).

CodeSystem:AggregationMode

How resource references can be aggregated.
CodeDisplayDefinition
containedContainedThe reference is a local reference to a contained resource.
referencedReferencedThe reference to a resource that has to be resolved externally to the resource that includes the reference.

CodeSystem:SlicingRules

How slices are interpreted when evaluating an instance.
CodeDisplayDefinition
closedClosedNo additional content is allowed other than that described by the slices in this profile.
openOpenAdditional content is allowed anywhere in the list.
openAtEndOpen at EndAdditional content is allowed, but only at the end of the list. Note that using this requires that the slices be ordered, which makes it hard to share uses. This should only be done where absolutely required.

CodeSystem:W3cProvenanceActivityType

This value set includes W3C PROV Data Model Activity concepts, which are treated as codes in this valueset. Some adaptations were made to make these concepts suitable values for the Provenance.activity element. Coded concepts are from PROV-DM and the display names are their counterparts in PROV-N (human readable notation syntax specification).[code system OID: http://www.w3.org/TR/2013/REC-prov-dm-20130430/ and http://www.w3.org/TR/2013/REC-prov-n-20130430/]
CodeDisplayDefinition
GenerationwasGeneratedByThe completion of production of a new entity by an activity. This entity did not exist before generation and becomes available for usage after this generation. Given that a generation is the completion of production of an entity, it is instantaneous.
Usageusedthe beginning of utilizing an entity by an activity. Before usage, the activity had not begun to utilize this entity and could not have been affected by the entity. (Note: This definition is formulated for a given usage; it is permitted for an activity to have used a same entity multiple times.) Given that a usage is the beginning of utilizing an entity, it is instantaneous.
CommunicationwasInformedByThe exchange of some unspecified entity by two activities, one activity using some entity generated by the other. A communication implies that activity a2 is dependent on another activity, a1, by way of some unspecified entity that is generated by a1 and used by a2.
StartwasStartedByWhen an activity is deemed to have been started by an entity, known as trigger. The activity did not exist before its start. Any usage, generation, or invalidation involving an activity follows the activity's start. A start may refer to a trigger entity that set off the activity, or to an activity, known as starter, that generated the trigger. Given that a start is when an activity is deemed to have started, it is instantaneous.
EndwasEndedByWhen an activity is deemed to have been ended by an entity, known as trigger. The activity no longer exists after its end. Any usage, generation, or invalidation involving an activity precedes the activity's end. An end may refer to a trigger entity that terminated the activity, or to an activity, known as ender that generated the trigger.
InvalidationwasInvalidatedByThe start of the destruction, cessation, or expiry of an existing entity by an activity. The entity is no longer available for use (or further invalidation) after invalidation. Any generation or usage of an entity precedes its invalidation. Given that an invalidation is the start of destruction, cessation, or expiry, it is instantaneous.
DerivationwasDerivedFromA transformation of an entity into another, an update of an entity resulting in a new one, or the construction of a new entity based on a pre-existing entity. For an entity to be transformed from, created from, or resulting from an update to another, there must be some underpinning activity or activities performing the necessary action(s) resulting in such a derivation. A derivation can be described at various levels of precision. In its simplest form, derivation relates two entities. Optionally, attributes can be added to represent further information about the derivation. If the derivation is the result of a single known activity, then this activity can also be optionally expressed. To provide a completely accurate description of the derivation, the generation and usage of the generated and used entities, respectively, can be provided, so as to make the derivation path, through usage, activity, and generation, explicit. Optional information such as activity, generation, and usage can be linked to derivations to aid analysis of provenance and to facilitate provenance-based reproducibility.
RevisionwasRevisionOfA derivation for which the resulting entity is a revised version of some original. The implication here is that the resulting entity contains substantial content from the original. A revision relation is a kind of derivation relation from a revised entity to a preceding entity.
QuotationwasQuotedFromThe repeat of (some or all of) an entity, such as text or image, by someone who might or might not be its original author. A quotation relation is a kind of derivation relation, for which an entity was derived from a preceding entity by copying, or 'quoting', some or all of it.
Primary-SourcewasPrimarySourceOfRefers to something produced by some agent with direct experience and knowledge about the topic, at the time of the topic's study, without benefit from hindsight. Because of the directness of primary sources, they 'speak for themselves' in ways that cannot be captured through the filter of secondary sources. As such, it is important for secondary sources to reference those primary sources from which they were derived, so that their reliability can be investigated. It is also important to note that a given entity might be a primary source for one entity but not another. It is the reason why Primary Source is defined as a relation as opposed to a subtype of Entity.
AttributionwasAttributedToAscribing of an entity (object/document) to an agent.
CollectionisCollectionOf An aggregating activity that results in composition of an entity, which provides a structure to some constituents that must themselves be entities. These constituents are said to be member of the collections.

CodeSystem:GroupType

Types of resources that are part of group.
CodeDisplayDefinition
personPersonGroup contains "person" Patient resources.
animalAnimalGroup contains "animal" Patient resources.
practitionerPractitionerGroup contains healthcare practitioner resources (Practitioner or PractitionerRole).
deviceDeviceGroup contains Device resources.
medicationMedicationGroup contains Medication resources.
substanceSubstanceGroup contains Substance resources.

CodeSystem:OperationKind

Whether an operation is a normal operation or a query.
CodeDisplayDefinition
operationOperationThis operation is invoked as an operation.
queryQueryThis operation is a named query, invoked using the search mechanism.

CodeSystem:HTTPVerb

HTTP verbs (in the HTTP command line). See [HTTP rfc](https://tools.ietf.org/html/rfc7231) for details.
CodeDisplayDefinition
GETGETHTTP GET Command.
HEADHEADHTTP HEAD Command.
POSTPOSTHTTP POST Command.
PUTPUTHTTP PUT Command.
DELETEDELETEHTTP DELETE Command.
PATCHPATCHHTTP PATCH Command.

CodeSystem:DefinitionStatus

Codes identifying the lifecycle stage of a definition.
CodeDisplayDefinition
draftDraftThe definition is in the design stage and is not yet considered to be "ready for use".
activeActiveThe definition is considered ready for use.
withdrawnWithdrawnThe definition should no longer be used.
unknownUnknownThe authoring/source system does not know which of the status values currently applies for this resource. Note: This concept is not to be used for "other" - one of the listed statuses is presumed to apply, but the authoring/source system does not know which.

CodeSystem:ExampleOnsetType(Reason)Codes

This value set includes example Onset Type codes which are used to identify the event for which the onset, starting date, is required.
CodeDisplayDefinition
lxmLast ExamDate of last examination.
symStart of SymptomsDate when symptoms were first noticed.
lmnLast MenstruationStart date of last menstruation.

ValueSet: LOINC Codes for Cholesterol in Serum/Plasma

This is an example value set that includes all the LOINC codes for serum/plasma cholesterol from v2.36.

ValueSet: LOINC Codes for Cholesterol in Serum/Plasma

This is an example value set that includes all the LOINC codes for serum/plasma cholesterol from v2.36.

ValueSet: ACMECholCodesPlasma

ACME Codes for Cholesterol: Plasma only - demonstrating the use of a filter defined in a CodeSystem

ValueSet: LOINC Codes for Cholesterol in Serum/Plasma

This is an example value set that includes all the LOINC codes for serum/plasma cholesterol from v2.36.

ValueSet: Example Hierarchical ValueSet

Demonstration of extensions that build a hierarchical contains

ValueSet: Common UCUM units

Commonly encountered UCUM units (for purposes of helping populate look ups.

ValueSet: All CPT codes

A value set that includes all CPT codes

ValueSet: Yes/No/Don't Know

For Capturing simple yes-no-don't know answers

ValueSet: NHIN PurposeOfUse

This value set is suitable for use with the provenance resource. It is derived from, but not compatible with, the HL7 v3 Purpose of use Code system.

ValueSet: Example-inactive

HL7 v3 ActMood Predicate codes, including inactive codes

ValueSet: ResourceSecurityCategory

Provides general guidance around the kind of access Control to Read, Search, Create, Update, or Delete a resource.

ValueSet: TestScriptProfileDestinationType

This value set defines a set of codes that are used to indicate the profile type of a test system when acting as the destination within a TestScript.

ValueSet: ConditionalReadStatus

A code that indicates how the server supports conditional read.

ValueSet: IdentifierUse

Identifies the purpose for this identifier, if known .

ValueSet: TransactionMode

A code that indicates how transactions are supported.

ValueSet: PropertyRepresentation

How a property is represented when serialized.

ValueSet: ListStatus

The current state of the list.

ValueSet: StructureMapInputMode

Mode for this instance of data.

ValueSet: ResourceType

One of the resource types defined as part of this version of FHIR.

ValueSet: CanonicalStatusCodesForFHIRResources

The master set of status codes used throughout FHIR. All status codes are mapped to one of these codes.

ValueSet: CapabilityStatementKind

How a capability statement is intended to be used.

ValueSet: QuestionnaireResponseStatus

Lifecycle status of the questionnaire response.

ValueSet: HL7Workgroup

An HL7 administrative unit that owns artifacts in the FHIR specification.

ValueSet: StructureMapContextType

How to interpret the context.

ValueSet: StructureMapGroupTypeMode

If this is the default rule set to apply for the source type, or this combination of types.

ValueSet: AbstractType

A list of the base types defined by this version of the FHIR specification - types that are defined, but for which only specializations actually are created.

ValueSet: DefinitionStatus

Codes identifying the lifecycle stage of a definition.

ValueSet: OperationParameterUse

Whether an operation parameter is an input or an output parameter.

ValueSet: DataElementSDCObjectClass

The allowed codes for identifying the ISO 11179 ObjectClass for a particular data element if intended for registration/use within the U.S. Structured Data Capture (SDC) project.

ValueSet: PostalAddressUse

Uses of an address not included in Address.use.

ValueSet: QuestionnaireTextCategories

Codes defining the purpose of a Questionnaire item of type 'text'.

ValueSet: ExampleScenarioActorType

The type of actor - system or human.

ValueSet: EntityNamePartQualifier

A set of codes each of which specifies a certain subcategory of the name part in addition to the main name part type.

ValueSet: MessageEvent

One of the message events defined as part of this version of FHIR.

ValueSet: SubscriptionStatus

The status of a subscription.

ValueSet: CompartmentType

Which type a compartment definition describes.

ValueSet: ConceptMapEquivalence

The degree of equivalence between concepts.

ValueSet: TemplateStatusCode

The status indicates the level of maturity of the design and may be used to manage the use of the design.

ValueSet: QuestionnaireQuestionCodes

Example list of codes for questions and groups of questions. (Not necessarily complete or appropriate.)

ValueSet: HTTPVerb

HTTP verbs (in the HTTP command line). See [HTTP rfc](https://tools.ietf.org/html/rfc7231) for details.

ValueSet: QuestionnaireItemUsageMode

Identifies the modes of usage of a questionnaire that should enable a particular questionnaire item.

ValueSet: UnitsOfTime

A unit of time (units from UCUM).

ValueSet: RestfulSecurityService

Types of security services used with FHIR.

ValueSet: CommonUCUMCodesForAge

Unified Code for Units of Measure (UCUM). This value set includes all UCUM codes

ValueSet: UCUMCodes

Unified Code for Units of Measure (UCUM). This value set includes all UCUM codes

ValueSet: DocumentMode

Whether the application produces or consumes documents.

ValueSet: DataType

A version specific list of the data types defined by the FHIR specification for use as an element type (any of the FHIR defined data types).

ValueSet: GuidePageGeneration

A code that indicates how the page is generated.

ValueSet: ExpressionLanguage

The media type of the expression language.

ValueSet: SPDXLicense

The license that applies to an Implementation Guide (using an SPDX license Identifiers, or 'not-open-source'). The binding is required but new SPDX license Identifiers are allowed to be used (https://spdx.org/licenses/).

ValueSet: NarrativeStatus

The status of a resource narrative.

ValueSet: NameUse

The use of a human name.

ValueSet: DaysOfWeek

The days of the week.

ValueSet: QualityOfEvidenceRating

A rating system that describes the quality of evidence such as the GRADE, DynaMed, or Oxford CEBM systems.

ValueSet: HumanNameAssemblyOrder

A code that represents the preferred display order of the components of a human name.

ValueSet: DoseAndRateType

The kind of dose or rate specified.

ValueSet: UnknownContentCode

A code that indicates whether an application accepts unknown elements or extensions when reading resources.

ValueSet: RestfulCapabilityMode

The mode of a RESTful capability statement.

ValueSet: SearchComparator

What Search Comparator Codes are supported in search.

ValueSet: ResourceValidationMode

Codes indicating the type of validation to perform.

ValueSet: QuestionnaireItemUIControlCodes

Starter set of user interface control/display mechanisms that might be used when rendering an item in a questionnaire.

ValueSet: BundleType

Indicates the purpose of a bundle - how it is intended to be used.

ValueSet: TestReportStatus

The current status of the test report.

ValueSet: CommonUCUMCodesForDistance

Unified Code for Units of Measure (UCUM). This value set includes common UCUM codes for units of distance

ValueSet: StrengthOfRecommendationRating

A rating system that describes the strength of the recommendation, such as the GRADE, DynaMed, or HGPS systems.

ValueSet: TimingAbbreviation

Code for a known / defined timing pattern.

ValueSet: AssertionDirectionType

The type of direction to use for assertion.

ValueSet: StructureMapModelMode

How the referenced structure is used in this mapping.

ValueSet: QuantityComparator

How the Quantity should be understood and represented.

ValueSet: NameRepresentationUse

A set of codes for each different representation of a name.

ValueSet: ContactPointSystem

Telecommunications form for contact point.

ValueSet: GroupType

Types of resources that are part of group.

ValueSet: SearchEntryMode

Why an entry is in the result set - whether it's included as a match or because of an _include requirement, or to convey information or warning information about the search process.

ValueSet: UsageContextType

A code that specifies a type of context being specified by a usage context.

ValueSet: DataElementSDCObjectClass

The allowed codes for identifying the ISO 11179 ObjectClass Property for a particular data element if intended for registration/use within the U.S. Structured Data Capture (SDC) project.

ValueSet: TestReportParticipantType

The type of participant.

ValueSet: GraphCompartmentRule

How a compartment must be linked.

ValueSet: ListEmptyReasons

General reasons for a list to be empty. Reasons are either related to a summary list (i.e. problem or medication list) or to a workflow related list (i.e. consultation list).

ValueSet: SlicingRules

How slices are interpreted when evaluating an instance.

ValueSet: ReferenceVersionRules

Whether a reference needs to be version specific or version independent, or whether either can be used.

ValueSet: XPathUsageType

How a search parameter relates to the set of elements returned by evaluating its xpath query.

ValueSet: RequestStatus

Codes identifying the lifecycle stage of a request.

ValueSet: StructureMapTransform

How data is copied/created.

ValueSet: RequestIntent

Codes indicating the degree of authority/intentionality associated with a request.

ValueSet: ResourceVersionPolicy

How the system supports versioning for a resource.

ValueSet: ExampleUseCodesForList

Example use codes for the List resource - typical kinds of use.

ValueSet: DefinitionUseCodes

Structure Definition Use Codes / Keywords

ValueSet: QuestionnaireCategoryCodes

Example list of potential categories for questionnaires.

ValueSet: NamingSystemType

Identifies the purpose of the naming system.

ValueSet: AssertionResponseTypes

The type of response code to use for assertion.

ValueSet: SmartCapabilities

Codes that define what the server is capable of.

ValueSet: AllLanguages

This value set includes all possible codes from BCP-47 (http://tools.ietf.org/html/bcp47)

ValueSet: Context of Use ValueSet

This value set defines a base set of codes that can be used to indicate that the content in a resource was developed with a focus and intent of supporting use within particular contexts.

ValueSet: CommonUCUMCodesForDuration

Unified Code for Units of Measure (UCUM). This value set includes all UCUM codes

ValueSet: AggregationMode

How resource references can be aggregated.

ValueSet: StandardsStatus

HL7 Ballot/Standards status of artifact.

ValueSet: SignatureTypeCodes

The Digital Signature Purposes, an indication of the reason an entity signs a document. This is included in the signed information and can be used when determining accountability for various actions concerning the document. Examples include: author, transcriptionist/recorder, and witness.

ValueSet: IssueType

A code that describes the type of issue.

ValueSet: AddressType

The type of an address (physical / postal).

ValueSet: ProbabilityDistributionType

Codes specifying the type of probability distribution.

ValueSet: GraphCompartmentUse

Defines how a compartment rule is used.

ValueSet: TestScriptRequestMethodCode

The allowable request method or HTTP operation codes.

ValueSet: MessageTransport

The protocol used for message transport.

ValueSet: PatientMedicineChangeTypes

Example Item Flags for the List Resource. In this case, these are the kind of flags that would be used on a medication list at the end of a consultation.

ValueSet: SystemRestfulInteraction

Operations supported by REST at the system level.

ValueSet: ContributorType

The type of contributor.

ValueSet: QuestionnaireResponseMode

Codes describing how the QuestionnaireResponse was populated

ValueSet: DiscriminatorType

How an element value is interpreted when discrimination is evaluated.

ValueSet: EventStatus

Codes identifying the lifecycle stage of an event.

ValueSet: StructureMapSourceListMode

If field is a list, how to manage the source.

ValueSet: CommonTags

Common Tag Codes defined by FHIR project

ValueSet: ConstraintSeverity

SHALL applications comply with this constraint?

ValueSet: QuestionnaireItemType

Distinguishes groups from questions and display text and indicates data type for questions.

ValueSet: ExtensionContextType

How an extension context is interpreted.

ValueSet: QuestionnaireAnswerCodes

Example list of codes for answers to questions. (Not complete or necessarily appropriate.)

ValueSet: StructureDefinitionKind

Defines the type of structure that a definition is describing.

ValueSet: TestScriptProfileOriginType

This value set defines a set of codes that are used to indicate the profile type of a test system when acting as the origin within a TestScript.

ValueSet: TypeDerivationRule

How a type relates to its baseDefinition.

ValueSet: SubscriptionTag

Tags to put on a resource after subscriptions have been sent.

ValueSet: IANATimezones

IANA Timezone Codes

ValueSet: QuestionnaireItemOperator

The criteria by which a question is enabled.

ValueSet: ConditionalDeleteStatus

A code that indicates how the server supports conditional delete.

ValueSet: SubscriptionChannelType

The type of method used to execute a subscription.

ValueSet: OperationOutcomeCodes

Operation Outcome codes used by FHIR test servers (see Implementation file translations.xml)

ValueSet: TypeRestfulInteraction

Operations supported by REST at the type or instance level.

ValueSet: FHIRDefinedType

A list of all the concrete types defined in this version of the FHIR specification - Data Types and Resource Types.

ValueSet: ReferenceHandlingPolicy

A set of flags that defines how references are supported.

ValueSet: TestReportActionResult

The results of executing an action.

ValueSet: BindingStrength

Indication of the degree of conformance expectations associated with a binding.

ValueSet: GuideParameterCode

Code of parameter that is input to the guide.

ValueSet: SearchModifierCode

A supported modifier for a search parameter.

ValueSet: MaxOccurs

Flags an element as having unlimited repetitions.

ValueSet: OperationKind

Whether an operation is a normal operation or a query.

ValueSet: SpecialValues

A set of generally useful codes defined so they can be included in value sets.

ValueSet: LOINCCodes

This value set includes all LOINC codes

ValueSet: NamingSystemIdentifierType

Identifies the style of unique identifier used to identify a namespace.

ValueSet: EnableWhenBehavior

Controls how multiple enableWhen values are interpreted - whether all or any must be true.

ValueSet: ConformanceExpectation

Indicates the degree of adherence to a specified behavior or capability expected for a system to be deemed conformant with a specification.

ValueSet: CommonLanguages

This value set includes common codes from BCP-47 (http://tools.ietf.org/html/bcp47)

ValueSet: EventCapabilityMode

The mode of a message capability statement.

ValueSet: SubjectType

Possible types of subjects.

ValueSet: IssueSeverity

How the issue affects the success of the action.

ValueSet: DataAbsentReason

Used to specify why the normally expected content of the data element is missing.

ValueSet: RelatedArtifactType

The type of relationship to the related artifact.

ValueSet: SortDirection

The possible sort directions, ascending or descending.

ValueSet: ListMode

The processing mode that applies to this list.

ValueSet: FHIRAllTypes

A list of all the concrete types defined in this version of the FHIR specification - Abstract Types, Data Types and Resource Types.

ValueSet: ListOrderCodes

Base values for the order of the items in a list resource.

ValueSet: BasicResourceTypes

This value set defines codes for resources not yet supported by (or which will never be supported by) FHIR. Many of the codes listed here will eventually be turned into official resources. However, there is no guarantee that any particular resource will be created nor that the scope will be exactly as defined by the codes presented here. Codes in this set will be deprecated if/when formal resources are defined that encompass these concepts.

ValueSet: TestScriptOperationCode

This value set defines a set of codes that are used to indicate the supported operations of a testing engine or tool.

ValueSet: SearchParamType

Data types allowed to be used for search parameters.

ValueSet: SNOMEDCTAnatomicalStructureForAdministrationSiteCodes

This value set includes Anatomical Structure codes from SNOMED CT - provided as an exemplar.

ValueSet: ContactPointUse

Use of contact point.

ValueSet: AssertionOperatorType

The type of operator to use for assertion.

ValueSet: MatchGrade

A Master Patient Index (MPI) assessment of whether a candidate patient record is a match or not.

ValueSet: TriggerType

The type of trigger.

ValueSet: EventTiming

Real world event relating to the schedule.

ValueSet: PublicationStatus

The lifecycle status of an artifact.

ValueSet: ChoiceListOrientation

Direction in which lists of possible answers should be displayed.

ValueSet: AddressUse

The use of an address.

ValueSet: StructureMapTargetListMode

If field is a list, how to manage the production.

ValueSet: TestReportResult

The reported execution result.

ValueSet: Mime Types

This value set includes all possible codes from BCP-13 (http://tools.ietf.org/html/bcp13)

ValueSet: AllUCUMExpressionForTime

Unified Code for Units of Measure (UCUM). This value set includes all UCUM codes for units of time

ValueSet: AllUCUMExpressionForDistance

Unified Code for Units of Measure (UCUM). This value set includes all UCUM codes for units of length

ValueSet: Iso3166-1-N

This value set defines the ISO 3166 Part 1 Numeric codes

ValueSet: Performer Function Codes

The types of involvement of the performer in the Event.

ValueSet: Common Languages (Written)

This value set includes common codes from BCP-47 (http://tools.ietf.org/html/bcp47) for the purpose of writing; this value set (unlike the common languages value set) doesn't include dialects except where they are relevant for written languages

ValueSet: Iso3166-1-2

This value set defines the ISO 3166 Part 1 2-letter codes

ValueSet: Iso3166-1-3

This value set defines the ISO 3166 Part 1 3-letter codes